News


Monthly Archives


A doc’s call against patent overdose  
(PT Jyothi Datta , 15-Dec-2014 , Business Line)

Public health groups have a supportive voice in American surgeon-author Atul Gawande in their fight to break “secondary patents” that drug companies seek on existing medicines. More...



A doc’s call against patent overdose  
(PT Jyothi Datta , 15-Dec-2014 , Business Line)

Public health groups have a supportive voice in American surgeon-author Atul Gawande in their fight to break “secondary patents” that drug companies seek on existing medicines. More...



Government may not act on Cipla’s patent plea  
(Sidhartha , 15-Dec-2014 , The Times Of India)

In a setback to Cipla, the homegrown generics medicine company, the government has so far found little merit in its plea for waiver and cancellation of patent rights for five drugs over which Novartis has exclusive rights. More...



Obama administration content with Modi govt taking 'baby steps' to improving country's weak IPR laws
(Nayanima Basu | New Delhi , 15-Dec-2014 , Business Standard)

Obama administration content with Modi govt taking 'baby steps' to improving country's weak IPR laws More...



India-led BRICS opposes UN arm’s move on model drug law
(Soma Das , 15-Dec-2014 , The Economic Times)

India has spearheaded a move by BRICS countries to oppose a United Nations agency's move to float without consultations with member states a model law on fraudulent drugs that has raised fears of genuine generic drugs getting disrupted. More...



India-led BRICS opposes UN arm’s move on model drug law
(Soma Das , 15-Dec-2014 , The Economic Times)

India has spearheaded a move by BRICS countries to oppose a United Nations agency's move to float without consultations with member states a model law on fraudulent drugs that has raised fears of genuine generic drugs getting disrupted. More...



Xiaomi's India ban exposes wider patent risks
(Reuters , 14-Dec-2014 , The Times Of India)

The court order that banned Chinese mobile maker Xiaomi from selling its phones in India has halted its breakneck expansion into the world's fastest growing major smartphone market and could be just the start of a string of patent challenges. More...



US closes out-of-cycle review of India's trade and patent policies
(HT Correspondent, Washington, , 14-Dec-2014 , Hindustan Times )

The United States Trade Representative (USTR) has announced closure of the out-of-cycle review of India’s trade and intellectual property rights practices, noting the progress made in recent months. More...



SHOT IN ARM FOR DESI COS, PATIENTS
(TNN , 13-Dec-2014 , The Times Of India)

SC order to boost access to medicines More...



US concludes OCR of India's intellectual property policies
(Press Trust of India | Washington , 13-Dec-2014 , Business Standard)

Citing positive steps taken by the new Indian government in addressing America's concerns on intellectual property (IP) rights, the US has concluded its Out-of-Cycle Review of India's intellectual property policies. More...



Protecting patents will boost innovation in India
(RANJANA SMETACEK , 12-Dec-2014 , Business Line)

This is also essential to meet the healthcare challenges facing the country More...



Google, YouTube face patent suit in Germany
(Reuters , 12-Dec-2014 , The Times Of India)

Technology company Max Sound said it filed a lawsuit against Google and YouTube in Germany earlier this month, alleging infringement of a video-streaming patent. More...



Max Sound files patent suit against Google, YouTube in Germany
(Reuters , 12-Dec-2014 , The Economic Times)

Technology company Max Sound Corp said it filed a lawsuit against Google Inc and YouTube in Germany earlier this month, alleging infringement of a video-streaming patent. More...



Agriculture department starts Geographical Indication process for Lasalgaon onions
(TNN , 12-Dec-2014 , The Times Of India)

Onions from Lasalgaon will get the Geographical Indication (GI) tag soon as the agricultural department of the state has started the process to grant the special status to the commodity produced in the district. More...



Delhi HC stops sale of Xiaomi phones over patent case
(PTI , 11-Dec-2014 , Livemint)

The court restrained Xiaomi from making, assembling, importing or offering for sale its devices which are infringing the patents of Ericsson More...



Will India, US Bridge Divide Over Intellectual Property Rights?
( Patralekha Chatterjee , 10-Dec-2014 , Intellectual Property Watch)

There is an uptick in India-United States relations. More...



India assumes frontline position in battles over intellectual property rights
(Amy Kazmin , 10-Dec-2014 , Financial Times)

As their cities grow more polluted, more people in India grapple with respiratory difficulties. More...



UN Office on Drugs and Crime scheduled to meet to firm up model law
(Dilasha Seth & Soma Das , 8-Dec-2014 , The Economic Times)

A United Nations agency is scheduled to hold two days of closed-door meetings in Vienna starting Monday to firm up a model law prescribing harsh penalties for 'falsified' drug-related crimes, reviving fears about seizures of Indian-made generics similar to those made by the European Union in 2008. More...



Cisco Systems sues rival Arista for patent infringement
(Reuters , 6-Dec-2014 , The Times Of India)

Network equipment maker Cisco Systems Inc filed two lawsuits against Arista Networks Inc, accusing the smaller rival of copying its networking technologies. More...



Keryx Biopharma receives US patent for Auryxia covering orally administrable forms
(New York , 6-Dec-2014 , Pharmabiz)

Keryx Biopharmaceuticals, a company focused on bringing innovative therapies to market for patients with renal disease, announced that the US Patent and Trademark Office issued US Patent No. 8,901,349. More...



Burger King in trademark soup
(BS Reporter | New Delhi , 6-Dec-2014 , Business Standard)

Burger King has about 13,000 outlets across the world and has had a trademark registration in India since 1979, which has been renewed by the company More...



Patent protection, a key issue for foreign hybrid seed companies
(TOMOJIT BASU , 05-Dec-2014 , Business Line)

With demand for hybrid seeds growing across the developing world for characteristics ranging from drought- and pest-resistance to higher yield, the protection of technology that goes into making is becoming a key issue for developers, usually large companies such as Monsanto, DuPont and Bayer. More...



Brands cry foul over counterfeit products on e-commerce sites like Flipkart, Snapdeal, Amazon & others
(ET Bureau , 3-Dec-2014 , The Economic Times)

Consumer brands and channel partners are turning the heat on India's online retailers, accusing them of not only undercutting prices but also encouraging the sale of counterfeit goods by sellers of dubious origins on their sites. More...



New Google Glass Patent Tips Successor Will Feature Slimmer Profile
(Ketan Pratap , 03-Dec-2014 , NDTV)

Reports have started to emerge about Google's next-generation Glass wearable. On Monday, a report suggested that the Google Glass successor will be powered by an Intel chip. More...



Cipla, Meda sue Apotex in US over nasal spray patent
(Our Bureau , 03-Dec-2014 , Business Line)

Swedish drug-maker Meda Pharmaceuticals Inc and India’s Cipla have sued Canadian pharmaceutical company Apotex in the US Federal District Court in Delaware to enforce their patents covering nasal spray Dymista. More...



Govt moves to protect 'khadi' trademark
(Sidhartha , 3-Dec-2014 , The Times Of India)

Hit by trademark infringement in Europe, the Khadi and Village Industries Commission (KVIC) has moved to quickly register 'khadi' as a 'wordmark' to check against further violation. More...



Public interest groups urge DIPP's IPR Think Tank not to revisit India’s Patent Act
(Ramesh Shankar, Mumbai , 3-Dec-2014 , Pharmabiz)

A large number of patient groups, public interest organisations including MSF, treatment providers and academia world-wide have urged the newly constituted IPR Think Tank not to revisit or challenge democratically-determined and legally-consistent intellectual property rules introduced under India’s Patent Act. More...



India, Japan spar over higher intellectual property standards
(Nayanima Basu , 2-Dec-2014 , Business Standard)

India and Japan locked horns over a higher standard in intellectual property rights, with a special focus on the pharmaceutical sector, at the negotiations for a Regional Comprehensive Economic Partnership. More...



IPAB asks UK-based bed maker and Indian firm to explore settlement
(Gireesh Babu | Chennai , 02-Dec-2014 , Business Standard)

Hypnos claims to be the supplier of beds and upholstery for Royal Family and Royal Household in Britain. More...



Panel to draft intellectual property policy riddled with conflict of interest
(Rema Nagarajan , 1-Dec-2014 , The Times Of India)

Increased focus on India's intellectual property and patent law has put the spotlight on the IP think tank set up by the Department of Industrial Policy and Promotion (DIPP). More...



CSIR files patent for leather tanning tech breakthrough
(PTI , 30-Nov-2014 , Zee News)

The CSIR has filed a patent for its breakthrough in leather tanning technology that does not require water. More...



If US had a patent law like ours, they would discover many more drugs: Anand Grover
(Rema Nagarajan , 30-Nov-2014 , The Times Of India)

India's intellectual property (IP) law has been hailed as one of the most progressive for safeguarding public interest, and several nations like Argentina, the Philippines and Brazil are looking to learn from it. More...



Government files for ‘Make in India’ trademark
(Nishtha Grover | New Delhi , 28-Nov-2014 , The Asian Age)

In order to prevent the misuse of the “Make In India” phrase and the symbol, the government has filed for the trademark of the much celebrated phrase. More...



Intel wants government to strengthen protection for trade secrets under IPR policy
(Dilasha Seth , 28-Nov-2014 , The Economic Times)

Intel, the world's largest manufacturer of computer chips, has called on the Indian government to strengthen protection for Trade secrets under the intellectual property rights policy, raising concerns that the current regime is not strong enough. More...



Differences on intellectual property rights between India and US widen
(Asit Ranjan Mishra , 28-Nov-2014 , Livemint)

US disappointed at the stature of joint working group; India insists the group is important to resolve bilateral issues More...



Patent expiries valued at $170 bn set Indian pharma to accelerate its complex generic programmes
(Nandita Vijay, Bengaluru , 28-Nov-2014 , Pharmabiz)

Indian pharmaceutical industry will now be able to make further inroads and garner a fair share of the global MARKET opportunity as blockbuster drugs valued at $170 billion are set to come off the patents. More...



Affordable healthcare is beyond compulsory licenses, US tells India
(Nayanima Basu | New Delhi , 26-Nov-2014 , Business Standard)

The discussion took place under the much-awaited India-US Trade Policy Forum More...



India to US: Tech companies violating copyright law
(Sidhartha,TNN , 26-Nov-2014 , The Times Of India)

For years, the US has blamed lax policing in countries such as India for a boost to piracy. More...



U.S. raises protection to firms in India, IPR issues
(Puja Mehra , 26-Nov-2014 , The Hindu)

Both countries to explore enhanced market access to farm products More...



India, US Trade Policy Forum meets after four years
(Nayanima Basu | New Delhi , 25-Nov-2014 , Business Standard)

Both sides have set a target of achieving $500 bn worth of trade in goods and services from the present $100 bn More...



Modi urged to stand up to US pressure to change patent law
(Rema Nagarajan , 25-Nov-2014 , The Times of India)

US Trade Representative meeting high-ranking Indian officials during his India visit is worrying public health activists that he will pressurise the government to weaken India's patent law which is seen to be pro-public health, with in-built safeguards that prevent pharma companies from getting extensions on patents by tweaking existing molecules and claiming them to be innovation. More...



India needs to look at IPR norms more closely: USTR Froman
(Press Trust of India | New Delhi , 25-Nov-2014 , Business Standard)

Raising concerns that issues related to Intellectual Property Rights (IPR) were impeding their bilateral trade, the US today asked India to look more closely at its IPR norms and address this problem mutually. More...



US urges India to toughen patent laws to draw investors
(AFP , 25-Nov-2014 , The Economic Times)

A top US trade envoy urged India on Tuesday to strengthen its drug and other intellectual property laws, saying such a move is needed to draw vital investment to spur a sputtering economy. More...



Indian company receives US patent for Alzheimer treating med
(Saswati Mukherjee , 24-Nov-2014 , The Times of India)

BCM-95, the patented turmeric extract formulation from Arjuna Natural Extracts Ltd has received a US patent (US Patent No. 8859020) for a composition for the treatment of Alzheimers disease comprising curcuminoid mixture and added essential oil of turmeric. More...



Arjuna Natural Extracts bags turmeric patent from US
(ET Bureau , 24-Nov-2014 , The Economic Times)

Arjuna Natural Extracts, a leading domestic manufacturer and exporter of botanical extracts, has said it has been granted a US patent related to a turmeric extract used for treatment of Alzheimer's disease. More...



Indian industry not taking advantage of IPR
(IANS | Kolkata , 24-Nov-2014 , Business Standard)

Due to lack of awareness on Intellectual Property Rights (IPR), the Indian industry is lagging behind in exploiting benefits of registering and protecting trademarks internationally, an official said here Monday. More...



US trade rep Froman urges India to create ‘world class’ IPR regime
(Amiti Sen , 24-Nov-2014 , Business Line)

Pitching for tighter intellectual property protection in India, US Trade Representative Michael Froman has said that the country needed to enforce a world-class IPR regime and deal with issues such as piracy, counterfeiting, trade secrets and compulsory licensing. More...



IPR unique opportunity for 'Make in India' innovations: WIPO official
(IANS | Kolkata , 24-Nov-2014 , Business Standard)

With Intellectual Property Rights (IPR) set to "play a major role" in Prime Minister Narendra Modi's "Make in India" campaign, Indian innovators and businesses need to opt for the Madrid System of trademark registrations to manage their portfolios internationally, an IP official said Monday. More...



India’s patent problems
(Dipti Jain , 24-Nov-2014 , Livemint)

India’s IP administration, which was widely criticized for lack of transparency in the initial years, has made its file movements and examination process public in just the first step More...



US industry patent lobby meeting with judges foiled
(Dilasha Seth & Soma Das , 24-Nov-2014 , The Economic Times)

Public health groups successfully prevented meetings that had been scheduled between a visiting delegation of a US industry patent grouping and judges of the Delhi High Court and the Intellectual Property Appellate Board last week after questioning the propriety of such discussions, people familiar with the matter told ET. More...



National IPR policy relook: Government moves slowly
(Nayanima Basu | New Delhi , 24-Nov-2014 , Business Standard)

India-US talks begin today at a high level, with little progress on New Delhi's homework in the two months since a review was to begin More...



Kerala biotech firm receives US patent for Alzheimer’s drug
(Sangeetha G. , 23-Nov-2014 , mydigitalfc.com)

Turmeric extract formulation made by Kerala-based Arjuna Natural Extracts has received a US patent for the treatment of Alzheimers disease. More...



Ebola vaccine running into patent cover in Canada?
(Sushmi Dey , 21-Nov-2014 , The Times Of India)

A Canadian patent protection may be blocking an Ebola vaccine even as the world is struggling to stop the spread of the deadly virus. More...



Google, Rockstar Agree to Settle Patent Litigation
(Reuters , 21-Nov-2014 , NDTV)

Google Inc has agreed to settle litigation with patent consortium Rockstar, though terms of the deal were not disclosed in a court filing made public this week. More...



Patent row: Delhi High Court asks Micromax to pay royalty to Ericsson
(y Soma Das & Anandita Singh Mankotia , 20-Nov-2014 , The Economic Times)

The Delhi High Court has asked homegrown handset maker Micromax to pay a royalty that amounts up to 1% of the selling price of its devices to Ericsson for using the Swedish equipment maker's patents on technologies that are essential to manufacture the products. More...



Claims of plagiarism pile on Kollywood
(Udhav Naig , 20-Nov-2014 , The Hindu)

The Tamil film industry has aggressively fought the issue of piracy, with some degree of success. But, the issue of plagiarism within its own ranks has not been taken seriously enough. More...



MSU to host workshop on 'Patents: concept and practice'
(Prashant Rupera , 19-Nov-2014 , The Times Of India)

The Department of Chemistry of M S University's Faculty of Science in association with the Baroda chapter of the Indian Society for Analytical Scientists and Infinvent IP is going to organize one day workshop on 'Patents: concept and practice' on November 29. More...



India-US trade meet on Nov 25; IPR, market access on agenda
(Press Trust of India | New Delhi , 19-Nov-2014 , Business Standard)

Intellectual property rights, market access for agri products, visa matters and a boost to investments are some of the issues that will come up for discussions during the Trade Policy Forum (TPF) meeting between India and the US on November 25 here. More...



India-US trade meet on Nov 25; IPR, market access on agenda
(Press Trust of India | New Delhi , 19-Nov-2014 , Business Standard)

Intellectual property rights, market access for agri products, visa matters and a boost to investments are some of the issues that will come up for discussions during the Trade Policy Forum (TPF) meeting between India and the US on November 25 here. More...



Govt’s engagement with MNCs on patent protection keeps domestic industry on edge
(Sushmi Dey , 19-Nov-2014 , The Times Of India)

The government's intention to engage with multinational companies and patent lawyers to discuss protection and enforcement of intellectual property rights in India has triggered concerns from the civil society, local firms and those advocating affordable medicines. More...



India Divided on Whether to Break Bristol-Myers Drug Patent
(Rajesh Roy , 18-Nov-2014 , The Wall Street Journal)

The Indian government is divided about whether to break a patent on a Bristol-Myers Squibb Co.cancer drug. More...



Campaign concerned over US-based IPOA's 'Innovation Dialog' being organised in India from Nov 16-22
(Ramesh Shankar, Mumbai , 18-Nov-2014 , Pharmabiz)

The Campaign for Affordable Trastuzumab has expressed grave concern over the intent and purpose of the “Innovation Dialog” being organised in India from November 16-22, 2014 by the Intellectual Property Owners Association (IPOA), a US-based group consisting of large corporations and law firms. More...



Foreign drug makers urge government to review IPR think tank
(Soma Das , 18-Nov-2014 , The Economic Times)

Foreign drug makers are urging the government to review the membership of a think tank it has set up to formulate intellectual property rights (IPR) policy in the next few months, saying that it lacks representation from innovator firms and needs to be more balanced. More...



Government holding IP conference with MNCs, their lawyers, excluding civil society, academics
(Rema Nagarajan , 17-Nov-2014 , The Times Of India)

The government of India claims to seek balance of public and private interests in intellectual property rights. More...



Life-saving drugs to show govt-fixed rates in bold red
(Sushmi Dey | New Delhi , 17-Nov-2014 , The Times of India, Mumbai.)

From January 2015, all life-saving drugs will come with a bold red strip on the pack highlighting the price as fixed by the government and specifying if the drug is under price control. More...



Group writes to SC, HC CJs against US patent body
(Rema Nagarajan , 16-Nov-2014 , The Times Of India)

The Campaign for Affordable Transtuzumab, a group of individuals and organisations fighting to increase access to medicines, has written to the chief justices of the Supreme Court and Delhi high court and to the chairperson of the Intellectual Property Appellate Board (IPAB) expressing grave concern over the meetings scheduled by the US lobby group Intellectual Property Owners Association (IPOA) with IPAB, a quasi-judicial body, the Delhi HC and the offices of the Controller of Patents. More...



US stand on India's IPR regime not arm twisting: Diplomat Charles Rivkin
(DIVYA RAJAGOPAL , 15-Nov-2014 , The Economic Times)

The US will push India into giving adequate protection to intellectual property regime (IPR, a major bone of contention between the two countries. More...



Appeal to chief justices to cancel meetings with US patent lobby
(Rema Nagarajan , 15-Nov-2014 , The Times Of India)

The Campaign for Affordable Transtuzumab, a group of individuals and organisations fighting to increase access to medicines, has written to the chief justices of the Supreme Court and the Delhi Court and to the chairperson of the Intellectual Property Appellate Board (IPAB) expressing grave concern over the meetings scheduled by the US lobby group, Intellectual Property Owners Association (IPOA) with IPAB, a quasi-judicial body, the Delhi High Court and the offices of the Controller of Patents. More...



A reality check on intellectual property concerns
(Moushami Joshi, Srividhya Ragavan , 15-Nov-2014 , The Hindu)

Alarms were sounded when the Indian Supreme Court rightly refused to endorse ever-greening of patents and denied patent protection on Glivec, a drug owned by Novartis.” More...



American envoy to focus on IPR protection during his visit
(Satyanarayan Iyer , 14-Nov-2014 , Business Line)

Emphasising that intellectual property rights (IPR) protection is in the “best interests of India,” the US Assistant Secretary of State for Economic and Business Affairs Charles Rivkin said that is will be one of the main focus areas of his visit. More...



Why it is important for India to defend its IPR
(DG SHAH , 14-Nov-2014 , Business Line)

The Office of the United States Trade Representative (USTR) is currently engaged in the Out-of-Cycle Review (OCR) of India’s intellectual property rights (IPR) regime, tracking its “progress” since March 2014. This article addresses the OCR and why it is important for India to defend its IPR regime. More...



Conflict of interest: US patent lobby to meet Indian judiciary, patent officials
(Rema Nagarajan , 13-Nov-2014 , The Times of India)

In a glaring instance of conflict of interest many pharmaceutical MNC representatives from the US will be meeting members of judicial tribunals and higher judiciary and officers who are dealing with intellectual property (IP) cases of these companies on a visit to India next week. More...



India, US IPR dialogue to begin this month
(Nayanima Basu | New Delhi , 12-Nov-2014 , Business Standard)

India says it will engage bilaterally through the TRADE Policy Forum but not cooperate in the review process More...



Sun Basks in Taro After-glow
(11-Nov-2014 , The Economic Times.)

Sun Pharma's stock hit a new high of `932 on Monday on strong performance of Taro, the Israeli company it acquired in 2010. This also pushed its latest buyout Ranbaxy Labs to a record high of `697.50.Sun Pharma stock got listed in 1994, an issue that was oversubscribed 55 times. More...



US lobbyists lose fire ahead of trade intellectual property review
(AESHA DATTA/AMITI SEN , 10-Nov-2014 , Business Line)

The US pharmaceutical lobby seems to have become less aggressive in its efforts to make India tighten its intellectual property norms to give more protection to their own industry. In a recent proposal sent to the US Trade Representative (USTR), which is carrying out an investigation into India’s intellectual property regime, the Global Intellectual Property Centre (GIPC), an arm of the US Chambers, has refrained from talking about any sanctions against the country. The same body, however, had asked for India to be listed as a priority country as late as April this year. More...



Sun Pharma, Ranbaxy Laboratories hit new high
(SI Reporter , 10-Nov-2014 , Business Standard)

Shares of Sun Pharmaceutical Industries and Ranbaxy Laboratories have hit their respective lifetime high and are up over 4% each on NSE after Sun Pharma’s US subsidiary, Taro Pharmaceutical Industries, reported a strong 49% year on year growth in net profit to $143.4 million for the quarter ended September 2014. More...



Cautious Japan Inc Reaches Out Via Lawyers
(Deepali Gupta , 10-Nov-2014 , The Economic Times.)

Business enquiries from Japan have nearly doubled since last year but actual work has increased only 5-10%, lawyers said. Most Japanese business houses are watching for regulatory changes to simplify norms for control and exit clauses. More...



NRIs filed 78% of the patent pleas in India
(Sushmi Dey , 07-Nov-2014 , The Times Of India)

India registered the third highest rate for patent filings by non-residents at 78% of the total applications, ahead of China at 18%, Japan at 16% and the US at 50%, the latest data from the Indian patent office showed. More...



US Federal Trade Commission settles first case in crackdown on 'patent trolls'
(Reuters , 06-Nov-2014 , The Economic Times)

The US Federal Trade Commission has for the first time taken action against a patent assertion entity (PAE) under its consumer protection authority, the agency said on Thursday. More...



LG, Google strike patent-sharing
(AFP , 5-Nov-2014 , Livemint)

The deal covers patents on a ‘broad range of products and technologies” that already exist and will be filed in the next 10 years. More...



Origiin IP considers Indian Patent Office effort to simplify analysis of patent applications a positive move
(Nandita Vijay, Bengaluru , 5-Nov-2014 , Pharmabiz)

Origiin IP Solutions views the move by the Indian Patent Office to simplify the method of analysing the patent applications of pharma companies a positive development. More...



Kaththi gets embroiled in plagiarism controversy once again
(M Suganth , 4-Nov-2014 , The Times Of India)

The controversies around AR Murugadoss's Kaththi just refuse to die down. Minjur Gopi, who had earlier filed a case in the Chennai City Civil Court stating that the story of the film was his, has now appealed again to the court after it had dismissed his petition earlier in September. More...



Indra Nooyi-headed Pepsi-Co backs India's much-disputed Intellectual Property Rights
(Dilasha Seth & Soma Das , 4-Nov-2014 , The Economic Times)

US pharmaceutical companies may be gunning for India's patent regime, but New Delhi has found a prominent MNC ally in this high-profile dispute. Indra Nooyi-headed Pepsi-Co has backed India's regime of intellectual property rights, it said in comments to the US Trade Representative. More...



Trademark war: ‘Khadi’ registered in Germany, Spain
(Sidhartha , 4-Nov-2014 , The Times Of India)

The government's efforts to promote 'khadi' are facing a trademark hurdle with the brand having been registered abroad, in countries such as Germany, as well as in India. More...



MNCs ,other organisations, like Pepsi, IPA back India's IP regime
(PTI , 03-Nov-2014 , The Economic Times)

Multinational organisations including PepsiCo and industry associations like IPA, have come in favour of India's intellectual property regime, which is being reviewed by the US administration. More...



Cipla-Novartis patent row: DIPP looking into merit of case
(PTI , 02-Nov-2014 , The Economic Times)

The Commerce and Industry Ministry is looking into the merit of Cipla's demand for revocation of patents of Swiss drug major Novartis for respiratory drug Indacaterol citing the need for public health access. More...



Commerce Ministry Looking Into Merit of Case in Cipla-Novartis Patent Row
(Press Trust of India , 02-Nov-2014 , NDTV)

The Commerce and Industry Ministry is looking into the merit of Cipla's demand for revocation of patents of Swiss drug major Novartis for respiratory drug Indacaterol citing the need for public health access. More...



Roche-Cipla patent row mediation fails
(Rupali Mukherjee , 31-Oct-2014 , The Times of India)

Efforts to end the long and bitter patent tussle between domestic pharma company Cipla and multinational Roche over a lung cancer drug have come to a naught, with the Delhi high court-appointed mediator submitting its "failure" report in the case. More...



Johnson & Johnson may buy electrolyte drink ORS-L for Rs 700cr
(Boby Kurian, TNN , 30-Oct-2014 , The Times of India)

The world's sixth largest consumer health and pharma giant Johnson & Johnson (J&J) has emerged as a front-runner to acquire electrolyte energy drink business of Jagdale Healthcare in a deal estimated at Rs 700 crore, people directly involved with the matter said. More...



Cipla asks government to revoke five patents held by Novartis
(ET Bureau , 30-Oct-2014 , The Economic Times)

It also urged the government to consider COPD as an epidemic worthy of being qualified as a "public health crisis" as it claims 50 lakh lives annually in India, which is more than the toll from HIV-AIDS, malaria, cancer and tuberculosis. More...



Patent office eases rule for pharma companies
(C.H. Unnikrishnan , 29-Oct-2014 , Livemint)

Office drops a proposed clause that would have enforced a more stringent examination of patent applications More...



Update on the grant of Patent to the Company
(BSE , 29-Oct-2014 , Business Line)

Omkar Speciality Chemicals Ltd has informed BSE that the Companys claim for process patent for an Advance Intermediate namely "BENZENESELENINIC ANHYDRIDE”, having special applications in pharmaceutical industry has been accepted by the Patents Office, Govt. of India, vide their Certificate No. 022/11999 Patent Registration No. 263298 dated October 17, 2014. More...



The IPR stand-off
(Business Standard Editorial Comment , 28-Oct-2014 , Business Standard)

Behind India's confrontation with the US on intellectual property More...



Under US pressure, Indian government is getting its act together on IP matters
(27-Oct-2014 , The Pharma Letter)

The pressure from the US government on India seems to be working. More...



Modi’s chief economic adviser Arvind Subramanian had opposed India on IPR till recently
(TNN , 25-Oct-2014 , The Times Of India)

he man who has been appointed the chief economic adviser to the government of India Arvind Subramanian was until recently urging the US to initiate disputes against India before the World TRADE Organization. More...



Centre mulls trademark for Brand Khadi
(Reshmi R Dasgupta & Vijaya Rathore , 25-Oct-2014 , The Economic Times)

Finally khadi seems to be on the way to getting its due, not only on the catwalk but also officially. More...



Govt sets up 6-member IPR think tank
(Dhananjay Mahapatra , 25-Oct-2014 , The Times Of India)

Taking into account India's dismal performance in protecting intellectual property rights over drug and agricultural products, the Centre has formed a six-member 'think tank' to draft national IPR policy and suggest legal means to handle undue pressure exerted by other countries on this issue. More...



Intellectual Property Rights and India's competitiveness
(Amit Kapoor , 22-Oct-2014 , The Economic Times)

Intellectual Property Rights are important from the standpoint of maintaining present as well as ensuring future competitiveness. More...



Trademark name issue being sorted out: Abhishek Bachchan
(Arun Venugopal , 22-Oct-2014 , The Hindu)

Chennai FC, a football club in the city, had sent a legal notice to Chennayin FC, asking to desist from using its trademark name. More...



DU to soon have policy on registration of patents
(PTI , 19-Oct-2014 , Zee News)

What research exactly is patentable? What are the legal issues involved? If the student pursues a research using university infrastructure, is the outcome students' intellectual property? More...



Erode-based phone manufacturer claims it has challenged trademark of iPhone in IPAB
(BS Reporter | Chennai , 19-Oct-2014 , Business Standard)

The company said that it has filed a rectification application to remove the trademark of iPhone from Indian Trademark Registry More...



Medical charity accuses US of pushing India to ease patent rules
(AFP , 18-Oct-2014 , The Economic Times)

Medical charity Medecins Sans Frontieres (MSF) on Saturday accused the United States of ratcheting up pressure on India's new government to relax strict patent conditions which have made the country the "world's pharmacy" More...



US complaints about India's IPR regime are bullying attempts
(Bibek Debroy , 16-Oct-2014 , The Economic Times)

If India agrees to higher standards of IPR protection than necessary, one needs to ask what India gets in return. More...



India says will not cooperate with US on IPR regime review
(Nayanima Basu | New Delhi , 16-Oct-2014 , Business Standard)

The Government of India has told American authorities that it will not cooperate with the out-of-cycle review (OCR) initiated by the Office of the US Trade Representative (USTR) as part of the latter’s annual ‘Special 301 Report’, on India's supposedly slack intellectual property rights (IPR) regime. More...



Patent office invites final comments on 'Revised draft guidelines for examination of patent applications'
(Ramesh Shankar, Mumbai , 16-Oct-2014 , Pharmabiz)

The Controller General of Patents, Designs and Trademarks (CGPDTM) has invited final comments and suggestions from the stakeholders and others on “Revised draft guidelines for examination of patent applications in the field of pharmaceuticals”. More...



US launches review of India's patent regime
(Press Trust Of India , 15-Oct-2014 , Business Standard)

The US on Tuesday launched a review of India's Intellectual Property Regime, in which the focus is to measure the engagement that New Delhi has pursued in terms of intellectual property. More...



US to launch fresh review of India's patent regime
(Sidhartha , 14-Oct-2014 , The Times Of India)

Within days of Prime Minister Narendra Modi's return from the US, the US TRADE Representative (USTR) has launched a fresh offensive against India's intellectual property rights (IPR) regime, a move that may lead to the government going slow on a bilateral dialogue with Washington. More...



Pharma patent regime may get stricter, say experts
(Soumonty Kanungo , 14-Oct-2014 , DNA)

In order to boost dollar inflows in pharma sector and establish stronger IPR regime, govt may affect patent amendments. More...



GI tag for basmati rice: Pakistan is MP’s new enemy
(Milind Ghatwai | Bhopal , 13-Oct-2014 , The Indian Express)

Madhya Pradesh which early this year celebrated a Geographical Indication (GI) tag for its basmati rice now has a new enemy: Pakistan. More...



Patent considerations
(Patrick Kilbride , 13-Oct-2014 , The Indian Express)

Among other things, they committed to establishing an annual intellectual property (IP) working group as a core element of the bilateral trade policy forum. More...



Pfizer wins patent for Voriconazole in India
(Gireesh Babu | Chennai , 12-Oct-2014 , Business Standard)

The patent application was opposed by pharma firms including Ranbaxy Labs and Natco Pharma More...



Bose and Beats Agree to Settle Headphone Patent Dispute
(Reuters , 11-Oct-2014 , NDTV)

A high-profile patent spat over noise cancelling headphones between Bose Corp and Beats Electronics ended on Friday with the two sides settling the case out of court. More...



Playing the frenemy card
(Viveka Roychowdhury , 10-Oct-2014 , Express Pharma)

The pricing pill looks set to choke pharmaceutical companies in India again. On October 9, barely a fortnight after the National Pharmaceutical Pricing Authority (NPPA) withdrew its now infamous ‘internal guidelines’, a Spicy IP blogpost reported that the All India Drug Action Network (AIDAN) had filed yet another PIL in the Delhi High Court. The AIDAN’s PIL alleges that the NPPA’s volte face was a result of 'browbeating' by the Secretary, Department of Pharmaceuticals (DoP). The PIL reportedly refers to internal memos where the DoP has sent an endorsed copy of its opinion on the guidelines and directed the NPPA to withdraw them. AIDAN alleges that this amounts to ‘sabotaging the efforts of the Union Government and the stand taken by the Union Government in their two affidavits' at 'huge financial benefits to the pharmaceutical industries.' More...



PILs challenge NPPA decision on price cap
(Apoorva | C.H. Unnikrishnan , 10-Oct-2014 , Livemint)

Two public interest litigations (PILs) filed on Thursday in the Supreme Court and Delhi high court challenged a 22 September decision by the National Pharmaceutical Pricing Authority (NPPA) to withdraw internal guideline to set prices of non-essential drugs following directions from the department of pharmaceuticals. More...



Google-Rockstar patent lawsuit goes to California court
(Reuters , 10-Oct-2014 , The Times Of India)

Google Inc will fight patent holder Rockstar Consortium in a California court instead of a Texas court that lawyers consider more friendly toward plaintiffs. More...



IPAB to take up TVS Motor’s patent appeal
(Sajan C Kumar | Chennai , 10-Oct-2014 , The Financial Express)

The Intellectual Property Appellate Board (IPAB) will hear TVS Motor Company’s appeal against... More...



Apple granted patent for digital newspaper
(Business Insider , 8-Oct-2014 , The Times Of India)

APPLE has been granted a patent for a flexible display that can be used as a self-updating digital newspaper. More...



Samsung initiates arbitration against Microsoft after patent royalty lawsuit
(Nate Raymond , 7-Oct-2014 , Livemint)

The arbitration was commenced under the terms of a business collaboration agreement More...



Sri Lanka seeks cinnamon trademark
(AAP , 06-Oct-2014 , Yahoo Finance)

Ten years after the Asian tsunami devastated Sarath Kumara's cinnamon plantation in Sri Lanka, forcing him to start over with nothing, the farmer faces a new threat from further afield. More...



The patent discord
(Feroz Ali , 06-Oct-2014 , The Financial Express)

India is probably the only country that is consciously working towards a system of open prosecution of patents. More...



DIPP Dismisses PM Modi’s Efforts To Resolve IPR Issues, Says India’s IPR Laws TRIPS Compliant
(Purba Das , 06-Oct-2014 , Business Insider)

In what could be a dismissal of Prime Minister Modi's efforts to resolve the US concern regarding India's Intellectual Property Rights (IPR) laws, the Department of Industrial Policy and Promotion (DIPP) has pointed out that there's already a committee to discuss IPR issues between the US and India. More...



Govt mulls IPR courts to fast-track cases
(Arun S , 06-Oct-2014 , The Financial Express)

The government is working on a new, comprehensive policy on intellectual property rights (IPR), which would pave the way for setting up special IPR courts comprising experts to fast-track adjudication on infringement cases concerning all forms of IPRs, official sources told FE. More...



Government says India’s intellectual property regime fully compliant with WTO norms
(ET Bureau , 4-Oct-2014 , The Economic Times)

India's intellectual property regime is fully compliant with WTO norms, the government said on Friday, two days after the two countries decided to set up a high-level working group on IPR during Prime Minister Narendra Modi's US visit to sort out the contentious issue. More...



India’s intellectual property regime fully compliant with WTO norms: Government
(ET Bureau , 4-Oct-2014 , The Economic Times)

India's intellectual property regime is fully compliant with WTO norms, the government said on Friday, two days after the two countries decided to set up a high-level working group on IPR during Prime Minister Narendra Modi's US visit to sort out the contentious issue. More...



India says US agrees to its stand on IPR
(BS Reporter | New Delhi , 04-Oct-2014 , Business Standard)

Says bilateral forum, mentioned in Obama-Modi statement, already exists More...



India’s intellectual property regime fully compliant with WTO norms: Government
(ET Bureau , 04-Oct-2014 , The Economic Times)

India's intellectual property regime is fully compliant with WTO norms, the government said on Friday, two days after the two countries decided to set up a high-level working group on IPR during Prime Minister Narendra Modi's US visit to sort out the contentious issue. More...



DIPP Statement on Bilateral Mechanism for Discussing IPR Issues with USA
(3-Oct-2014 , Business Standard)

The US- India Joint Statement issued by the Prime Minister of India and the President of the United States of America after the bilateral summit had the following reference to IPR issues Agreeing on the need to foster innovation in a manner that promotes economic growth and job creation the leaders committed to establish an annual high level Intellectual Property (IP) Working Group with appropriate decision making and technical level meetings as a part of the TRADE policy forum. More...



Country's IPR regime is fully compliant with global norms: Government
(PTI , 04-Oct-2014 , The Economic Times)

Amidst the US raising concern over the country's IPR laws, government today said its intellectual property rights regime is fully compliant with the global norms. More...



Has PM Modi bowed to US pressure on patent laws?
(Rema Nagarajan , 03-Oct-2014 , The Times Of India)

A paragraph buried in the US-India joint statement, which talks of establishing an annual high-level Intellectual Property (IP) working group as part of the Trade Policy Forum, has made health activists across the world apprehensive that the Modi government might be bending to US pressure to change its patent laws. More...



Real-time online app opens India’s patent process to public eye
(C.H. Unnikrishnan , 2-Oct-2014 , Livemint)

The public will be able to access digital updates at each stage of file movement on the patent office’s website from September More...



Apple wins LTE patent case against WiLan
(Reuters , 2-Oct-2014 , The Times Of India)

Canadian patent licensing company WiLan Inc said a US judge had ruled in favor of APPLE Inc in a litigation case against it. More...



Online push buoys patent filings
(P. T. JYOTHI DATTA , 1-Oct-2014 , Business Line)

The Government’s efforts to encourage people to file their patent applications online seem to be paying off. More...



Modi must resist U.S. pressure on drug patents - MSF
(NITA BHALLA , 30-Sep-2014 , Reuters)

Prime Minister Narendra Modi must not give in to U.S. pressure to change intellectual property laws which allow India to produce generic medicines poor people can afford, the medical charity Doctors Without Borders (MSF) said. More...



The right prescription in the IPR debate
(29-Sep-2014 , Hindustan Times)

Chief on the list will be the US TRADE Representative’s (USTR’s) requirement that India wind back parts of its posture on patents. More...



The right prescription in the IPR debate
(29-Sep-2014 , Hindustan Times)

Chief on the list will be the US TRADE Representative’s (USTR’s) requirement that India wind back parts of its posture on patents. More...



India’s draft rules on patenting drugs draw mixed response
(29-Sep-2014 , Livemint)

India’s latest draft rules on patenting drugs that say modifications of existing medicines can be patented only if they show increased therapeutic value has drawn sharp reaction from international pharma companies. More...



IPR: US expert hopes to see commitment from Modi
(Press Trust of India | New York , 28-Sep-2014 , Business Standard)

Underscoring the need to strengthen India's IP policy for creating a conducive environment for foreign investors, a US expert has expressed hope to see a principled commitment by Prime Minister Narendra Modi to amend country's patent laws to boost economic growth and global competitiveness. More...



NGOs call upon Modi not to commit flexibilities in Indian Patents Act during his US visit
(Ramesh Shankar , 24-Sep-2014 , Pharmabiz)

Ahead of Prime Minister Narendra Modi’s scheduled visit to the United States next week, experts and NGOs in the pharma sector have called upon the Prime Minister not to make any legal or political commitment that compromises flexibilities in the Indian Patents Act for facilitating access to medicines and safeguarding public health, which is based on policies and principles approved by Indian Parliament and is fully consistent with international laws. More...



NPPA withdraws May drug price control guideline
(C.H. Unnikrishnan , 24-Sep-2014 , Livemint)

India’s drug price regulator scrapped a May guideline giving itself sweeping powers to set the price of non-essential medicines. The move is likely to find favour with drug companies that have protested and also legally challenged a July order by the National Pharmaceutical Pricing Authority (NPPA) capping the price of 108 non-essential drugs More...



BITTER PILL - Drug pricing: `Govt bowed to lobbies'
(24-Sep-2014 , The Times of India, Mumbai.)

In a move that will disappoint many patients, the government has withdrawn certain powers of the drug pricing regulator that allowed it to cap prices of widely-prescribed anti-diabetes, cancer, tuberculosis, HIV and cardiac medicines. The National Pharmaceutical Pricing Authority (NPPA) said it is withdrawing “with immediate effect“ a May 29 guideline that had allowed it to put price caps on crucial drugs, to comply with a government “direction''. More...



US raps India's IPR regime
(Rupali Mukherjee | TNN , 23-Sep-2014 , The Times of India, Mumbai.)

US has rapped India's weak intellectual property regime on the eve of Prime Minister Narendra Modi's visit to the country , saying US companies “seek to invest“ in India, but “need transparent governance, a fair regulatory environment, and strong legal mechanisms“ to protect their investments More...



Cipla grants patent rights in Rifaximin Complexes family to Salix Pharma
(Our Bureau, Mumbai , 19-Sep-2014 , Pharmabiz)

Cipla, a Rs.9,800 crore plus fifth largest Mumbai based pharma major, has signed an agreement with Salix Pharmaceuticals, Inc., a US-based speciality pharmaceutical company. More...



Software patent guidelines in the offing, says official
(BS Reporter | Chennai , 19-Sep-2014 , Business Standard)

Currently, software is not patentable under the existing Act and it needs to be registered under copyright More...



Fresh opposition on Gilead’s Hepatitis C drug
(PT JYOTHI DATTA , 18-Sep-2014 , Business Line)

The last word is far from heard on drugmaker Gilead’s Hepatitis C drug sofosbuvir in India. More...



India sends substandard generic drugs to Africa, say researchers
(Anna Edney , 18-Sep-2014 , Livemint)

Generic drugs that some Indian companies send to African countries are lower quality than the same medicines the companies sell at home and outside Africa, according to tests of 1,470 samples, researchers said. More...



A strong IPR regime benefits India
(17-Sep-2014 , The Financial Express)

India’s growing population, at 1.3 billion citizens now, represents the second-largest consumer MARKET in the world, and may soon be the largest. Its productive capacity is also growing More...



Draft Guidelines could lead to unnecessary bias against pharma patent applications: USIBC
(Ramesh Shankar , 15-Sep-2014 , Pharmabiz)

The US-India Business Council (USIBC) has stated that the Draft 'Guidelines for Examination of Patent Applications in the Field of Pharmaceuticals' issued recently by the Indian Patent Controller could lead to an unnecessary bias against pharmaceutical patent applications. More...



Gilead to license Sovaldi to Indian generics drug firms Read more at: http://www.livemint.com/Industry/no7AnbJi4dRkjJY7dn4SOI/Indian-companies-to-sign-generic-licensing-deal-for-Hepatiti.html?utm_source=copy
(C.H. Unnikrishnan , 15-Sep-2014 , Livemint)

The licensing agreements will allow the generic drug companies to make and sell copies of the expensive pill for low- and middle-income countries at lower prices More...



Weaker currency, patent expiration boost for healthcare firms
(Sneha Padiyath , 15-Sep-2014 , Business Standard)

Stocks of Indian pharma companies seem to be in the pink of health as investor-interest in them rises on the back of a weakening currency, the expiry of generic-drug patents later this year and a slew of US FDA approvals. More...



Government to hear out US pharma companies' patent fears
(Sidhartha , 15-Sep-2014 , The Economic Times)

After months of skirmishes, the government is finally going to sit down with American pharma giants this week to hear out their concerns, a move that comes weeks before Prime Minister Narendra Modi leaves for the US. More...



India uses ancient texts to foil US bid to patent lotus to treat obesity
(Vanita Srivastava , 14-Sep-2014 , Hindustan Times)

The claim made by a US company on the usefulness of lotus and cowhage (a herb) for treatment of obesity and hunger at the European Patent Office (EPO) has been foiled by India, largely because of submission of prior art evidence from ancient Hindu texts that refutes the claim of novelty. More...



Increasing patent expiration may brighten India's export prospects: CARE Ratings
(Sanjay Pingle , 13-Sep-2014 , Pharmabiz)

CARE Ratings has pointed out that the drug patent expiry in the USA will create new opportunity for Indian pharmaceutical industry in the coming years and the pharma industry will gain a larger foothold in the world's generic market. More...



PM Modi's US Visit: India, US discuss WTO, visa, IPR related issues
(PTI , 12-Sep-2014 , The Economic Times)

Ahead of Prime Minister Narendra Modi's visit to the US, a senior American official today met Commerce and Industry Nirmala Sitharaman and discussed various issues including India's stand in the WTO on the food security issue. More...



India’s drug industry to touch $48 billion by 2018
(C.H. Unnikrishnan , 12-Sep-2014 , Livemint)

Industry may see growth on back of patent expiry of some blockbuster drugs in US and local demand More...



Fresh, detailed norms for drug patent filing examiners
(Sajan C Kumar | Chennai , 12-Sep-2014 , The Financial Express)

Fresh and detailed guidelines are being put in place for examiners of drug patent filings More...



McDonald's Files Trademark Petition for 'McBrunch'
(BurgerBusiness , 11-Sep-2014 , NDTV)

McDonald's is in need of a secret weapon that will help boost sales and bring back lost customers. More...



Novartis files lawsuit against Zydus
(Premal Balan & Sohini Das | Ahmedabad , 10-Sep-2014 , Business Standard)

Zydus is accused of infringing patents related to a drug used to treat Alzheimer's and Parkinson's diseases More...



IPR policy on the cards to protect national interests, says Nirmala Sitharaman
(ET Bureau , 09-Sep-2014 , The Economic Times)

India has proposed a national intellectual property rights (IPR) policy to safeguard its interests and bring clarity to existing laws ahead of Prime Minister Narendra Modi's visit to the US this month. More...



Novartis drags DRL to US court for patent violation
(fe Bureau | The Financial Express , 09-Sep-2014 , The Indian Express)

Switzerland-based Novartis AG and Novartis Pharmaceuticals Corporation (NPC) have sued Dr Reddy’s Laboratories in a the United States’ District Court for the District of Delaware for a patent infringement action on the drug Gleevec. More...



Poly Medicure wins long patent battle against German pharma giant B Braun
(Soma Das , 8-Sep-2014 , The Economic Times)

Poly Medicure, an Indian medical devices firm with annual sales of just over Rs 320 crore, has won a five-year long patent battle with Rs 40,000 crore German medical devices and pharma giant B Braun as the European Patent Office (EPO) revoked two of the latter's patents covering features of intravenous (IV) safety catheters. More...



India revamps intellectual property policy in face of western anger
(Amy Kazmin in New Delhi , 8-Sep-2014 , The Financial Times)

India is hiring 1,000 officials for its patent offices and has vowed to clear the backlog of all pending applications over the next 18 months as it seeks to defend itself against western allegations that it tramples on companies’ intellectual property rights. More...



Gitam scholars patent millet biscuits
(TNN , 5-Sep-2014 , The Times Of India)

Researchers of Gitam University's food science and technology department have successfully registered a patent for millet rich biscuits. More...



Sun Shines on Pharma Chart, Wockhardt Dims
(Kiran Somvanshi , 5-Sep-2014 , The Economic Times.)

Mumbai-based Sun Pharma has made it to the top of the domestic drug makers' leaderboard through overseas acquisitions and quadrupling of revenue in five years. Others like Aurobindo Pharma and Glenmark, too, have outperformed their peers during this period. More...



Sun-Ranbaxy deal may hit fair trade: CCI
(Agencies , 05-Sep-2014 , The Times of India, Mumbai.)

Launching the first-ever public scrutiny of an M&A deal in India, the fair trade watchdog on Thursday said it has prima facie found that the $4-billion merger of Ranbaxy Labs into rival Sun Pharma is likely to have an “appreciable adverse impact” on competition in the market. More...



Apple loses bid for Samsung US sales ban after patent win
(Joel Rosenblatt , 28-Aug-2014 , Livemint)

A US Judge denied Apple’s bid for what the company had pitched as a narrowly tailored ban on some older Samsung smartphone models More...



Disney patents filing reveals plan for flying puppets
(Reuters , 27-Aug-2014 , The Times Of India)

Walt Disney has filed for three drone-related patents that it says could lead to an era of aerial movie screens and larger-than-life puppets flying through the sky. More...



REVISED NORMS FOR ISSUE OF PATENTS
(P A Francis , 27-Aug-2014 , Pharmabiz)

The Section 3(d) of the amended Indian Patent Act of 2005 is a key safeguard against ever greening of a drug patent by the inventor companies by making some incremental changes to the original molecule. More...



Gwyneth Paltrow slapped with copyright infringement lawsuit
(Press Trust of India | Los Angeles , 27-Aug-2014 , The New Indian Express)

Gwyneth Paltrow has been slapped with a copyright infringement lawsuit over her lifestyle website Goop. More...



Researchers earn patent for wooden honey box
(TNN , 23-Aug-2014 , Business Standard)

For the first time in India, two farmers, who are also researchers, have got design patent for their wooden honey box design. Efforts are on to get process patent for the same product, as it uses a simple method to extract honey without damaging the honeybee colony. More...



Monkey does not own selfie, rules US Copyright Office
(Express News Service | New Delhi , 22-Aug-2014 , The New Indian Express)

The copyright regulator ruled that "the Office will not register works produced by nature, animals, or plants. More...



IPAB allows Pfizer to appeal against rejection of patent for Tofacitinib
(Gireesh Babu | Chennai , 22-Aug-2014 , Business Standard)

Patent Office rejected Pfizer's application in June, 2011, and a review application in March 27, 3014 More...



Microsoft-backed patent buyer to layoff 19% employees
(Reuters , 20-Aug-2014 , The Times Of India)

Patent buyer Intellectual Ventures announced its second round of staff cuts this year, saying it will reduce its global workforce by 19% as the firm increasingly turns to litigation to generate licensing revenue. More...



US Patent to VIT Alumnus for Travel Aid Gizmo that Doesn't Need Internet
(V NarayanaMurthi , 20-Aug-2014 , The New Indian Express)

Imagine travelling in a long-distance train with no idea about the current location, no internet connectivity to identify the spot through GPRS and not knowing when to alight. More...



Payyannur Pavithra Mothiram in a Geographical Indication tag ownership tussle
(P Sudhakaran , 20-Aug-2014 , The Times Of India)

Payyannur Pavithra Mothiram, a unique gold ornament with a mythical tradition has been caught up in a battle over the Geographical Indication registration awarded to it in 2004. More...



Apple’s curved touchscreen patents hints at smartwatch
(Techradar , 20-Aug-2014 , The Times Of India)

Moto 360 will bring the first circular screen to wearables, but it looks like Apple may be looking to one-up Motorola with a curved touchscreen. More...



Rise in ex-parte orders upset generic drugmakers' future business plans
(Soma Das , 19-Aug-2014 , The Economic Times)

A growing number of cases in the pharma sector, where courts forbid Indian drugmakers from launching generic versions of patented drugs (ex-parte injunction, without even hearing defendants) or ask them to furnish undertakings proclaiming that they have no plans to launch such a drug, has rattled domestic drugmakers. More...



Govt set to revise patent norms for pharma
(Sushmi Dey | New Delhi , 19-Aug-2014 , Business Standard)

Guidelines won't replace present structure, but will let examiners adopt standard procedure in evaluating complex applications More...



Swedish retailer Ikea locks horns over brand name with Varanasi-based fabric maker Ekaya
(Maulik Vyas , 18-Aug-2014 , The Economic Times)

Swedish retailer Ikea has objected to a Varanasi-based fabric maker's brand name 'Ekaya' on the grounds that it can create confusion among its customers as it sounds pretty similar to its own and urged the Registrar of Trademarks to strike it down. More...



Cipla Favours Zero Monopoly in Healthcare
(ENS Economic Bureau , 18-Aug-2014 , The New Indian Express)

Amid growing tension with the US over Intellectual Property Rights (IPR)-related issues, pharma major Cipla said free competition, zero monopoly in healthcare and adoption of a pragmatic IPR policy will aid growth of pharma sector. More...



BU Prof’s Patented Technique to Purify Water Could Bring Hope to Several Lives
(Bharath Joshi , 18-Aug-2014 , The New Indian Express)

Millions of children can be saved from the ill-effects of fluoride and arsenic contamination in water with the use of a nanoparticle technology patented by a Bangalore University professor. More...



Indian drug regulator plugs quality gaps after drawing flak from USFDA
(Our Bureau , 17-Aug-2014 , Business Line)

The Indian drug regulator, the Central Drugs Standard Control Organisation, is busy reforming itself and plugging all quality gaps by organising skills development programs for its officers and inspectors to make them more attuned to international standards. More...



India’s action in WTO
(New Delhi Times , 17-Aug-2014)

On January 1 1995 when World Trade Organization came into existence the entire economy of the world was affected in respect of international trade because WTO framed the new global trade rules for international trade. More...



Research lab to help fight patent war
(Shounak Ghosal , 13-Aug-2014 , The Times Of India)

A laboratory, devoted to research and document qualities of certain indigenous plants and crops that are at the risk of being patented by multi-national companies, started rolling off EM Bypass on Tuesday. More...



THE PATENT SETTLEMENTS
(P A Francis , 15-Aug-2014 , Pharmabiz)

A new trend of collusion of multinational drug corporations with large Indian companies is emerging in the Indian pharmaceutical market to overcharge essential drugs which are under patent. More...



Samsung-Apple patent war: What was it good for? Nothing
(Bloomberg , 13-Aug-2014 , The Times Of India)

The decision by Apple to scale back its patent battle with Samsung may represent more of a reboot than a truce. More...



Delhi HC issues notice on a PIL filed by Prof. Shamnad Basheer, seeking overriding powers of RTI Act against other Statutes and for declaring S.144 of Patent Act ultravires
(Apoorva Mandhani , 6-Aug-2014 , Live law.in)

Delhi High Court today issued notice in a Public Interest Litigation filed by Prof. Shamnad Basheer, founder of SpicyIP and leading academician in the country, with path-breaking research in the field of Intellectual Property Rights, praying inter alia to declare that the mechanism under the Right to Information Act, 2005 overrides all other mechanisms under any other statute or rule for discharge of information from public authorities to the extent of inconsistencies therein and to declare Section 144 of the Patents Act, 1970 is ultra vires the Constitution of India. More...



Samsung, Apple drop patent disputes pending in courts outside US
(By Reuters , 06-Aug-2014 , The Economic Times.)

Samsung Electronics Co Ltd and Apple Inc said they had agreed to drop all patent litigation outside the United States, scaling down a protracted legal battle between the smartphone rivals. The iPhone and Galaxy handset makers issued nearly identical statements announcing the global ceasefire while vowing to pursue ongoing litigation in the United States, which analysts say involves much bigger amounts of potential damages More...



Apple, Samsung agree to end patent lawsuits outside US
(06-Aug-2014 , BusinessLine)

Apple and Samsung, two of the world’s top technology companies, agreed to end ongoing patent lawsuits against each other outside of the US, the companies said in a joint statement on Wednesday. More...



FDA chief who cracked down on erring chemists shunted out
(Prafulla Marpakwar , 6-Aug-2014 , The Times of India, Mumbai.)

Bowing to the mounting pressure of chemists and a section of multinational firms, CM Prithviraj Chavan on Tuesday shunted out Food and Drug Administration (FDA) commissioner Mahesh Zagade on the ground that he has completed his tenure. While no new assignment has been given to Zagade, director of municipal administration Purushottam Bhapkar will replace him. Significantly , Bhapkar, an IAS officer of the 1997 batch, did not complete even one year as the director. More...



CCI to scan drug patent settlements
(C.H. Unnikrishnan , 3-Aug-2014 , Livemint)

The country’s competition regulator may examine details of patent settlements being negotiated between foreign branded medicine companies and local generic drug makers as these agreements may restrict the access of cheaper drugs to the sick. More...



Get wonder drugs that cure hepatitis at subsidized cost, patients and doctors in Mumbai urge health ministry
(Times News Ntework , 28-Jul-2014 , The Times of India, Mumbai.)

City patient groups, NGOs and doctors have jointly petitioned the Union health ministry to procure two wonder drugs, which promise 90% cure for hepatitis C patients, at a subsidized cost. More...



More drug price caps soon Regulator examines prices of vaccines & medicines used in treatment of cancer, asthma, TB & malaria
(Sushmi Dey | New Delhi , 15-Jul-2014 , Business Standard)

The government is scrutinising prices of vaccines and drugs used to treat cancer, viral infections, asthma, tuberculosis and malaria after having slashed prices of expensive anti-diabetic and cardiovascular medicines. More...



Bombay HC upholds IPAB order on Nexavar’s generic copy
(Khushboo Narayan, C.H Unnikrishnan , 15-Jul-2014 , livemint)

The Bombay high court on Tuesday dismissed a challenge by Bayer AG against a decision to allow drug maker Natco Pharma Ltd to manufacture and sell a generic copy of a patent-protected cancer drug made by the German company. More...



Pharma Cos Find New Price Controls Difficult to Swallow
(Divya Rajagopal , 15-Jul-2014 , The Economic Times.)

The drug price regulator's move to control the prices of more commonly used diabetes and heart-disease medicines has made pharmaceutical companies furious, as they fear it would wipe out their margins just when they seemed to recover from the previous government's decision to slash the prices of more than 300 drugs. More...



QUALITY ISSUES - Glenmark joins pharma cos setting up US plants
(15-Jul-2014 , The Times of India, Mumbai.)

With quality issues continuing to dog domestic pharma industry , more companies are de-risking their growth strategy by setting up manufacturing facilities in the US, the world's most lucrative market. The latest to jump on the bandwagon is Mumbaibased Glenmark Pharma, which is planning to set up a greenfield facility to serve the US market, which has sales of generic drugs totalling $65 billion. Over the years, leading companies like Ranbaxy , Sun Pharma and Dr Reddy's have either invested in greenfield facilities or acquired existing plants to grow their share in the fast-growing generics business. India is the largest supplier of generic medicines to the US, around 20% in volume and 12% in value terms, according to IMS. More...



Diabetes, cardiac drugs to become up to 35% cheaper
(14-Jul-2014 , The Times of India, Mumbai.)

Coping with the inflation demon will become a tad easier for the burdened consumer. In a move that has shaken the pharma industry , prices of widely-used expensive anti-diabetic and cardiac medicines will reduce over the next few weeks by as much as 35%, with the drug pricing regulator, the National Pharmaceutical Pricing Authority (NPPA), deciding to bring them under price control. More...



India emerges world's top consumer of antibiotics
(Kounteya.Sinha@timesgroup.com , 14-Jul-2014 , The Times of India, Mumbai.)

India has emerged as the world’s largest antibiotics consumer, with a 62% rise in use over the past decade. ‘Global Trends in Antibiotic Consumption, 2000-2010’, a study by Princeton University scientists, has found that worldwide antibiotic use has risen 36% in the same period, with Brics countries — Brazil, Russia, India, China and South Africa — accounting for over three-quarters of the surge. Among 16 antibiotics groups studied, cephalosporins, broad-spectrum penicillins and fluoroquinolones accounted for over half the increase — consumption rising 55% from 2000. More...



Merck seeks to settle patent row with Glenmark
(Rupali Mukherjee, TNN , 12-Jul-2014 , The Times of India, Mumbai.)

In the long-winding patent battle on a widely-prescribed diabetes drug, Januvia (sitagliptin), multinational company Merck (MSD) has sought a settlement to end the dispute with generic company, Glenmark on the blockbuster drug. Last year, US-based Merck's subsidiary in India dragged Glenmark to court, seeking a stop on the sale of a more affordable version of its diabetes drug, Januvia, joining the list of MNCs engaged in turf wars with generic companies in the country. More...



Google, Dropbox and other top tech companies band together to fight patent trolls
(Martyn Williams , 10-Jul-2014 , pcworld.com)

Google, Dropbox and a few other high-tech firms have come up with a new way to help defend themselves against patent trolls. Patent trolls, or “non-practicing entities,” are companies that buy up old patents and try to monetize them by accusing others of infringement. They usually request a one-off licensing fee to end a lawsuit, something many companies reluctantly pay because it’s cheaper than defending the claim. More...



Unconventional Energy Boom Drives Oil and Gas Patents to Record
(Reuters , 30-Jun-2014 , profit.ndtv.com)

A boom in the search for unconventional forms of energy such as shale gas or oil sands has led to a record high in new oil and gas patents filed across the world, research published by Thomson Reuters' legal business showed. More...



Copyright shocker on Thyagaraja kritis
(25-Jun-2014 , The Hindu)

A spate of copyright-violation notices issued to video channels on YouTube for uploading Carnatic music rendition of compositions of saint Thyagaraja, has raised the hackles of musicians and fans of the art form. More...



US company denied patent on anti-cancer drug
(Rupali Mukherjee | TNN , 24-Jun-2014 , The Times of India, Mumbai.)

The Indian Patent Office has refused a patent on US firm Abraxis BioSciences' anti-cancer drug Abraxane, paving the way for domestic companies to launch affordable versions in the local market. The application was refused on the grounds of the US firm's claims lacking of inventive step, not being patentable and insufficiency, legal sources say. More...



Patent medicine
(Tarun Khanna , 23-Jun-2014 , The Economic Times.)

In the patenting literature, economists and legal scholars have focused on improving the quality of prior art available to patent examiners and mitigating the filing and granting of patents where prior art exists in common knowledge. More...



Mahindra to Review Tesla Patents for Applicability to its Electric Vehicles
(Press Trust of India , 22-Jun-2014 , profit.ndtv.com)

Homegrown auto major Mahindra & Mahindra, which has been developing a range of electric vehicles, will review technology patents that American electric carmaker Tesla Motors has made free for applicability to its products. More...



Microsoft's Android Patents Revealed for the First Time
(NDTV Correspondent , 17-Jun-2014 , gadgets.ndtv.com)

Microsoft's smartphone platform might be a distant third compared to Google's Android and Apple's iOS, but Microsoft has been earning a significant amount of money from Android device manufacturers through its patents, and has even sued some of these companies More...



Nissan and BMW Keen To Collaborate with Tesla
(AFP , 17-Jun-2014 , auto.ndtv.com)

Electric car-makers Nissan and BMW are keen to collaborate with rival Tesla after the US company agreed to share its patents with competitors, the Financial Times reported today. More...



MNC drug companies like Roche, Merck Serono, Novartis see top deck reshuffle
(Divya Rajagopal , 17-Jun-2014 , The Economic Times.)

Multinational drugmakers including Roche, Merck Serono, Novartis and Bristol Myers Squibs are witnessing top-level changes in their management in India, with their chief executives exiting the country at a time when the Rs 72,000-crore market appears to be as challenging as it is potentially lucrative. More...



Nirmala Sitharaman discusses intellectual property rights related issues with officials
(PTI , 17-Jun-2014 , The Economic Times.)

Amidst the US targeting India's intellectual property rights regime, Commerce and Industry Minister Nirmala Sitharaman today discussed various IPR related issues with her officials More...



Electric car maker Tesla Motors is handing over the keys to its technology in an unusual effort to encourage other automakers to expand beyond gasoline-burning vehicles.
(Ameya Naik , 13-Jun-2014 , auto.ndtv.com)

Tesla CEO Elon Musk revealed that the company will allow other automakers to use their patents and will not initiate patent lawsuits against anyone who, in good faith, wants to use their technology. The message to the world is loud and clear, that the company wants electric vehicles on the road and the only way they see it happening is getting through to the competition and sharing expertise. More...



Roche and Cipla are ordered to mediate in a new twist on Indian IP fights.
(Eric Palmer , 13-Jun-2014 , Fierce Pharma)

Roche and Cipla are writing a new chapter in the bitter battles that have been fought by Western drugmakers over their patents in India. They are in mediation over the patent for Roche's blockbuster cancer fighter Tarceva, in what may be the first case to take this route. More...



Electric Car Maker Tesla Handing Over the Keys to its Technology
(Associated Press, San Francisco, California , 13-Jun-2014 , ndtv.com)

Electric car maker Tesla Motors is handing over the keys to its technology in an unusual effort to encourage other automakers to expand beyond gasoline-burning vehicles. More...



Patent Case Against Facebook Goes to Trial in the US
(Associated Press , 12-Jun-2014 , gadgets.ndtv.com)

Facebook infringed on patents held by a Dutch computer programmer who tried to launch a similar site called "Surfbook" more than a decade ago, according to a lawsuit heard by a federal jury Wednesday. The civil trial was underway in U.S. District Court in Alexandria, where social media giant Facebook is being sued by a holding company called Rembrandt Social Media. More...



Plea alleges patent process biased against Indians
(TNN , 22-May-2014 , The Times of India)

Highlighting an anomaly in patent laws, a PIL filed in the Madras high court has said that while foreign applicants are eligible for express processing of their applications, similar facility is being denied to Indian individuals and companies, resulting in delay in awarding patent for Indian products More...



USFDA warns Sun Pharma on import ban
(Reuters , 21-May-2014 , The Times of India, Mumbai.)

Generic drugmaker Sun Pharmaceutical Industries’ response to an import ban on one of its plants lacked “sufficient corrective actions”, the US Food and Drug Administration said in a warning letter published on Tuesday. The FDA banned imports from Sun Pharma’s Karkhadi plant in Gujarat in March, but the reason for the ban was not clear at that time. More...



Merck HIV Drug Strategy Seen Shielding Patent: Corporate India
(Ketaki Gokhale , 20-May-2014 , Bloomberg)

Merck & Co. (MRK) is set to sell an HIV medication in India by mid-year in partnership with local company Cipla Ltd. (CIPLA), a strategy that may help the U.S. drugmaker protect its patent as the Asian nation seeks cheaper generics. More...



Apple, Samsung, Google Stop Suing Each Other And Start Focusing On Patent Reform
(Cameron Fuller , 20-May-2014 , International Business Times)

With Apple, Samsung and Google calling a truce on their interlocking patent lawsuits, the money they’ll save in legal costs and damages is now expected to go to innovation and patent reform. Good news for consumers, bad news for patent trolls. More...



US Court Refuses to Revive Samsung Patent Case Against Apple
(Reuters , 14-May-2014 , profit.ndtv.com)

A US appeals court on Wednesday affirmed a decision by the International Trade Commission that Apple Inc was innocent of violating three patents owned by Samsung Electronics to make its iPhones and iPads. More...



Copyright act violated, 2 held
(Mohammed Akhef , 14-May-2014 , The Times Of India)

The crime branch of the city police on Tuesday arrested two persons under the Copyright Act for allegedly downloading and distributing songs and movies from a mobile shop he runs. More...



Column: Get prudent with the patents law
(Pravin Anand , 13-May-2014 , The Financial Express)

To start with, India should rethink its ‘ever-greening’ argument given to justify Section 3(d) rules More...



Defending India’s patent law
(Prabha Sridevan , 12-May-2014 , The Hindu)

No one can attack India’s well-founded Intellectual Property regime as being weak merely because a drug that is claimed to be an invention fails the test of law More...



UK to review EU ban on Indian mangoes; IPR attorneys welcome call
(A Subramani , 11-May-2014 , The Times Of India)

Intellectual Property Rights Attorneys Association here has welcomed the British parliament's decision to go into the controversial European Union ban on the import of mangoes from India, and go through India's inspection process to prevent pest and insecticide presence in export materials. More...



Govt looking at incentive scheme to retain patent examiners
(Amiti Sen , 11-May-2014 , Business Line)

With the Indian Patent Office finding it difficult to retain patent examiners on Government pay-scales, a move is underway to increase remuneration by introducing an incentive scheme. More...



Pfizer, Roche end association with US-India Business Council
(Soma Das , 9-May-2014 , The Economic Times)

Tension over intellectual property rights (IPR) between the US and India has led to cracks in the US India Business Council (USIBC), a grouping of hundreds of companies present in both countries, to the extent that a section of Big Pharma has chosen to end its association with the organisation seemingly in a huff. More...



Don’t Buckle under US Pressure on IP Rights
(The New Indian Express , 8-May-2014 , The New Indian Express)

Special 301 report 2014, the US Trade Representative (USTR) has identified India as a “priority watch country” for failure to protect intellectual property. More...



Patent institute remains non-starter after recruitment ban
(Shishir Arya , 7-May-2014 , The Times Of India)

There is jubilation over Nagpur Orange getting a geographical indication (GI) tag but a massive building of the very department dealing in such matters, which include patents and intellectual property rights, awaits to get a befitting status. More...



India needs to modify Intellectual Property Rights regime to attract FDI: Report
(PTI , 07-May-2014 , The Economic Times)

India needs to modify its Intellectual Property Rights (IPR) regime and fast-track legal system to attract foreign investments, a report said today. More...



Cancer drug patent waiver move lifts hopes
(Shimona Kanwar , 7-May-2014 , The Times Of India)

For 60-year-old Gian Tomar, who hails from Sirmour district in Himachal Pradesh, financial crunch has been more painful than his wife's suffering with Chronic Myelogenous Leukemia (CML), a type of blood cancer. More...



After BMS's patent rights for Dasatinib, expensive drugs should be brought under price control
( ET Bureau , 7-May-2014 , The Economic Times)

The health ministry has reportedly sought a waiver of drugmaker Bristol-Myers Squibb's (BMS) patent rights for cancer drug Dasatinib, citing an emergency. More...



PDKV becomes guardian of Nagpur orange
(Shishir Arya , 07-May-2014 , The Times Of India)

As the good old Nagpuri Santra gets a special status on the basis of its geographical origin, Akola-based Panjabrao Deshmukh Krishi Vidyapeeth (PDKV) has become the guardian of this household fruit. More...



Bayer to buy Merck arm for $14bn
(TNN , 07-May-2014 , The Times of India, Mumbai.)

Germany’s Bayer has trumped rival bidders for Merck & Co’s consumer care business in a $14.2-billion deal, adding to a string of major cross-border deals in the healthcare industry. “This acquisition marks a major milestone on our path towards global leadership in the attractive non-prescription medicines business,” Bayer’s CEO Marijn Dekkers said in a statement on Tuesday. More...



India spending billions of dollars on IPR imports: ASSOCHAM
(Capital Market , 6-May-2014 , Business Standard)

India is estimated to have spent a tidy sum of over USD five billion in the fiscal 2013-14 on imports of the intellectual property rights (IPRs) clearly negating concerns over India's IPR track record by the countries like the US which has been threatening trade sanctions against New Delhi by putting it under the Priority Watch List under an American trade law, an ASSOCHAM paper on IPR Imports has pointed out. More...



US faces pressure to take India to WTO
(Sidhartha , 6-May-2014 , The Times Of India)

The US government is coming under intense pressure from lawmakers to act against India at the World Trade Organization (WTO) for what they say are violations of patent rules. More...



Intellectual Property Rights Attorneys Association petitions British envoy over mango ban
(PTI , 6-May-2014 , The Economic Times)

With the British Parliament scheduled to debate EU ban on mango imports from India on May 8, the city-based Intellectual Property Rights Attorneys Association (IPRAA) has written to the British high Commissioner in India seeking UK's intervention in the matter. More...



Apple-Samsung jury leaves $120 million patent verdict intact
(Joel Rosenblatt , 6-May-2014 , Livemint)

The jury recalculated damages and arrived at the same grand total as three days ago More...



Government mulls cancer drug patent waiver for Dasatinib
(Sidhartha , 05-May-2014 , The Economic Times)

The health ministry has reopened the issue of waiving a global drug giant's patent rights for Dasatinib, a cancer drug, arguing the move is needed to deal with an "emergency". More...



S wants more transparency on inter-ministerial panel on compulsory license issue
(Joseph Alexander, New Delhi , 05-May-2014 , Pharmabiz)

While keeping India in its `priority watch list’ as in the previous years, the US Trade Representative (USTR) 2014 “Special 301 Report’ has called for greater transparency about the ongoing inter-ministerial process that is considering over a dozen patented medicines as candidates for government- initiated compulsory licenses. More...



Apple vs Samsung: Patents at dispute
(AP , 05-May-2014 , The Times Of India)

Apple and Samsung are suing each other in courts and trade offices around the world, each making claims that the other copied patented mobile device features. More...



Govt mulls cancer drug patent waiver
(Sidhartha , 5-May-2014 , The Times Of India)

The health ministry has reopened the issue of waiving a global drug giant's patent rights for Dasatinib, a cancer drug, arguing the move is needed to deal with an "emergency". More...



US expects its restraint on IPR to pay off after polls
(Shastri Ramachandaran , 5-May-2014 , DNA)

The Obama administration wants American big business, especially Big Pharma, to pause before reviving the push to prise open the Indian market. More...



India Shaken But Not Stirred by US Concerns About Patent Laws
(Sunitha Natti , 04-May-2014 , The New Indian Express)

India had a few anxious moments on April 26, when countries and companies globally observed World Intellectual Property Day. More...



Amarin Pharma files patent infringement case against Dr Reddy's Laboratories on lipid lowering drug, Vascepa
(PTI , 04-May-2014 , The Economic Times)

Dublin-based Amarin Pharma has filed a patent infringement case against Dr Reddy's Laboratories alleging that the latter is attempting to come out with generic versions of its patented drug Vascepa. More...



Make essential drugs affordable for all: Cipla
(PTI , 04-May-2014 , ZeeBiz)

Amid US firms' allegations of patent norm violations against Indian pharma companies, leading domestic drug maker Cipla has said that "essential" medicines be made available to people at affordable rates and should not be sold under "monopoly". More...



Cipla for Making Essential Drugs Affordable for All
(Press Trust of India , 4-May-2014 , profit.ndtv.com)

Amid American firms' allegations of patent norm violations against Indian pharmaceutical companies, domestic drug maker Cipla has said that "essential" medicines should be made available to people at affordable rates and not be sold under "monopoly". More...



Amarin files patent case against DRL on lipid lowering drug
(Press Trust of India | Hyderabad , 04-May-2014 , Business Standard)

Amarin alleges Abbreviated New Drug Application seeking to market generic version would infringe patent of Vascepa on 16 counts More...



Drug MNCs stall generics with RTI
(Rupali Mukherjee , 03-May-2014 , The Times Of India)

A huge spurt in infringement suits (stay orders) recently against domestic drug companies highlight that multinational firms are increasingly using the right to information (RTI) route to enforce intellectual property and block entry of affordable generics. More...



Patent trial: US jury orders smartphone maker Samsung to pay Apple $119.6 mn
( Reuters , 3-May-2014 , The Economic Times)

A US jury on Friday ordered Samsung Electronics Co Ltd to pay $119.6 million to Apple Inc, a big loss for the iPhone maker in the latest round of their globe-spanning mobile patent litigation. More...



US jury says Samsung, Apple both infringed patents
(Reuters , 03-May-2014 , The Times Of India)

A US jury on Friday ordered Samsung Electronics Co Ltd to pay $119.6 million to Apple Inc, a big loss for the iPhone maker in the latest round of their globe-spanning mobile patent litigation. More...



USTR report: Global drug makers, patient groups lock horns over Indian pharma IPR
(C.H. Unnikrishnan , 2-May-2014 , Livemint)

Report retains India on its ‘priority watch’ list of countries that are alleged violators of US patent laws. More...



Patent relief
(Summary , 2-May-2014 , The Indian Express)

India escapes being downgraded by the US for IP violations, with a compelling self-defence. More...



Commerce secy raps US step on IPR issue
(Nayanima Basu , 2-May-2014 , Business Standard)

The Union commerce secretary has rapped the US Trade Representative’s (USTR’s) decision to retain India on that country’s “Priority Watch” (PW) list for various perceived deficiencies in India’s intellectual property rights (IPR) rules. More...



Column: The US IPR hypocrisy
(Biswajit Dhar , 02-May-2014 , The Financial Express)

The USTR Special 301 report on IP violations singles out India for naming and shaming More...



India won't participate in unilateral US probe on IPR
(PTI , 01-May-2014 , The Economic Times)

India today made it clear it will not take part in any unilateral investigation by the US on its intellectual property rights (IPR). More...



India dodges bullet from Big Pharma in patent war
(Chidanand Rajghatta , 01-May-2014 , The Times Of India)

The Obama administration has resisted pressure from the American domestic business lobby, notably Big Pharma, and avoided escalating a simmering trade dispute with New Delhi. More...



India invites U.S. to discuss IP, market access after polls
(Manoj Kumar, NEW DELHI , 01-May-2014 , Reuters)

India said on Thursday it would hold trade talks on intellectual property rights with the United States after its general election, buying time to address friction over drug patents until a new government is formed. More...



India invites US to discuss IPR
(Reuters , 1-May-2014 , The Financial Express)

US wants access to the Indian market for its own firms. More...



US-India business lobby for dialogue on IPR issues
( IANS , 01-May-2014 , The Economic Times)

As the US retained India on its Priority Watch List of ten countries with "growing concerns" about protection of Intellectual Property Rights (IPR), a US-India business advocacy group called for a dialogue on the issue. More...



Apple Inc. vs Samsung Electronics patent case: Jurors end day without verdict
(Associated Press | San Jose , 01-May-2014 , The Indian Express)

California jurors failed to decide a patent-infringement case involving the world's two biggest smartphone makers. More...



India defends IPR laws, won't take part in unilateral US probe
(PTI , 01-May-2014 , ZeeBiz)

Stressing that its IPR regime complies with international laws, India on Thursday bluntly said it will not take part in any unilateral investigation by the US on its intellectual property rights. More...



Intellectual Property Right experts flay EU ban on Indian mangoes
(A Subramani , 30-Apr-2014 , The Times Of India)

While the European Union's ban on Indian mangoes, including the famed Alphonso varieties, set to take effect on May 1, intellectual property right (IPR) attorneys in the country are citing provisions of Free Trade Agreements (FTAs) between EU and India and saying the former should have resolved the issue under the WTO instead of imposing unilateral ban. More...



No downgrade but India still on US priority watch list on intellectual property rights
(Asit Ranjan Mishra , 30-Apr-2014 , Livemint)

US trade representative says it will try to resolve ongoing concerns through bilateral engagement More...



U.S. resists pressure to give India worst offender rating in IP review
(Krista Hughes , 30-Apr-2014 , Reuters)

The United States has resisted lobbying by U.S. drug and pharmaceutical companies to take tougher trade action against India for its intellectual property policies, deciding against risking ties with a likely new government in New Delhi. More...



India not in the worst IPR classification of US
(PTI , 30-Apr-2014 , Zee News)

The US on Wednesday kept India out of Priority Foreign Country list, a worst classification, and said it will hold discussions with the next government in New Delhi on enforcement and protection of intellectual property rights. More...



Respect for intellectual property rights leads to innovation, investment
(Aesha Datta , 30-Apr-2014 , Business Line)

Need to see how India can improve its IP system: US trade chamber official More...



Pfizer isolated in campaign against Indian patent regime, say Indian pharma alliance
(Soma Das , 30-Apr-2014 , The Economic Times)

A grouping of top domestic drugmakers, Indian Pharma Alliance, has told the government that global pharma giant 'Pfizer Inc is getting isolated in its campaign' to push the US to 'downgrade India' to a 'priority foreign country' in a review of its intellectual property (IP) regime. More...



Europe warns Google, Samsung on phone patent abuse
(AP , 29-Apr-2014 , The Economic Times)

The European Commission moved on Tuesday to stem aggressive patent lawsuits by smartphone and tablet makers against rivals, ruling that Motorola Mobility had broken EU law by taking such action against Apple. More...



Novartis files injunctions against 4 cos
(Times News Ntework , 29-Apr-2014 , The Times of India, Mumbai.)

Drug MNCs are aggressively guarding their home turf and taking measures to safeguard against competition. Novartis has filed injunctions in the Delhi high court against four generic companies including Glenmark Generics, Cadila Healthcare, Alembic Pharma and Bajaj Healthcare, preventing them from launching generic versions of its blockbuster anti-diabetic drug Galvus (Vildagliptin). More...



AstraZeneca rejects Pfizer’s 2nd $100bn offer
(Reuters , 29-Apr-2014 , The Times of India, Mumbai.)

US drugmaker Pfizer is working on its next move in a potential $100 billion battle for Britain’s AstraZeneca after having two bids rejected, as deal-making grips the healthcare industry. Pfizer said on Monday it made a 59-billion pounds ($99 billion) bid for AstraZeneca in January and had contacted its British rival again on April 26 seeking further discussions about a takeover. More...



There is a rush for patents
(Madhumathi D. S. , 29-Apr-2014 , The Hindu)

Karnataka working on a new intellectual property policy More...



Alibaba on Patent-Buying Spree May Avoid Tech IPO Pitfall
(Susan Decker , 29-Apr-2014 , Bloomberg)

Alibaba Group Holding Ltd. is beefing up its patent holdings in the U.S., a move that may help avoid the pitfalls that bedeviled Google Inc., Facebook Inc. and Twitter Inc. ahead of their initial public offerings. More...



Apple, Samsung set for closing arguments in patent trial
(AP , 28-Apr-2014 , The Times Of India)

The high-stakes battle between the world's largest smartphone makers is scheduled to wrap up this week after a month-long trial that has pulled the curtain back on just how very cutthroat the competition is between Apple and Samsung. More...



Aurobindo Pharma in patent litigation cases in US
(PTI , 28-Apr-2014 , Livemint)

Three multinational drug makers take Aurobindo to court in separate cases More...



Apple patents technology to prevent texting and driving
(Agencies , 28-Apr-2014 , The Times Of India)

American tech giant Apple has filed a patent application for a system that aims to make texting at the wheel impossible by blocking drivers from sending messages from cellphones. More...



HC asks Centre to reply on appointments in patents panel IPAB
(PTI , 28-Apr-2014 , Zee News)

The Delhi High Court on Monday sought a response from the Centre on a plea seeking quashing of certain provisions that lay down criteria for appointment of Vice Chairman and the judicial member of the patents' panel. More...



Govt Urged to Encourage Patents
( Express News Service - CHENNAI , 28-Apr-2014 , The New Indian Express)

Intellectual Property Rights (IPR) is the next milestone in services sector revolution that’s being engineered by the middle class, said P Vanangamudi, Vice-Chancellor, Tamil Nadu Dr Ambedkar Law University. More...



Apple patent lawsuit against Google revived by US appeals court
(Reuters , 28-Apr-2014 , NDTV)

A U.S. appeals court on Friday revived patent claims Apple made against Google subsidiary Motorola Mobility that were dismissed by an Illinois court shortly before trial. More...



India strikes a balance on IPR regime
(Sudipto Dey | New Delhi , 27-Apr-2014 , Business Standard)

As India awaits the outcome of Special 301 report brought out by the office of the US Trade Representative, an annual survey of countries with lax intellectual property rights regime, the administration is getting ready to set its own IPR house in order. More...



New Apple patent seeks to prevent drivers from texting
(PTI , 27-Apr-2014 , The Economic Times)

American tech giant Apple has filed a patent application for a system that aims to make texting at the wheel impossible by blocking drivers from sending messages on cell phones. More...



Step up patent awareness drive
(Our Bureau , 27-Apr-2014 , Business Line)

There is an urgent need to create IP awareness to augment domestic filing of IP applications, said Amitabh Kant, Secretary, Department of Industrial Policy and Promotion, Ministry of Commerce and Industry. More...



American drug major Abbott backs India’s drug patent regime
(Sidhartha , 26-Apr-2014 , The Times Of India)

The government has received support from an unexpected quarter in its battle against the US on the intellectual property (IP) regime. More...



Ballot Petty' and 'Netamaker' Slug It out over IP Rights
(Nidheesh M K - KOCHI , 26-Apr-2014 , The New Indian Express)

It’s raining apps in Kerala as many companies in the state, both big and small, have developed applications in Android and other platforms; so do controversies. More...



Geological Indications tag for Nagpur orange, Kannauj perfume
(A Subramani , 26-Apr-2014 , The Times Of India)

Intellectual Property Right (IPR) Day is observed on April 26. But the celebrations seem to have reached India a day early. More...



U.S. envoy calls on India to engage in discussions regarding intellectual property rights
(ANI | New Delhi , 26-Apr-2014 , Business Standard)

U.S. Ambassador to India, Nancy Powell, has asked India to engage in discussions related to Intellectual Property Rights (IPR). More...



Innovation that includes
(Shamnad Basheer , 26-Apr-2014 , The Indian Express)

The pharmaceutical industry needs to shed its archaic blockbuster model. More...



India's pharma export growth hits a 15-year low as US holds on to import curbs
(25-Apr-2014 , domian-b.com)

Hit hard by the continuing row over intellectual property rights related to generic equivalents of some patented medicines and regulatory concerns in the West over the quality of India-made drugs, pharmaceutical exports from the country registered the slowest growth in at least 15 years of 1.2 per cent to $14.84 billion last fiscal. More...



India: Robin Hood of the pharma world
(Feroz Ali Khader , 25-Apr-2014 , Business Line)

India’s pro-consumer patent regime is an exciting alternative to the dominant IP model pushed by the US More...



US envoy raises IPR, taxation issues with India
(Nayanima Basu | New Delhi , 25-Apr-2014 , Business Standard)

US had been extremely critical of some of India's trade and industrial policies. More...



Nude patent heels must-have fashion!
(IANS , 25-Apr-2014 , The Times of India)

Nude court shoes are storming up the fashion charts - thanks to the Duchess of Cambridge, who has made them a must-follow trend. More...



U.S. appeals court revives an Apple patent lawsuit against Google
(Diane Bartz and Dan Levine , 25-Apr-2014 , Reuters)

A U.S. appeals court on Friday revived patent claims Apple made against Google subsidiary Motorola Mobility that were dismissed by an Illinois court shortly before trial. More...



Not facing any significant IPR challenges in India: Abbott
(Press Trust of India | Washington , 25-Apr-2014 , Business Standard)

They added that India was an investment priority and fundamentally important to the future of the company. More...



United States’ 1999 assurance to WTO may help India’s IPR case
(Dilasha Seth & Soma Das , 25-Apr-2014 , The Economic Times)

An undertaking given by the United States to a WTO dispute settlement panel on unilateral trade action in 1999 may prove to be an important ammunition in New Delhi's hands if the Obama administration takes action against India on its intellectual property regime. More...



Pfizer complains about India’s intellectual property regime again
(Soma Das , 24-Apr-2014 , The Economic Times.)

In a letter to Jaishankar, India's Ambassador to the US a copy of which was seen by ET, Pfizer's senior vice-president for global policy and international public affairs, Justin McCarthy, has said that "a series of regulatory initiatives and legal challenges have frayed relations between the Indian government and global pharmaceutical firms", and urged the government to "shift from using destructive IP policy as an access strategy" More...



Ericsson takes Intex to court over patent infringement
(Staff Reporter , 24-Apr-2014 , The Hindu)

The Swedish-based company moved the Delhi High Court last week, saying that it was taking legal action after failing to negotiate a licence agreement with Intex for "products compliant with GSM, EDGE, and UMTS/WCDMA standards. More...



Abbott wins patent battle against Glenmark
(BS Reporter , 23-Apr-2014 , Business Standard)

US-based Abbott Labs has won a patent battle against Glenmark Pharmaceuticals related to generic launch of Abbott's version of anti-hypertension drug, Tarka ((trandolapril/verapamil hydrochloride). More...



India businesses unlikely to be affected immediately
(HT Correspondent , 23-Apr-2014 , Hindustan Times )

While Novartis AG, GlaxoSmithKline and Eli Lilly are unclear about the long-term impact of deal on their India businesses, there is unlikely to be any direct or immediate impact. More...



Glenmark Pharma drops after losing appeal to invalidate Abbott's TARKA patent
(Capital Market , 22-Apr-2014 , Business Standard)

Key benchmark indices trimmed intraday gains in early afternoon trade. More...



Samsung files 'patent-infringement' suit against Apple
(ANI , 22-Apr-2014 , Zee News)

Samsung has filed a 'patent- infringement' case against Apple saying that the American multinational infringed the '239 patent in its iPhone through the use of FaceTime. More...



Govt prepares to battle US pressure on patents
(Nayanima Basu | New Delhi , 22-Apr-2014 , Business Standard)

Top officials meet amid apprehension of sanctions under US law; decide to take Washington to the World Trade Organization if such action taken. More...



Glenmark loses patent case to Abbott; stock plunges
(R. Yegya Narayanan , 22-Apr-2014 , Business Line)

Shares of Glenmark Pharmaceuticals were down by Rs 17.45 on the BSE after the company said it has lost its appeal to invalidate Abbott Laboratories' Tarka (trandolapril/verapamil hydrochloride) patent in a US court. More...



Boost for Natco Pharma as Teva denied stay in Copaxone patent fight
(Lawrence Hurley , 21-Apr-2014 , Livemint)

US Supreme Court denies Teva’s request to stay ruling that favours developers of generic versions of Copaxone. More...



We need to open up defence 100 pc to FDI: Amitabh Kant, DIPP secretary
(ET Bureau , 21-Apr-2014 , The Economic Times)

Compulsory licensing has been over talked about. More...



India-US ties headed for rough weather over drug IP issue
(Amiti Sen , 20-Apr-2014 , Business Line)

Facing the threat of sanctions by the US for what it terms India’s lax intellectual property (IP) rules, the Commerce Ministry is studying the possible impact on trade with the US if Washington goes ahead with its action. More...



Patent rights meet on US concerns
(BS Reporter | New Delhi , 19-Apr-2014 , Business Standard)

Cabinet Secretary Ajit Seth will on Monday meet officials from various ministries to discuss concerns raised by the US on India’s management of intellectual property rights (IPRs), it is learnt. More...



On Mobile settles patent infringement dispute with US firm
(Agencies , 19-Apr-2014 , The Times Of India)

Mobile VAS company OnMobile has settled a patent infringement case with US-based Synchronoss Technologies for $ 3 million or about Rs 18 crore. More...



Committee of secretaries to take up Indo-US IPR issues
(fe Bureau | New Delh , 19-Apr-2014 , The Financial Express)

A committee of secretaries, led by cabinet secretary Ajit Seth, will meet next week to discuss the issues related to India’s intellectual property rights and the concerns raised by the US on the same. More...



Insecticides (India) gets patent for insecticide preparation process
(PTI , 18-Apr-2014 , The Economic Times)

Agrochemical firm Insecticides (India) Ltd has been granted a patent for the preparation process of a chemical compound to control pests. More...



Apple-backed patent group Rockstar loses bid to move Google case
(Reuters , 18-Apr-2014 , The Times Of India)

A US judge on Thursday rejected a request by patent consortium Rockstar to transfer patent litigation from Google's home turf in California to Texas, according to a court ruling. More...



‘Patent laws for IT sector needs clarity’
(Our Bureau , 16-Apr-2014 , Business Line)

The need for clearer regulations with regard to patents for computer-related inventions was underlined by experts at the two-day executive programme on Strategic Intellectual Property Management for Electronics and IT Sector, which began here today. More...



Cadila, Depomed Inc settle patent dispute
(BS Reporter | Ahmedabad , 15-Apr-2014 , Business Standard)

The settlement permits Cadila and Zydus to begin selling generic versions of Gralise More...



NSE alleges software trademark violation; sues domain registrar
( Khushboo Narayan | Malvika Joshi , 15-Apr-2014 , Livemint)

The firm drags GoDaddy and a Hyderabad-based tech firm to court over alleged copyright and trademark infringement of its software. More...



Indian laws should not be considered discriminatory: Group
(Press Trust of India | Washington , 15-Apr-2014 , Business Standard)

Asserting that Indian patent and pharma laws falls within the bounds of what is allowed under the rules of the World Trade Organization, a top American non-profit consumer rights advocacy group has said Indian pharma laws should not be considered discriminatory. More...



Novartis Sues Dr Reddy's Labs Over Patent Infringement
(ENS Economic Bureau - HYDERABAD , 15-Apr-2014 , The New Indian Express)

Novartis Pharmaceuticals Corporation moved the District Court of Delaware, US against city-based Dr Reddy’s Laboratories Ltd (DRL) for alleged infringement of its patents. More...



Cadila, Depomed settle US patent dispute on neuro pain drug Gralise
(C.H. Unnikrishnan , 15-Apr-2014 , Livemint)

Cadila can now launch its generic version of Gralise in the US soon after the expiry of Depomed’s original patent. More...



Indian patent and pharma laws should not be considered discriminatory: Public Citizen
(PTI , 15-Apr-2014 , The Economic Times)

Asserting that Indian patent and pharma laws falls within the bounds of what is allowed under the rules of the World Trade Organization, a top American non-profit consumer rights advocacy group has said Indian pharma laws should not be considered discriminatory. More...



Are intellectual property and patent laws hampering innovation, research and development?
(Ruchi Kumar , 14-Apr-2014 , DNA)

With over 200,000 filings, 2013 saw the highest intellectual property applications, says UN report. More...



FICCI discusses IPR issue with US delegation
(PTI , 14-Apr-2014 , Buisness Line)

Industry body FICCI today raised the issue of US proposal to declare India as a ‘Priority Foreign Country for IPR violations with a visiting delegation of American companies. More...



Are intellectual property and patent laws hampering innovation, research and development?
(Ruchi Kumar , 14-Apr-2014 , DNA)

With over 200,000 filings, 2013 saw the highest intellectual property applications, says UN report. More...



Natco moves to oppose Gilead hepatitis C drug patent
(Ramnath Subbu , 12-Apr-2014 , The Hindu)

Under India’s patent laws, a third party can dispute the validity of a pending patent application. More...



Experts highlight importance of intellectual property rights
(TNN , 11-Apr-2014 , The Times Of India)

Protecting intellectual property right is very important. More...



Natco seeks to block Gilead’s drug
(REUTERS , 11-Apr-2014 , The Times of India, Mumbai.)

Natco Pharma has formally asked the Indian patent office to deny US drug maker Gilead Sciences’ new Hepatitis C drug Sovaldi a patent in India, a source with direct knowledge of the matter said. If successful, the move could clear the way for the Indian company to launch a cheap generic version of the drug. More...



Sun Pharma Refutes Allegations of Insider Trading Ahead of Ranbaxy Acquisition
(Our Bureau, Mumbai. , 10-Apr-2014 , The Economic Times.)

Sun Pharma on Wednesday refuted allegations of insider trading by Sudhir Valia, the executive director and brother-in-law of managing director Dilip Shanghvi, in the run-up to the Ranbaxy deal. More...



SAIL encashes bank guarantees of re-rollers misusing its trademark
(ENS Economic Bureau | New Delhi , 10-Apr-2014 , The Financial Express)

Over more than a year, SAIL has been receiving tip-offs that spurious steel products bearing its trademark have flooded marketsmarkets across the country. More...



Natco seeks to block Gilead's hepatitis C drug patent in India - source
(Zeba Siddiqui , 10-Apr-2014 , Reuters)

India's Natco Pharma Ltd (NATP.NS) has formally asked the Indian patent office to deny U.S. drugmaker Gilead Sciences Inc's (GILD.O) new hepatitis C drug Sovaldi a patent in India, a source with direct knowledge of the matter said. More...



SUN-RANBAXY DEAL: Pharma MNCs May Need New Prescription for Growth Here
(Divya Rajagopal , 10-Apr-2014 , The Economic Times.)

Sun Pharmaceutical’s acquisition of Ranbaxy Laboratories, the largest consolidation move in the Indian market, may force multinational pharmaceutical companies to change their strategy considering that the combined entity will become the country’s largest drug maker and the fifth-largest generic company in the world. It will command a turnover of $4 billion globally, while in India it will have estimated sales of . 6,921 crore More...



ONE-ON-ONE Israel Makov | CHAIRMAN, SUN PHARMA
(Rupali Mukherjee TNN , 10-Apr-2014 , The Times of India, Mumbai.)

Admitting there are “challenges” in every acquisition, and even in this one, Sun Pharma chairman Israel Makov expressed confidence in handling them, including the sticky FDA issue which has been plaguing Ranbaxy over the past six years. In an interview with TOI, he said the company will reconsider whether it wants to use the Ranbaxy brand in the US — its largest and most lucrative market, and where it has faced a huge distrust. On the manpower front, he said the plan is to keep everyone who is good. Excerpts… More...



D-St questions Ranbaxy spike
(Times News Ntework , 10-Apr-2014 , The Times of India, Mumbai.)

The 33% rise in Ranbaxy’s stock in just six days prior to the announcement of its merger with Sun Pharma has come under public scrutiny, raising pressure on market regulator Sebi to dig deeper into the trading patterns in the counter for any possible violations of securities laws. More...



Samsung should pay over $2 bln for patent infringement: Apple
(ANI | Washington , 09-Apr-2014 , Business Standard)

The figure comes from evaluating the scale of infringement, time span and the head-to-head rivalry between Apple and Samsung More...



Rovi loses patent fight with Amazon
(Reuters , 09-Apr-2014 , The Times Of India)

Rovi has lost a patent fight with Amazon.com when a federal appeals court upheld a US district judge's ruling in favour of the world's largest online retailer. More...



Popular Ghee Brand Loses Trademark
(Express News Service - CHENNAI , 09-Apr-2014 , The New Indian Express)

The Intellectual Property Appellate Board cancelled the trademarks ‘Udhayam’ and ‘GRB’s Udhayam’ of a popular ghee brand in the southern States in an order passed by the board on Friday. More...



Court relief on NTT Docomo’s patent plea for network tech
(Sajan C Kumar | Chennai , 08-Apr-2014 , The Financial Express)

In a major relief to Japan-based telecommunication major NTT Docomo More...



BlackBerry wins patent lawsuit against NXP in the US
(Reuters , 08-Apr-2014 , NDTV)

A federal jury in Florida on Monday ruled in favor of Blackberry Ltd in a lawsuit accusing the company of infringing three patents belonging to Dutch semiconductor company NXP BV. More...



Teva's patent plea rejected in US: Natco
(TNN , 7-Apr-2014 , The Times Of India)

Hyderabad-based Natco Pharma said on Friday in a BSE filing that the US Patent and Trademark Office has issued a final office action rejecting Israel-based Teva Pharma's application on its blockbuster drug Copaxone. More...



US Patents rejects Teva's plea on Copaxone; Natco shares up
(ET Bureau. , 5-Apr-2014 , The Economic Times)

The US Patent and Trademark Office has rejected the application of Israel's Teva Pharmaceutical seeking re-issue of patent for its blockbuster multiple sclerosis drug Copaxone. More...



Apple loses bid to show patent use in trial
(Bloomberg | San Jose/ California , 5-Apr-2014 , Business Standard)

Apple Inc, accusing Samsung Electronics Co of misleading jurors at the start of a $2-billion trial over smartphone technology, lost its bid to show jurors how it uses three of five patents disputed in the case. More...



Poll fever cure: Ragaflam, Namo tablets fly off pharmacy shelves
(Rahul Anand TNN , 5-Apr-2014 , The Times of India, Mumbai.)

As election fever grips the country, Namo and Ragaflam tablets, named after BJP’s Narendra Modi and Congress’s Rahul Gandhi, are flying off pharmacy shelves. Neither Modi nor Rahul may have all the answers to what ails the nation, but generic drugs named after them are certainly getting people’s votes. More...



Biocon rejects Novartis patent accusations
(AFP , 04-Apr-2014 , Livemint)

Biocon has a reputation for respecting all valid intellectual property and intends to operate within the applicable laws, the firm said More...



Novartis sues Biocon for patent breach
(BS Reporter | Zurich , 4-Apr-2014 , Business Standard)

According to industry estimates, Galvus, one of the best-selling medicines of Novartis, clocks Rs 200 crore of sales annually More...



Samsung: Patents Developed by Google Engineers
(AP , 03-Apr-2014 , The New Indian Express)

Samsung fired back at Apple's accusations of patent theft Tuesday, saying the South Korean tech giant didn't write any of the Android software on its smartphones and tablets, Google did. More...



IPAB defers hearing on trademark dispute between Diageo, Khoday
(BS Reporter | Chennai , 03-Apr-2014 , Business Standard)

Dispute is on Khoday Brewing's registration of 'Black Label' for beer More...



Lupin Approaches Cabinet Secy to Push FII Cap Proposal
(Deepshikha Sikarwar & Soma Das, New Delhi. , 3-Apr-2014 , The Economic Times.)

Lupin has approached the nation’s senior most bureaucrat, seeking his intervention to secure approval to increase foreign institutional investor (FII) holding in the pharmaceutical major to 49% from 33%, according to a person with knowledge of the matter. More...



Torn Records Led to Sun Plant’s Ban
(Soma Das, New Delhi , 3-Apr-2014 , The Economic Times.)

Torn documents, partially destroyed raw data showing undesirable results and unclean toilets were among the reasons cited by the US drug regulator for the ban it imposed last month on a Gujarat based facility of Sun Pharma, the largest Indian drugmaker by market capitalisation. More...



PE ChrysCap invests $40m in Torrent Pharma
(Rupali Mukherjee TNN , 3-Apr-2014 , The Times of India, Mumbai.)

Private equity firm ChrysCapital has invested around $40 million in drug company Torrent Pharma, expanding its portfolio of healthcare companies and taking up the total exposure in the sector to nearly $300 million. ChrysCapital, which has over $2.5 billion assets under management in India, will hold the largest non-promoter stake — of around 3% — in the drug firm, sources close to the development told TOI. More...



Novartis sues Biocon for patent infringement on Galvus
( Archana Shukla, CNBC-TV18 , 03-Apr-2014 , MoneyControl)

In yet another patent infringement battles in India, Swiss drug maker Novartis has taken Indian biotech firm Biocon to court on anti-diabetes drug. More...



Compulsory licence for another cancer drug?
(Amiti Sen , 2-Apr-2014 , Business Line)

DIPP wants to know why generic version of Bristol-Myers Squibb’s drug is needed More...



Samsung puts 'blame' on Google in Apple patent trial
(AP , 2-Apr-2014 , The Times Of India)

Samsung fired back at Apple's accusations of patent theft, saying the South Korean tech giant didn't write any of the Android software on its smartphones and tablets, Google did. More...



GI tags stopped as poll code is in force
(R. Sivaraman , 2-Apr-2014 , The Hindu)

The tags help identify goods — originating from a definite territory — with special characteristics More...



Chipmaker Marvell fined $1.54 billion over patent violation
(Reuters , 2-Apr-2014 , The Times Of India)

A federal judge ordered Marvell Technology to pay nearly $1.54 billion to Carnegie Mellon University for selling billions of semi-conductors that infringed the school's two hard disk drive patents. More...



Natco Pharma, Teva Patent Row Now in US Court
(ENS Economic Bureau - HYDERABAD , 2-Apr-2014 , The New Indian Express)

Natco Pharma Ltd’s plan to sell multiple sclerosis drug Copaxone is likely to be further delayed with the patent battle between Natco and the innovator company Teva Pharmaceutical Industries Ltd among others, entering a new phase. More...



Apple and Samsung trade barbs as new patent trial opens
(AFP , 2-Apr-2014 , The Economic Times)

Lawyers for Apple and Samsung exchanged barbs as a major new patent trial opened Tuesday, and debated the role of a company not even part of the case. Google. More...



Copyright Suit Against Bieber, Usher Dismissed
(AP - NORFOLK, VIRGINIA , 01-Apr-2014 , The New Indian Express)

A judge has dismissed a $10 million lawsuit that claimed Justin Bieber and Usher copied parts of a song written by two Virginia songwriters. More...



Intellectual property office mops up 282cr despite staff crunch
(A Subramani , 31-Mar-2014 , The Times Of India)

Despite battling severe staff crunch and requiring critical infrastructure, the intellectual property office has mopped up more than Rs 282 crore in revenue for 2012-13. More...



US Supreme Court to scrutinise eligibility of software for patent protection
(Reuters , 31-Mar-2014 , NDTV)

The U.S. Supreme Court will on Monday delve into the hotly contested question of when software is eligible for patent protection. More...



Patent trolls target US businesses, consumers ultimately foot the bill
( Heesun Wee , 31-Mar-2014 , CNBC)

Patent asserting groups that bully businesses and entrepreneurs into paying licensing fees or settlements—as opposed to actually using the patents—are not new, especially in the technology space. More...



In trademark battle, TN co beats US clothing giant
(Manish Raj , 29-Mar-2014 , The Times Of India)

In another example of David trouncing Goliath, an Erode-based hosiery manufacturer has humbled a US clothing giant by staving off a trademark infringement suit. More...



First Case: Ed Seizes Assets for Faking SAIL Trademark
(PTI - NEW DELHI , 28-Mar-2014 , The New Indian Express)

In the first case of money laundering charges being slapped for violation of the Trade Marks Act in the country, the Enforcement Directorate has seized Rs 7 crore assets of two Chhattisgarh based firms for allegedly fake branding of public sector SAIL. More...



Corning joins growing US firms doing business in India
(Yashwant Raj , 28-Mar-2014 , Hindustan Times)

They had heard harrowing stories about infrastructure, bad patent laws. More...



Cisco sued by Spherix for patent infringement
(Reuters , 27-Mar-2014 , The Times Of India)

Spherix Inc, which buys and licenses technology patents, said it filed a lawsuit against Cisco Inc alleging infringement of 11 patents Spherix acquired from Nortel Networks. More...



New-age zamindars
(Bhupesh Bhandari | New Delhi , 27-Mar-2014 , Business Standard)

Thanks to the regime of product patents India inherited, home-grown companies like Cipla found their attempts to make medicines blocked by multinationals. More...



Cheaper Versions of Cancer Drug Dasatinib Will Have to Wait
(Dilasha Seth & Soma Das, New Delhi , 27-Mar-2014 , The Economic Times.)

The department of industrial policy and promotion (DIPP) has shot down a health ministry proposal to consider a government-initiated compulsory licence (CL) for cancer drug Dasatinib on the ground that it is unaffordable. This comes at a time when the US is reviewing India’s intellectual property regime that, in the worst case, could lead to trade sanctions. More...



Patent opportunis
(Feroz Ali Khader , 27-Mar-2014 , The Indian Express)

India’s trailblazing balance of patent law and necessary access falls foul of an IP index released by US companies. More...



Apple wins patent ruling against Samsung in Japan
(ANI , 26-Mar-2014 , The Times Of India)

Apple has won another legal bout against Samsung in its ongoing patent row. More...



IPAB stays revocation of Pfizer's patent on drug Detrol
(Gireesh Babu | Chennai , 26-Mar-2014 , Business Standard)

Justice K N Basha says that Ranbaxy had enough time to appear and argue the matter of stay petition More...



Patent seal on device to check vehicle pollution
(Abhijeet Patil , 26-Mar-2014 , The Times Of India)

A motor mechanic from Tardel, a non-descript village around 30km from Kolhapur, has earned the patent for a device developed by him, which he claims can bring down fuel consumption in both two- and four-wheelers. More...



Apple wins another legal bout against Samsung in patent row
(ANI | Washington , 26-Mar-2014 , Business Standard)

Samsung said it will analyze the decision and possibly appeal it More...



Indian generic drug firms court US off-patent market
(Pallavi Ail , 25-Mar-2014 , Financial Express)

With $32 billion worth of drugs going off patent in the next two years. More...



Plea against Gilead's patent bid
(TNN , 25-Mar-2014 , The Times Of India)

A patient group and a UK-based intellectual property law firm have together filed a patent opposition before the Delhi Patent Office to prevent US-based pharma company Gilead from gaining protection on a life-saving hepatitis-C drug in India. More...



IPAB to take up Wockhardt plea against Novartis
(Gireesh Babu | Chennai , 25-Mar-2014 , Business Standard)

The Intellectual Property Appellate Board (IPAB) has decided to proceed with the hearing of a revocation petition by Wockhardt against the patent of a diabetes drug of Swiss pharma major Novartis, even as a dispute between the parties on an alleged infringement of patent of the same product is pending with the Delhi High Court. More...



Delay in Microsoft deal may lead to more Nokia patent concessions
(Reuters , 24-Mar-2014 , NDTV)

Nokia does not expect to close the sale of its phone business to Microsoft until April as talks with Asian regulators drag on, it said on Monday, fuelling speculation it may have to make technology patent concessions to get the deal done. More...



Friction over drug patents
(24-Mar-2014 , The Hindu)

Differences over intellectual property rights (IPRs) have emerged as a strong undercurrent in India’s economic relations with the U.S. More...



India ready to discuss intellectual property rights norms at WTO if US wants: Anand Sharma
(PTI , 23-Mar-2014 , The Economic Times)

Rejecting US allegations related to intellectual property rights (IPR), India said that it is ready to discuss the matter at WTO as it has not breached any international agreement. More...



Changes to India's patent law will impact prices of life-saving drugs
(Rupali Mukherjee , 23-Mar-2014 , The Times Of India)

India's trade and investment policies, particularly balancing right to health with intellectual property and public health safeguards, are being questioned in a US investigation. More...



Indian pharma sector still attractive for foreign investors
(C.H. Unnikrishnan , 23-Mar-2014 , Livemint)

Section 3(d) of India’s patent law that denies patent protection for modified forms of already known drugs, unless they are proved to result in higher therapeutic benefits, has irked many foreign drug makers. More...



IPAB to take up Wockhardt plea against Novartis
(Gireesh Babu | Chennai , 22-Mar-2014 , Business Standard)

A patent infringement case between the two over a diabetes drug is pending with the Delhi HC. More...



Health organisations demand affordable access to oral HCV drugs; oppose patent on new hepatitis C drug
(Our Bureau , 22-Mar-2014 , Pharmabiz)

With the availability of oral drugs promising to simplify and improve hepatitis C treatment in India, the Delhi Network of Positive People wants the ministry of health to start rolling out treatment with the same, for the millions of patients waiting. More...



Apple's new patent hints at stylus for iPad
(Techradar , 21-Mar-2014 , The Times Of India)

Apple's latest patent is titled simply "Input Device Having Extendable Nib," but don't let that fool you; this may be the long-awaited iStylus. More...



Pharma firm gets FDA notice
(Maitri Porecha , 21-Mar-2014 , DNA)

Drug authority issues notices to Wockhardt’s three plants in Aurangabad and seeks explanation on poor compliance with good manufacturing practices. More...



Quality Woes Point to a Generic Drugs Shake-out: Novartis CEO
(Ben Hirschler & Caroline Copley, Basel, Switzerland. , 21-Mar-2014 , The Economic Times.)

Recent manufacturing problems in India suggest some makers of generic drugs will struggle to compete in the face of a rising quality bar, pointing to a likely shake-out in the low-cost sector, according to Novartis. Chief executive Joe Jimenez said the Swiss group’s Sandoz unit — a world leader in making cheap off-patent medicines — was well placed to thrive in an era of tougher standards. More...



Indian Data Comes in Handy for US Tirade against Sub-standard Drugs
(Our Bureau, New Delhi , 20-Mar-2014 , The Economic Times.)

About 2.3% of drugs tested by the Drug Controller General of India (DCGI) since December 2012 were found to be sub-standard. As many as 1,123 samples were tested of which 26 failed to qualify, according to a surveillance report prepared by the central drug regulator early this month. More...



Merck HIV drug strategy in India seen shielding patent
(Ketaki Gokhale , 20-Mar-2014 , Livemint)

Merck is set to sell an HIV medication in India by mid-year in partnership with local company Cipla More...



US leads the world in use of compulsory licenses: KEI
(PTI , 20-Mar-2014 , The Economic Times)

While the US Government and strong American pharma sector have been up in arms against India for issuing compulsory licence in the sector, an eminent global non-governmental organisation has said that it is the United States which leads the world in use of compulsory licenses. More...



Google, Viacom Settle YouTube Copyright Suit
(PTI - NEW YORK , 18-Mar-2014 , The New Indian Express)

Google and Viacom announced a settlement today in a long-running lawsuit claiming the Internet giant's YouTube video-sharing site promoted copyright infringement. More...



On intellectual property, a new strategy
(Meir Perez Pugatch , 17-Mar-2014 , The Indian Express)

India could use IP rights to take its rightful place as a leader in global innovation. More...



India undermining intellectual property: Pfizer
(PTI , 14-Mar-2014 , The Economic Times.)

Months after its patent for a cancer medication was revoked by India, American firm Pfizer has told US lawmakers that New Delhi is undermining intellectual property by misuse of its compulsory licence provisions. More...



Google unmasks patent accuser
(Bloomberg | Washington , 14-Mar-2014 , Business Standard)

Google Inc wanted to find out who was behind a company called Suffolk Technologies LLC that accused the world's largest search engine's owner of using its internet-search technology without permission. More...



FICCI lambasts US for pressurising India to increase IPR protection beyond TRIPS
(Our Bureau, Mumbai , 14-Mar-2014 , Pharmabiz)

The Federation of Indian Chambers of Commerce and Industry has taken strong exception to the effort being made by the US to declare India as 'Priority Foreign Country' under the Special 301 provisions of the US Trade Act of 1974. More...



US firms like Honeywell and Boeing, professors back India on patent regime
(Dilasha Seth , 14-Mar-2014 , The Economic Times)

Leading US companies such as Honeywell and Boeing, and professors of US universities have backed India before the US by shopping-chip" More...



Drug makers pump up injectables as US patent cliff looms
(Pallavi Ail , 13-Mar-2014 , Financial Express)

Indian and foreign generic drug makers seem to focus increasingly on the relatively fast-growing injectables segment to ramp up their revenues. More...



How to strengthen India's case on intellectual property rights
(ET Bureau , 12-Mar-2014 , The Economic Times)

New Delhi is well within its rights to rebuff the US pharma lobby's attempt to label India a habitual intellectual property rights offender. More...



Big Pharma still betting on "messed up" Indian drugs market
(Ben Hirschler and Zeba Siddiqui , 12-Mar-2014 , Reuters)

Global drugmakers have had a nauseous time in India's $14 billion market. More...



The thorn in India-US business ties
(Arvind Subramanian , 12-Mar-2014 , Business Standard)

As the Office of the US Trade Representative (USTR) turns its lens on India's intellectual property and patents regime, Business Standard brings you what Arvind Subramanian, columnist and economist, More...



Strand Lifesciences’ virtual liver gets US patent
(Our Bureau , 12-Mar-2014 , Business Line)

Strand Lifesciences has received a US patent for virtual liver, which would aid the pharmaceutical industry in understanding liver-related issues better. More...



US and India could accomplish a lot together: Obama
(Chidanand Rajghatta,TNN , 12-Mar-2014 , The Times of India)

India's new ambassador to the United States, Dr S Jaishankar, presented his credentials to President Obama at the White House on Monday in a formal ceremony at which the American President essayed an anodyne ''the U.S and India could accomplish a lot together,'' at a time New Delhi has largely fallen off Washington's radar, in part because of India's pre-occupation with the general elections. More...



How to strengthen India's case on intellectual property rights
(ET Bureau , 12-Mar-2014 , The Economic Times)

New Delhi is well within its rights to rebuff the US pharma lobby's attempt to label India a habitual intellectual property rights offender. More...



Sun Pharma recalls batch of drug in US
(Times News Ntework , 11-Mar-2014 , The Times of India, Mumbai.)

Following Ranbaxy’s drug recall in the US, another domestic company, Sun Pharma has recalled 2,528 bottles of its generic version of diabetes drug Glumetza. More...



Indian patent laws sound, unchallenged: Drug companies tell US International Trade Commission
(Soma Das , 11-Mar-2014 , The Economic Times)

The World Health Organization has strongly endorsed India's patent laws and no country, including the United States, has challenged these laws at the WTO claiming that these infringe trade-related intellectual property rights, Indian drugmakers have told the US International Trade Commission. More...



Clinical trials: SC asks govt to give details on deaths
(Agencies , 11-Mar-2014 , The Times of India, Mumbai.)

he Supreme Court on Monday directed the Centre to provide details on the number of deaths and severe adverse effects caused to people who were subjected to clinical trials. More...



Indian patent laws sound, unchallenged: Drug companies tell US International Trade Commission
(Soma Das , 11-Mar-2014 , The Economic Times)

The commission, a quasi-judicial body set up by the US Congress, is investigating whether Indian policies discriminate against American manufacturers and is due to submit its views later this year. More...



GSK pays $1bn to up stake in Indian arm to 75% from 50.7%
(Times News Ntework , 11-Mar-2014 , The Times of India, Mumbai.)

GlaxoSmithKline Plc has increased its stake in its Indian pharma subsidiary, GlaxoSmithKline Pharmaceuticals, from 50.7% to 75%, following a recent open offer. The company announced that the subsidiary will remain publicly-listed. The offer of Rs 3,100 per share values the transaction at approximately Rs 6,400 crore ($1 billion). More...



Cipla may put patent for new HIV drug in open access pool
(C.H. Unnirkishnan , 10-Mar-2014 , Livemint)

Cipla says product under development, doesn’t have a time frame for completion as yet More...



U.S. pharma companies benefit from large Indian generic market
(Ramnath Subbu , 9-Mar-2014 , The Hindu)

The tirade by the U.S. against India with regard to its ‘unfriendly’ business environment, particularly the Indian pharmaceutical sector, is largely misplaced according to the Indian Pharmaceutical Alliance. More...



A flimsy case against Indian pharma
(Mike Palmedo , 09-Mar-2014 , Business Line)

Much of the controversy surrounds flexibilities in Indian patent law designed to promote access to generic medicines. More...



MNC buys Mangalore fisheries college's patent
(Staff Correspondent , 8-Mar-2014 , The Hindu)

In a major boost for the research capabilities of the College of Fisheries in Mangalore city, its patent on a shrimp disease testing kit will be sold to a private multinational company for mass distribution. More...



Seed savers network formed to fight intellectual property rights by corporations
(Jayashree Nandi , 07-Mar-2014 , The Times of India)

Farmers from 15 states are all set to form a national seed savers network that will be one of the largest repositories of seeds for crops and vegetables in India. More...



Sun Pharma Seeks to Enter Japan Via Buys, Deals
(REUTERS , 07-Mar-2014 , The Economic Times.)

Sun Pharmaceutical Industries, India’s biggest drugmaker by market value, is looking for partnerships or acquisitions to enter Japan, an especially lucrative market for manufacturers of low-cost drugs, a senior executive said. More...



Patent office issues draft pharma norms
(C.H. Unnikrishnan , 7-Mar-2014 , Livemint)

The guidelines are aimed at minimizing the risk of patent litigations of the kind that Novartis AG fought for seven years over its cancer drug Glivec. More...



U.S. fears for patents on next-generation drugs in India
( Douglas Busvine and Zeba Siddiqui , 06-Mar-2014 , Reuters)

The United States on Thursday voiced concern over protection of patents on safer and more effective next-generation medicines in India amid fears that authorities are considering allowing more Indian firms to make new varieties of cheap generic drugs still on patent. More...



Now, Indian industry raises its voice against US
(Nayanima Basu | New Delhi , 06-Mar-2014 , Business Standard)

High chances that US in its Special 301 report will put India as 'Priority Foreign Country' More...



Patent filing fees doubled for cos, up 60% for individuals
(Rupali Mukherjee , 6-Mar-2014 , The Times Of India)

Invention and innovation will now cost more. More...



Targeting India’s IP laws undermines WTO’s legitimacy’
(PTI , 6-Mar-2014 , Business Line)

A Geneva-based inter-governmental organisation of developing countries has slammed America and developed world countries for pressurising India over its IP (intellectual property) laws, which it alleged undermines the legitimacy of WTO. More...



Patent attorneys demand fair deal for Indian applicants
(A Subramani , 5-Apr-2014 , The Times Of India)

Highlighting a major anomaly in the Indian Patents Act, 1970 which provides for fast-track award of patent to foreign entities, attorneys specializing in patents have demanded similar facility for individuals and companies from India as well. More...



Sharma Accuses US of Trade Protectionism
(Our Bureau, New Delhi , 5-Mar-2014 , The Economic Times,Mumbai)

Commerce and industry minister Anand Sharma on Tuesday accused the United States of protectionist trade policies while asserting that India’s trade and intellectual property rights are compliant with the respective multilateral regimes. More...



PSU Insurers may Stay Out of GSK Open Offe
(Dheeraj Tiwari & Soma Das, New Delhi , 5-Mar-2014 , The Economic Times,Mumbai)

State-run financial institutions Life Insurance Corporation, General Insurance Corporation of India and Oriental Insurance are unlikely to take part in UK drug maker GlaxoSmithKline’s ongoing open offer to shareholders of its Indian subsidiary GlaxoSmithKline Pharmaceuticals. More...



India’s IPR regime in line with global pacts: Sharma
(Times News Ntework , 5-Mar-2014 , The Times of India, Mumbai.)

The government on Tuesday said its laws on intellectual property were fully in line with global agreements and rejected arguments that New Delhi had not followed global practices. More...



Sanofi files cases against Glenmark on patent infringement
(PTI , 05-Mar-2014 , The Economic Times)

French drug-maker Sanofi filed patent infringement petition against Glenmark on cardiac drug Multaq, in the district court of Delaware, on three counts. More...



India must call the US' bluff on patents
(Arvind Panagariya , 04-Mar-2014 , Business Standard)

Apart from the deterioration of the business environment generally, which impacts both domestic and foreign investors, retrospective taxation has figured most prominently in the media as the principal cause of growing scepticism among foreign investors. More...



Foundation stone laid for Intellectual Property Appellate Board building in Chennai
(Manish Raj , 04-Mar-2014 , The Times Of India)

Supreme Court judge Justice F M Ibrahim Kalifulla has laid the foundation stone for a new building of the Intellectual Property Appellate Board (IPAB) at Kelambakkam on the outskirts of Chennai. More...



Anand Sharma accuses US of protectionism, says India's patent laws WTO compliant
(Reuters , 04-Mar-2014 , Business Standard)

Says has approached finance ministry to ease gold import curbs More...



Is the Indian patent regime weak?
(4-Mar-2014 , The Financial Express)

India's Patent Act is no weak IPR regime given its ability to scupper ever-greening bids through an innovation filter. More...



Cadila R&D unit served closure notice over pollution
(Paul John TNN , 4-Mar-2014 , The Times of India, Mumbai.)

The Gujarat Pollution Control Board (GPCB) has issued closure notices to the research wing of pharma major Cadila Healthcare— Zydus Research Centre (ZRC)—at Changodar on the outskirts of Ahmedabad. The notice was issued on March 1 after the company was found allowing waste water from its laboratories to percolate through a dead borewell into an underground aquifer. More...



Outside the patent monopolies
(Ritu Kamal , 4-Mar-2014 , The Indian Express)

India’s role in pharmaceutical patent wars has broadened access to healthcare. More...



AstraZeneca Jumps 20% on Delisting Plan
(Our Bureau, Mumbai , 4-Mar-2014 , The Economic Times,Mumbai)

British drug maker AstraZeneca’s India unit has revived its plan of delisting the company from the stock markets, an announcement about which sent the company’s shares soaring 20% to hit the upper circuit on the BSE on Monday. More...



Google, Samsung said to express Microsoft-Nokia concern to China
(Steven Yang , 03-Mar-2014 , Livemint)

Google, Samsung express concern that Microsoft’s bid to take over Nokia may result in higher patent licensing fees. More...



Natco wins Indian patent dispute case
(Special Correspondent , 03-Mar-2014 , The Hindu)

Natco Pharmaceuticals, the Hyderabad-based drug manufacturer, has won a patent case against Teva Pharmaceuticals of Israel. More...



Novartis Chief Rules out Merger with Rival Roche
(Reuters Zurich , 3-Mar-2014 , The Economic Times,Mumbai)

Swiss pharma group Novartis will work more closely with rival Roche but rules out a merger, its chairman said in a newspaper interview on Sunday. Asked whether the two companies wanted to stay independent, Joerg Reinhardt, who took over as Novartis chairman in August, told Swiss newspaper SonntagsZeitung: “Absolutely.” More...



Sequoia Looks to Exit GVK Bio
(Sneha Shah , 3-Mar-2014 , The Economic Times,Mumbai)

Venture capital fund Sequoia Capital is looking to exit its seven-year-old investment in GVK Group’s GVK Biosciences, a biotech research and development outsourcing company. The fund has appointed investment bank Avendus to look for buyers for its 20% stake in the company, said three people with knowledge of the development More...



Bid to get GI tag for Tirunelveli 'halwa', Tuticorin macaroons
(TNN , 3-Mar-2014 , The Times Of India)

After 'Kancheepuram Silk', 'Madurai Malli' and Coimbatore wet grinders, makers of 'Tirunelveli Halwa', famous for its taste and long shelf-life and Tuticorin macaroons, an Indianised dish of European macaroons, are trying to get Geographical Indication tag. More...



Innovation Incubator
(Deepshikha Punj , 3-Mar-2014 , The New Indian Express)

In 2012-13, 94 patents were filed, and Indian trademark and design and copyright registered by the Institute, a rise of nearly 400 per cent from 2008-09, in which 19 were filed. In 2013-14, already 89 patents have been filed. More...



Tirupati laddu gets stern with imitators
(Our Bureau , 02-Mar-2014 , Business Line)

Makers of clones or identically named versions of the Tirupati laddu, beware. More...



Govt cautious on cancer drug patent regimes
(Sidhartha , 1-Mar-2014 , The Times of India)

Amid heightened scrutiny of the intellectual property regime, the government has decided to tread with caution on a compulsory licence for a cancer drug to ensure that its decision is in line with the legal provisions. More...



Apple wins dismissal of $2.2-bn German patent suit
(Bloomberg | Berlin , 1-Mar-2014 , Business Standard)

The rulings are a blow to Munich-based patent holding company IPCom, which has sued mobile-device makers over technology it acquired from Robert Bosch GmbH in 2007 More...



Now, Geographical Indication rights for 'Tirupati laddu'
(IANS | Hyderabad , 28-Feb-2014 , Business Standard)

Tirumala Tirupati Devasthanam (TTD), which runs the affairs of the richest Hindu temple, is enforcing Geographical Indication (GI) rights for its famous 'Tirupati laddu'. More...



Applications for trademark on the rise
(Bindu D Menon , 28-Feb-2014 , Business Line)

The International Trademark Association (INTA) has said that the number of applications for trademark from India is on the rise, with more companies seeking brand protection. More...



Apeda moves patent board over order on basmati rice
(Gireesh Babu | Chennai , 27-Feb-2014 , Business Standard)

The move by IPAB came amidst protests from rice producers, processors and the state govt of MP, against the Apeda's application for registration of basmati as GI in class 30 under the Geographical Indications of Goods (Registration & Protection) Act, More...



Apple asks Chinese court to overturn patent ruling
(AFP , 27-Feb-2014 , The Economic Times)

US technology giant Apple on Thursday asked a Beijing court to strike down a patent ruling by state authorities, as it fights an intellectual property battle with a Chinese firm. More...



Ranbaxy Suspends Shipment of Drug Ingredients from Two Plants
(Our Bureau, New Delhi , 26-Feb-2014 , The Economic Times,Mumbai)

Gurgaon-based drugmaker Ranbaxy Laboratories on Tuesday said it has suspended all shipments of drug ingredients produced at two of its India-based plants located at Dewas and Toansa ‘voluntarily’ to review processes and controls. The Punjab-based Toansa facility and Madhya Pradesh-based Dewas plant are already facing a ban from the US drug regulator on quality concerns More...



Drug Regulator Seen Failing US Quality Test
(Divya Rajagopal , 26-Feb-2014 , The Economic Times,Mumbai)

US drug regulator Margaret Hamburg’s recent visit to India has done little to clear the air about the quality of drugs manufactured by Indian companies and one reason for this may be India’s drug controller. There is a growing perception in the US that the drug regulator is unwilling to monitor the quality of drugs manufactured by the local companies, said Roger Bate of Washington DC-based think tank, the American Enterprise Institute. More...



Patent laws safe from US challenge: India
(Amiti Sen , 25-Feb-2014 , Business Line)

India has said its patent laws cannot be successfully challenged by the US either in a bilateral or multilateral forum as they strictly comply with the intellectual property agreement of the World Trade Organization. More...



Chinese firm awaits ruling in Apple Siri patent infringement lawsuit
(Agence France-Presse , 25-Feb-2014 , NDTV)

A Chinese company suing Apple over similarities between its product and the "Siri" personal assistant believes its case has merit and is awaiting a court ruling, a lawyer said Tuesday. More...



US industry wants India designated Priority Foreign Country
(PTI , 25-Feb-2014 , The Economic Times)

Ramping up their anti-India campaign, an influential section of American businesses, in particular those from the pharma and manufacturing sectors, here on Monday urged the Obama Administration to designate India as a Priority Foreign Country. More...



India, US trade spat intensifies
(Sidhartha TNN , 25-Feb-2014 , The Times of India, Mumbai.)

Amid the ongoing trade spat, the government has advised deputy US Trade Representative Wendy Cutler to defer her planned trip to India next month in the view of the “flux” as well as the fiscal year-end commitments of officials. More...



US, India must stop trading petty insults over various issues
(ET Bureau , 25-Feb-2014 , The Economic Times)

This is more substantive than the childish tantrums over cancelled or postponed visits to India of senior US officials in the wake of India's tough stance and childish retaliations against US embassy personnel over the US decision to prosecute Indian diplomat Devyani Khobragade. More...



India ready to take on US over patents at World Trade Organization
(TNN , 25-Feb-2014 , The Times Of India)

The government is readying for a fresh battle with the US at the World Trade Organization in the wake of the continued pressure over its intellectual property rights regime. More...



57 farm products enjoy GI status in India
(Press Trust of India | New Delhi , 24-Feb-2014 , Business Standard)

Government has granted Geographical Indicator status to around 57 agricultural products such as Darjeeling tea, Pokkali rice and Dharwad Pedha in the last ten years. More...



US-India trade war worsens
(Sachin Parashar TNN , 24-Feb-2014 , The Times of India, Mumbai.)

India-US ties are again under stress—this time over trade and investment. There are calls in the US for designating India a Priority Foreign Country (PFC), the worst downgrading of status by the US Trade Representative for inability to protect intellectual property rights. More...



India set to take on US over probe into IPR laws
(Nayanima Basu | New Delhi , 24-Feb-2014 , Business Standard)

To deny visa to trade officials planning to scrutinise country's trade & industrial practices More...



India-US ties are under stress again, this time over trade and investment
(Sachin Parashar , 23-Feb-2014 , The Times Of India)

US pharmaceutical companies like Pfizer have demanded that India amend its patents law by doing away with section 3(d) altogether. More...



Apple, Samsung fail to reach settlement in US patent infringement case
(ANI | Washington , 23-Feb-2014 , Business Standard)

The mediator's settlement proposal to the parties was unsuccessful More...



India hardens stance against US Says Disputes Should Go To WTO, Officials To Skip Trade Body Meet
(Sidhartha TNN , 22-Feb-2014 , The Times of India, Mumbai.)

The government is set to ask all its officials to stay away from any interaction with a delegation from the US International Trade Commission (USITC), a quasi-judicial agency, probing the impact of India’s trade and investment regime on the American economy in what is seen as the latest sore point in economic ties between the two countries. More...



‘Illegal e-purchase of pharma drugs a growing concern’
(Sanjiv Shivadekar TNN , 22-Feb-2014 , The Times of India, Mumbai.)

There are growing concerns in the state food and drug administration (FDA) over Maharashtra’s gradual rise as a hub for drugs sold overseas through illegal internet pharmacies. More...



APEDA rues delay in traditional basmati growers' protection by MP govt
(Shashikant Trivedi | Bhopal , 20-Feb-2014 , Business Standard)

Agricultural and Processed Food Products Export Development Authority (APEDA) on Thursday said that intervention of Madhya Pradesh government will unnecessarily delay the process of protecting "traditional" basmati rice growers of India. More...



India has to indicate its position on certain aspects of IPR: Kiran Mazumdar-Shaw
(Vidya Krishnan , 20-Feb-2014 , Livemint)

Biocon head addresses issue of US lobbies demanding trade sanctions against India if it does not take a tough stand on intellectual property rights. More...



Ranbaxy, Teva Settle US Case Over Competition
(OUR BUREAU NEW DELHI , 20-Feb-2014 , The Economic Times,Mumbai)

Ranbaxy Laboratories, the largest India-based drugmaker, and Israeli generic drug giant Teva Pharma have reached a settlement with the New York Attorney General, which will end a 2010 pact between the two companies that “restricted competition” in the US market. More...



Ranbaxy, Teva settle claims in US
(Agencies , 20-Feb-2014 , The Times of India, Mumbai.)

Ranbaxy Laboratories and Israel-based Teva Pharmaceuticals have agreed to settle allegations levelled by New York state that the two rival generic drug makers made an unlawful agreement to restrict competition. More...



Onerous licensing regime killing legal digital music
(TNN , 20-Feb-2014 , The Times of India, Mumbai.)

Last Friday, one of four major legal music streaming services — Dhingana — shut down, leaving only Gaana.com, Saavn, and Hungama as the remaining digital music outlets broadcasting music from India for consumption in India and abroad. This follows another recent shutdown of Flyte, a music download service offered by Flipkart, a company that has raised over $200 million to date. More...



India should put more resources to keep pace with global practices: de Acedo
(C.H. Unnikrishnan , 20-Feb-2014 , Livemint)

Etienne Sanz de Acedo speaks about the critical issues that India should address in the transformation phase More...



GI Basmati: CM urges PM to step in for state's inclusion
(TNN , 20-Feb-2014 , The Times of India)

Expressing 'shock and deep dismay' over apex agency monitoring India's agricultural exports deciding to oppose inclusion of Madhya Pradesh areas for Geographical Indication tag for basmati, chief minister Shivraj Singh Chouhan has written to Prime Minister Manmohan Singh to intervene in state's favour. More...



Patent error
(Shamnad Basheer , 20-Feb-2014 , The Indian Express)

In its criticism of India’s IP regime, the US takes its cue from flawed rankings. More...



‘Indian drug cos must meet US standards’
(Times News Ntework , 19-Feb-2014 , The Times of India, Mumbai.)

When US Food & Drug Administration commissioner Margaret Hamburg signed off her 9-day visit to India on Tuesday, she praised everything Indian with a steely demand for quality. More...



Intellectual property and economic development
(Rod Hunter , 20-Feb-2014 , Business Day)

In his recent State of the Union address, US President Barack Obama reiterated his ambition to complete the Trans-Pacific Partnership, a proposed trade agreement among the US and 11 Pacific countries. More...



US FDA Plans to Deploy More Inspection Staff in India
(Divya Rajagopal , 19-Feb-2014 , The Economic Times, Mumbai.)

The US Food and Drug regulator said on Tuesday that it will increase the number of its inspection staff in India. Currently, the FDA deploys 12 officials in India, which the regulatory body plans to increase by 19, said Margaret Hamburg, Commissioner, US Food and Drug Administration in the course of an interaction in Mumbai. More...



A FAIR GAME: RPG Life loses domain name battle
(Lubna Kably TNN , 19-Feb-2014 , The Times of India, Mumbai.)

A complaint filed by RPG Life Sciences, a pharma company that is part of the diversified RPG Group, against the owner of the domain name ‘rpglife.com’ has been denied by an international arbitration panel. Interestingly, the owner has now offered to sell the domain name to RPG Life. More...



Separate Copyright Office for Authors, Performers: Raju
( IANS - NEW DELHI , 19-Feb-2014 , The New Indian Express)

A separate copyright office and a permanent copyright board is being set up to provide better services to the authors, performers and creators of various works," Raju said. More...



Indian firms under pressure on drug patent regime, as global majors mount lobbying
(Yashwant Raj and Himani Chandna Gurtoo , 19-Feb-2014 , Hindustan Times)

India is defending its patent regime more aggressively than ever before from attacks in the US that have come to define the state of ties between the two countries lately. More...



Research funding body a growth tonic for pharma cos
(TEAM TOI , 18-Feb-2014 , The Times of India, Mumbai.)

Research and development (R&D) in innovation and technology-driven sectors is expected to get a boost with the fi nance minister announcing the setting up of a ‘research funding organisation’ to fund projects selected through a competitive process. More...



Success strategies for Indian pharma industry in an uncertain world
(Manish Panchal, Charu Kapoor and Mansi Mahajan , 17-Feb-2014 , Business Standard)

The Indian pharmaceutical industry is going through a period of significant volatility and uncertainty, requiring companies to re-visit their traditional growth strategies to succeed More...



IISc professor’ virtual liver product gets patent in US
(Anshul Dhamija , 17-Feb-2014 , The Times Of India)

Strand Life Sciences, founded by professors at the Indian Institute of Science, Bangalore, was awarded a patent in the US last week for its two-year-old virtual liver product, used by pharmaceuticals companies across the world to test new drug toxicity in the liver. More...



Novartis puts pressure on India over patent abuse
(Andrew Ward in London and Amy Kazmin in New Delhi , 16-Feb-2014 , The Financial Times)

Novartis has urged US and European governments to “apply pressure” on India to respect intellectual property and warned New Delhi that its stance on patents is deterring investment. More...



Geographical indication tag to Patan patola to end feud over name
(Rupam Singh Gupta , 15-Feb-2014 , The Times Of India)

The geographical indication (GI) tag to Patan patola puts an end to the conflict between the Salvi brothers of Patan and the Rajkot weavers over the name patola. More...



Indian policy on clinical research restrictive: US pharma cos
(Press Trust of India | Washington , 15-Feb-2014 , Business Standard)

American pharma companies and their advocacy groups today rued at the alleged restrictive India policies on clinical research, saying such policies are harming the companies. More...



India has strong legal framework to protect intellectual property rights: Boeing
(PTI , 15-Feb-2014 , The Times Of India)

Even as a section of the US' corporate sector lobbies against India over protection of intellectual property rights, American aircraft major Boeing, On Saturday said the country has a strong legal framework to protect such rights. More...



Doctors association slams US for pressuring India on pharma patent laws
(PTI , 15-Feb-2014 , The Economic Times)

A Geneva-based non-profit doctors association has criticised the US and its pharma lobby for exerting pressure on India over its patent laws, saying such actions undermine the global trading system. More...



Patent troll Intellectual Ventures lays off 5% employees
(Reuters , 14-Feb-2014 , The Times Of India)

Privately held patent owner Intellectual Ventures has cut about 5% of its global workforce and "consolidated positions" in a corporate restructuring. More...



Suven Life Sciences gets patent approval from New Zealand
(14-Feb-2014 , Business Line)

Suven Life Sciences has received patent rights from New Zealand for two products More...



Time to call the US bluff on pharmaceuticals
(Shishir Asthana | Mumbai , 13-Feb-2014 , Business Standard)

While Indian drug makers are expected to adhere to norms in the US, one of their key markets, why aren't US companies operating in India following the laws here? More...



India faces US sanction threat
(Rupali Mukherjee , 13-Feb-2014 , The Times Of India)

India is facing multiple threats on its trade and investment policies. More...



MORE BACKING FROM BIG PHARMA
(R SRIRAM & DIVYA RAJAGOPAL MUMBAI , 13-Feb-2014 , The Economic Times,Mumbai)

The US Chamber of Commerce may think India is an inhospitable terrain for innovation, but surprisingly, Big Pharma doesn’t agree. Merck Serono, whose pharmaceutical roots go back to 1668, has not only become the latest global giant to support lower pricing for emerging markets and but has also opposed incremental innovation — a favourite bugbear of the Indian government and local industry. More...



U.S. probing ‘discrimination’ in Indian trade policies
(Narayan Lakshman , 13-Feb-2014 , The Hindu)

India’s policies for regulating foreign trade and investment, particularly in the context of intellectual property rights affecting the pharmaceutical industry, were in the crosshairs of the US Congress this week, as a lengthy investigation was launched into whether such policies were harming the US economy by discriminating against American firms. More...



Trade team in US to explain India’s position
(P. T. Jyothi Datta , 12-Feb-2014 , Business Line)

Indian drugmakers and IT representatives will be in Washington tomorrow, making submissions before the US International Trade Commission to explain India’s trade policies. More...



A duel on drugs
(T S Vishwanath , 12-Feb-2014 , Business Standard)

The discussions between the SA govt and pharma giants on intellectual property policy should keep both the needy and the inventor in mind More...



Majority of Indian IT-BPM firms at an initial stage of IP development: Report
(Rajesh Kurup , 12-Feb-2014 , Business Line)

Majority of the Indian Information Technology-Business Process Management firms are at an initial stage of Intellectual Property rights development. More...



US FDA Refuses to Sweeten Indian Drug Cos’ Bitter Pill
(Soma Das , New Delhi , 12-Feb-2014 , The Economic Times,Mumbai)

The head of the US drug regulatory body has turned down Ranbaxy Laboratories’ plea to allow drugmakers to continue exporting from banned manufacturing facilities while they take remedial measures to rectify the issues flagged. More...



‘EU rules denying kids of cancer drugs’
(Kounteya Sinha TNN , 12-Feb-2014 , The Times of India, Mumbai.)

Children with cancer are being denied entry into potentially life-saving drug trials because of loopholes in European Union regulations. Of the 28 cancer drugs which have received authorization in Europe since 2007, 26 have the potential to work on children but 14 of them have been waived from being tested on under-18-year-olds. More...



‘Dumb Starbucks’ a TV stunt, shut down
(12-Feb-2014 , The Times of India, Mumbai.)

Long lines formed outside the shop over the weekend as word of mouth and social media attracted large crowds. On Monday Canadian comedian Nathan Fielder, known for a Comedy Central prank show, said it was his idea. In a “press meet” outside the shop, he said: “By adding the word ‘dumb’, we are legally allowed to use the Starbucks name and logo. More...



Editorial: Patent problems
(12-Feb-2014 , The Financial Express)

While the agreement between the US FDA and its Indian counterpart to share information and perhaps coordinate action is good news as both regulators will now be on the same page, the need of the day is for the Indian regulators to be more stringent and conduct more surprise tests in the manner the FDA does. More...



After Starbucks parody, trademark violations take center stage: Here's all you need to know about Trademark laws
(Vishal Manve , 11-Feb-2014 , DNA)

When King, the makers of popular game, Candy Crush Saga trade-marked the word Candy, there were protests around the world. More...



CII feels International IP Index does not give true picture of India's IP ecosystem
(ANI | New Delhi , 11-Feb-2014 , Business Standard)

Commenting on the Global Intellectual Property Centre's International IP Index 2014 which presents India as the weakest among 25 countries, the Confederation of Indian Industry on Tuesday said the index does not represent the true picture of India's IP ecosystem. More...



Nokia, HTC settle long-running patent battles, agree on collaboration
(ANI , 11-Feb-2014 , DNA)

Nokia and HTC have reportedly settled their long-running patent infringement battles by agreeing on a 'patent and technology collaboration' that would settle all outstanding litigation. More...



Big Pharma's profiteering protests
(Amit Gupta , 11-Feb-2014 , Business Standard)

The war against the Indian patent regime is little more than multinationals' chagrin at their inability to exercise monopolies More...



India Raises Concerns over FDA Actions on Local Drug Companies
(Our Bureau, New Delhi , 11-Feb-2014 , The Economic Times,Mumbai)

India will issue an informal note to the US in which it will protest against the “disproportionate” action targeting Indian pharmaceutical companies, commerce and industry minister Anand Sharma said after his meeting with visiting US Food and Drug Administration (US FDA) chief Margaret Hamburg More...



COFFEE TIME JOKE? ‘Dumb Starbucks’: A parody cafe in LA
(Adam Withnall , 11-Feb-2014 , The Times of India, Mumbai.)

An independent coffee shop has opened up in LA using the same name, logo and store layout as any branch of the Starbucks chain — with one crucial exception — the prefix ‘dumb’. “Dumb Starbucks” has rocketed to social media fame by claiming to be completely legal under “parody law”, with its mysterious owners insisting it makes “fair use” of the chain’s famous brand. More...



India faces trade action from US
(Times News Ntework , 11-Feb-2014 , The Times of India, Mumbai.)

Washington’s Retaliatory Move Aimed At Govt’s Stance On Patent Regime More...



India faces US trade action over patents
(TIMES NEWS NETWORK , 11-Feb-2014 , The Times Of India)

The US, which recently downgraded the DGCA’s safety ratings, is expected to announce traderelated measures in what is seen as a retaliatory move against India’s recent stand on the patent regime. More...



US challenges India's requirements for solar products in WTO
(IANS | Washington , 11-Feb-2014 , Business Standard)

In another potential blow to India-US ties after the Khobragade affair, US Monday challenged India's domestic content requirements in Phase II of India's National Solar Mission. More...



India patent regime not about access to medicine: U.S body
(Staff Reporter , 11-Feb-2014 , The Hindu)

Representative Michael Froman set to announce a trade enforcement action tied to India, the highly influential U.S Chamber of Commerce has lashed out at India’s recent pattern of pharma patent denials, pointing out that the country’s actions “are not about access to medicine.” More...



US business pressure again on Indian IPR
(Nayanima Basu | New Delhi , 11-Feb-2014 , Business Standard)

Tells trade representative's office that New Delhi's already bad record got worse last year; wants action, even as bilateral investment treaty being negotiated. More...



India, US seek to better drug-making processes
(fe Bureau , 11-Feb-2014 , The Financial Express)

No surprise checks on drug firms as US FAA and its Indian counterpart agree to coordinate in drug making. More...



Intellectual property rights: US set to punish India
(TNN , 10-Feb-2014 , The Economic Times)

Tensions over the Khobragade episode are yet to fully dissipate, but the two sides are locking horns again over intellectual property rights. More...



Immense opportunities await Indian pharma manufacturing industry: Study
(Peethaambaran Kunnathoor, Chennai , 10-Feb-2014 , Pharmabiz)

Immense opportunities are waiting for the Indian pharmaceutical industry, both at the domestic and at the global level, and the future will be extremely promising with many more milestones, according to a research study conducted by Dr G Selvaraju, former director of drugs control, Tamil Nadu for the Vinayaka Mission University, Salem, Tamil Nadu. More...



India raises concerns over USFDA actions
(10-Feb-2014 , Hindustan Times)

The government on Monday expressed clearly to the US its growing unease over its drug regulator USFDA’s "disproportionate penalties" on India’s generic pharmaceutical companies, many of these which have been rattled by a string of import bans without getting sufficient opportunity to clarify details. More...



IPA slams methodology used by US Chamber of Commerce to rank IP environment of India
(Joseph Alexander , 10-Feb-2014 , Pharmabiz)

The Indian Pharmaceutical Alliance, representing large domestic drug-makers in India, has taken exception to the methodology that the Global Intellectual Property Centre of the US Chamber of Commerce adopted to rank India in the recent International Intellectual Property index. More...



HTC, Nokia ink deal on patent lawsuits
(AFP | Taipei , 09-Feb-2014 , The Financial Express)

Under the deal, HTC will make payments to Nokia and the collaboration will involve HTC’s LTE patent portfolio. More...



Trade Groups Seek More US Pressure on India over Patent Protection
(Bill Berkrot | Reuters - US Chamber of Commerce , 8-Feb-2014 , The New Indian Express)

The US Chamber of Commerce on Friday called on the government to ratchet up pressure on India over intellectual property rights, in a move that could help prevent Indian companies from producing cheap generic versions of medicines still under patent protection. More...



Novartis sues Dr Reddy’s Laboratories over patent infringement on cancer drug
(fe Bureau | Hyderabad , 8-Feb-2014 , The Financial Express)

The patent and Novartis' new drug application, approved by the FDA in 2001. More...



HTC, Nokia reach truce in patent dispute
(AFP , 8-Feb-2014 , The Times of India)

Taiwan's smartphone maker HTC said it has signed a patent and technology collaboration agreement with Finnish phone giant Nokia to end all pending patent litigation between them. More...



Apple gets patent for autocorrect review system: Report
(ANI , 07-Feb-2014 , The Times Of India)

Apple has reportedly patented an autocorrect review system in which autocorrect changes are highlighted to a user once they press the send button. More...



Cancer drug may lose patent shield
(Rupali Mukherjee , 7-Feb-2014 , The Times Of India)

The government is studying options to issue a compulsory licence on life-saving anti-cancer drug dasatinib, which could bring down its price by over 90%. More...



Roche sues Biocon, Mylan, DCGI over breast cancer drug
(Soma Das , 7-Feb-2014 , The Economic Times)

The Indian arm of Swiss pharma major Roche, which unexpectedly gave up its patent on it s $6 billion breast cancer drug Herceptin in India last year, has sued Bangalore based BioconBSE 2.29 % and US generic giant Mylan Inc in Delhi High Court for launching world's first biosimilar version of the original drug in India. More...



Patents and Copyrights Are Not for Violation
(The New Indian Express , 7-Feb-2014 , The Times Of India)

India has for the second time in succession found itself at the bottom of the International Intellectual Property Index issued by the US apex trade body’s Global Intellectual Property Centre. More...



Big pharma firms pushes for US action against India over patent worries
(Reuters , 06-Feb-2014 , The Economic Times)

Global pharmaceutical firms are pressuring the United States to act against India to stop more local companies producing up to a dozen new varieties of cheap generic drugs still on-patent, sources with direct knowledge of the matter said. More...



Turning down knowledge
(Business Standard Editorial Comment , 05-Feb-2014 , Business Standard)

Troublingly, India is an outlier on intellectual property. More...



Cisco, Google sign patent-sharing agreement
(Reuters , 05-Feb-2014 , The Times Of India)

Google Inc entered into a patent cross-licensing agreement with Cisco Systems Inc, the internet search giant's second such deal in as many months. More...



India slips in rankings as slowdown hits pharma
(Rupali Mukherjee | TNN , 4-Feb-2014 , The Times of India, Mumbai.)

India has slipped from the 8th rank as forecast in 2016 to the 11th position in 2017, figures culled from IMS Health said. The downgrade suggests that the market may not be growing at the pace projected earlier, and has lost value due to the currency fluctuation, impacting the country’s global ranking, experts say. More...



Mylan launches biosimilar for cancer
(TNN , 4-Feb-2014 , The Times of India, Mumbai.)

Mylan Inc, a leading generic and specialty pharmaceutical company, said that its Indian subsidiary Mylan Pharmaceuticals has launched the world’s first trastuzumab biosimilar in India. The product, which will be marketed under the brand name Hertraz, is a biosimilar to Roche’s Herceptin More...



Registering trademarks turns cheaper for firms
(C.H. Unnikrishnan , 3-Feb-2014 , Livemint)

New system works on a single registration fee to be paid in India, is likely to help firms save more money More...



Patent filing by IIT Bombay up by nearly 400%, students major contributors
(Mihika Basu , 3-Feb-2014 , The Indian Express)

In 2012-13, 94 patents were filed and Indian trademark and design and copyright registered, a rise of nearly 400 per cent from 2008-09, when 19 were filed. More...



India's IP environment has deteriorated in last 2 years: Jasper MacSlarrow
(Sudipto Dey , 02-Feb-2014 , Business Standard)

Interview with Executive Director of International IP, Global Intellectual Property Center, US Chamber of Commerce More...



Apple gets 'sapphire window' and pressure-sensitive display patents granted
(Robin Sinha , 31-Jan-2014 , NDTV)

Apple, a tech firm best known for its innovations, after introducing a sapphire- based fingerprint sensor on its iPhone 5s, got one of its important patents granted by the USPTO on Thursday, detailing a cutting and processing method for sapphire material. More...



Twitter buying 900 IBM patents to end infringement dispute
(Susan Decker , 31-Jan-2014 , Livemint)

The agreement also resolves a dispute that prompted IBM to write to Twitter last year about possible infringement of at least three patents. More...



IPAB sets aside Patent Office's order for Roche's anti-viral drug
(Gireesh Babu | Chennai , 30-Jan-2014 , Business Standard)

The Intellectual Property Appellate Board has set aside an order of Indian Patent Office, which revoked the patent of Hoffmann-La Roche's antiviral drug Valganciclovir, branded as Valcyte, and remanded the matter back to the patent official for fresh consideration. More...



Protecting patents: India worst in world
(Surabhi Agarwal | New Delhi , 30-Jan-2014 , Business Standard)

Ranking by arm of US Chamber of Commerce; study says all BRICS countries lack the required drive to enforce patents; Indian law & SC rulings rapped More...



Basmati WARS
(Summary , 30-Jan-2014 , The Financial Express)

Madhya Pradesh joining the battle for geographical indications gives it a new twist More...



Doha talks will be back on track: WTO
(Times News Ntework , 29-Jan-2014 , The Times of India, Mumbai.)

The Doha Round of talks on lowering world trade barriers would resume this year, following the successful trade talks in Bali recently:WTO More...



Venus Remedies bags US patent for painkiller injection
(PTI , 29-Jan-2014 , The Economic Times)

Venus Remedies Ltd, a research oriented global pharmaceutical company today said it has bagged a patent from US Patent Office for Achnil, a once-a-day painkiller injection developed by Venus Medicine Research Centre, the R&D wing of Venus Remedies. More...



Apple patents 'magnetic add-on camera lens' for iPhones
(ANI | Washington , 29-Jan-2014 , Business Standard)

The external camera lens could be attached securely to the iPhone with magnets and aligned with its camera. More...



US Record Company Sues Vietnam Site for Copyright
(Chris Brummit | AP - HANOI , 28-Jan-2014 , The New Indian Express)

A record company that accuses a Vietnamese entertainment portal of making its songs available for free download has filed suit in an American court against the U.S- venture capital firm which invested in the website, seeking millions in damages for copyright violations. More...



Ericsson agrees to end patent dispute with Samsung
(Reuters | Stockholm , 28-Jan-2014 , Business Standard)

Ericsson said on Monday it had signed a cross-licensing deal with Samsung Electronics Co, ending a long-running patent dispute and boosting fourth-quarter sales by 4.2 billion crowns. More...



Google, Samsung sign patent agreement
(Eric Pfanner | Washington , 28-Jan-2014 , Business Standard)

The deal covers existing patents as well as some that would be filed during the next 10 years. More...



GI battle: Madhya Pradesh govt puts basmati in a rice soup
(Sandip Das , 28-Jan-2014 , Indian Express)

The state has asked for inclusion in basmati rice growing zone although being outside the Indo-Gangetic plain. More...



MSF criticises Bayer CEO's comments on CL issued by Indian patent office on Nexavar
(Ramesh Shankar , 28-Jan-2014 , Pharmabiz)

German drug major Bayer's CEO Marijn Dekkers' reported comments that “We did not develop this medicine for Indians,” have come in for severe criticism from the international medical humanitarian organization Médecins Sans Frontières. More...



Sanofi India stock likely to be re-rated on company's improving fundamentals
(Narendra Nathan , 27-Jan-2014 , The Economic Times)

Sanofi India is a subsidiary of Sanofi, one of the world's leading pharmaceutical companies. More...



Patented drugs face price caps
(Sidhartha , 27-Jan-2014 , The Times Of India)

After sitting on it for years, the government is finally initiating steps to regulate the price of patented medicines and medical devices, a move that may provide relief to patients suffering from life-threatening diseases. More...



Safeguarding your intellectual property rights
(Sakina Babwani , 27-Jan-2014 , The Economic Times)

Have you wondered what you would do if someone sells their products under your brand name or uses the content you have written without your permission? More...



Google and Samsung Electronics, which are frequently involved in patent infringement lawsuits but not against each other, announced that they have reached a global patent cross-licensing agreement.
(Reuters , 27-Jan-2014 , The Times Of India)

Google and Samsung Electronics, which are frequently involved in patent infringement lawsuits but not against each other, announced that they have reached a global patent cross-licensing agreement. More...



IPAB directs patent office to consider Schering Corporation's application afresh
(Gireesh Babu | Chennai , 26-Jan-2014 , Business Standard)

The Intellectual Property Appellate Board has directed the patent office to consider the patent application of US-based Schering Corporation for a crystalline form of a compound for treatment of heart related disease afresh. More...



USFDA bans Ranbaxy’s 4th plant
(Rupali Mukherjee , 25-Jan-2014 , The Times of India, Mumbai.)

India’s largest drug maker Ranbaxy faced fresh regulatory trouble due to manufacturing violations at its fourth domestic facility, which may threaten new drug launches and jeopardize lucrative revenues from the US, the world’s biggest pharma market. More...



Developed cancer drug for 'western patients' who could afford, not 'for Indians': Bayer's CEO
(AFP , 25-Jan-2014 , The Times Of India)

Global medical charity Medecins Sans Frontieres slammed on Friday a statement by Bayer's chief executive that the giant German firm only developed its cancer drug Nexavar for people who could afford the medicine, not "for Indians". More...



European office upholds 3G patent disputed by Nokia, HTC, Apple
(PTI , 25-Jan-2014 , Zee News)

The European Patent Office has upheld a narrowed version of a patent on 3G technology rejecting claims from Nokia, HTC, Apple, Ericsson and Vodafone. More...



Nokia says Indian mobile app downloads rise 15-fold globally
(Press Trust of India | New Delhi , 24-Jan-2014 , Business Standard)

Mobile handset company Nokia has seen a 15-fold increase in downloads of applications developed by Indian companies globally on a yearly basis. More...



Google, Intellectual Ventures face off as patent trial begins
(Reuters , 24-Jan-2014 , The Times Of India)

Opening statements began in patent owner Intellectual Ventures' trial against Google's Motorola Mobility unit in a lawsuit that could be a bellwether on public opinion toward intellectual property. More...



GI tag won, hopes soar for MP’s basmati
(Milind Ghatwai | Bhopal , 24-Jan-2014 , The Indian Express)

Basmati rice, in the cultivation of which Madhya Pradesh has already taken long strides, has finally got what it had been seeking for a long time: a geographical indication tag. More...



Qualcomm buys Palm patents from Hewlett-Packard
(AP , 24-Jan-2014 , The Times Of India)

Cellphone chip-maker Qualcomm said that it has acquired patents once owned by smartphone maker Palm from Hewlett-Packard for an undisclosed amount. More...



Mera-vala pink
(B Desikan , 23-Jan-2014 , Business Line)

Colours, sounds, smells, gestures and moves… you can trademark them all. More...



Apple wins 'autocomplete' patent claim against Samsung
(TOI Tech & Agencies , 23-Jan-2014 , The Times Of India)

Apple has won a patent claim against Samsung, after a US Judge ruled that the South Korean electronics giant infringed on auto complete patent owned by the iPhone maker. More...



With a GI tag in the bag, Udupi farmers cash in on rare green brinjal
(AJ Vinayak , 23-Jan-2014 , Business Line)

‘Mattu Gulla’, a special variety of green brinjal grown in Karnataka’s Udupi district for over five centuries now, is now attracting special attention from growers. More...



HC Restrains Jubilant Co from Infringing Pidilite's Trademarks
(PTI , 23-Jan-2014 , The Indian Express)

Holding that it was a case of an infringement of copyright and passing off goods in someone else's name, the Bombay High Court has restrained M/s Jubilant Agri & Consumer Products Ltd from using the registered trademarks of M/s Pidilite Industries Ltd. More...



IPAB refers opposition to anti-cancer drug to patent office
(Gireesh Babu | Chennai , 22-Jan-2014 , Business Standard)

Board has set aside an earlier order of Assistant Controller of Patent stating that it was passed in 'flagrant violation of principles of natural justice' More...



Merck to Bristol-Myers Face More Threats on India Drug Patents
(Ketaki Gokhale , 21-Jan-2014 , Bloomberg)

Pharmaceutical companies from Merck & Co. to Bristol-Myers Squibb Co. face fresh threats to protecting their patents in India as a government-appointed panel prepares to evaluate more drugs for local makers to copy. More...



Sherlock Holmes just escaped the bonds of copyright, new adventures beckon
(21-Jan-2014 , The Times Of India)

Its elementary a character in public domain cannot be appropriated as private intellectual property. More...



Biocon’s copy of Roche breast cancer drug still expensive for India
(Naomi Kresge, Ketaki Gokhale , 21-Jan-2014 , Livemint)

Biocon will sell its version of Herceptin, which it is calling Canmab, at a 25% lower price More...



No More 'Tricky' Postures can Get a Yoga Copyright
( Wilson George Thomas - COIMBATORE , 20-Jan-2014 , The New Indian Express)

Practitioners of yoga lose no time in waxing eloquent of its antiquity. More...



IBM leads in tech patent filings in 2013
(ANI , 20-Jan-2014 , The Times Of India)

IBM has retained its patent crown in 2013, while Google climbed to No. 11 in the rankings. More...



Google set to face Intellectual Ventures in landmark patent trial
(Reuters , 20-Jan-2014 , The Economic Times)

Intellectual Ventures is set to square off this week against Google Inc's Motorola Mobility unit in the first trial that the multibillion-dollar patent-buying firm has undertaken since it was founded. More...



Unbranded generics way to cheaper cure
(Rupali Mukherjee | TNN , 18-Jan-2014 , The Times of India, Mumbai.)

Rajasthan, TN implement Model that cuts prices of branded drugs by at least 30%. More...



Patent mapping system to find more innovation
(Leslie D’Monte , 16-Jan-2014 , Livemint)

Patent maps provide visual representation of where universities, companies and other organizations are protecting intellectual property produced by their research More...



Swarovski drops 'Crystal' mark after Indian company challenge
(Manish Raj , 17-Jan-2014 , The Economic Times)

In a letter to the Intellectual Property Appellate Board, Austrian crystal jewellery and accessories maker Swarovski said it will not renew its trademark 'Crystal Glamour' for its clothing, footwear and headgear More...



No copyright over yoga, pranic healing techniques: HC
(Aneesha Mathur , 15-Jan-2014 , The Indian Express)

The court has held that the expression ‘pranic healing’ cannot be monopolised as trademark by the institute. More...



India has an impeccable Copyright Act - now it needs teeth: Javed Akhtar
(Arnab Banerjee , 15-Jan-2014 , The Times Of India)

Poet and writer Javed Akhtar is also Vice President of the Brussels-based International Confederation of Societies of Authors and Composers (CISAC), addressing copyrights, intellectual property rights, etc. More...



Allergan wins lawsuit against Lupin, two others over Lumigan
(Susan Decker , 14-Jan-2014 , Livemint)

The patent will prevent copies of Allergan’s Lumigan glaucoma treatment from entering the US until 2027. More...



Gujarat-based CMSCRI gets European patent for 'green plastic'
(Avinash Nair | Ahmedabad , 13-Jan-2014 , The Financial Express)

The institute developed biodegradable plastic by using a residue generated from Jatropha. More...



Why India needs to take intellectual property seriously
(Rod Hunter , 11-Jan-2014 , Business Standard)

Without reform of IP law, Indian companies - and broader economic growth - will remain stunted. More...



Pharma companies rope in third-party advisors to deal with compliance issues
(Pallavi Ail | Mumbai , 11-Jan-2014 , The Financial Express)

Inadequate resources, coupled with rising demand, has proved to be a stumbling block for Indian pharmaceutical companies More...



Apple did not violate Google patents: US court
(Reuters , 11-Jan-2014 , The Times Of India)

The US Court of Appeals for the Federal Circuit upheld a decision by the International Trade Commission in April that Apple did not violate a Google patent to make the popular iPhone. More...



Solvay wins two rare earth mixed oxides patent cases against HySci in China
(BS B2B Bureau | Brussels , 10-Jan-2014 , Business Nair)

Solvay has won two rare earth mixed oxides patent cases against China-based HySci (Tianjin) Specialty Materials Co Ltd. Solvay was awarded RMB 5.6 million (Euro 0.67 million) in damages and HySci was ordered to immediately stop the production and the sale of certain rare earth mixed oxides used in automotive catalysts. More...



After Basmati rice, MP govt to seek patent for rare poultry breed
(Shashikant Trivedi | Bhopal , 09-Jan-2014 , Business Standard)

Farmers Welfare and Agriculture Development department will file applications for patenting breed soon. More...



Glenmark's anti-diabetes drugs shake up Indian anti-diabetes market
(DIVYA RAJAGOPAL , 9-Jan-2014 , The Economic Times)

Mumbai-based Glenmark Pharmaceuticals has shaken up India's Rs 3,000-crore lucrative anti-diabetes market dominated by multinationals with its new drugs, Zitamed and Zita. More...



Pharma FDI: No Ban on Non-compete Clause
(Our Bureau, New Delhi , 09-Jan-2014 , The Economic Times,Mumbai)

The government has decided against a blanket ban on the incorporation of a ‘non-compete’ clause if an Indian pharma company is acquired by a foreign drug company. The ban was mooted by the Department of Industrial Policy and Promotion (DIPP) as a safeguard to ensure large scale acquisition of Indian pharma companies does not lead to shortage of critical drugs. More...



Apple, Samsung agree to mediation in US patent fight
(Reuters | San Francisco , 9-Jan-2014 , Business Standard)

The rivals are facing a March trial date in the United States More...



Ghansal rice variety set to attain GI status
(Nikhil Deshmukh , 9-Jan-2014 , The Times Of India)

Following the footsteps of Kolhapur jaggery, the Ghansal variety of rice grown in the Ajara tehsil is set to attain geographical indication status to preserve its aroma and peculiarity. More...



Centre to SC: No advantage in contesting US patent of wheat variety
(Utkarsh Anand , 8-Jan-2014 , The New Indian Express)

The Centre has told the Supreme Court that it was not "advantageous" to contest the United States' patent of a wheat variety, similar to Indian Nap Hal, since the patent granted to American multinational chemical and agricultural biotechnology corporation Monsanto had already expired in 2010. More...



Nestle's cumin extract patent bid raises hackles
(Sushmi Dey | New Delhi , 8-Jan-2014 , Business Standard)

Company claims new use for kala jeera extract, provoking alarmed campaigners here and abroad; says reaction not based on facts More...



India sees sharp drop in patent applications
(Mihika Basu , 8-Jan-2014 , The Indian Express)

While patent filing at the Indian patent office has seen a rise of 23.97 per cent from 2007-08 to 2012-13, assessment shows that only a meagre 22 per cent of them have been filed by Indian applicants in 2012-13. More...



Madhya Pradesh’s basmati plea may delay India’s geographical indication battle
(Sanjay Vijayakumar , 7-Jan-2014 , The Economic Times)

India's battle to protect the distinctive identity of basmati rice name, fought in part through a filing for a geographical indication protection by state-run export registration agency Apeda, is facing a hurdle in Madhya Pradesh. More...



Student Gets Patent for her Innovation
(Express News Service - KOCHI , 07-Jan-2014 , The New Indian Express)

An MTech student from Alappuzha has developed a sensor faucet with a sensor-controlled flow kit which ensures that water is provided manually through the water taps in case of electronic failure. More...



Software patents: US Supreme Court needs to clear the air
(Anurag K Agarwal , 6-Jan-2014 , DNA)

Granting a patent involves three important criteria – novelty or inventive step, non-obviousness and utility. More...



Microsoft’s Nokia deal to face China limits on patent fees
(Bloomberg , 2-Jan-2014 , The Economic Times)

Chinese mobile phone makers asked regulators to make sure Microsoft's 5.44-billion euro bid to take over Nokia Oyj's handset business doesn't result in higher patent fees on wireless technology, said two government officials with knowledge of the matter. More...



Health ministry sought tough laws for drugs, clinical trials.
(By PTI , 01-Jan-2014 , The Economic Times)

As India inches towards being a polio-free country, the health sector made some rapid strides in strengthening regulations for drugs and clinical trials, and saw stronger food laws and re-establishment of an elected medical regulator during 2013. More...



Glenmark faces patent infringement suit in US
(PTI , 1-Jan-2014 , The Economic Times)

Glenmark Pharmaceuticals has been slapped with a patent infringement case by US-based Cephalon Inc over plans to sell generic version of leukaemia treatment drug Treanda in the American market. More...



Samsung, Apple working on patent deal: Report
(TOI Tech , 31-Dec-2013 , The Times Of India)

Arch rivals Apple and Samsung are reportedly back to the negotiating table. More...



Haleem makers vie for international geographical indication tag
(Rohit PS , 31-Dec-2013 , The Times Of India)

The savoury Haleem may soon be sold in Europe with the Hyderabadi tag proudly displayed on the packaging if makers manage to bag an international geographical indication tag for it. More...



Naidu has Patent for Graft: Botcha
(Express News Service - HYDERABAD , 31-Dec-2013 , The New Indian Express)

Taking exception to TDP chief N Chandrababu Naidu alleging that AICC supremo Sonia Gandhi is encouraging corruption in the country, PCC president Botcha Satyanarayana said Naidu was the embodiment of corruption and had got ‘patent rights’ for graft. More...



PIL wants additional statutory protection for GI-tagged handicrafts
(Subra Mani , 30-Dec-2013 , The Times Of India)

While GI-tagged liquor and spirits of foreign make enjoy additional protection in India, nearly 130 Indian handicraft products having GI status do not have such additional protection overseas, intellectual property rights (IPR) attorneys have informed the Madras high court. More...



The cancer divide
(Gardiner Harris , 30-Dec-2013 , Livemint)

Alka Kudesia needs an expensive drug to treat her breast cancer, but refuses to tell her children for fear they will take loans to buy the medicine and spend the rest of their lives in debt. More...



Sole right to make ‘Tirupati laddu’ will vest with TTD
(R. Sivaraman , 30-Dec-2013 , The Hindu)

Madras High Court restrains Chennai sweet stall from making and selling ‘laddus’ under a near similar name. More...



2013: Few bitter pills, booster injections for pharma sector
(Press Trust of India , 29-Dec-2013 , NDTV)

Domestic firms coming under increased scrutiny of global regulators, resulting in Ranbaxy paying a record $500-million fine, and drugs becoming cheaper in India thanks to a new pricing policy marked a roller-coaster year 2013 for the pharma industry. More...



Traditional knowledge, culture can be patented
(Rupali Mukherjee , 27-Dec-2013 , The Times Of India)

Traditional Knowledge and Traditional Cultural Expression reflecting a community's cultural and social identity, handed down generations, may soon be recognized as a form of intellectual property. More...



Google files lawsuit against Apple, Microsoft backed Rockstar patent group
(ANI , 27-Dec-2013 , Zee News)

Google has reportedly filed a lawsuit against Apple and Microsoft backed consortium Rockstar, claiming that its patent campaign is unfairly targeting Google's Android partners and customers. More...



Govt may have to Reset Prices of Essential Drugs
(Soma Das , 24-Dec-2013 , The Economic Times,Mumbai)

Seven months into the new pharma pricing regime, the government may have to go back to the drawing board and reset prices of essential drugs, adding to the prevailing confusion in the domestic drug market. More...



CMIA’s summit to provide platform to patent holders
(Mohammed Akhef , 24-Dec-2013 , The Times Of India)

The Chamber of Marathwada Industries and Agriculture will organise a first-of-its-kind innovation summit on January 7 for industries, education and service sectors to discuss ways of exploring more opportunities. More...



New patenting norms may put India's software innovation into sleep mode
(Surabhi Agarwal | New Delhi , 24-Dec-2013 , Business Standard)

Technology experts argue the guidelines defeat the very objective of most software applications - to be hardware agnostic and interoperable More...



Chennai Patent Office revokes Pfizer's second patent on Detrol
(Our Bureau, Mumbai , 24-Dec-2013 , Pharmabiz)

In yet another blow to the multinational drug companies in patent cases in India, the Chennai Patent Office has revoked Pfizer's patent on Detrol, a drug used to manage overactive bladder symptoms. More...



Japanese companies keen to establish telecom gear test labs in India
(Kalyan Parbat , 24-Dec-2013 , The Economic Times)

Japanese companies are keen to establish telecom gear test labs in India even as the government prepares to invite bids from private lab operators to pave the way for local testing from July 2014. More...



Pharma firms might resume sales of analgin-based drugs
(Sushmi Dey , 23-Dec-2013 , Business Standard)

Soon, drug makers might be able to resume the sale of analgin, the popular pain-relief drug. The Drugs Controller General of India is considering the recommendations of its advisory body to revoke the suspension of the sale of analgin-based medicines in the country More...



New patenting norms may put India's software innovation into sleep mode
(Surabhi Agarwal , 23-Dec-2013 , Business Standard)

Patenting of software applications could virtually become impossible in the country if the draft guidelines on computer-related innovation come into force. The rules, the first ever for software applications in the country, were recently issued by the patent office and mandate each new software to be "machine-specific" and packaged with "new hardware" to qualify for a licence. Technology experts argue the guidelines defeat the very objective of most software applications - to be hardware agnostic and interoperable. More...



He Has the Patent to Cure Many Ills
(Shevlin Sebastian , 22-Dec-2013 , The New Indian Express)

This was Shet’s 79th patented invention in his 30-year career as an inventor. More...



Ramnad farmers seek GI tag for their ‘Madurai Malli’ plants
(Walter Scott , 21-Dec-2013 , The Hindu)

Claiming that ‘Madurai Malli’ which was recently given the coveted Geographical Indication tag, had its origin in Ramanathapuram, farmers have urged the district administration to help them secure GI mark also for the plants raised in the district and which produced ‘Madurai Malli.’ More...



Apple granted patent for flexible sapphire display
(TOI Tech , 20-Dec-2013 , The Times Of India)

Flexible and bendable screens are the new buzzwords in the technology industry, with all major manufacturers readying display panels for the next generation of gadgets. More...



Hisar university issued patent to estimate multi residue in milk and milk products
(Madhvi Sally , 20-Dec-2013 , The Economic Times)

Chaudhary Charan Singh Haryana Agricultural University Hisar has been issued a patent on a technique for estimation of multi residue in milk and milk products, announced the Vice-Chancellor, Dr K.S. Khokhar. More...



Patent war spills over to non-cancer drugs
(Rupali Mukherjee , 19-Dec-2013 , The Times Of India)

The turf war between Big Pharma and generic companies, which was largely restricted to exorbitantly priced drugs for cancer and HIV, is now spilling over to chronic and lifestyle problems. More...



ZTE says India operations unaffected in Vringo patents row
( Danish Khan , 18-Dec-2013 , The Economic Times)

Chinese telecom gear maker ZTE said that the Delhi High Court has set aside the injunction sought against the company's products by Vringo Inc. More...



Lack of awareness about GI spelling doom for many products
(Press Trust of India | Kolkata , 18-Dec-2013 , Business Standard)

Lack of awareness about the importance of geographical indicators for goods is pushing many products, unique to India, out of business, according to the Trade Marks & GI Registry, the Intellectual Property office of India. More...



Indian pharma company wins patent war against US firm
(Express News Service , 18-Dec-2013 , The Indian Express)

Gujarat-based La Renon Healthcare Pvt Ltd has successfully got revoked the Indian patent held by a US firm for a proprietary probiotic formulation, named Renadyl. More...



GSK to spend $1 billion to raise stake in Indian unit
(Reuters , 16-Dec-2013 , NDTV)

GlaxoSmithKline Plc said on Monday it plans to raise its stake in its Indian pharmaceutical unit to up to 75 per cent from 50.7 per cent through an open offer in a deal worth about 629 million pounds. More...



Presence of law to protect copyright 'not effectual': CJI
(PTI , 15-Dec-2013 , Zee News)

Observing that the revenue of conventional record labels has plunged in recent years due to copyright infringement, Chief Justice of India P Sathasivam on Sunday said in spite of the existence of a law, its implementation was not "effectual" as envisaged. More...



MNCs lead in patenting of both product and processes in India after change in patent law: Origiin IP
(Nandita Vijay, Bengaluru , 14-Dec-2013 , Pharmabiz)

Origiin IP Solutions LLP has observed that there is an impressive number of foreign multinational pharmaceutical companies which have taken a lead in patenting activities in India. More...



Nod for anti-depressant cheers Indian pharma
(BS Reporter | Mumbai , 13-Dec-2013 , Business Standard)

Five companies get US regulator's approval for Cymbalta generic More...



Seoul court rules in favour of Apple in patent row with Samsung
(ANI | Washington , 13-Dec-2013 , Business Standard)

A Seoul court has reportedly ruled that Apple did not infringe on some of Samsung's patents, in a patent battle that has spread to multiple continents. More...



Cadila, Zydus Pharma in pact with Warner Chilcott to settle US patent issue
(Our Bureau , 12-Dec-2013 , Business Line)

Warner Chilcott had lodged a suit in the Delaware federal court in 2011 seeking to stop Cadila Healthcare and its US unit from launching a generic version of Asacol. More...



Medicines Patent Pool, BMS sign agreement to increase access to key HIV medicine
(Rupali Mukherjee , 12-Dec-2013 , The Times Of India)

The Medicines Patent Pool, a UN-backed organisation, and pharma company Bristol-Myers Squibb have signed a licensing agreement to increase access to a key HIV medicine, atazanavir, in 110 developing countries, including India. More...



11 more items from Bengal identified for GI tag
(Our Bureau , 12-Dec-2013 , Business Line)

After Darjeeling tea, 11 more items from West Bengal are in line to get Geographical Indication tag. More...



HC Favours Colgate in HUL Ad Row
(Our Bureau , 12-Dec-2013 , The Economic Times,Mumbai)

The battle for supremacy in the oral care segment took another interesting turn on another turf when market leader Colgate Palmolive obtained a favourable court order against its arch rival Hindustan Unilever (HUL), India’s largest consumer goods company. More...



Apple Inc scores legal victory over Samsung on sales of iPhone 4S, iPhone 5 in South Korea
(Reuters , 12-Dec-2013 , The Indian Express)

Apple Inc products such as the iPhone 5, iPhone 4S and iPad2 do not violate Samsung Electronics patents, said a Seoul judge. More...



Cadila Healthcare gains after settling patent litigation with Warner Chilcott
(Capital Market , 12-Dec-2013 , Business Standard)

Cadila Healthcare rose 2.63% to Rs 744.50 after the company said it has settled a patent litigation with US-based Warner Chilcott Company LLC. More...



Samsung loses patent lawsuit in South Korea against Apple
(IANS , 12-Dec-2013 , Business Standard)

The three technologies under the legal dispute included those related with multi-tasking service while writing text messages. More...



Former Google executive Michelle Lee to run US patent office
(Reuters , 11-Dec-2013 , The Economic Times)

Former Google Inc executive Michelle Lee has been named deputy director of the US Patent and Trademark Office and will run the agency until a new director is named, the agency said on Wednesday. More...



MSME Dept Bats for IPR
( Express News Service - CUTTACK , 11-Dec-2013 , The New Indian Express)

The State MSME Department has pressed the entrepreneurs, manufacturers and producers to protect their innovations, designs and work processes through Intellectual Property Rights. More...



Apple granted patent for curved touchscreen
(ANI , 11-Dec-2013 , The Economic Times)

Apple has been reportedly granted patent for curved touchscreen designs for smartphones and other devices. More...



Intellectual Property Appellate Board crippled due to poor infrastructure, PIL says
(A Subramani , 10-Dec-2013 , The Times Of India)

Despite being a premier body settling disputes over intellectual property rights and trademark rows, the Intellectual Property Appellate Board headquartered in Chennai has neither proper infrastructure nor finance to function efficiently, said a PIL in the Madras high court. More...



No clarity on pricing, patents
(P. T. Jyothi Datta , 10-Dec-2013 , Business Line)

Interview with Pfizer India chief, Aijaz Tobaccowalla, on prospects and pitfalls of doing business in India. More...



With most patents, China biggest intellectual property growth driver, says report
(Vanita Srivastava , 10-Dec-2013 , Hindustan Times)

China– with the highest number of patents filed and received– was the biggest driver of the intellectual property growth in 2012, according to the World Intellectual Property Organisation. More...



Baring India sees geographical diversification driven by patent expires, rise in R&D spend as 2 emerging trends
(Nandita Vijay, Bengaluru, , 10-Dec-2013 , Pharmabiz)

Baring India, a leading private equity fund, signals that Indian pharmaceutical sector seems to suggest two clear emerging trends. More...



Global patents for Mahindra Two Wheelers
(10-Dec-2013 , The Indian Express)

Mahindra Two Wheelers Ltd — the scooter and motorcycle making arm of Mahindra and Mahindra Ltd — has obtained international patents for four of its indigenously developed technologies. More...



Sell drugs at govt rates, not higher prices mentioned on box, says SC
(Utkarsh Anand , 10-Dec-2013 , The Indian Express)

The Supreme Court on Monday ruled that drug manufacturers and retailers cannot sell medicines at higher prices mentioned on the label of the boxes if the government notifies a lower rate. They must implement the price fixed under the Drugs (Prices Control) Order (DPCO) within 15 days from the date of notification. More...



No reprieve for drug cos in new DPCO prices
(Jayati Ghose, Indu Bhan , 10-Dec-2013 , The Financial Express.)

Reducing the leeway for drug firms to sell older stocks of price-regulated medicines in the market at previously notified — rather than new — prices, the Supreme Court on Monday held that the firms are liable to replace these stocks within the grace period provided by the National Pharmaceuticals Pricing Authority (NPPA). More...



Drug retailing: SC upholds 15-day deadline for price-control rollout
(BS Reporter , 10-Dec-2013 , Business Standard)

The Supreme Court ruled on Monday that manufacturers and importers of pharmaceutical products must implement the Drugs (Prices Control) Order within 15 days from the date of notification or receipt of the order. More...



European Union warns Nokia not to become 'patent troll
(AP , 09-Dec-2013 , The Economic Times)

Europe's top regulator has warned Nokia not to try to become a "patent troll'' after the Finnish company sold most of its cellphone-making business to Microsoft Corp. this year but retained its patent portfolio. More...



India records growth in patent filings
(Rupali Mukherjee , 09-Dec-2013 , The Times Of India)

Global patent filings in 2012 increased at its strongest rate in nearly two decades as industrial-design registration notched its best-ever rate of growth, a report says. More...



Samsung may need to offer more to settle patent dispute: Almunia
(Reuters , 09-Dec-2013 , The Economic Times)

Samsung Electronics Co Ltd will likely need to do more to settle an investigation over whether its use of patent lawsuits against Apple Inc breached EU rules, the EU antitrust chief said on Monday. More...



Global patent growth hits 18-year high: World Intellectual Property Organization
(AFP , 09-Dec-2013 , The Economic Times)

Global patent filings grew at their fastest pace in almost two decades in 2012, with China the driving force, the UN's intellectual property agency said Monday. More...



Patents law
(Poonam Jain , 9-Dec-2013 , The Times Of India)

Anirban Mazumdar, associate professor of law at West Bengal National University of Juridical Sciences, on career options in patents law. More...



WTO: 5 Gains for World Trade
(9-Dec-2013 , The Economic Times,Mumbai)

Even the diehard optimist did not believe the Bali Ministerial of the World Trade Organization (WTO) would achieve anything.The sceptics said its failure would be a nail in the coffin of multilateral attempts at equitable trade orders, after all in its 12 years the Doha Round had nothing to show. Unexpectedly, Bali did deliver a result.ET deciphers the gains from Bali..... More...



US Supreme Court case could mean 'death' of software patents
(Associated Press , 7-Dec-2013 , IBN Live)

The US Supreme Court decided Friday to hear an appeal of a lower court decision that a federal judge called the "death" of software patents. More...



US House passes IT firms-backed patent bill
(Reuters , 06-Dec-2013 , The Times Of India)

The US House of Representatives has approved a bill aimed at reining in "patent trolls," companies that buy or license patents from others, then extract licensing fees or file infringement lawsuits viewed by many as frivolous. More...



Govt may issue compulsory licences on diabetes drugs
( C.H. Unnikrishnan , 5-Dec-2013 , Livemint)

Health ministry panel may suggest compulsory licences for at least two patented drugs that are yet to be identified. More...



India to showcase drugmaking facilities to global regulators
(Raji Reddy Kesireddy , 4-Dec-2013 , The Economic Times)

India is showcasing its best pharmaceutical manufacturing facilities to regulators from emerging economies to counter adverse publicity the country's drug industry has endured in recent times. More...



IPAB scraps 7 trademarks of TT Industries in favour of Korean firm Tageu Tec
(Gireesh Babu | Chennai , 04-Dec-2013 , Business Standard)

South Korean firm says TT Industries has not sold or marketed a single product under the impugned marks despite obtaining registration. More...



Indian pharma seeks women part-time sales force in Tier II cities to ensure diversity, stability in cos
(Nandita Vijay, Bengaluru , 04-Dec-2013 , Pharmabiz)

Indian pharma companies are now seeking out to employ women part time sales work force in Tier II cities. The move comes in because the industry is seen grappling with an attrition rate of 18-20 per cent particularly in sales and marketing. More...



J&J faulty implants: $2.5b payout in US, Indians left in lurch
(Sumitra Deb Roy , 4-Dec-2013 , The Times of India, Mumbai.)

Pharmaceutical giant Johnson & Johnson recently agreed to pay $2.5 billion (over Rs 15,000 crore) as compensation to around 8,000 US citizens who had sued the company after being fitted with its faulty hip implants More...



Pharma industry has a deep culture of corruption
(Chirantan Chatterje , 3-Dec-2013 , Business Line)

Circumventing 56 patents protecting a medicine to re-invent a novel process and procure a 57th one for Eli Lilly’s drug Cefaclor had been Ranbaxy’s biggest claim to fame in the last couple of decades. But in 2013, the situation flipped in what can be termed as its summer of dirty medicine. More...



Medical Device Cos Urge Govt not to Punish All for a Quality Lapse
(Soma Das , 03-Dec-2013 , The Economic Times,Mumbai)

Cos want input providers, component suppliers to also be held responsible for a faulty device More...



Pharmaceuticals: Compulsory licensing & reasonable efforts
(Anurag K Agarwal , 02-Dec-2013 , DNA)

Globally harmonised patenting laws recognise the sovereignty of nations like India which retain the right to compulsory licensing. More...



Govt to dissolve panel on patented drug pricing
(Sushmi Dey , 2-Dec-2013 , Business Standard)

Almost six years after forming a committee to derive a mechanism to negotiate and bring down prices of patented medicines in the country, the government has decided to dissolve the panel and dump the report the body submitted at the start of this year. More...



US biotech firm Kibow to enter India after favourable patent ruling
( C.H. Unnikrishnan , 2-Dec-2013 , Livemint)

Kibow has sought marketing approval for Renadyl, a biological supplement that helps kidney patients sustain themselves without dialysis, and has already set up a local entity. More...



14 items on GI tag list
(A Subramani , 2-Dec-2013 , The Times Of India)

Oranges of Nagpur, paintings of Kangra, Moradabad metal craft and Kolhapur jaggery are among 14 items waiting for Geographical Indications (GI) tag. More...



Facts about the WTO
(AAP , 2-Dec-2013 , Yahoo)

The World Trade Organisation (WTO) meets for its ninth ministerial conference on the Indonesian island of Bali this week, fighting to salvage a deal on slashing barriers to global commerce. More...



IP tribunal upholds US company’s product patent
(Our Bureau , 29-Nov-2013 , Business Line)

The Intellectual Property Appellate Board has upheld its 2009 decision to grant US-based Kibow Biotech a patent for a probiotic dietary supplement that will augment kidney function, according to a statement by the company. More...



India to investigate Ericsson in smartphone patent row
(Reuters | Stockholm , 28-Nov-2013 , The Financial Express)

Ericsson had sued Micromax in March 2013 for patent infringement. More...



Interview Dr. Jeremy Desai - “The pharma industry is going through a major transition”
(Sheetal Srivastava , 28-Nov-2013 , The Economic Times,Mumbai)

Dr. Jeremy Desai, president and COO of Apotex Inc. discusses with Sheetal Srivastava the future of the pharmaceutical industry More...



Wockhardt Revenues may Dip Up to $250 m on USFDA Ban
(Divya Rajagopal , 28-Nov-2013 , The Economic Times,Mumbai)

Wockhardt may suffer an annual revenue fall of up to $250 million and its American operations may grind to a halt after the US’s drug regulator banned the sale of medicines produced from the firm’s Chikalthana plant in the world’s biggest pharma market. More...



KKR Set to Pick Up 35% Stake in Gland Pharma
(Arun Kumar , 28-Nov-2013 , The Economic Times,Mumbai)

At about . 1,300 crore, it will be one of the largest private equity deals in pharmaceutical sector More...



Wockhardt’s 2nd plant faces US ban
(Rupali Mukherjee , 28-Nov-2013 , The Times of India, Mumbai.)

Drug major Wockhardt suffered a huge blow on Wednesday with the US Food and Drug Administration (FDA) banning products shipped from its key plant located at Chikalthana in Maharashtra. More...



Centre mulling new premises for Intellectual Property Appellate Board in Chennai
(Aparna Ramalingam , 27-Nov-2013 , The Times Of India)

The Union commerce ministry is in the process of setting up new premises for the Intellectual Property Appellate Board (IPAB) here. More...



Industry to benefit from utility model for patents
(BS Reporter | Chennai , 27-Nov-2013 , Business Standard)

After the elections, Centre may bring an amendment in the 2014 sessions of the Parliament, to accept the utility model in Indian Patent Act More...



Government mulls stricter norms for patents in pharma space
(Soma Das , 27-Nov-2013 , The Economic Times)

In a move that could usher in more transparency in the pharma patent landscape, the Indian Patent Office is considering a proposal that seeks to make it mandatory for drug firms to disclose the WHO-assigned generic names of drugs, whenever known, while applying for their patent. More...



EU lays down data protection steps for US
(27-Nov-2013 , The Economic Times)

The EU on Wednesday laid down steps Washington must take to restore trust after a huge spying scandal, including giving EU citizens the right to US legal redress to protect personal data. More...



WTO deal teeters, some blame Indian electioneering
(Reuters , 27-Nov-2013 , NDTV)

India may hold the key to the credibility of the World Trade Organization and to a trillion-dollar trade deal that apparently was derailed this week, diplomats in Geneva said on Tuesday. More...



Biocon, Mylam get approval for biosimilar of cancer drug Herceptin
(C.H. Unnikrishnan , 26-Nov-2013 , Livemint)

Biocon says the biosimilar Trastuzumab will be sold in India under the brand name Canmab. More...



Sony seeks ‘SmartWig’ patent in US
(Grace Huang , 26-Nov-2013 , Livemint)

SmartWig hairpieces can be used to navigate, check blood pressure or control a slideshow and can communicate wirelessly with another device. More...



Govt should not interfere with cross-fertilisation in Indian pharma sector
(Habil Khorakiwala , 26-Nov-2013 , The Economic Times,Mumbai)

The last 10 years in the Indian pharmaceutical industry have been characterised by many events that led to its stellar performance. More...



The NDTV Dialogues: Why is India's healthcare in critical condition?
(Sonia Singh , 25-Nov-2013 , www.ndtv.com)

India's health parameters are amongst the worst in the world right now and a child born in India today has less chances of survival than in Nepal or Bangladesh. On The NDTV Dialogues, Dr Srinath Reddy, Kiran Mazumdar Shaw, Dr Binayak Sen and Dr Ashok Seth join NDTV's Sonia Singh to look at why India's healthcare is in a critical condition. More...



Suggestion of WTO complaint irks public health workers in India
(P. T. Jyothi Datta , 25-Nov-2013 , Business Line)

A US trade lawyer’s observation on the possibility of hauling India to the World Trade Organisation, “for violating international patent treatises”, has ruffled feathers back in India. More...



European Patent Office to slash fee to euro 5,000 by 2015
(BS Reporter | Hyderabad , 25-Nov-2013 , Business Standard)

Says lack of complete database on Indian patents slowing down patent filing by local inventors. More...



Indian health activists move to prevent Gilead’s drug patent
(Andrew Jack in London , 24-Nov-2013 , The Financial Times )

Indian health activists are seeking to prevent Gilead from patenting its new treatment for Hepatitis C in the country in a fresh battle over affordable access to medicine. More...



Gilead’s patent application on hepatitis C drug opposed
(P. T. Jyothi Datta , 23-Nov-2013 , Business Line)

US drug-maker Gilead Sciences’ patent application on hepatitis C drug sofosbuvir has been opposed at the Indian Patent Office by legal group I-MAK — Initiative for Medicines, Access & Knowledge. More...



Samsung shares rise despite patent case setback
(AFP , 22-Nov-2013 , The Times Of India)

South Korean markets took in stride a US federal jury's order for Samsung to pay $290 million in damages to Apple, with Samsung shares going up 0.69% on Friday. More...



Now, a bid to trademark ‘stem cells’
(Bindu D. Menon , 22-Nov-2013 , Business Line)

After bima (insurance) and manjal (turmeric), a company now wants to be the brand owner of the word ‘stem cell’. More...



India, EU should address regulatory problems, tariff issues
(PTI , 22-Nov-2013 , The Economic Times)

Seeking deeper co-operation with India, European Union today said both sides need to work on eliminating tariff barriers and regulatory difficulties in their bilateral economic exchanges. More...



Creative Commons: thinking beyond copyright
(T. Ramachandran , 22-Nov-2013 , The Hindu)

Are there ways of going beyond copyright when it comes to promoting and sharing original work and content online? Yes, think of Creative Commons, which has been relaunched in India. More...



Biocon ups generic war with nod for Roche's cancer drug clone
(Soma Das , 22-Nov-2013 , The Economic Times)

Two months after the Swiss innovator firm Roche threw in a surprise by announcing that it would no longer pursue a patent on breast cancer drug Herceptin in India, it will have to brace up for generic competition, probably much earlier than it anticipated. More...



India’s monopoly regime stops us from making many drugs here: Cipla’s Hamied
( C.H. Unnikrishnan , 22-Nov-2013 , Livemint)

Cipla’s market is not India alone and it has to go global, says Yusuf K. Hamied, who stepped down as MD in February. More...



US Jury awards Apple $290 million in Samsung patent case
(AFP , 22-Nov-2013 , The Economic Times)

A US federal jury Thursday ordered Samsung to pay $290 million in damages to Apple in a partial retrial of the blockbuster patent case involving the two smartphone giants. More...



Microsoft sues Acacia over smartphone patents
(Reuters , 21-Nov-2013 , The Times Of India)

Microsoft filed a lawsuit against Acacia Research, charging that Acacia broke a contract to license various smartphone and mobile computing technologies to Microsoft. More...



US house panel passes bill targeting ‘patent trolls’
( Reurtes , 21-Nov-2013 , Livemint)

The bill requires companies filing infringement lawsuits to provide specific details on what patent is infringed, how it is used. More...



IPAB revokes a patent of US-based Kibow Biotech
(BS Reporter | Chennai , 20-Nov-2013 , Business Standard)

The revocation petition was filed by the Indian firm after it was challenged by Kibow Biotech in the Madras High Court. More...



Samsung sued for patent infringement
(AFP , 20-Nov-2013 , The Times Of India)

A Taiwanese electronics company said that it has filed a lawsuit against South Korean tech giant Samsung for allegedly infringing on its optics technology patents. More...



Expiry of patent to make rheumatic drugs cheap
(Shimona Kanwar , 20-Nov-2013 , The Times Of India)

With the patent date of drugs used in the treatment of rheumatic diseases nearing its expiry, those suffering with the crippling disease would soon be able to afford the expensive treatment. More...



When Cadbury replaced its eclairs
(Viveat Susan Pinto | Mumbai , 19-Nov-2013 , Business Standard)

Mondelez, the parent, recently, was asked to remove three of its Chocolate Eclairs label trademarks by the Intellectual Property Appellate Board following a case lodged by rival ITC. More...



Emerging economies' trademark filings rise
(AAP , 18-Nov-2013 , Yahoo Finance)

Emerging economies have almost tripled their trademark applications over the past three decades, underscoring the growing store they place in branding, the World Intellectual Property Organisation says. More...



‘It’s Wholly Reasonable for India to Think About Pricing’
(Divya Rajagopal & Sagar Malviya , 18-Nov-2013 , The Economic Times,Mumbai)

Glaxo CEO Andrew Witty says MNCs need to look at things from India’s perspective. It might hurt to go through price adjustments but there are alternative ways to have a good dialogue More...



'Superbugs may erase medical advances'
(Charlie Cooper , 18-Nov-2013 , The Times of India, Mumbai.)

Even Routine Operations Could Become Deadly 'In The Very Near Future', say Doctors. More...



Whose tribunal is it anyway?
(Justice Prabha Sridevan , 18-Nov-2013 , The Hindu)

The independence of specialist tribunals must be ensured. But this is not happening, as the functioning of the Intellectual Property Appellate Board shows More...



WikiLeaks expose: Drug makers see red
(Sushmi Dey | New Delhi , 16-Nov-2013 , Business Standard)

Approach govt to open negotiations on generics More...



Natco wins patent war against Teva
(Fe Bureau : New Delhi/ Hyderabad , 15-Nov-2013 , The Indian Express)

Hyderabad based-Natco Pharma has won a patent battle against Israeli drug giant Teva Pharmaceuticals, which could enable it to launch a generic version of the multiple sclerosis drug Copaxone in the US market in 2014. More...



Emerging economies' trademark filings climb sharply: WIPO
(AFP | Geneva , 14-Nov-2013 , Business Standard)

Emerging economies have almost tripled their trademark applications over the past three decades, underscoring the growing store they place in branding, the World Intellectual Property Organization said today. More...



Apple wants $380 mn in patent trial with Samsung
(PTI , 14-Nov-2013 , Business Line)

Apple demanded today that Samsung Electronics pay it $380 million for copying vital iPhone and iPad features, as a billion-dollar patent fight between the world’s two biggest smartphone makers resumed in a Silicon Valley courtroom. More...



Jury selection starts in Samsung-Apple patent trial
(DPA , 13-Nov-2013 , Business Line)

Smartphone giants Apple and Samsung renewed their US court battle on Tuesday in a trial to determine damages for Samsung’s violation of Apple’s iPhone and iPad patents. More...



Ignorance to blame for basmati setback
(TNN , 11-Nov-2013 , The Times Of India)

Indian inventors lack the knowledge of patenting and hence lose out to international competitors. More...



Government rejects BDR Pharma's CL application for anti-cancer drug
(PTI , 10-Nov-2013 , The Economic Times)

The government has rejected a compulsory licensing application by BDR Pharmaceuticals to manufacture the generic version of patented anti-cancer drug 'Dasatinib', a decision that is seen as evidence that IP rules prevail in India. More...



Rakesh Roshan to pursue Krrish 3 copyright violation case
(Geety Sahgal , 9-Nov-2013 , The Indian Express)

Rakesh Roshan is a relieved man that the Bombay HC did not entertain an appeal by Uday Singh Rajput. More...



Reliance Telecom's domain name plea rejected
(LUBNA KABLY , 8-Nov-2013 , The Times Of India)

The company filed a complaint against the domain name holder with World Intellectual Property Organisation (WIPO), an international arbitration service provider for settlement of domain name disputes. More...



Cadbury loses battle with ITC over Chocolate Eclairs
(Sanjay Vijayakumar , 07-Nov-2013 , The Times Of India)

After Kellogg's and Bata, it is now the turn of Cadbury to lose a trademark for non-use, 'eclairs' in this case, leaving experts intrigued as to why the chocolate maker couldn't come up with enough evidence of its use when asked in a court. More...



Apple patents tech for tracking homes via iPhone
(ANI , 06-Nov-2013 , The Times Of India)

Apple has reportedly patented a technology that would allow users to track certain events in their home while they are commuting back home or away for a holiday. More...



It’s strategies sans frontiers in pharma patent filings
(Pallavi Ail , 6-Nov-2013 , The Financial Express)

Despite seemingly strict criteria, pharmaceutical patents are not that hard to come by in India More...



Takeda drags DRL to US court for infringement
(ENS Economic Bureau - HYDERABAD , 6-Nov-2013 , The Indian Express )

Japanese pharma major Teijin Ltd and Takeda Pharmaceutical USA Inc together dragged city-based Dr Reddy’s Laboratories Ltd (DRL) to a US court allegedly for infringing their patent. More...



Japan's Eisai to launch breast cancer drug in India
(DIVYA RAJAGOPAL , 6-Nov-2013 , The Economic Times)

Japan's Eisai Pharma, a 741 billion yen ( Rs 46,439-crore) pharma major, is slated to launch in India its novel anti-cancer drug Eribulin, sold under the brand name of Halaven, as part of its strategy to expand its presence in the emerging markets. More...



Strong patent regime needed for GM crops, says MoS Tariq Anwar
(IANS , 05-Nov-2013 , The Economic Times)

Congress 2013 began here Tuesday with union Minister of State for Agriculture Tariq Anwar calling for a strong patent regime to regulate genetically modified (GM) crops in the country. More...



In patent fight, IBM's arsenal dwarfs Twitter's
(Reuters , 05-Nov-2013 , The Times Of India)

International Business Machines Corp's patent demand against Twitter Inc as it approaches an initial public offering highlights how few patents the social media company possesses compared with the established tech players. More...



GI tag: applications filed for eight articles
(Special Correspondent , 05-Nov-2013 , The Hindu)

Applications have been submitted for getting Geographical Indication (GI) tag for eight articles, according to P.Sanjai Gandhi, Geographical Indication (GI) Attorney and Additional Government Pleader. More...



Samsung extends patent licence deal with Nokia
(Reuters , 4-Nov-2013 , The Times Of India)

Finland's Nokia said Samsung Electronics has extended a phone patent licence agreement between the two companies for five years. More...



BDR’s compulsory licence bid for MNC cancer drug rejected
(Rupali Mukherjee , 31-Oct-2013 , The Times OF India)

India's second compulsory licensing application filed by domestic company BDR Pharma on dasatinib, an anti-cancer drug patented by Bristol-Myers Squibb, has been rejected by the Indian Patent Office, denying millions of patients access to the affordable version at a fraction of the cost of the patented one. More...



Nokia wins mobile patent judgment in UK against HTC
(Reuters , 30-Oct-2013 , The Economic Times)

Finnish telecoms group Nokia scored another victory on Wednesday in its patent battle against Taiwan-based rival HTC Corporation with a British court ruling in its favour over mobile telecoms technology. More...



IPAB refuses use of trademark 'Sony' by India's AB Textiles
(Gireesh Babu | Chennai , 29-Oct-2013 , Business Standard)

The IPAB came down heavily on the decision of the deputy registrar in refusing the Japanese firm's opposition and allowing the textile firm to register the trade mark. More...



IPAB refuses use of TM 'Sony' by Indian firm
(Gireesh Babu , 28-Oct-2013 , Business Standard)

Sides with Sony Corp in trademark case. More...



Samsung files patent to rival Google Glass
(26-Oct-2013 , DNA)

The South Korean firm's patent, filed on March 8, shows that it is working on a device it calls 'Sports Glasses' that are likely its response to Google's Internet-connected eyewear. More...



Getting IP owners to blow the whistle can check piracy
(TNN , 26-Oct-2013 , The Times Of India)

Containing infringement of intellectual property rights and piracy will require efforts to educate people about its impact. More...



Samsung files patent to rival Google Glass
(ANI , 26-Oct-2013 , DNA)

The South Korean firm's patent, filed on March 8, shows that it is working on a device it calls 'Sports Glasses' that are likely its response to Google's Internet-connected eyewear. More...



GIPC urges India to strengthen IP laws to utilize its vast knowledge pool and create more jobs
(Our Bureau , 25-Oct-2013 , Pharmabiz)

The US Chamber of Commerce’s Global Intellectual Property Centre has urged India to encourage innovation in the country and strengthen its Intellectual Property laws to utilize its vast knowledge pool and create more jobs. More...



Emerging markets like Brazil, South Africa initiate reforms in patent laws in line with India’s IP policy
(ET Bureau , 24-Oct-2013 , The Economic Times)

Days before the Supreme Court ruled that Novartis’ cancer drug Glivec is not a new invention good enough to be granted patent in April, a top executive of Pfizer had told a US Congress sub-committee, “India’s action reverberates far beyond its borders.” More...



US pharma firms lobby to protect patents in India
(Amiti Sen , 23-Oct-2013 , Business Line)

US pharma majors are putting pressure on the Government to stop issuing permits to domestic companies for making low-priced copies of patented life saving drugs. More...



India yet to seriously take up loopholes in new EU regulation on customs enforcement
(Joseph Alexander, New Delhi , 22-Oct-2013 , Pharmabiz)

India is yet to seriously take up with the European Union the alleged loopholes in the recent EU regulation on customs enforcement of intellectual property rights even as the public interest groups claimed that the new regulation was nothing better than the original one of 2003 that led to the seizure of Indian generic drugs and could pose serious hurdles again for Indian industry. More...



'India has failed to recognise IP rights;deterring investors'
(PTI , 21-Oct-2013 , The Economic Times)

A US trade body has asked India to spur innovation and strengthen its intellectual property laws, saying failure to recognise IP rights was dissuading investors and keeping Indian economy in a logjam. More...



?'India is committing selective genocide in healthcare'
(Rema Nagarajan , 20-Oct-2013 , The Times Of India)

The recent release of the documentary Fire in the Blood has revived the debate on whether patents block access to life-saving medicines. More...



When patents, not patients, matter more
(Narayan Lakshman , 19-Oct-2013 , The Hindu)

Neither the long-term health of their clientele nor the affordability or true effectiveness of a drug matches profit-making as a motivator for drug companies. More...



PGI for patent cell to market research
(Shimona Kanwar , 19-Oct-2013 , The Times Of India)

In a recent open house the PGI faculty sought the director's permission to allow their medical research to be translated into marketable commodities for affordable healthcare. More...



Samsung offers to stop patent lawsuits in Europe
(AP , 18-Oct-2013 , The Times Of India)

Samsung Electronics has offered not to launch any patent lawsuits over key mobile telephone technology in Europe for the coming five years, in hopes of avoiding a fine from the European Commission. More...



Samsung offers concessions to EU in patent case
(AP , 17-Oct-2013 , The Times Of India)

The European Commission is calling for comments or objections to a proposal by Samsung to end one type of patent dispute over mobile telephones in Europe for the coming five years. More...



Invention to detect fake currency gets US patent
(Laxmi Ajai Prasanna , 15-Oct-2013 , The Times Of India)

Rarely though there is a 400 per cent increase in counterfeit currency circulation in the country according to the national financial intelligence unit. More...



Nokia India tax dispute: India to discuss case WTO cooperation with Finland
(fe Bureau , 15-Oct-2013 , Financial Express)

Nokia's dispute with Indian tax authorities is likely to figure in a high level bilateral meeting. More...



New Ferrari revealed in patent images
(Autocar India , 14-Oct-2013 , Hindustan Times)

Several official illustrations, which appeared online after being submitted for design registration, show the new Ferrari in detail. More...



Madras HC sets aside IPAB order in Enercon GmbH patent case
(Gireesh Babu | Chennai , 11-Oct-2013 , Business Standard)

Court has directed IPAB to look at maintainability of petition filed by Indian partner and submit its decision within two months. More...



Samsung gadgets to face US import ban over Apple patent row
(ANI , 09-Oct-2013 , Business Standard)

Apple won a case at the US International Trade Commission that found Samsung had infringed the two patents. More...



US patents granted to inventions to contain suicide bombers
(Bloomberg , 7-Oct-2013 , The Economic Times)

Among the recently granted US patents is an invention to contain suicide bombers, technology that prevents you from getting shot, and a way to rest in peace. More...



Indian pharma majors step up R&D spend by 19.7% in 2012-13
(Sanjay Pingle, Mumbai , 7-Oct-2013 , Pharmabiz)

Expenditures on Research & Development by 30 leading Indian pharmaceutical companies have gone up significantly by 19.7 per cent during the year ended March 2013 over the previous year. More...



The right cure for pharma frauds
(KPMG , 06-Oct-2013 , Business Line)

Drugs estimated at $116 billion are going off-patent in the next five years. More...



Kalanamak rice, ‘Buddha’s gift’, awarded GI tag
(Manish Raj , 4-Oct-2013 , The Times Of India)

If you think Basmati rice, a subject of many patent battles, is the best, here is Kalanamak rice More...



Ispat Nigam Limited eyes patent route to consolidate position
(Manish , 03-Oct-2013 , The Times Of India)

State-run steel major Rashtriya Ispat Nigam Limited which expects to complete its 6.3 million tonnes per annum expansion plan soon, now also aims to strengthen its research and development wing to consolidate its position in the steel industry. More...



India's IPR regime - Moving beyond the myths of US pharma
(Hemant Krishan Singh & Aman Raj Khanna , 03-Oct-2013 , Business Standard)

It is time for the Indian government to address the growing trust deficit with foreign pharmaceutical manufacturers on the question of IPRs and improve the enforcement of patent protection. More...



US, EU irked by India’s compulsory licence plan for green technologies
(Amiti Sen , 02-Oct-2013 , Business Line)

The US and the EU have raised strong objections to India’s decision to allow compulsory licensing in the green technology sector. More...



Restricting FDI in pharma may prove counter-productive
(Subir Roy | Kolkata , 1-Oct-2013 , Business Standard)

One way India can ensure supply of cheap generics is by reviving the half-dead state-owned pharma companies. More...



Patent battles healthy for pharma
(Rajeshwari Hariharan , 30-Sep-2013 , DNA)

The Indian pharma space has seen a number of battles between innovators and generic companies — the Novartis war and Merck-Glenmark being one of the recent ones. More...



‘Patan Patola’ gets GI registration
(R. Sivaraman , 30-Sep-2013 , The Hindu)

Patan Patola a double-sided saree from Gujarat and a favourite of Congress president Sonia Gandhi has got recognition from Geographical Indication Registry. More...



Nilambur teak to get geographical indication tag soon
(T P Nijish , 30-Sep-2013 , The Times Of India)

Nilambur teak will soon become the first forest resource from India to get GI (geographical indication) tag of World Trade Organisation. More...



Patent battles healthy for pharma
(Rajeshwari Hariharan , 30-Sep-2013 , DNA)

The Indian pharma space has seen a number of battles between innovators and generic companies the Novartis war and Merck - Glenmark being one of the recent ones More...



TN distillery stopped from brewing French Cognac
(Express News Service - CHENNAI , 30-Sep-2013 , The New Indian Express)

The Madras High Court has restrained a firm in the State from manufacturing and selling a branded liquor saying the brand name ‘French Cognac’ enjoyed Geographical Indication protection and that it exclusively belonged to a French company. More...



Indian pharma market isn’t going to be that rosy
(Ramnath Subbu , 29-Sep-2013 , The Hindu)

Glenn Saldanha, Chairman & Managing Director, spoke to The Hindu on a range of issues in the pharmaceutical industry. More...



DRL would infringe on Lunesta patent: US court
(Press Trust Of India : Hyderabad , 28-Sep-2013 , The Indian Express)

The United States Court of Appeals for the Federal Circuit has ruled that Dr Reddy's Laboratories Ltd would infringe on the patent of Sunovion Pharmaceuticals blockbuster drug Lunesta. More...



New ordinance against piracy
(TNN , 28-Sep-2013 , The Times Of India)

However, the Copyright (Amendment) Act 2012, which came into force in July 2012 following the President's assent, has the provision for punishment up to two years along with a fine for dealing in fake cassettes, CDs and DVDs. More...



Samsung moves to appease EU on Apple patent fight
(AFP , 27-Sep-2013 , The Economic Times)

South Korea's Samsung has answered accusations by Brussels that the company abused its dominant market position by taking out unfair injunctions against rival Apple, the European Commission said on Friday. More...



Dr Reddy’s loses insomnia drug patent case in US court
(Our Bureau , 27-Sep-2013 , Business Line)

A US Court of Appeals has ruled that Dr Reddy’s Laboratories Ltd infringed on the patent of insomnia drug Lunesta of Sunovion Pharmaceuticals. More...



Obama to raise industry concerns at patent regime in India with Singh
(BS Reporter | New Delhi , 27-Sep-2013 , Business Standard)

Alliance for Free Trade with India today urged the US President to 'stand up for the American industry'. More...



Tech giants fear spread of patent wars to Europe
(Danny Hakim , 27-Sep-2013 , Business Standard)

The European headquarters of Google Inc in Dubin, Ireland. Google is concerned about a proposed change in the European Union's patent court system. More...



Japan fines Apple for patent infringement
(IANS - TOKYO , 26-Sep-2013 , The New Indian Express)

Saito filed an application with Tokyo Customs for an injunction against iPod imports for the patent infringement in 2007, said the report. More...



Refrain aggressive buying of large-cap pharma firms: G Chokkalingam, Centrum Wealth Management
(ET Now , 26-Sep-2013 , The Economic Times)

G Chokkalingam: I am nervous on very large-cap pharma companies because ever since the courts have revoked patent for pharma companies, we have seen a lot of qualitative restriction, especially from the US for Indian pharma companies. More...



Forest files patent suits against Lupin, Ranbaxy and others
(Press Trust of India | New Delhi , 26-Sep-2013 , Business Standard)

Joint lawsuits have been filed in the Court for the District of Delaware. More...



Cautious moves
(Sujay Mehdudia , 26-Sep-2013 , The Hindu)

Governments should safeguard public interests while negotiating Free Trade Agreements, says a CUTS study. More...



US wants MNCs to have right to sue India abroad
(Rupali Mukherjee , 25-Sep-2013 , The Times Of India)

Most bilateral investment treaties include a broad definition of investment, covering just every aspect from financial transactions to intellectual property to any form of asset, Dhar added. More...



Suven Life Sciences gains after securing three product patents
(Capital Market , 25-Sep-2013 , Business Standard)

Suven Life Sciences rose 2.29% to Rs 44.65 at 11:13 IST on BSE after the company said it has secured three product patents corresponding to the new chemical entities for the treatment of disorders associated with Neurodegenerative diseases. More...



Samsung, LG end patent dispute over display tech
(AFP , 24-Sep-2013 , The Times Of India)

South Korean electronic giants Samsung and LG have agreed to end a year-long battle over display technology patents that spawned a series of lawsuits. More...



HTC violates Nokia's patents: US judge
(Reuters , 24-Sep-2013 , The Times Of India)

HTC Corporation infringed on two Nokia patents in making its mobile telephones and tablets, a judge said in a preliminary ruling issued on Monday for the US International Trade Commission. More...



Kerala man gets US patent for device that generates power 'anywhere, anytime'
(Indo-Asian News Service , 24-Sep-2013 , NDTV)

MC David, a 57-year-old amateur magician from Kerala, has secured a US patent for an invention that generates electricity "anywhere, anytime". More...



Samsung, LG end patent dispute on display technology
(AFP , 24-Sep-2013 , The Economic Times)

South Korean electronic giants Samsung and LG have agreed to end a year-long battle over display technology patents that spawned a series of lawsuits. More...



Dr Reddy's plunges nearly 2% on patent infringement suit
(ECONOMIC TIMES.COM , 23-Sep-2013 , The Economic Times)

Dr Reddy's Laboratories Ltd plunged as much as 1.85 per cent in a weak market on Monday, after Genzyme Corporation, a fully-owned subsidiary of drug major Sanofi-Aventis, filed a suit against Dr. Reddy's Laboratories. More...



Pharmaceutical Price Regulation - Is the government being two-faced?
(DNA/Saurav Datta , 23-Sep-2013 , ZeeNews)

Pharmaceutical Prices Regulation- the government’s deception needs to be called out. More...



Genzyme Corporation files patent infringement suit against DRL
(PTI , 22-Sep-2013 , The Economic Times)

Genzyme Corporation, a fully-owned subsidiary of drug major Sanofi-Aventis, has filed a suit against Dr. Reddy's Laboratories alleging that the Indian drug maker infringed patents of its blockbuster cancer drug Mozobil on three counts. More...



Watson Laboratories send patent challenge notice to Ranbaxy for acne drug
(PTI , 20-Sep-2013 , The Economic Times)

Drug firm Ranbaxy Laboratories has said its US arm has received a notice from Watson Laboratories Inc, challenging the patent of acne treatment drug Absorica. More...



Ranbaxy to contest US pharma company to protect drug patent
(Our Bureau , 20-Sep-2013 , Business Line)

Ranbaxy Laboratories Inc, the US-based wholly-owned subsidiary of Ranbaxy Laboratories Ltd, has received a Paragraph IV Certification Notice of filing from Watson Laboratories Inc of an Abbreviated New Drug Application to the US Food and Drug Administration for a generic version of Absoric (isotretinoin capsules), the company said in an official statement on Thursday. More...



Teva drug copy to boost Natco Pharma sales
(Bloomberg , 19-Sep-2013 , Livemint)

Natco says sales will jump 62% in two years once it starts selling generic version of Copaxone to treat multiple sclerosis More...



Princeton Sues Princeton for a Share of Its Patent Millions
(David Voreacos and Susan Decker , 19-Sep-2013 , Business Week)

More than three decades ago, Princeton University professor Edward Taylor invented the compound that became the anticancer drug Alimta. More...



Are Indian pharma companies being victimised by US FDA?
(Shishir Asthana | Mumbai , 17-Sep-2013 , Business Standard)

US FDA has increased its focus on Indian pharma cos but is it deliberate. More...



In pursuit of geographical indication tag
(S M Arun , 17-Sep-2013 , The Times Of India)

Geographical Indication tag has been sought for four products Erode turmeric, Salem mango, Hosur rose and Namakkal makkal stone work that have a distinctive character compared to similar products from other parts of the state. More...



Nagpur firm's drug developed for crop protection gets US patent
(Press Trust Of India | Ahmedabad , 16-Sep-2013 , Business Standard)

He claimed that this drug can reduce use of pesticides to the tune of Rs 50,000 cr. More...



US drug regulator red flags Ranbaxy, Strides
(HT Correspondent , 16-Sep-2013 , Hindustan Times)

The US drug regulator has blacklisted Ranbaxy Laboratories’ Mohali plant, its third factory to face such an import ban, dealing a body blow to the company’s reputation and bringing its share prices crashing by 30.3% on Monday. More...



India's War On Intellectual Property Rights May Bring With It A Body Count
(16-Sep-2013 , Forbes)

Last month, drug maker Roche withdrew its patents for the breast-cancer drug Herceptin in India — and thus gave tacit approval to other companies to make low-cost generic versions of the drug. More...



Foreign drug makers won 77% of all patents in last 3 years
(C.H. Unnikrishnan , 15-Sep-2013 , Livemint)

India issued 1,001 drug patents between April 2010 and March 2013, of which 771 were given to foreign drug makers. More...



Amended Patents Act: Of medicines and increased back-room activities
(P. T. Jyothi Datta , 15-Sep-2013 , Business Line)

Multinational pharmaceutical companies such as Novartis have been major beneficiaries of India’s patent regime. More...



Indian pharma draws more scrutiny as US exports rise
(Reuters | Mumbai , 14-Sep-2013 , Business Standard)

India produces nearly 40% of generic drugs and over-the-counter products and 10% of finished dosages in the US. More...



Petition against trademark on temple dismissed
(Express News Service - KOCHI , 13-Sep-2013 , The New Indian Express)

The Kerala High Court on Thursday dismissed a plea against a decision by the Controller General of Patents, Designs and Trademarks granting certificate of trademark on the picture of the deity at Attukal Devi Temple and the description that the temple is the ‘Sabarimala of women.’ More...



Who used my Ajinomoto, the real maker asks
(Viveat Susan Pinto | Mumbai , 13-Sep-2013 , Business Standard)

The latter is a registered trademark of Ajinomoto Co Inc, a Japanese food ingredients major, which has been operating in the domestic market for the last 10 years. More...



Interesting turn in Dasatinib patent war
(Rupali Mukherjee , 12-Sep-2013 , The Times Of India)

The BMS affidavit is an attempt ``to mislead the court through false information'', when the order by the Patent Office has not been communicated officially, yet. This may influence the court decision, Andreya Fernandes of the law firm said. More...



BDR Pharmaceuticals plea for compulsory licence on cancer drug rejected
(DIVYA RAJAGOPAL , 12-Sep-2013 , The Economic Times)

The Indian Patent Office has rejected Mumbai-based BDR Pharmaceuticals application for compulsory licence on cancer drug Dasatinib according to an affidavit filed by Bristol Myers Squibb, the patent holder for the drug. More...



Apple, Google back in court over mobile phone patent lawsuit
(Diane Bartz , 12-Sep-2013 , Reuters)

Apple and Google subsidiary Motorola Mobility on Wednesday squared off in court over whether a judge should reopen a lawsuit in which the companies accuse one another of illegally using patented mobile phone technology. More...



ApplGoogle back in court over mobile phone patent lawsuit
(Reuters , 12-Sep-2013 , The Economic Times)

Apple and Google subsidiary Motorola Mobility on Wednesday squared off in court over whether a judge should reopen a lawsuit in which the companies accuse one other of illegally using their patented mobile phone technology. More...



Samsung sued by Dyson over patent violation
(Reuters , 12-Sep-2013 , The Times Of India)

British manufacturer Dyson said it had begun legal action against Samsung Electronics, to protect against what it claims is a "cynical rip off" by the Korean group of the British firm's patented technology. More...



Wockhardt stock soars on patent row settlement
(Sushmi Dey | New Delhi , 11-Sep-2013 , Business Standard)

Deal allows drug major to sell generic version of Neudexta from 2026. More...



Mylan will not shy away from pursuing ‘frivolous’ patents
(P. T. Jyothi Datta , 11-Sep-2013 , Business Line)

Multinational drug-maker Mylan has hinted that it is willing to get its hands dirty in India, even if this meant pursuing frivolous or invalid patents to bring in less-expensive generic medicines. More...



Panel backs compulsory licence on cancer drug
(Vidya Krishnan , 11-Sep-2013 , Livemint)

If the DIPP approves the recommendation, it will be India’s second compulsory licence. More...



Siddhivinayak Temple trust moves to patent ' Mahaprasad'
(DNA , 11-Sep-2013 , Zee News)

The Siddhivinayak Temple Trust proposes to patent the mahaprasad laddus that it sells to devotees, who visit the city’s most popular shrine to Lord Ganesh. More...



Losing ground to Big Pharma, bit by BIT
(Prabhash Ranjan/ Deepak Raju , 6-Sep-2013 , The Hindu)

India needs to revisit its bilateral investment treaties programme to ensure that multilateral gains on patents are not lost. More...



Microsoft wins jury trial over Google’s patent licensing
(Bloomberg , 5-Sep-2013 , Livemint)

The jury in Seattle acts in its first day of deliberations and awards Microsoft about $14.5 million in damages: reports More...



Salim-Javed settle with producers over copyright of Zanjeer
(PTI , 4-Sep-2013 , DNA)

Under section 38(3)(c) of the Act, a court can grant permanent injunction in cases where the defendant invades plaintiff's right, and the invasion is such that compensation in money would not afford adequate relief. More...



Roche had lost patent on breast cancer drug, Herceptin in Europe earlier
(Rupali Mukherjee , 04-Sep-2013 , The Times Of India)

Multinational pharmaceutical company Roche which decided to drop monopoly rights on its blockbuster breast cancer drug, Herceptin in India, had lost the same patent in Europe earlier More...



Patent lies and convenient truths
(Shamnad Basheer , 4-Sep-2013 , The Hindu)

The attempt by U.S. pharma majors to falsely depict India as an under-protector of intellectual property smacks of hypocrisy More...



Why Nokia didn't sell patents to Microsoft
(Reuters , 04-Sep-2013 , The Times Of India)

Nokia may have sold its handset business to Microsoft, but by hanging on to its valuable patent portfolio, the Finnish company could also get a big future payoff at the expense of Android phone makers. More...



Nokia patent move may mean big payoff post Microsoft
(Dan Levine , 4-Sep-2013 , Reuters)

Nokia may have sold its handset business to Microsoft Corp but by hanging on to its valuable patent portfolio the Finnish company could also get a big future payoff at the expense of Android phone makers. More...



Kolkata doctors patent neem extract to fight cancer
(Prithvijit Mitra , 3-Sep-2013 , The Times Of India)

A neem extract, which fortifies the immune system and helps fight cancer, has been patented by the Chittaranjan National Cancer Research Institute. More...



Cost cutting: Silicon Valley patent office shelved
(AP , 02-Sep-2013 , The Times Of India)

Silicon Valley's high-tech firms are fighting what they consider a deeply personal federal cut this summer that shelves a planned patent office in this innovation-fueled region. More...



Exhibition of Bengal sarees, handicrafts begins
(Press Trust of India | New Delhi , 30-Aug-2013 , Business Standard)

An exhibition of exquisite and exclusive handicrafts and handloom creations from West Bengal is on here in the run up to the Durga Puja. More...



Indian patent law doesn't discriminate against US companies: IPA
(Soma Das, ET Bureau , 29-Aug-2013 , The Economic Times)

India's intellectual property policy doesn't discriminate against US firms, Indian Pharma Alliance (IPA) representing major domestic drugmakers has told Pfizer's Intellectual Property chief Counsel Roy Waldron. More...



Indian patent regime a thorn in the flesh of global drug makers: Arun Narasani
(Nandita Vijay, Bengaluru , 29-Aug-2013 , Pharmabiz)

Brain League IP Services and Origin IP Solutions LLP have expressed that India needs to be taken seriously by global pharma majors when it comes to revoking of patents. More...



Govt refutes Novartis' allegations on patents
(PTI , 28-Aug-2013 , ZeeNews)

Tearing into the allegations made by Novartis on India's 'discriminatory' patent practices, the government has said global firms, including the Swiss drug major, have benefited more from the country's rules cornering over 80 percent of the patents granted. More...



Patent regime not discriminatory, India tells Novartis
(Special Correspondent , 28-Aug-2013 , The Hindu)

Commerce Secretary S. R. Rao has asserted that global firms, including Swiss drug major Novartis AG, have benefited more from the country’s rules. More...



More companies take to trademarks
(Our Bureau , 28-Aug-2013 , Business Line)

An increasing number of Indian companies are registering their trademarks. More...



Chennai region has the highest number of patents filed in India
(Express News Service - CHENNAI , 28-Aug-2013 , Indian Express)

Chennai region has the highest number of patents filed in India and it accounts for 30 to 35 per cent of the total patents filed last year, according to Chaitanya Prasad, controller general of patents, designs, trademarks and registrar of geographical indications. More...



Right prescription for pharma
(S. Srinivasan , 28-Aug-2013 , Business Line)

The Parliamentary Standing Committee report is correct in recommending a cautious approach to FDI in pharma. More...



Applications for registering trademark increasing 12% annually
(Press Trust of India | Chennai , 27-Aug-2013 , Business Standard)

The Controller General of Patents, Designs and Trademarks under the Commerce Ministry has received over 1.94 lakh applications from industries for registering their trademarks in the last fiscal and it is growing at 12% annually, a top official said today. More...



RCI getting ready to patent its technology
(Jatinder Kaur Tur , 27-Aug-2013 , The Times Of India)

Research Centre Imarat is all set to go for patenting of its products and technologies, its director G Satheesh Reddy said during the organization's silver jubilee celebrations. More...



Dictionary words in software patent guidelines puzzle industry
(C.H. Unnikrishnan | Leslie D’Monte , 26-Aug-2013 , Livemint)

Terms not defined in draft guidelines on patents for computer-related inventions leaves room for misinterpretation. More...



Techie's plastic-to-fuel device passes patent office tests
(Manish Raj, TNN , 26-Aug-2013 , The Times Of India)

Is necessity the mother of invention? Well, not always. More...



Indian Pharmaceutical Alliance slams US over charges on Indian patent law
(PTI , 25-Aug-2013 , The Economic Times)

Indian Pharmaceutical Alliance has contested US allegations that India's patent Act is discriminatory and said America can go to WTO's dispute settlement mechanism if such is the case. More...



IPA slams US over charges on Indian patent law
(Press Trust of India | New Delhi , 25-Aug-2013 , Business Standard)

Says, America can go to WTO's dispute settlement mechanism More...



Microsoft, Motorola set for second round of trial over patents
(Bill Rigby | Dan Levine , 25-Aug-2013 , Livemint)

The argument between the companies is just one facet of a wide-ranging global patent war surrounding smartphone and Internet technology. More...



Patent litigation case: Apple, Samsung do not have to disclose profit details
(Reuters , 24-Aug-2013 , The Indian Express)

Apple Inc and Samsung Electronics Co Ltd do not have to make public the financial details submitted to a US court during high-profile patent litigation, a federal appeals panel ruled on Friday. More...



Judge upholds $1.17 billion patent verdict against Marvell
(Bernard Vaughan , 24-Aug-2013 , Yahoo News)

A federal judge on Friday upheld a $1.17 billion award a jury imposed on chipmaker Marvell Technology Group Ltd for infringing two patents held by Carnegie Mellon University. More...



Google buys patents from Apple Inc product manufacturer Hon Hai
(Reuters : San Francisco , 24-Aug-2013 , The Indian Express)

Taiwan's Hon Hai Precision Industry said it sold Google Inc part of a patent portfolio involving the superimposition of virtual images on real-world photos. More...



Ratlami Sev all set to get global recognition
(Vivek Trivedi, Daily News & Analysis , 23-Aug-2013 , Daily Bhaskar)

Ratlami Sev renowned for its unique crispiness and non-staining quality is all set to attain global recognition as an application has been filed for receiving Geographical Indication certification for this product. More...



Individual cases to dictate MNC drug cos’ approach to patents
(DIVYA RAJAGOPAL , 22-Aug-2013 , The Economic Times)

Swiss drug maker Roche's move to give up its India patent for anti-cancer drug Herceptin is unlikely to set a precedent for multinational drug manufacturers, a lobby group of MNC drug manufacturers said. More...



Compulsory Licenses and “Statements of Working” in India
(Michael Lin , 21-Aug-2013 , IPWatchDog)

This brief note provides an update of the quickly-changing Compulsory License and Statement of Working situations in India. More...



Serum, Univ of Pune bag US patent for new vaccine adjuvant from Ashwagandha
(Nandita Vijay, Bengaluru , 21-Aug-2013 , Pharmabiz)

Serum Institute of India and the Interdisciplinary School of Health Sciences, University of Pune’s work leading to an innovative product and technology using Ashwagandha or Withania somnifera as vaccine adjuvant has received the US patent. More...



1.58 lakh patent applications pending for examination: Govt
(PTI , 20-Aug-2013 , The Hindu)

As many as 1.58 lakh patent applications are pending for examination before the government due to manpower shortage, Parliament was informed on Tuesday. More...



AOL patent sale case dismissed
(Reuters , 20-Aug-2013 , The Times Of India)

A federal judge on Monday dismissed a lawsuit accusing AOL and some of its executives of fraud for repurchasing 14.8 million shares in 2011 without disclosing that the company would sell a $1 billion portfolio of patents to Microsoft months later More...



IPAB revokes one more patent of Aloys Wobben in a petition of Enercon India
(BS Reporter | Chennai , 18-Aug-2013 , Business Standard)

This is the fourth patent of Wobben the Appellate Board revokes since the beginning of June this year. More...



Novartis lashes out at India for not respecting IPR
(PTI , 18-Aug-2013 , Business Line)

Hitting out at India’s way of dealing with Intellectual Property Rights issues, drug major Novartis has said India is losing investments in research and development from MNCs to China due to lack of an ecosystem that fosters innovation. More...



Cipla chief calls for ‘obligatory’ drug licensing
(PTI , 17-Aug-2013 , The Hindu)

The Chairman of pharmaceutical firm Cipla has asked the Indian government to push for ‘obligatory licensing’ of drugs to improve access to essential medicines in the Third World. More...



Roche's patent pain to be Biocon's gain
(Reghu Balakrishnan , 17-Aug-2013 , Business Standard)

Indian firm to soon launch copycat of anti-breast-cancer drug. More...



Swiss drug major Roche to drop anti-cancer drug Herceptin patent in India
(DIVYA RAJAGOPAL , 16-Aug-2013 , The Economic Times)

Swiss drug major Roche has decided not to pursue its patent for anti-cancer drug Herceptin, the patent which had come up for extension till 2019, paving the way for generic drug makers to manufacture this drug. More...



No hostile climate for US-based companies: Nirupama Rao
(PTI , 15-Aug-2013 , The Economic Times)

In the op-ed,'India honors not dishonors patent laws', Rao said the most prominently cited example of alleged patent infringement is actually a case study in patent protection. More...



No plans to restore Herceptin patent in India, says Roche
(C.H. Unnikrishnan , 15-Aug-2013 , Livemint)

Move marks change in strategy by Roche, which was otherwise aggressive in protecting patents More...



Panel for FDI ban in pharma companies
(Mahendra Singh , 14-Aug-2013 , The Times Of India)

A Parliamentary panel has recommended a ban on foreign direct investment in existing pharmaceutical companies, a suggestion which is going to provide ammunition to the commerce and industry ministry that has been opposing the entry of overseas players that are acquiring stakes in Indian drug manufacturers. More...



Roche misses renewal deadline, loses Herceptin patent in India
(C.H. Unnikrishnan , 13-Aug-2013 , Livemint)

If Roche does not restore the patent in six months, manufacturers can legally produce the drug in the country More...



Sudarshan Chemicals wins UK patent case
(Dileep Athavale , 13-Aug-2013 , The Times Of India)

The High Court of UK has exonerated Pune-based pigments and performance colorant manufacturer Sudarshan Chemicals in a patent-related appeal raised by German chemicals major Clariant Produkte (Deutschland) and awarded costs and damages for wrongful threats to Sudarshan. More...



Ajanta Pharma succeeds in revoking 2 Allergan patents
(Our Bureau, Mumbai , 12-Aug-2013 , Pharmabiz)

In yet another landmark victory to the Indian patent scenario, Ajanta Pharma, a specialty focused pharmaceutical formulation company, emerged successful in revoking two composition patents of Allergan Inc. used for eye-related treatments. More...



iWar and Peace
(Reynolds Holding , 12-Aug-2013 , Business Standard)

Apple appeal may bring smartphone patent ceasefire More...



Drug companies seek PM role in new pricing enforcement
(Soma Das , 12-Aug-2013 , The Economic Times)

Top domestic drugmakers have urged the prime minister's office to intervene in the manner the new drug pricing control order is being implemented, complaining that 'all sections of the pharmaceutical industry are frustrated'. More...



Sun Pharma to pay Rs 2,517 crore to settle patent suit
(PTI , 11-Aug-2013 , The Economic Times)

Drug firm Sun Pharmaceutical Industries has said it will pay its dues of Rs 2,517.41 crore soon as part of settlement agreement with Wyeth(now a division of Pfizer Inc.) and Altana Pharma AG (now known as Takeda GmbH). More...



Apple wins patent fight against Samsung
(ANI , 11-Aug-2013 , DNA)

As the ITC has sent the findings to President Barack Obama to be reviewed within 60 days and if he gives his veto, Samsung might as well be out of the US market. More...



New vaccine adjuvant from 'Ashwagandha' gets US patent
(Vishwas Kothari , 10-Aug-2013 , The Times Of India)

The US patent office has granted patent to an innovative industry-academia research project that has led to a new vaccine adjuvant extracted from ' Ashwagandha', also known as Indian Ginseng, a medicinal plant used in Ayurveda as an immunity enhancer. More...



Sun Pharma posts R1,276 cr Q1 loss on patent settlement
(ENS Economic Bureau , 10-Aug-2013 , The Indian Express)

India's largest pharmaceutical firm by market capitalisation, Sun Pharmaceutical Industries, on Friday reported a net loss of Rs 1,276.1 crore for the April-June quarter, resulting from an exceptional charge on account of the settlement in a patent infringement litigation related to generic versions of Protonix. More...



IPAB revokes two patents of Allergan's ophthalmic drugs
(BS Reporter | Chennai , 09-Aug-2013 , Business Standard)

The Intellectual Property Appellate Board has revoked two patents related to two ophthalmic drugs of US-based Allergan Inc, finding that the claimed inventions were obvious. More...



Allergan loses patents for two drugs
(R. Sivaraman , 09-Aug-2013 , The Hindu)

Ajantha Pharma alleged that the patent was obtained on false representation More...



India revokes patents on Allergan eye drugs Ganfort and Combigan
(Reuters , 9-Aug-2013 , The Economic Times)

India revoked patents on two of Allergan Inc's eye drugs on Thursday, the latest in a series of intellectual property setbacks suffered by Western drugmakers. More...



Apple vs Google: Court ruling revives patent case
(Reuters , 08-Aug-2013 , The Times Of India)

A US appeals court ruled that Apple should be able to renew its arguments at the International Trade Commission that Google's Motorola Mobility unit violated two patents relating to the iPhone. More...



Javed Akhtar's on a copyright mission
(Subhash K Jha , 6-Aug-2013 , DNA)

After taking up the issue of copyright and royalty rights for Bollywood writers, Akhtar now wants to highlight cross-border copyright infringement More...



Low IPR awareness costing Indian SMEs heavily
(Komal Amit Gera | Chandigarh , 05-Aug-2013 , Business Standard)

All states in India now have patent facilitation centres and SMEs need to consult them to find out how they can benefit from them More...



Kolkota Patent Office denies reports of partly revoking patent to Roche’s cancer drug
(Our Bureau, New Delhi , 05-Aug-2013 , Pharmabiz)

Patent authorities in India have denied reports that India had partly revoked patent granted to Roche for its breast cancer drug herceptin. More...



Patent Office clarifies action on Roche application
(Our Bureau , 05-Aug-2013 , Business Line)

Says drug-maker ignored opportunities to be heard. More...



Roche lost Herceptin patent due to procedural problems
(Vidya Krishnan , 4-Aug-2013 , Livemint)

Health ministry says patent for the breast cancer drug had lapsed due to procedural delays on the part of the Swiss company. More...



India partly revokes Roche cancer drug patent
(Reuters , 04-Aug-2013 , The Times Of India)

India has partly revoked patents granted to Roche Holding AG for its breast cancer drug Herceptin, a spokesman for the drugmaker confirmed on Sunday. More...



Apple import veto risks undermining patent protection push
(James Politi , 04-Aug-2013 , CNBC)

President Barack Obamas move to overturn a looming import ban on older iPhone and iPad models favoring Apple over Samsung in a long running legal battle risks undermining the US administration's aggressive push for stricter intellectual property regimes around the world. More...



GSK’s breast cancer drug patent upheld till 2019
(Rupali Mukherjee , 3-Aug-2013 , The Times Of India)

The Intellectual Property Appellate Board has upheld a patent granted on the original compound (lapatinib) of GSK's breast cancer drug, Tykerb, which ensures monopoly rights on the drug till 2019 in the domestic market. More...



Organic kaipad rice set to get pride of place
(Byju Aryad | ENS - KOCHI , 02-Aug-2013 , The New Indian Express)

Kaipad, a rice variety from the state, will soon receive a Geographical Indications tag. More...



IPAB upholds patent on basic compound of GSK's breast cancer drug
(Rupali Mukherjee , 02-Aug-2013 , The Times Of India)

The Intellectual Property Appellate Board (IPAB) has upheld a patent granted on the original compound (lapatinib) of GSK's breast cancer drug, Tykerb, which ensures monopoly rights on the drug till 2019 in the domestic market. More...



In desi Viagra market, companies fight over names
(Manish Raj , 2-Aug-2013 , The Times Of India)

Kamagra Silagra, Edegra, Penegra, Zenegra the complete list can fill reams. More...



Delhi HC reserves verdict on MSD-Glenmark drug patent row
(PTI , 01-Aug-2013 , Livemint)

US firm had earlier appealed against the order refusing to restrain Glenmark from manufacturing Zita and Zita-Met. More...



India Asks U.S. To Stiffen Their Own Laws on Patent Regime
(SiliconIndia , 01-Aug-2013 , SiliconIndia)

For some time now the U.S. government was criticizing India’s laws on intellectual property rules. More...



GI tag for Nagpur orange, Dharmavaram saris
(Sharath S. Srivatsa , 1-Aug-2013 , The Hindu)

The juicy Nagpur orange, the famous tribal Warli art, Dharmavaram saris and Kerala’s Kaipad rice have been cleared for inclusion in Geographical Indications registry in the country. More...



India asks US to tighten patent regime to curb misuse
(Amiti Sen , 31-Jul-2013 , Business Standard)

Our intellectual property rules are in compliance with global rules, says Govt. More...



Mirna Therapeutics Announces Important Expansion of microRNA Patent Portfolio
(AUSTIN, Texas--(BUSINESS WIRE) , 30-Jul-2013 , Yahoo)

U.S. Patent and Trademark Office Allows microRNA Mimic Composition of Matter Patent. More...



Patents are not just about pharma
(RISHIKESHA T. KRISHNAN , 30-Jul-2013 , Business Line)

Innovators in IT and other sectors need protection as well. More...



Obama’s recent orders on ‘patent trolls’ could impact biotech cos more than pharma cos
(Nandita Vijay , 30-Jul-2013 , Pharmabiz)

Intellectual Property has been a strategic tool for business advantage in the developed regions for quite a while now. More...



Natco Pharma up 20% post US ruling on Copaxone patent case
(29-Jul-2013 , Money Control)

We are pleased to announce the US Court of Appeals for the Federal Circuit ruling, reversing a district court's finding related to Teva's US patent for Copaxone," Natco said in its filing More...



Domestic IPR: Dependence on imported equipment proves costly
(T. E. Raja Simhan , 28-Jul-2013 , Business Line)

Large-scale dependence on imported equipment deprived the Indian telecom industry from developing its own Intellectual Property Rights. More...



Small Indian retailer locked in trademark fight with Gap
(Abhaya Srivastava , 28-Jul-2013 , Livemint)

In March, the owners of Green the Gap were slapped with a legal notice by Gap asking them to change their name within 14 days. More...



New techs to drive patent filings in India
(BS Reporter | Hyderabad , 26-Jul-2013 , Business Standard)

Patent filings in India would be more and more driven by new technologies, which are either kept secret or patented. In line with this, there will be a big shift towards protection of innovation rather than just granting the patents, said Chaitanya Prasad, Controller General of Patents, Design and Trade Marks, Indian Patent Office. More...



S. Africa group writes to USTR in support of Indian drugs
(P. T. Jyothi Datta , 25-Jul-2013 , Business Line)

As India’s intellectual property protection policy comes under intense criticism in the United States a pro-health group, South Africa’s Treatment Action Campaign, has come out in support of the Indian generic drugs industry. More...



Google buys speech rec patents from SR Tech
(Richard Chirgwin , 24-Jul-2013 , The Register)

A company established last year to negotiate royalties from patents filed by previously low-profile individuals from Cincinnati has vaulted into public eye courtesy of Google, which has bought rights to two of its patents. More...



Natco drops Albupax launch despite overcoming patent, safety hurdles
(C.H. Unnikrishnan , 23-Jul-2013 , Livemint)

While Natco has been unable to launch its biosimilar version of the breast cancer drug, three other firms have introduced theirs. More...



Price control, IP Act & regulatory framework: Revisiting some imp issues about Indian pharma
(Ramesh Adige , 23-Jul-2013 , The Economic Times)

Pricing of patented medicines, though, continues to evade an equitable solution and discussions are ongoing. More...



UCB drags 15 cos to court for patent violation
(fe Bureau : Hyderabad , 23-Jul-2013 , The Financial Express)

Belgium-based UCB Inc, a global biopharmaceutical company focusing on central nervous system and immunology treatment and research, has filed separate patent infringement cases against as many as 15 drug makers in a Delaware court to prevent generic drug makers such as Ranbaxy, Aurobindo, Sun Pharma, Glenmark, Sandoz, Glenmark, Watson from entering the market with versions of its epilepsy treatment drug Vimpat. More...



Health ministry ups ante against patents
(Sidhartha , 23-Jul-2013 , The Times Of India)

The health ministry has asked for a cancellation of patent to Trastuzumab a medicine which treats a form of breast cancer using a rarest of the rare provision in the Indian Patents Act. More...



UCB files cases against Ranbaxy, Aurobindo, Glenmark, Sun Pharma, others on patent issue
(PTI , 22-Jul-2013 , The Economic Times)

UCB, a global biopharma company, alongwith others has filed separate cases against as many as 15 drug makers, including India's Ranbaxy, Aurobindo, Zydus, Sun PharmaBSE -1.08 %, GlenmarkBSE 0.83 % and Alembic Pharmaceuticals for allegedly infringing its patented drug Vimpat. More...



Forgotten email patent holder pings Chennai
(Karthikeyan Hemalatha , 19-Jul-2013 , The Times Of India)

He has a patent for email and is fighting to be recognized for it. More...



The growing trust deficit in India
(Pramath Raj Sinha , 18-Jul-2013 , Livemint)

The recent Merck Sharp and Dohme vs Glenmark case highlights an important regulatory gap between Indias drug licensing authorities and its patent offices. More...



Mylan says court dismisses some of Teva's patent claims on MS drug
(Pallavi Ail in Bangalore and Bill Berkrot in New York , 17-Jul-2013 , Reuters)

A federal court in New York ruled that Mylan Incs generic application for a multiple sclerosis drug has not infringed some of Teva Pharmaceutical Industries patents Mylan said. More...



IPAB lays rules for granting of interim orders
(Sruthisagar Yamunan - CHENNAI , 16-Jul-2013 , The New Indian Express)

In a major judgement that has come as a respite to patent law practitioners in the country, the Intellectual Property Appellate Board has asserted that it indeed had powers to grant interim orders on applications and has framed guidelines to be followed for issuing the same. More...



NGOs call upon Indian govt to reject US pressure on economic policies including CL on life-saving drugs
(Ramesh Shankar, Mumbai , 16-Jul-2013 , Pharmabiz)

A coalition of over 75 civil society groups in the country, under the banner of Forum Against Free Trade Agreements in India, has called upon prime minister Dr Manmohan Singh to review its forthcoming economic engagements with the USA, and to reject pressure from the US government and business lobby groups on India’s economic policies, including its recent decision to allow compulsory licensing for life-saving drugs. More...



Glenmark Pharma inches up after confirming patent fight for a generic in US
(Capital Market , 15-Jul-2013 , Business Standard)

The announcement was made after market hours on Friday, 12 July 2013. More...



India has weak intellectual property rules: Michael Froman
(Nayanima Basu | New Delhi , 15-Jul-2013 , Business Standard)

Michael Froman, who was appointed the US Trade Representative on June 21, is President Barack Obama's principal advisor, negotiator and spokesperson on international trade and investment issues. More...



SMS, RTI potent tools of drug companies fighting patent battle
(Soma Das, ET Bureau , 15-Jul-2013 , The Economic Times)

As patent wars heat up in the pharma space, mobile phone messages and Right to Information filings have emerged as potent weapons in the hands of multinationals keen to delay competition from low-cost generic versions of their patented products in India. More...



US visa is non-tariff barrier for IT, says FM
(BS Reporter | Washington , 13-Jul-2013 , Business Standard)

He said Indian law affirms intellectual property rights and the process of granting compulsory licence and patent registration were World Trade Organisation-compliant and subject to judicial review. More...



Chidambaram tells US India respects IPRs
(Arun Kumar | IANS - WASHINGTON , 12-Jul-2013 , The New Indian Express)

Chidambaram stressed the "importance of India becoming a manufacturing hub for meeting its own domestic needs and for rebalancing the global economy". More...



Glenmark confirms patent challenge for its generic versions of VIMPAT in the US Court
( Vishal Dutta, ET Bureau , 12-Jul-2013 , The Economic Times)

Mumbai-based Glenmark Generics Ltd confirms that it has filed Abbreviated New Drug Applications for Lacosamide tablets and oral solution with the US drug authorities with a Paragraph IV certification for the Orange-Book listed patent. More...



US welcomes India's decision on PMA, express concerns over IPR
(Press Trust of India | Washington , 12-Jul-2013 , Business Standard)

Welcoming the recent Indian decision to put a hold on its policy of Preferential Market Access the United States has expressed its concern over continued investment climate in India and its policies related to Intellectual Property Regime. More...



Metro planning to patent indigenous electrical design
(Rumu Banerjee , 12-Jul-2013 , The Times Of India)

It was lack of space at the upcoming Chirag Dilli Metro station that made Delhi Metro think up an indigenous electrical solution it is now planning to patent. More...



US to probe China's Sany Heavy for alleged patent infringement
(Reuters , 12-Jul-2013 , The Economic Times)

The US International Trade Commission will launch a probe into Sany Heavy Industry Co Ltd after Manitowoc Co Inc accused China's biggest maker of construction equipment of infringing its crawler crane patents. More...



Visa issues, patents to dominate India-US trade talks
(Amiti Sen , 11-Jul-2013 , Business Line)

While concerns on visa restrictions for Indian professionals top the country’s agenda in the India-US high-level bilateral trade talks that started on Thursday, Commerce Minister Anand Sharma will also make a case for allowing LNG exports to India and the need to finalise a social security agreement that would save over $1 billion of annual contributions made by temporary Indian workers. More...



Monsantos climate-resilient crop patent claims rejected
(Sanjay Vijayakumar , 10-Jul-2013 , The Economic Times)

India's patent appeals board has denied Monsanto a patent for a genetically-engineered method of increasing climate resilience in plants. More...



Anand Sharma defends India’s IP Law at Indo-French CEOs meet
(ET Bureau , 10-Jul-2013 , The Economic Times)

Commerce and industry minister Anand Sharma defended India's intellectual property regime in his address at the Indo-French CEOs forum in Paris on Monday. More...



Monsanto’s climate-resilient crop patent claims rejected
(Sanjay Vijayakumar , 10-Jul-2013 , The Economic Times)

India's patent appeals board has denied Monsantoa patent for a genetically-engineered method of increasing climate resilience in plants. More...



Generic Pharma Association study says patent settlements netted $25.5 bn in savings for US health system
(Our Bureau, Mumbai , 10-Jul-2013 , Pharmabiz)

Generic pharmaceuticals launched prior to patent expiration due to a patent settlement helped the US health system save $25.5 billion from 2005-2012 and brought generic medicines to market on average 81 months sooner than patent expiry, according to a new analysis conducted for the Generic Pharmaceutical Association by the IMS Institute for Healthcare Informatics. More...



Falling standards of pharma companies is industry's big bane: GV Prasad, Chairman, Dr Reddy’s Lab
(CR Sukumar & Raji Reddy Kesireddy , 10-Jul-2013 , The Economic Times)

The pharmaceutical industry is facing pressure from regulators in the US because companies have allowed standards to decline, the head of one of India's biggest drug makers has said. More...



The Holy Grail of new drug development
(Professor of Corporate Strategy and Policy at IIM-B, Jugaad to Systematic Innovation: The Challenge for India. , 9-Jul-2013 , Business Line)

Pioneering Indian pharmaceutical companies started on the journey of new drug development in the early 1990s when India announced its decision to sign the WTO agreement and bring in a product patent regime in drugs from January 1 2005. More...



SSWL soars on bagging patent for semi-full face wheels
(SI Reporter | Mumbai , 9-Jul-2013 , Business Standard)

The patent is for the company's innovative design concept in semi-full face wheels. More...



Trademark registration goes global from Monday
(A Subramani , 07-Jul-2013 , The Times Of India)

Come Monday, the Madrid Protocol for a single window trademark registration for 90 member-countries will come into operation. More...



Protect innovation to secure growth
(Ron Somers , 6-Jul-2013 , Business Standard)

There are grave concerns about intellectual property protection in India. More...



US patent for Gujarat weed that gives IQ high
(Tushar Prabhune , 07-Jul-2013 , The Times Of India)

Sounds unbelievable, but the humble seaweed growing in abundance along Gujarat's 1,600-km coastline can yield a health drink that boosts brain functioning and increases immunity. More...



Venus Remedies surges after Japan grants patent for 'Elores'
(SI Reporter | Mumbai , 03-Jul-2013 , Business Standard)

The company is expecting to launch this product in Japanese market by end of 2015. More...



EU threat to Indian farmers
(K P Prabhakaran Nair , 3-Jul-2013 , The New Indian Express)

The protective cover given to the EU products under the Geographical Indication tag with over 3,000 registered GIs, of which 130 are for dairy products, will make things worse for Indian dairy products. More...



Apple's Siri in China court over alleged patent infringement
(Agence France-Presse , 03-Jul-2013 , NDTV)

A case against US technology giant Apple brought by a Chinese firm for alleged patent infringement in its digital personal assistant "Siri" has begun in a Shanghai court, state media said on Wednesday. More...



Apple applies for 'iWatch' trademark in Japan
(Associated Press - TOKYO , 3-Jul-2013 , The New Indian Express)

Apple Inc. has applied for a trademark in Japan for "iWatch" as rumors suggest it may be developing a smart wristwatch. More...



IP environment deteriorating in India: US pharma industry
(Press Trust of India | Washington , 2-Jul-2013 , Business Standard)

India however maintained that the India Patent Act was in accordance with the TRIPS Agreement & the Paris Convention. More...



US ups its pressure on India over generics industry
(Regulatory , 01-Jul-2013 , PMLive)

Follows complaints from Pfizer about the country’s patent laws. More...



Patent Fight Short Circuits 'Laser Peg' Toy Plan
(Ashley Lagzial , 30-Jun-2013 , CNBC)

It took several years for inventor Jon Capriola to get his toy to market. More...



Indian varsities account for 5% of patents
(DNA Correspondent , 27-Jun-2013 , DNA)

Universities in India are not only gradually upgrading their innovation radars, but are also increasingly filing patent applications on innovations. More...



Sun, Merck sign patent licensing agreement for Januvia
(Archana Shukla ,CNBC-TV18 , 27-Jun-2013 , MoneyControl)

Merck Sharp & Dhome and Sun Pharma, who have a co-marketing tie up for Merck's diabetes drug Januvia, have now included a patent licensing agreement in their arrangement in a bid to strengthen their case. More...



Apple loses bid to add Galaxy S4 to Samsung patent lawsuit
(Bloomberg , 27-Jun-2013 , Livemint)

Judge rules that adding another product to the Apple-Samsung patent lawsuit is a tax on the court’s resources More...



India ready to discuss patent policies with U.S. lawmakers
(PTI , 26-Jun-2013 , The Hindu)

Asserting that the Indian Patents Act related to pharmaceutical products is not discriminatory against foreign companies, Indian Ambassador to the United States, Nirupama Rao, offered lawmakers concerned to discuss the issue for the sake of long-term bilateral and strategic partnership between the two countries. More...



Intellectual Property creation witnessing steady growth in India: Report
(PTI , 26-Jun-2013 , The Economic Times)

The country's contribution to Intellectual Property creation is witnessing a steady growth, however, investments in R&D and patent activities in the country are still relatively slow when compared to developed nations, a report says. More...



WIPO reaches agreement on treaty for blind
(Pankaj Mishra , 26-Jun-2013 , Livemint)

India has 63 million visually impaired people, of whom about 8 million are blind, according to WHO More...



GI Tag: Varanasi-Mau-Bhadohi leading in UP
(Saurabh Gupta , 26-Jun-2013 , SME Times)

Varanasi, Bhadohi and Mau clusters, the three very renowned districts of Uttar Pradesh, are now having the Geographical Indications tag. More...



India ready to discuss patent policies with US lawmakers: Nirupama Rao
(PTI , 26-Jun-2013 , The Times Of India)

Asserting that the Indian Patents Act related to pharmaceutical products is not discriminatory against foreign companies, the Indian ambassador to the United States, Nirupama Rao, offered concerned lawmakers to discuss the issue for the sake of long-term bilateral and strategic partnership between the two countries. More...



NPPA formula for fixing ceiling prices of essential drugs under new DPCO confusing
(Ramesh Shankar, Mumbai , 26-Jun-2013 , Pharmabiz)

Even as the drug price regulator NPPA has started fixing ceiling prices of 348 essential drugs as per the new DPCO 2013, confusion prevails over the formula being used by the NPPA for calculation of ceiling prices as the industry says that it is contrary to the formula specified in the NPPP 2012 and the DPCO 2013. More...



Merck Sharp and Dohme Corporation gets relief on diabetes drug patent row
(TNN , 26-Jun-2013 , The Times Of India)

The Delhi high court has restrained an Indian pharmaceutical company from launching its diabetes drug allegedly having identical molecule and derivative salt of the patented drug manufactured by US drugmaker Merck Sharp and Dohme Corporation. More...



Shilpa Medicare in pact with medicines patent pool for entering HIV space
(P. T. Jyothi Datta , 26-Jun-2013 , Business Line)

The United Nations-backed Medicines Patent Pool, Shilpa Medicare and Gilead Sciences have entered into an agreement to increase the access to medicines for HIV/AIDS treatment. More...



Breakingviews - India should take U.S. pharma complaints seriously
(Katrina Hamlin , 25-Jun-2013 , Reuters)

U.S. drug giants are once again pushing for stronger patent protection in India. Their arguments may be transparently self-serving - but there are still good reasons for India to take note. More...



India counters US over patents
(Sidhartha , 25-Jun-2013 , The Times Of India)

The government has taken on the United States, defending its intellectual property regime, and has gone to the extent of suggesting that Washington could draw from the Indian experience in checking frivolous patents. More...



Court upholds Apple’s $ 625 mn patent victory
(DPA , 25-Jun-2013 , Business Line)

The US Supreme Court yesterday upheld lower court rulings that cleared Apple of three patent violations that carried fines of 625 million dollars. More...



Google patents photo-capturing walking stick
(ANI , 24-Jun-2013 , The Times Of India)

Google has got its new invention, a walking stick that takes pictures whenever it hits the ground, patented. More...



European wines seek geographical indication tag with India proposing a steep duty cut
(ET Bureau , 24-Jun-2013 , The Economic Times)

Popular European wine brands are making a beeline for geographical indication registration in India. More...



US Secretary of state's complex task in today's talks
(Jyoti Malhotra | Toronto , 24-Jun-2013 , Business Standard)

US Admn seems divided on supporting India membership in APEC; Afghan and trade issues also to come up. More...



Intas settles patent litigation with Hoffmann-La Roche for capecitabine tablet
(Vishal Dutta , 24-Jun-2013 , The Economic Times)

Ahmedabad-based drug maker Intas Pharmaceuticals Ltd and its US-based wholly owned subsidiary Accord Healthcare Inc. has entered into a settlement and license agreement with Hoffmann-La Roche Inc. to resolve pending patent litigation on XELODA Tablets. More...



Developed markets turn spotlight on generic drug settlements
(Ravi Ananthanarayanan , 23-Jun-2013 , Livemint)

Increasing scrutiny poses uncertainty for Indian generic firms, adding to the list of uncertainties for investors. More...



India pushes back against US industry's charges
(Indira Kannan | Toronto , 21-Jun-2013 , Business Standard)

Just ahead of the next round of the strategic dialogue with the United States, the Indian government is pushing back against allegations from American industry groups that it engages in discriminatory trade practices and does not respect global intellectual property standards More...



Patent justice
(21-Jun-2013 , The Hindu)

The U.S Supreme Courts landmark ruling that DNA segments are a product of nature and hence not patent-eligible has worldwide significance because it settles the controversial issue of patenting human genes in the one jurisdiction where it has come to matter the most. More...



FTC is said to plan inquiry of frivolous patent lawsuits
(Edward Wyatt, The New York Times , 20-Jun-2013 , NDTV)

The chairwoman of the Federal Trade Commission is expected on Thursday to recommend a sweeping investigation of "patent trolls," companies that buy large portfolios of technology patents and use them to sue software designers and makers of products like smartphones and tablet computers, people briefed on the inquiry said. More...



Zydus infringed Takeda Pharma's patent : US court
(Sohini Das | Ahmedabad , 20-Jun-2013 , Business Standard)

Zydus Pharmaceutical USA, a subsidiary of Ahmedabad-based Cadila Healthcare, has lost a patent infringement suit in the US. More...



The patent truth
(Ritu Kamal , 20-Jun-2013 , The Indian Express)

The US Supreme Court's judgment on gene patents is fair to patients. More...



Ranbaxy, 8 other companies fined Rs 1,000 crore
(TNN , 20-Jun-2013 , The Times Of India)

EU antitrust regulators on Wednesday imposed fines totalling 146 million euros (Rs 1,150 crore) on nine global drugmakers, including Ranbaxy, for blocking the supply of cheaper versions of Danish company Lundbeck's antidepressant drug citalopram. More...



Dr Reddy’s sued for infringement of thyroid injection patent
(PTI , 19-Jun-2013 , The Hindu)

U.S. drug maker AbbVie filed petition in U.S. court More...



IIT-D scholars patent prosthetic limb guided by good leg
(Naveed Iqbal , 19-Jun-2013 , The Indian Express)

Two young scientists from IIT-Delhi have received a provisional patent for the prototype of a prosthetic limb that will enable amputees to walk "without having to drag their leg". More...



Drug price control formula leaves companies shaky, cos approach pharma department
(Soma Das , 19-Jun-2013 , The Economic Times)

The government's interpretation of 'brand' while fixing price caps of essential drugs has prompted leading domestic manufacturers to approach the pharma department and seek a halt to immediate implementation of the new drug price control order. More...



In India, copycat drug firms get off lightly compared with US
(Jayati Ghose , 18-Jun-2013 , The Indian Express)

Indian drug major Sun Pharmaceutical Industries last week agreed to pay $550 million to New York-based Pfizer as part of an out-of-court settlement of the Protonix patent infringement lawsuit. More...



Copyright issue plagues Shah Rukh Khan’s Om Shanti Om
(MAYURA JANWALKAR , 18-Jun-2013 , The Indian Express)

Nearly six years after the movie's release, Ajay Monga — claiming to be the original script writer of the Shah Rukh Khan-Deepika Padukone starrer Om Shanti Om, that released in November 2007 — has sought restoration of a suit he had filed earlier alleging infringement of his copyright. More...



Venus Remedies gets patent for Potentox from Mexico
(PTI , 17-Jun-2013 , Business Line)

Venus Remedies Limited, a research-based global pharmaceutical company, has received patent from Mexico for its novel antibiotic product Potentox. More...



US Supreme Court's judgment on gene patents is neither ethical nor logical
(Noah Feldman , 17-Jun-2013 , The Economic Times)

Can you patent genes? In Association for Molecular Pathology vs Myriad Genetics, the US Supreme Court answered this imponderable question with a split decision you can't if they are naturally occurring and you've simply discovered the gene but if you've crafted a synthetic gene you've invented it and you can keep the patent. More...



J&J’s Depuy Synthes Wins $16 Million in Patent Case
(Phil Milford , 16-Jun-2013 , Bloomberg)

Johnson & Johnsons DePuy Synthes unit, a maker of artificial spinal repair products, won $16 million in damages from Globus Medical Inc. More...



Patent body dismisses HUL's appeal on hair-conditioner
(T E Narasimhan , 15-Jun-2013 , Business Standard)

The Intellectual Property Appellate Board has dismissed an appeal by fast-moving consumer goods company Hindustan Unilever Ltd for recognising the company's patent claim for a hair-conditioning agent. More...



Now, licence to play copyrighted music in public places
( Express News Service - BANGALORE , 15-Jun-2013 , The New Indian Express)

Next time you hear your favourite song playing at a bar, restaurant or even an airplane remember that the shopowner might well be in contravention of the Copyright Act of 1957 which makes it mandatory for public establishments playing copyrighted music to procure a public performance licence. More...



Patent ruling a boost to genetic research
(The New Indian Express , 15-Jun-2013 , The New Indian Express)

The US Supreme Courts ruling that DNA in the human genome is a “product of nature” that cannot be patented is of great significance. More...



'Happy Birthday' song in court over copyrights issue
(PTI , 14-Jun-2013 , The Indian Express)

The beloved 120-year-old ditty 'Happy birthday to you' is in court over copyright issues after a documentary film company filed a USD 5 million lawsuit to bring the popular song into public domain. More...



GI certificate for Toda embroidery formally handed over to tribals
(Special Correspondent , 13-Jun-2013 , The Hindu)

Toda tribal representatives on Thursday formally received a Geographical Indication certificate for their unique embroidery, which is known for its striking colours. More...



Pfizer’s India patents, revenue grow despite adverse testimony
(C.H. Unnikrishnan , 14-Jun-2013 , Livemint)

Firm says India’s patent regime protectionist, but has been one of the top patent winners in pharma in the country. More...



US court says human genes cannot be patented
(AP , 14-Jun-2013 , The Times Of India)

The US Supreme Court ruled on Thursday that companies cannot patent parts of naturally-occurring human genes, a decision with the potential to profoundly affect the emerging and lucrative medical and biotechnology industries. More...



Sun Pharma sues Novartis in US court
(Sushmi Dey | New Delhi , 13-Jun-2013 , Business Standard)

Demands rights to Gleevec generic before Novartis' patent expires More...



Sun to pay Pfizer, Takeda Rs 3K cr over Protonix patent
(Ashish K Tiwari , 13-Jun-2013 , DNA)

Sun Pharmaceutical Industries will pay as much as Rs 3,178 crore this year as its share of the settlement reached with US-based Pfizer Inc and Japans Takeda Pharma in the case of patent infringement relating to generic Protonix a blockbuster acid reflux medicine. More...



Eastern Mills in carpet city Bhadohi has loose ends to tie up as IKEA bolsters link
(Nivedita Mookerji | Bhadohi (near Varanasi) , 13-Jun-2013 , Business Standard)

The group, which started supplying to the global retail major four years ago, is seeing winds of change at its factories. More...



Goa government seeks geographical indication status for azulejos, crochet, coconut craft
(Anisha Francis , 13-Jun-2013 , The Times Of India)

The office of the development commissioner for handicrafts has sought GI status for three handicraft items they claim are unique to Goa—azulejos crochet and the centuries-old handicraft of coconut carving. More...



Sun Pharma in action after reaching settlement on patent lawsuit
(Capital Market , 13-Jun-2013 , Business Standard)

Sun Pharmaceutical Industries after market hours on Wednesday, 12 June 2013 announced that it together with its subsidiaries, has settled an ongoing litigation pending in the United States District Court, District of New Jersey regarding Sun Pharma subsidiary's generic pantoprazole. More...



A Strategy for Combating Patent Trolls
(CHARLES E. SCHUMER , 12-Jun-2013 , The Wall Street Journal)

With so many weak patents being used just to get a payoff, it's time to make patents stronger. More...



Patents must balance profit with social cost
(The New Indian Express , 12-Jun-2013 , The New Indian Express)

The US Supreme Court’s verdict on a rather unique case, which seeks to answer the question if human genes can be patented, will soon be available. More...



India needs to show the world it respects intellectual property rights: Kiran Mazumdar-Shaw
(PTI , 10-Jun-2013 , The Economic Times)

India needs to show the world that it respects intellectual property rights if it wants global pharmaceutical firms to invest in India, according to Biocon Chairman and Managing Director Kiran Mazumdar-Shaw. More...



Is it all right for firms like Myriad Genetics to patent genes?
(Hari Pulakkat , 10-Jun-2013 , The Economic Times)

The US Supreme Court will rule on Monday on a case challenging some patents by Myriad Genetics, a company that offers predictive genetictesting services for breast cancer More...



New US biz centre to boost ties with Indian SMEs
(Vijay C Roy | Chandigarh , 10-Jun-2013 , Business Standard)

ABC's activities will include dissemination of catalogues of US and Indian products to potential buyers, and staging of workshops and seminars on topics ranging from trade and finance to IPR. More...



Copy right?
(Shubashree Desikan , 09-Jun-2013 , The Hindu)

With the publishers taking up the case against course packs, students have also jumped into the fray to represent their side. More...



Tata Motors moves court against trademark infringement
(Press Trust of India , 09-Jun-2013 , Business Standard)

Tata Motors has filed a complaint before a Delhi court alleging infringement of its trademark and copyright by unknown persons manufacturing and marketing spurious ancillary automobile products under its name. More...



Delhi University students impleaded on copyright row
(Shubashree Desikan , 9-Jun-2013 , The Hindu)

With the publishers taking up the case against course packs, students have also jumped into the fray to represent their side. More...



Google files 'facial password' patent to increase Android security
(ANI , 7-Jun-2013 , DNA)

It says examples of the requests that might be made include, a frown, a tongue protrusion, an open-mouth smile, a forehead wrinkle, an eyebrow movement. More...



Motorola settles patent dispute with TiVo
(AP , 07-Jun-2013 , The Times Of India)

Motorola Mobility said that it has reached a settlement with digital video recording pioneer TiVo ahead of a patent trial that was to start in a Texas court next week. More...



Google files 'facial password' patent to increase Android security
(ANI , 07-Jun-2013 , DNA)

It says examples of the requests that might be made include, a frown, a tongue protrusion, an open-mouth smile, a forehead wrinkle, an eyebrow movement. More...



US lawmakers express concern over Indian economic policies
(PTI , 7-Jun-2013 , The Indian Express)

US lawmakers and some top business organisations of the country have alleged that the "restrictive" and "protectionist" policies of India is hampering bilateral trade, an issue said to be of deep concern for the Obama administration. More...



Apathy leaves tangaliya in tangles
(Rupam Singh Gupta , 7-Jun-2013 , The Times Of India)

It has been almost four years since tangaliya, a 700-year-old indigenous craft of Saurashtra, got the geographical indication tag. More...



Mumbai firm loses Maggi trademark to Nestle
(Sruthisagar Yamunan - CHENNAI , 6-Jun-2013 , The New Indian Express)

The Intellectual Property Appellate Board has held as invalid a Mumbai-based firm’s claim over the trademark Maggi a world famous brand name that has been popularised by Swiss firm Nestle. More...



Samsung gets a bite on Apple in epic patent war
(Chidanand Rajghatta , 6-Jun-2013 , The Times Of India)

A US trade panel has ruled that homegrown legend Apple has infringed on a patent held by South Korean giant Samsung, providing a surprising new twist to the ongoing war between the two electronic majors. More...



Now, an exchange for trading patent rights
(New York Times News Service , 05-Jun-2013 , The Hindu)

Patent rights, which are usually bought and sold in private transactions, are set to be publicly traded on a new exchange. More...



iPhone 4 imports banned in US patent case
(AP , 05-Jun-2013 , The Times Of India)

A US trade agency on Tuesday issued a ban on imports of Apple's iPhone 4 and a variant of the iPad 2 after finding the devices violate a patent held by South Korean rival Samsung Electronics. More...



Pfizer's slams India's patent regime, says Indian standards are vague and malleable
(Soma Das , 5-Jun-2013 , The Economic Times)

American drugmaker Pfizer Inc has slammed the patent regime in India telling a domestic industry body in a letter that all patents that the company has managed to get in the country do not have any meaning. More...



Apple Inc. infringes Samsung patent on older iPhones, iPads: US agency
(Associated Press , 5-Jun-2013 , The Indian Express)

Samsung Electronics scored a victory over rival Apple Inc in their long-running dispute over mobile device patents after a US trade agency issued an order banning older but still-popular Apple products from the US market. More...



iPhone 4 imports banned in US patent case
(AP , 5-Jun-2013 , The Economic Times)

A US trade agency on Tuesday issued a ban on imports of Apple's iPhone 4 and a variant of the iPad 2 after finding the devices violate a patent held by South Korean rival Samsung Electronics. More...



More drug companies join patent pools to aid drug discovery for neglected diseases
(Rema Nagarajan , 04-Jun-2013 , The Times Of India)

As drug pipelines dry up and finding new treatments for diseases afflicting the developing world remains a challenge, governments, drugs companies, research institutes and donors are forging partnerships to boost drug discovery. More...



Pfizer gets relief in patent revocation case for anti-cancer drug 'Sutent'
(PTI , 04-Jun-2013 , The Economic Times)

In a relief to pharma major Pfizer, the Intellectual Property Appellate Board here has set aside the revocation of the patent of the company's anti-cancer drug 'Sutent.' More...



White House issues orders to curb 'patent trolls'
(AFP , 04-Jun-2013 , The Times Of India)

The White House issued a series of executive orders aimed at curbing so called patent trolls who use the legal system to stifle innovation especially in the tech sector. More...



Commerce Dept bats for pharma exporters
(Our Bureau , 3-Jun-2013 , Business Line)

The Commerce Department has come out in strong support of the Indian pharmaceutical industry facing criticism from the media on quality issues following a series of action taken by the US drug controller against top Indian companies. More...



Shire, Teva settle generic Intuniv patent infringement lawsuit
(Philadelphia , 03-Jun-2013 , Pharmabiz)

Shire LLC a subsidiary of Shire plc. has settled its litigation against Teva Pharmaceuticals USA Inc. in connection with Teva’s Abbreviated New Drug Application for a generic version of Shire’s Intuniv extended release tablets for the treatment of Attention Deficit Hyperactivity Disorder. More...



US drug firm raises red flag over ‘blatant’ patent violation
(Gaurav Choudhury , 02-Jun-2013 , Hindustan Times)

US pharmaceutical giant Merck Sharp and Dohme said it is concerned about the blatant patent violation in India over two of its blockbuster anti diabetes drugs Januvia and Janumet. More...



Apple Inc vs Samsung group: Panel to review split ruling in patent fight
(Reuters , 31-May-2013 , The Indian Express)

A trade panel that specializes in patent cases will reconsider a split decision made by one of its judges in a long-running patent battle between Apple Inc and Samsung group. More...



Surti zari set for global presence
(Melvyn Reggie Thomas , 31-May-2013 , The Times Of India)

Surtizari one of the oldest crafts of Gujarat is all set to mark its exclusive presence in the country and abroad with 21 zari manufacturers from the city getting nod from Chennai based Geographical Indication Registry to manufacture zari and sell their products using the official logo SuratZari Craft. More...



Can genes be patented?
(Devangshu Datta , 30-May-2013 , Business Standard)

Angelina Jolie has inadvertently highlighted a key question about patenting. More...



Patents that have brought the Everest closer
(Leslie D’monte , 29-May-2013 , Livemint)

Several new products under patent aim to make the climb to world’s highest peaks safer and easier. More...



Pfizer, pharma sector spar over patent protection issues
(P. T. Jyothi Datta , 29-May-2013 , Business Line)

Multinational drug-maker Pfizer and a key association of the Indian pharmaceutical industry have locked horns over the protection of intellectual property in India. More...



Apple patent case against Samsung set for additional US review
(Bloomberg , 29-May-2013 , Livemint)

US trade panel seeks more information before deciding whether Samsung should be barred from entering the US. More...



ndian pharma companies filed 417 DMFs in US during 2012 and 79 in Q1 of 2013
(Sanjay Pingle, Mumbai , 27-May-2013 , Pharmabiz)

ndian pharmaceutical companies filed 417 Drug Master Files with the US FDA during the year 2012 as against 404 DMFs in the previous year. The DMF filings during the year 2010 and 2009 were at 311 and 271 respectively. More...



Microsoft did not violate Google patent: ITC
(Reuters , 24-May-2013 , The Economic Times)

Microsoft Corp did not violate a patent owned by Google subsidiary Motorola Mobility when it made its popular Xbox, the International Trade Commission said on Thursday. More...



Indian pharma under the microscope
( Vidya Krishnan, C.H. Unnikrishnan , 23-May-2013 , Livemint)

The local drug industry also faced intellectual property related issues while exporting drugs. More...



Apple wants to include Samsung Galaxy S4 in patent lawsuit
(AFP , 23-May-2013 , The Times Of India)

Apple has asked a federal judge in Silicon Valley to add Samsung's new flagship Galaxy smartphone to the list of devices targeted in a patent lawsuit involving Siri personal assistant software. More...



Patent row: Delhi HC to hear diabetes drug case
(CNN-IBN , 23-May-2013 , IBN Live)

The patent battle between US pharmaceuticals major Merck Sharp and Dohme and Indian firm Glenmark Pharmaceuticals over the sale of diabetes drug Januvia comes up for hearing in the Delhi High Court on Thursday. More...



Apple wants patent lawsuit to include Samsung Galaxy S4
(AFP , 23-May-2013 , Hindustan Times)

Apple has asked a federal judge in Silicon Valley to add Samsung's new flagship Galaxy smartphone to the list of devices targeted in a patent lawsuit involving Siri personal assistant software. More...



ICAR moves to patent Goa’s Feni manufacturing process
(PTI , 21-May-2013 , Business Line)

After obtaining Geographical Indication status for the famous Goa Feni researchers and producers in the coastal State are now trying to patent the process to manufacture this local brew, which is also known for its medicinal benefits. More...



Japan FTA widening trade deficit, government says
(TNN , 18-May-2013 , The Times Of India)

The government on Friday admitted that the trade agreement with Japan was resulting in greater benefit to exporters from the East Asian giant, reflected in widening trade deficit. More...



When it is right to copy
(Apar Gupta , 18-May-2013 , The Indian Express)

Intellectual property litigation is not a binary battle between the rights-holder and the infringer. More...



Brain League expects developing nations to follow India, may frame tough patent laws
(Nandita Vijay, Bengaluru , 18-May-2013 , Pharmabiz)

Brain League, the Intellectual Property company serving national and global markets, sees that many developing countries could follow India model in enacting tough drug patent laws. More...



Apple to make Galaxy S4 part of patent battle
(TOI Tech , 15-May-2013 , The Times Of India)

Apple plans to include the newly launched Galaxy S4 in its patent battle against South Korean giant Samsung. According to Foss Patents, after analyzing. More...



US keenly watching Indian moves on compulsory licensing in pharma sector
(Joseph Alexander, New Delhi , 15-May-2013 , Pharmabiz)

Placing India again in the 'Priority Watch List in 2013', the United States has expressed concerns on the Supreme Court decision on the patent issue in the pharmaceutical sector and said it would be keenly watching the developments concerning the compulsory licensing. More...



Bangalore Blue Grapes gets Geographical Indication status
(Rhik Kundu , 15-May-2013 , The Times Of India)

Bangalore Blue Grapes, exclusively grown in districts around the city, has been given the Geographical Indication status. More...



Court dismisses Roche's patent petition against Intas
(BS Reporter , 14-May-2013 , Business Standard)

According to Roche Intas was in the process of selling erlotib the generic version of the drug in TN. More...



Suven Life gets three patent products for CNS molecules
(PTI , 11-May-2013 , Zee News)

Life Sciences today said it has received a total of three product patents for CNS molecules, which could be used for treating various central nervous system disorders. More...



Kebabs from Lucknow may get geographical indication recognition soon
(Rajiv Srivastava , 11-May-2013 , The Times Of India)

Soon after the Lucknow Zardozi was accorded geographical indication recognition, the delicious kebabs from the city of nawabs, the petha and marble from Agra and dress material and cotton bedsheets from Mau are next in line to get the GI tag a form of Intellectual Property Right from the Controller General of Patents Designs and Trademarks. More...



MSF wants newly appointed WTO DG to ensure access to medicines for all WTO member states
(Our Bureau , 10-May-2013 , Pharmabiz)

Médecins Sans Frontières an international medical humanitarian organisation, wants the incoming director general Roberto Azevedo of the World Trade Organisation to focus on making access to affordable medicines a priority. More...



India, EU yet to reach consensus on vexed issues for FTA
(Press Trust of India , 08-May-2013 , Business Standard)

India and the EU, which are negotiating a free trade agreement since 2007, have yet to reach a consensus on vexed issues including duty cuts in automobile sector, Parliament was informed today. More...



Top generic drugmakers look to US as patents end
(Reuters , 08-May-2013 , NDTV)

India's top drugmakers, among the world's biggest producers of cheap generic medicines, are looking beyond their own shores to generate revenue, seeking to profit from big-selling drugs going off-patent this year in the lucrative U.S. market. More...



Don't link compulsory licensing with price: Pharma companies
(Soma Das , 8-May-2013 , The Economic Times)

Indian drug makers have urged the government to retain the option of compulsory licensing of a patented drug even as it considers a policy that will allow it to negotiate with drug companies on prices of patented drugs. More...



German beer company allowed to retain trademark
(Sruthisagar Yamunan , 8-May-2013 , Indian Express)

What could happen if you get a trademark registered and do not use it for a long time? More...



Google files patent for Policy Violation Checker tool
(ANI , 07-May-2013 , The Times Of India)

Google has reportedly filed a patent for a tool that will detect potentially problematic phrases or words from electronic correspondence which in turn will help companies or individuals avoid lawsuits. More...



Bajaj’s two-wheeler patent not to be revoked
(R. Sivaraman , 06-May-2013 , The Hindu)

The Intellectual Property Appellate Board here on Thursday dismissed an application of LML seeking to revoke patent granted to Bajaj Auto Ltd. in respect of an improved two-stroke engine for its two-wheelers. More...



EU regulator takes aim at Google over Apple mobile patent lawsuit
(Reuters , 06-May-2013 , The Economic Times)

The European Commission said it believed Motorola Mobility, a unit of Google, was abusing its market position by seeking and enforcing an injunction against Apple in Germany over patents essential to mobile phone standards. More...



A reflection of tradition
(ANASUYA MENON , 05-May-2013 , The Hindu)

A sale of traditional Aranmula mirrors is on at the Kairali outlet. More...



How patent wars are hurting IT companies
(Reuters , 4-May-2013 , The Times Of India)

Patent demands are taking a big toll on technology companies, with results that range from forcing companies to tweak their products to exiting their business altogether, according to a study from the Santa Clara University School of Law. More...



Bajaj Auto wins 7-year patent spat against LML
(Ashwin Mohan , 2-May-2013 , The Economic Times)

In a boost for India's leading two-wheeler manufacturer Bajaj Auto, the Chennai bench of the IPAB or the Intellectual Property Appellate Board has dismissed an appeal filed by rival LML Ltd which had sought the revocation of a patent granted to Bajaj Auto on air & fuel intake systems for engines. More...



US slams patent, trade policies
(Sidhartha , 2-May-2013 , The Times of India)

A United Nations report projected that FDI in Africa will touch $100 billion in 2014 where India trails France United States United Kingdom, China, Malaysia and Korea. Airtel can look at more in market acquisitions in Africa while it looks to stabilize the $10.7-billion buyout of Zain's continental unit three years ago. More...



U.S. trade office hits out at Novartis ruling
(Narayan Lakshman , 2-May-2013 , The Hindu)

Appears to confirm that India’s law creates a special, additional criterion for select technologies More...



Teva settles patent dispute with Orchid Pharma
(C R Sukumar , 1-May-2013 , The Economic Times)

Israeli drugmaker Teva Pharmaceutical Industries has settled patent dispute with the Indian pharmaceutical firm Orchid Chemicals & Pharmaceuticals pertaining to Parkinsons disease drug Azilect in the US market. More...



Patented drug entry could be delayed in India: Deloitte
(PTI , 1-May-2013 , Business Line)

Launch of patented drugs in India could be delayed due to the government’s “thought process on linking patented drug prices to the country’s per—capita income”, according to a report by consultancy firm Deloitte. More...



Indian tech start-ups filing patents to get government funding
(Harsimran Julka , 1-May-2013 , The Times Of India)

The Centre has announced a scheme through which it will provide financial support to young technology companies filing international patents a move that underscores the growing support for emerging ventures in the country. More...



Motorola buy delivers Google more heartbreak than patent help
(Bloomberg , 29-Apr-2013 , Livemint)

Microsoft owes only pennies in royalties per sale of Xbox and Windows instead of billions Google sought in patent case More...



WTO unimpressed with patent violation charges against India
(Amiti Sen , 26-Apr-2013 , Hindu Business Line)

No country has objected to India issuing compulsory licence or refusing patent for drugs: WTO chief Pascal Lamy. More...



Ever-greening of patents cannot be permitted: DIPP
(PTI , 26-Apr-2013 , The Economic Times)

Amid concerns expressed by multi-national companies over the Supreme Court's judgement in the Novartis India today said its laws are WTO compliant and no country could allow "ever-greening" of patents. More...



An asymmetric deal
(Devashish Mitra , 26-Apr-2013 , The Indian Express)

India has limited bargaining power in negotiating the EU-India FTA. More...



Microsoft gets upper hand in first Google patent trial
(Bill Rigby , 26-Apr-2013 , Reuters)

Microsoft Corp came out on top in the first of two patent trials versus Google Inc's Motorola Mobility unit on Thursday, as a federal judge in Seattle ruled largely in its favor. More...



Microsoft signs Android patent deal with ZTE
(ANI , 25-Apr-2013 , Zee News)

Microsoft has signed a patent deal with China’s smart phones maker ZTE linked to its use of the Android and Chrome operating systems. More...



Lucknow zardozi gets GI registration
(Virendra Singh Rawat | New Delhi/ Lucknow , 24-Apr-2013 , Business Standard)

The world famous textile embroidery handicraft of ‘Lucknow Zardozi’ is now a brand. More...



German court dismisses Nokia patent claims against HTC
(AFP , 24-Apr-2013 , The Economic Times)

Taiwan's top smartphone maker HTC said Wednesday it was "delighted" after a German court dismissed another patent infringement complaint brought against it by Finnish phone giant Nokia. More...



IPAB complains lack of manpower, infrastructure as major hurdles
(BS Reporter | Chennai , 24-Apr-2013 , Business Standard)

It also complained on the allocation of insufficient funds, which lead the Board to reduce the circuit sittings in the last quarter of the financial year 2012-13 More...



Apple wins patent case on eve of results
(Bloomberg | Washington , 24-Apr-2013 , Business Standard)

Averts iPhone 4 import ban after Motorola Mobility loses case More...



FTA talks with EU on the fast track, Sharma tells LS
(ENS Economic Bureau - NEW DELHI , 23-Apr-2013 , The New Indian Express)

Commerce and Industry Minister Anand Sharma on Monday informed the Lok Sabha that the negotiations between India and the European Union (EU) for a free trade agreement (FTA) have been intensified. More...



Parliamentary panel asks govt to protect dairy sector under India-EU FTA
(PTI , 23-Apr-2013 , The Economic Times)

A Parliamentary panel today urged the government to take adequate steps for protecting the interest of domestic dairy sector under the proposed India-EU bilateral free trade agreement (FTA). More...



VirnetX sues Microsoft over Skype patent infringement
(ANI , 23-Apr-2013 , Zee News)

Internet security software company VirnetX has filed a lawsuit against Microsoft, saying the software giant’s Skype service violates six of its patents. More...



GI tag to add grandeur to Mamallapuram sculptures
( Express News Service - CHENNAI , 23-Apr-2013 , The New Indian Express)

Efforts are afoot to get the Geographical Indication (GI) tag for the stone sculptures made in Mamallapuram and wooden sculptures of Thammampatti, the State Assembly was told on Monday. More...



Copyright organisation asks colleges to buy licence to photocopy book portions
(Soma Das & Urmi Goswami , 22-Apr-2013 , The Economic Times)

This summer, many students cramming for their exams are confused whether their photocopied notes are legal or not. More...



Madras HC bars Ravikumar Distilleries from using trademark
(Our Bureau , 21-Apr-2013 , Business Line)

In response to the petition filed by the IMFL manufacturer Golden Vats Pvt Ltd regarding trademark violation by the Puducherry-based listed entity Ravikumar Distilleries Ltd, the Madras High Court has granted an interim injunction restraining the latter from using the brand Golden Vat. More...



India now in position of a thought leader on pharma patents: Kiran Mazumdar Shaw
(Kiran Mazumdar Shaw , 19-Apr-2013 , The Economic Times)

Weeks after the Supreme Court ruling on Novartis AG's cancer drug, Glivec, one thing is clear: India is now in the position of a thought leader on pharmaceutical patents. More...



Bring down patent walls in pharma, free the knowledge locked up by patent holders
(Rajni Bakshi , 19-Apr-2013 , The Economic Times)

Following the Supreme Court judgment rejecting Novartis' claim for a patent, there has been impassioned debate about patents versus patients, and profits over people. More...



India, EU eye more sops, fail to clinch trade deal
(TNN , 17-Apr-2013 , The Times Of India)

India and the European Union failed to clinch a deal on the Bilateral Trade and Investment Agreement that has been in the works for six years as both sides sought more concessions for the deal to go through. More...



DISALLOW PATENT LINKAGE
(P A Francis , 17-Apr-2013 , Pharmabiz)

The issue of linking grant of marketing approval to the patent status of a drug is being raised by the multinational drug companies once again in the country. More...



Another India-EU meet in June to thrash out FTA irritants
(ET Bureau , 17-Apr-2013 , The Economic Times)

India and European Union will hold another ministerial meeting in June to trash out the contentious issue dogging the free trade pact that has been in the works for nearly six years, suggesting that the Brussels ministerial failed to achieve any significant progress. More...



EU court rejects Spain, Italy challenge to landmark patent law
(AFP , 16-Apr-2013 , Livemint)

Spain and Italy had complained against a provision requiring that a patent be translated into only three languages—English, French and German More...



Big pharma's uncertain future in India
(Sushmi Dey , 16-Apr-2013 , Business Standard)

Multinationals are worried about the country's patent regime, but India is too big a market to be ignored. More...



Novartis patent verdict not a problem, other issues pose risks to Indian pharma innovation
(Hari Pulakkat & DIVYA RAJAGOPAL , 16-Apr-2013 , The Economic Times)

The recent Supreme Court judgement against Novartis has reopened old debates on drug patents, affordable healthcare and India as a destination for pharma innovation. More...



US justices wary of wide human gene patent ruling
(Reuters , 16-Apr-2013 , The Times Of India)

US Supreme Court justices on Monday signaled reluctance to issue too broad a ruling about patents on human genes, and some indicated they might seek a compromise distinguishing between types of genetic material. More...



Only 3% of patents filed by MNC pharma firms under dispute: Study
(DIVYA RAJAGOPAL , 16-Apr-2013 , The Economic Times)

On April 1, when the Supreme Court rejected Swiss pharmaceutical major Novartis' plea for a patent on an updated version of its cancer drug Glivec, it evoked different reactions: More...



Delhi HC order on Januvia revives MNCs' clamour for patent linkage
(Ramesh Shankar, Mumbai , 16-Apr-2013 , Pharmabiz)

The Delhi High Court's recent interim order in the Merck versus Glenmark case over the diabetes drug Januvia has once again revived the multinational drug companies' clamour for patent linkage in the country, for linking marketing approval of a product to its patent status. More...



India, EU talks on FTA expected to make headway
(Press Trust of India , 15-Apr-2013 , Business Standard)

Reduction on import duty in the auto sector & raise in the FDI cap for the insurance sector are high on EU's demands More...



Why Novartis case will help innovation
(Achal Prabhala, Sudhir Krishnaswamy , 15-Apr-2013 , The Hindu)

The Supreme Court judgment on Glivec is a blow for a patent regime with a higher threshold of inventiveness More...



With 219 patents, Novartis might have little to complain about
(Sushmi Dey , 15-Apr-2013 , Business Standard)

Data contradicts Swiss drug major's claim that India does not respect IPR More...



U.S.Supreme court weighs patentability of human genes
(Reuters , 15-Apr-2013 , The Indian Express)

Soon after learning that his son had autism, Hollywood producer Jon Shestack tried to get researchers investigating the genetic causes of the disorder to pool their DNA samples, the better to identify genes most likely to cause that disorder. More...



Indian perfume-maker wins right to ‘Gatsby’ trademark
(R. Sivaraman , 15-Apr-2013 , The Hindu)

Who would have thought Scott Fitzgerald’s Gatsby, a fictional character portrayed as a decadent dandy in the 1920s, will leave an ‘intellectual’ legacy to fight over? More...



Impromptu poet with a trademark headgear
(Rajagopalan Venkataraman , 15-Apr-2013 , The New Indian Express)

There was a special reason why singer P B Sreenivas who passed away on Sunday afternoon was attired in a headgear, similar to the Mysore Peta. The man with the lilting voice felt he looked infinitely better when he wore it. More...



Patent expiry hits profitability of top 15 global pharma cos in 2012, Novartis overtakes Pfizer in sales
(Sanjay Pingle , 15-Apr-2013 , Pharmabiz)

International pharmaceutical companies' are passing through difficult phase and are facing challenging operating environment with loss of patent exclusivity and limited R&D success. More...



MSD-Glenmark case replay of Bayer-Cipla patent feud
(Jayati Ghose , 13-Apr-2013 , Indian Express)

In the 2010 Bayer-Cipla case on "patent linkage", a single-judge bench of the Delhi High Court and, subsequently, a division bench had refused to ask the government to link the patent status of a drug to grant of marketing approval for generic versions. More...



India-EU FTA won't hit generic drugs industry: EU envoy
(Nayanima Basu , 13-Apr-2013 , Business Standard)

EU had demanded an amendment to the Indian patent law, in the wake of a patent being rejected to Novartis, for its cancer drug, Glivec. More...



A patent victory under threat
(Brook K. Baker , 12-Apr-2013 , Business Line)

Proposed clauses in the EU-India FTA could undo all gains from the Supreme Court’s Glivec ruling. More...



No patent extension clause in free trade deal: EU
(Vidya Krishnan , 12-Apr-2013 , Livemint)

Pact with India won’t impose data exclusivity, demand anything that goes beyond trade-related IPR, says EU official More...



Drug patent row: HC seeks Glenmark’s response by May 22
(PTI , 12-Apr-2013 , Business Line)

The Delhi High Court today sought the response of Glenmark Pharmaceuticals on US drug major Merck Sharp and Dohme’s appeal against the single judge bench order refusing to restrain the Indian firm from manufacturing and selling anti-diabetes drugs Zita and Zita-Met. More...



India refutes US charges over trade barriers
(Asit Ranjan Mishra , 12-Apr-2013 , Livemint)

Commerce ministry says India’s policies are consistent with its international and bilateral obligations More...



Law change linked to EU's demand for wider patent term
(Sushmi Dey , 12-Apr-2013 , Business Standard)

Currently, article 33 of the WTO's agreement on TRIPs provides for 20 years of patent protection from the date of filing of patent application. More...



Lawyers can be patent agents without clearing exam: HC
(A Subramani , 12-Apr-2013 , The Times Of India)

A controversial amendment to the Patents Act, 1970, through which a lawyer's automatic right to appear before tribunals as 'patent agent' was taken away by the Centre and the controller of patents, More...



Patients or patents?
(Vidya Krishnan & Jacob Koshy , 12-Apr-2013 , Livemint)

India’s top court misses an opportunity to answer this question decisively with an all-too-specific judgement in the contentious Glivec case More...



Should pharma MNCs be peeved?
(Bhupesh Bhandari , 11-Apr-2013 , Business Standard)

In spite of all their complaints, pharma MNCs have been gaining market share in India. More...



After Glivec verdict, India might face patent regime heat
(Sushmi Dey | New Delhi , 10-Apr-2013 , Business Standard)

Stir has already begun with Anand Sharma defending govt's patent regime at WIPO Geneva this week More...



Drug patent row: U.S. firm files appeal against interim order
(PTI , 10-Apr-2013 , The Hindu)

U.S. pharmaceutical major Merck Sharp and Dohme (MSD) has filed an appeal before the Delhi High Court, challenging its single bench order refusing to grant interim relief to it on a patent row against Glenmark Pharmaceuticals. More...



Trade deal with European Union will TRIP patent law
(Dinesh C. Sharma , 10-Apr-2013 , India Today)

When Prime Minister Manmohan Singh meets German Chancellor Angela Markel this week, the long pending India-EU Broad Based Trade and Investment Agreement will be high on his agenda. More...



SIGNING FTA WITH EU
(P A francis , 10-Apr-2013 , Pharmabiz)

The free trade agreement between Indian government and the European Union is expected to be finalized by the middle of this month. More...



The Indian way in pharma regulation
(Subir Roy , 9-Apr-2013 , Business Standard)

The Supreme Court verdict denying a patent to Novartis for an updated version of the firm's anti-cancer drug Glivec may have a far greater impact in India and outside than was earlier realised, when India became TRIPS compliant by amending its patent Act in 2005. More...



Novartis case: Anand Sharma defends India's patent regime, advocates affordable healthcare solutions
(ET Bureau , 9-Apr-2013 , The Economic Times)

A week after the Supreme Court rejected Swiss pharma firm Novartis' patent plea for Glivec, commerce and industry minister Anand Sharma on Monday strongly defended India's decision not to give patent protection to the drug at the World Intellectual Property Organisation in Geneva. More...



Purdue sues Dr Reddy’s for patent infringement
(ENS Economic Bureau , 9-Apr-2013 , The New Indian Express)

In yet another patent infringment suit, Dr Reddy’s Laboratories Ltd was dragged to court, by Purdue Pharma LP, which filed a petition in New Jersey Federal Court for alleged infringement of its insomnia drug — Intermezzo. More...



Global trademark registration: India joins Madrid Protocol
(PTI , 08-Apr-2013 , The Hindu)

India on Monday joined the Madrid Protocol which will enable domestic companies and entrepreneurs to obtain cost effective global trademark registration. More...



Most big patented drugs skip India
(Rupali Mukherjee , 8-Apr-2013 , The Times Of India)

Big pharma may be crying hoarse over India's "weak'' intellectual property environment, but over the past five years or so, they have introduced only a handful of their patented blockbusters in the country. More...



Fear in Indian pharma over EU's demand to seize drugs in transit
(Sushmi Dey , 8-Apr-2013 , Business Standard)

Indian pharmaceutical firms have faced trouble over IPR-related issues in European ports in the past as well More...



Pharma verdicts bring major changes in patents
(Niraj Mishra | ENS - NEW DELHI , 8-Apr-2013 , The New Indian Express)

The recent landmark judgements by the Supreme Court and the Delhi High Court in the Novartis and the Merck cases respectively have brought about largescale changes in the global pharma industry relating to the manufacture, marketing and even patent protection laws. More...



Patent loss pushes Lipitor to 17th rank in 2012, Abbott's Humira is world's largest selling drug
(Sanjay Pingle , 8-Apr-2013 , Pharmabiz)

The most significant development in the global pharmaceutical market in 2012 is the displacement of Lipitor of Pfizer from its number one pharmaceutical product by Humira of Abbott. More...



Indian pharma is high on profit, low on R&D
(Business Standard , 8-Apr-2013 , Business Standard )

The Indian pharmaceutical sector is in the news, with generic makers winning a series of administrative and judicial victories against patent-holders. More...



Patent industry gets ready with budding agents
(Atul Sethi , 8-Apr-2013 , The Times Of India)

Twenty-three-year-old R Srinivas is a botany graduate who spends most of his time reading up the Indian Patents Act nowadays. More...



India: pariah or pathbreaker of pharma world?
(8-Apr-2013 , DNA)

The Supreme Court ruling last week dismissing Swiss drug major Novartis AG’s bid for a patent for its cancer drug Glivec hinged on the interpretation of Section 3(d) of India’s patent law which defines what are not “inventions” under Indian law, and therefore not patentable. More...



First patent war in India’s diabetes market gets intense
(C.H. Unnikrishnan , 07-Apr-2013 , Livemint)

HC has rejected interim relief to Merck against Glenmark saying it had not made a strong case for an injunction. More...



If you erode patents, where will innovations come from?, asks Dr Brian Druker
(Chidanand Rajghatta , 7-Apr-2013 , The Economic Times)

As a physician I want to see patients get the best treatment at an affordable cost. More...



Patent justice
(Sakthivel Selvaraj , 7-Apr-2013 , The Hindu)

The Supreme Court’s patent denial to Novartis for its anti-cancer drug Gleevec leaves the door open for Indian pharmaceutical companies to produce their own versions of the drug. More...



And now, patents for genes
(Livemint , 07-Apr-2013 , Livemint)

India must quickly tighten its position on patenting genes and explicitly defining incremental innovation More...



Is Section 3 (d) of Patents Act good for innovation? - Yes
(Gopakumar G. Nair , 6-Apr-2013 , Business Line)

It is heartening to note that Section 3(d) has so far been largely implemented in India by the office of the Controller General of Patents, and has now been elegantly upheld by the Supreme Court. More...



System lacuna a bitter pill for patent holders
(Jayati Ghose , 6-Apr-2013 , The Financial Express)

No ‘linkage’ between regulators, patents office More...



Apple's patent claim rejected in Germany
(AFP , 6-Apr-2013 , The Times Of India)

Germany's patent court invalidated on Friday a patent held by Apple and contested by rivals Motorola and Samsung on its "slide to unlock" function for smartphones, but the ruling can still be appealed. More...



Glenmark-Merck Patent row: Delhi HC refuses interim relief to Merck
(Harish V Nair , 05-Apr-2013 , Hindustan Times)

Diabetes patients will continue to get cheap medicines manufactured in India thanks to Delhi high court which for the time being ruled in favour of an Indian company caught in a row over patent rights with a US pharmaceutical major. More...



Growing brood of patent agents indicator of India’s ready-to-take-off IPR industry
(Atul Sethi , 05-Apr-2013 , The Times Of India)

23-year-old R Srinivas is a Botany graduate who spends most of his time reading up the Indian Patents Act nowadays. More...



SAIL unit seeks patent cover for its products
(Jaideep Deogharia , 05-Apr-2013 , The Times Of India)

From electrical towers, railway wagons, offshore platforms to nuclear reactors, the 24 steel products developed by the research and development centre for iron and steel has a wide area of application. More...



EU, Australia, Canada may follow India's Patent Law
(DIVYA RAJAGOPAL , 4-Apr-2013 , The Times Of India)

India's strong stance on minor drug innovations could reverberate in national parliaments and courthouses of the developed world as Australia, the EU and Canada get ready to discuss and ban patent protection for frivolous improvements. More...



Six products from state get geographical indication tag, south tops list
(Daniel P George , 4-Apr-2013 , The Times Of India)

The trademarks and geographical indication authorities on Wednesday awarded the unique tag to 21 products after a spurt in applications for the special status in the first three months of the year. More...



Compulsory licensing could be big business for drug makers
(Sushmi Dey , 4-Apr-2013 , Business Standard)

With over 500,000 people dying of cancer every year in India, the argument over compulsory licensing seems to be headed in one direction in favour of those who can produce inexpensive life-saving drugs. More...



Leukaemia patients caught in patent war
(Bushra Baseerat , 4-Apr-2013 , The Times Of India)

Blood cancer patient M Srinivas, 38, is battling for life at a city hospital in Tarnaka after a life-saving drug, Dasatinib, was taken off the shelves recently, thanks to a bitter battle between a multinational and a Hyderabad-based pharma company over patent rights. More...



US business groups say verdict to impact pharma innovation in India
(Indira Kannan | Toronto , 4-Apr-2013 , Business Standard)

Business groups in the US have sharply criticised the Supreme Court of India judgment against Swiss drugmaker Novartis in denying patent protection to the company’s anti-cancer drug Glivec. More...



Novartis verdict will encourage genuine innovation: Prathiba M Singh
(03-Apr-2013 , IBN)

Prathiba M Singh, advocate for Ranbaxy and Cipla, fought the Glivec patent case against Novartis. More...



Indian drugs will now face backlash, warn analysts in US after Novartis ruling
(Namrata Brar , 03-Apr-2013 , NDTV)

Has India's Novartis ruling just killed its own innovation dreams? More...



Cancer patients will get cheaper drugs
()




Cancer patients will get cheaper drugs
(NDTV , 2-Apr-2013 , NDTV/YouTube)

The Supreme Court verdict against Novartis has made sure that the cancer patients will keep getting the drubgs at cheaper price. (Audio in Hindi) More...



Destroying patent model is no solution’
(Raghuvir Srinivasan , 3-Apr-2013 , Business Line)

Cross-subsidy is one solution to make medicines affordable: Novartis MD More...



Glivec lesson for pharma: Patented drugs must be priced smartly
(Kiran Mazumdar Shaw , 3-Apr-2013 , The Economic Times)

To ensure access to healthcare for all, India must harness innovation in discovering drugs, in developing therapeutics and in delivering affordable healthcare. More...



US trade office reviewing Supreme Court's Novartis patent ruling
(Reuters , 3-Apr-2013 , NDTV)

The United States said on Tuesday it was considering its response to the Supreme Court ruling that US drug manufacturers warn is the latest sign of a deteriorating environment for intellectual property rights in the country. More...



Now, domestic companies in patent war
(Rupali Mukherjee , 3-Apr-2013 , The Times Of India)

In a twist in patent wars, a domestic generic company has dragged another to court. More...



Merck unit sues Glenmark Pharmaceuticals for infringing patent on diabetes drugs
(DIVYA RAJAGOPAL , 2-Apr-2013 , The Economic Times)

US-based MSD Pharma, the third-largest pharma company in the world by revenues, has asked the Delhi High Court to bar Mumbai-based Glenmark from selling two popular anti-diabetic drugs, triggering yet another legal battle between an Indian generic company and a member of Big Pharma. More...



India's Patent law: Some provisions of the Patents Act 1970
(02-Apr-2013 , The Economic Times)

Patents are a key incentive for any innovator. More...



European Union sets tough conditions under FTA
(Asit Ranjan Mishra, Vidya Krishnan , 02-Apr-2013 , Livemint)

EU has proposed its customs authorities will have the right to seize drugs in transit in case of IPR infringements More...



Novartis lost patent case on technical ground
(ET Bureau , 02-Apr-2013 , The Economic Times)

The Supreme Court judgment denying Novartis a patent for the beta crystalline form of its leukaemia wonder drug Imatinib Mesylate (sold as Glivec) is not a blow against research and innovation More...



Apple seeks patent for its wraparound display
(AP , 02-Apr-2013 , The Times Of India)

Apple is seeking a patent for an iPhone that has a display that wraps around the edges of the device, expanding the viewable area and eliminating all physical buttons. More...



Stung by landmark Indian patent defeat, western drugmakers will be wary but cannot afford to quit
(Reuters , 02-Apr-2013 , The Economic Times)

Stung by a landmark patent defeat, Western drugmakers will be wary about launching new products in India, but they cannot afford to quit a country tipped to be the world's eighth largest market for medicines by 2016. More...



Thumbs up from pro-health groups, domestic drug makers
(Our Bureaus , 1-Apr-2013 , Business Line)

Marks affordable access to medicines in developing countries More...



Glivec patent denial may affect investments to India
(Vidya Krishnan , 1-Apr-2013 , Livemint)

US Chamber of Commerce says decision to hurt businesses’ ability to invest in medical, technological advancements More...



Novartis India says will continue to file for patents
(Kaustubh Kulkarni , 1-Apr-2013 , Reuters)

Novartis India Ltd a unit of Swiss drugmaker Novartis AG will continue to file for patents in India its vice chairman said on Monday after the country's top court rejected its plea for patent protection of its drug Glivec. More...



What is section 3(d) of the Indian Patent Act
(ET Bureau & Agencies , 1-Apr-2013 , The Economic Times)

Swiss pharma major NovartisBSE -0.50 % AG on Monday lost a seven-year long legal battle for getting its blood cancer drug Glivec patented in India and to restrain Indian companies from manufacturing generic drugs, with the Supreme Court rejecting the multinational company's plea. More...



Supreme Court dismisses plea of Novartis for patent of cancer drug
(TNN , 01-Apr-2013 , The Times Of India)

The Supreme Court on Monday dismissed the plea of Swiss pharma giant Novartis AG for getting its blood cancer drug Glivec patented in India. More...



Novartis wants Indian patent system to improve, compares with China
(ET Bureau , 1-Apr-2013 , The Economic Times)

Novartis India Ltd a unit of Swiss drugmaker Novartis AG, will continue to file for patents in India, Ranjit Shahani its vice chairman said on Monday, after the Supreme Court rejected its plea for patent protection of its drug Glivec. More...



Novartis wants Indian patent system to improve, compares with China
(ET Bureau , 1-Apr-2013 , The Economic Times)

Novartis India Ltd a unit of Swiss drugmaker Novartis AG, will continue to file for patents in India, Ranjit Shahani its vice chairman said on Monday, after the Supreme Court rejected its plea for patent protection of its drug Glivec. More...



Patent war over drugs goes chronic
(Rupali Mukherjee , 01-Apr-2013 , The Times Of India)

Turf war between Big Pharma and generic companies, which was largely restricted to exorbitantly priced life-saving drugs for cancer and HIV, is now spilling over to other chronic ailments like diabetes, and threatening to change dynamics of the nearly Rs 70,000 crore Indian pharma market. More...



Apple seeks patent for an iPhone with 'wraparound' display
(Associated Press , 01-Apr-2013 , NDTV)

Apple is seeking a patent for an iPhone that has a display that wraps around the edges of the device, expanding the viewable area and eliminating all physical buttons. More...



Waiving drug patents global trend
(Sidhartha , 01-Apr-2013 , The Times Of India)

For the past several months, Indian officials and ministers have spent a lot of time explaining to their overseas counterparts that India has only used provisions of an international treaty to waive Bayer Corporation's patent right on a cancer drug. More...



Novartis warns India over drug patent
( Andrew Jack in London and Amy Kazmin in New Delhi , 31-Mar-2013 , The Financial Times)

Novartis, the Swiss pharmaceuticals group, has threatened to stop supplies of new medicines to India if the country’s top court refuses on Monday to grant a patent for Glivec, its cancer drug. More...



Innovate at your own risk
(SWATI PIRAMAL , 31-Mar-2013 , Business Line)

With a weak legal system, India’s pharma innovators may not consider it worthwhile to invest in new inventions. More...



US Patent Office denies 'iPad Mini' trademark
(AFP , 31-Mar-2013 , The Times Of India)

The US patent and trademark office has denied Apple's application for a trademark to safeguard its widely popular iPad mini tablet, saying the case to own the phrase was too weak. More...



Supreme Court may pronounce final verdict in Glivec case on April 1
(Our Bureau, Mumbai , 30-Mar-2013 , Pharmabiz)

The long-drawn patent battle between the Swiss pharma major Novartis and the government of India over the sustainability of Section 3(d) of India's Patents Act which prohibits 'evergreening' will come to an end soon as the Indian Supreme Court is all set to the pronounce its much-awaited verdict in the imatinib mesylate (Glivec) case on April 1, it is learnt. More...



Apple patents iPhone with wraparound display
(AP , 30-Mar-2013 , The Economic Times)

Apple is seeking a patent for an iPhone that has a display that wraps around the edges of the device, expanding the viewable area and eliminating all physical buttons. More...



HC dismisses plea challenging probe against Bloomberg Finance
(P Vasanth Kumar , 30-Mar-2013 , The Times Of India)

The Karnataka high court dismissed two petitions challenging investigation against the chairman, the global head and the legal advisors of New York-based Bloomberg Finance LP on a complaint related to hacking of two e-mails of a Bangalore -based company. More...



Big Pharma waits nervously on India drug patent verdict
()




Apple in court in China over 'Siri' claim
(Reuters , 27-Mar-2013 , The Indian Express)

Apple appeared in a Shanghai court today, accused by a Chinese firm of copying software used for the "Siri" personal assistant on its hugely popular iPhones. More...



Indian pharma sector fears India-European Union FTA could imperil local industry
(Soma Das , 27-Mar-2013 , The Economic Times)

Drugmakers and healthcare activists are worried that the India European Union Free Trade Agreement which is in the works, may contain a provision that could imperil local industry and have urged the government to keep patent infringement issues out of FTAs. More...



Drugmaker AstraZeneca settles Crestor patent case
(AFP , 25-Mar-2013 , Livemint)

Firm says that the deal will protect its sales of the anti-cholesterol drug until 2016. More...



BDR Pharma seeks licence to sell version of Bristol-Myers Squibb cancer drug
()




Compulsory licence likely for three cancer drugs
(Divya Rajagopal , 14-Jan-2013 , The Economic Times.)

The government has appointed a panel to look into issues related to compulsory licensing of drugs and whether cheaper versions of cancer medicines Trastuzumab, Ixabepilone and Dasatinib can be launched under the provision, a person with knowledge of the development said. More...



Intellectual property rights to play key role in value-addition to exports
()




Goan gets patent for mechanical device invention
(11-Dec-2012 , TImes of India)

In a development that should bring some cheer to the Goan engineering community, a Goan has been granted a patent from the Indian patent office. More...



Google, Apple team up to buy Kodak's 1,100 patents for $500 million
(9-Dec-2012 , Times of India)

Apple and Google have joined forces to offer more than $500 million to buy Eastman Kodak's patents out of bankruptcy, said people familiar with the situation. More...



Ranbaxy hits US with Lipitor copy
(C.H. Unnikrishnan & Namrata Nandakumar , 2-Dec-2011 , Livemint)

Patent protection for the Pfizer Inc cholesterol pill ended on Wednesday. More...



Indian drug companies like Glenmark, Dr Reddy's, Sun Pharma break into world’s fastest growing list
(Rupali Mukherjee , 30-Aug-2012 , The Economic TImes)

In yet another instance of India Inc occupying a larger seat in the global league tables three out of the top 10 fastest-growing generic companies globally are now from India More...



Doha climate talks: Rich nations reject India's offer on intellectual property concerns
(Nitin Sethi , 6-Dec-2012 , The Times Of India)

The developed world rejected Indias offer of a diluted reference to concerns about intellectual property rights in the climate negotiations as the talks in Doha peaked More...



Birla Institute of Technology Patna hosts intellectual property meet
(TNN , 6-Dec-2012 , The Times Of India)

The importance of patents for business houses to avoid litigation was stressed by S K Jain, department of management studies IIT Delhi, at a workshop on Intellectual Property Rights organized at the Birla Institute of Technology Patna on Wednesday. More...



Delhi HC asks Cipla to prove its drug doesn’t infringe Roche patent
(C.H. Unnikrishnan , 3-Dec-2012 , Livemint)

A division bench asked Cipla to prove that its anti-lung cancer drug doesn’t infringe a patent belonging to Roche More...



Global patent filings on the rise
(Our Bureau , 2-Dec-2012 , Business Line)

Filing of patents by researchers across the global has increased. More...



CLSA raises target price of Lupin Cipla Sun Pharma
(30-Nov-2012 , The Economic Times)

CLSA has increased target prices of pharmaceutical majors Lupin Cipla and Sun Pharmaceuticals. More...



IPAB dismisses Astra Zeneca’s cancer drug patent appeal
(P. T. Jyothi Datta , 28-Nov-2012 , Business Line)

Company was refused patent in 2007 More...



Apple iPad mini infringed patent, claims Samsung
(ANI , 24-Nov-2012 , The Hindu)

Adds the iPad mini to a list of products it claims violate patents on radio signalling technologies More...



Appellate Board sets new ground rule for GI tags
(Vinson Kurian , 23-Nov-2012 , Business Line)

The Intellectual Property Appellate Board has set aside grant of Geographical Indication registration for Payyannur Pavithra ring. More...



Patent clearance slower in India, says scientist
(Express news service , 24-Nov-2012 , The Indian Express)

A leading Scientist working with the Tata Consultancy Services Dr Hiranmay Ghosh on Friday said that the pace of clearing patents in India was slower than in developed countries like the US. More...



Ranbaxy shares down over 3% after drug recall in US
(PTI , 23-Nov-2012 , Zee News)

Ranbaxy was the first company to launch generic Lipitor in the US market after Pfizers patent expired last year. More...



Patent paradox
(Staff Writer , 23-Nov-2012 , Livemint)

Patent approvals fall across sectors in 2011. More...



Microsoft files patent for augmented reality smart glasses
(23-Nov-2012 , BBC News)

A patent applied for by the US tech firm describes how the eyewear could be used to bring up statistics over a wearers view of a baseball game or details of characters in a play. More...



India approves policy to cap prices of 348 drugs
(Reuters / NEW DELHI/ MUMBAI , 22-Nov-2012 , Business Standard)

India approved a new drug pricing policy designed to increase the number of drugs deemed essential that are subject to price caps two ministers told reporters. More...



CEWiT research may get incorporated into the global standards of 4G
(Sangeetha Kandavel , 22-Nov-2012 , The Economic Times)

India needs to emulate China in creating enough patents to avoid paying royalties. More...



Samsung now accuses iPad Mini, new iPad, iPod Touch of patent infringement
(Tech , 22-Nov-2012 , IBN Live)

Over the last few months Apple and Samsung have been seen including new products in their legal battles. More...



Samsung gets review in patent case with Apple
(Bloomberg , 21-Nov-2012 , The Times Of India)

Samsung the world's biggest maker of smartphones, will get another chance to convince a US trade agency that Apple's iPhone and iPad infringe its patents. More...



NSF introduces Atorvastatin Calcium Reference Standard Kits to maintain highest quality standards for Indian mfrs
(Ann Arbor, Michigan , 21-Nov-2012 , Pharmabiz)

NSF International an independent global public health organization that develops high quality reference standards has released Atorvastatin Calcium Reference Standard Kits which are traceable to official US and European pharmacopoeial standards. More...



Microsoft-Google trial ends first phase
(Reuters , 21-Nov-2012 , NDTV)

A Google expert witness testified on Tuesday that Microsoft will make roughly $94 billion in revenue through 2017 from its Xbox game console and Surface tablet that use Google's patented wireless technology. More...



US ITC will review Apple Samsung patent decision
(Reuters , 20-Nov-2012 , The Economic Times)

The US International Trade Commission will review a judges decision which found that Apple did not violate patents owned by Samsung Electronics in making the iPod touch iPhone and iPad. More...



HTC 'happy' with Apple settlement, slams media estimates
(Reuters , 20-Nov-2012 , The Economic Times)

Taiwan's HTC Corp is happy with its patent settlement with Apple Inc, but regards media reports on details of the licensing agreement as "outrageous", chief executive Peter Chou told reporters on Tuesday. More...



Apple now gets the virtual 'page turn' patent
(IBNLive.com , 19-Nov-2012 , IBN Live)

Apple which was recently granted the design patent on rectangular shape with rounded edges has now been given the exclusive rights to the page turn in an e-reader app reports The New York Times. More...



WHO meet on fake medicines whips up controversy on NGO participation
(P.T. Jyothi Datta, A.M. Jigeesh , 19-Nov-2012 , Business Line)

A World Health Organisation meet on tackling fake medicines in Buenos Aires has drawn attention of a different kind involving India. More...



Apple awarded patent for virtual page turn feature for iBooks
(ANI , 18-Nov-2012 , DNA)

Tech giant Apple has awarded a patent this week for a 'page-turn' feature that is used in iBooks. More...



'GMO poses threat to GI tag of crops'
(Kevin Mendonsa , 17-Nov-2012 , The Times of India)

The entering of Genetic Modified Organism crops into the district poses threat to Geographical Indication crops said K N Ramachandra convener of Southern Action on Genetic Engineering. More...



Hearing in controversial Glivec case between Novartis & Union of India enters crucial stage
(Ramesh Shankar, Mumbai , 17-Nov-2012 , Pharmabiz)

Hearing in the controversial imatinib mesylate (Glivec) case between the Swiss pharma major Novartis AG and the Union of India & Others is continuing in the Supreme Court of India which is expected to conclude by the end of this month. More...



'Amul' loses trademark battle against US giant in Gujarat HC
(PTI , 16-Nov-2012 , DNA)

The Gujarat High Court has refused to set aside an order which cancelled Amuls registration of its trademark Trix on which a US firm has claimed its right. More...



Apple quietly acquires 1,024 Nortel patents from own consortium
(NDTV Correspondent , 16-Nov-2012 , NDTV)

Apple may be getting ready to step on the patent offensive once again after acquiring over a 1000 patents from a consortium led by the Cupertino based giant itself. More...



Set up an authority for fast approval of patents: Assocham
(PTI , 16-Nov-2012 , Zee News)

Government should set up a National Intellectual Property Right Strategy Authority in order to expedite clearances of patent applications industry body Assocham has said. More...



iPhone 5, Android 4.1, Galaxy S III, Note 10.1 dragged into patent fight
(Reuters , 16-Nov-2012 , The Times Of India)

A US judge on Thursday allowed Samsung Electronics to pursue claims that the iPhone 5 infringes its patents while also allowing Apple to add claims that the Samsung Galaxy Note 10.1 Galaxy S III and Android 4.1 operating system violate its patents. More...



Traditional knowledge and limits to GI
(Nitya Nanda, Indrani Barpujari , 15-Nov-2012 , Business Line)

It is often considered that geographical indications can be used to protect traditional knowledge and communities. More...



Samsung ‘has no intention’ to settle patent suits with Apple
(ANI , 15-Nov-2012 , Zee News)

South Korean electronics maker Samsung has said that it will not follow HTCs lead and settle its patent lawsuits with Apple. More...



R&D spending of 30 pharma companies surge by19.6% in FY 2011-12
(Sanjay Pingle, Mumbai , 12-Nov-2012 , Pharmabiz)

The Indian pharmaceutical segment has established strong presence in the international market with higher investments in Research and Development during last decade and launched several new affordable high quality generic products. More...



Shares of HTC limit up after settling patent issues with Apple
(Reuters , 12-Nov-2012 , The Economic Times)

Shares of HTC Corp jumped by their permitted daily limit on Monday after the Taiwanese smartphone maker and Apple Inc announced a global patent settlement and 10-year licensing agreement. More...



Pharma firms quit AP for greener pastures
(Koride Mahesh , 11-Nov-2012 , The Times Of India)

Thanks to a lack of incentives from its government and the ongoing power crisis in the state the pharmaceutical sector in Andhra Pradesh is shrinking. More...



Apple to court: Include Android 4.1 in patent suit
(AFP , 08-Nov-2012 , The Times Of India)

A US judge on Wednesday was considering a request by Apple that would pull Google from the sidelines in a long-running patent war with Samsung over mobile gadgets powered by Android software. More...



Sun Pharma Q2 profit down 46%
(Our Bureau , 08-Nov-2012 , Business Line)

Drug maker Sun Pharmaceutical saw a 46 per cent dip in its net profit in the July September quarter because of Rs 584 crore set aside towards potential damages it may have to pay in a patent infringement case on heart burn drug Protonix in the United States. More...



Apple violated patents in FaceTime, fined $368 million
(Reuters , 08-Nov-2012 , The Times Of India)

Shares of VirnetX Holding jumped 27 percent after a jury asked Apple to pay about $368 million to the internet security software maker for infringement of four patents. More...



Patent expiration hit sales, profits of top 10 MNCs in 9 months of 2012, Novartis in No1 position
(Sanjay Pingle, Mumbai , 7-Nov-2012 , Pharmabiz)

Financial performances of 10 leading global pharmaceutical companies have received a major setback during the first nine months of the current year ended September 2012 on account of patent expirations stiff generic competition austerity measures in regulated markets and US healthcare reform. More...



REVOKING PEGASYS & SUTENT
(P A Francis , 7-Nov-2012 , Pharmabiz)

Indias patent office took two significant decisions of cancelling patents issued to two leading International pharmaceutical companies namely Pfizer and Roche during the last 30 days. More...



Glenmark settles patent case with Janssen in US
(C.H. Unnikrishnan , 06-Nov-2012 , Livemint)

Settlement allows Glenmark to enter the market with a generic version even before the patent expiry of Janssens drug More...



US judge tosses Apple suit against Motorola
(AFP , 6-Nov-2012 , The Times Of India)

A federal judge has tossed out an Apple lawsuit accusing Google-owned Motorola Mobility of trying to charge the iPhone maker too much for licenses to essential technology for mobile devices. More...



Pattamadai mats likely to get GI mark soon
(R. Sivaraman , 6-Nov-2012 , The Hindu)

In line of Tirupathi laddu and Kanchipuram silk saris the famous mats Pattamadai pai from Tirunelveli district and traditional lamps from Nachiarkoil in Thanjavur district are to get the geographical indication mark very soon. More...



India to be among top 10 pharma markets globally by 2020
(PTI , 05-Nov-2012 , Zee News)

Indias pharmaceutical industry is on good growth trajectory and is likely to be among the top 10 global markets in value terms by 2020 according to a CII PwC report released on Monday. More...



Indias patent fix
(Sushmi Dey / New Delhi , 04-Nov-2012 , Business Standard)

While the government has been battling patents on traditional Indian remedies abroad the Patent Office back home has granted a handful of such patents causing an embarrassment of sorts More...



PM for early conclusion of trade talks with EU, Asean
(BS Reporter , 3-Nov-2012 , Business Standard)

The two sides also differ on inclusion of intellectual property rights and data security in the agreement. More...



Patents appeal board revokes patent on Roche hepatitis drug
(Reuters , 02-Nov-2012 , The Economic Times)

Patents appeal board has revoked a patent granted to Roches hepatitis C drug Pegasys citing a lack of evidence the drug is superior to existing treatments and its high price. More...



IPAB order not a healthy signal say drug makers
(P.T.Jyothi Datta , 2-Nov-2012 , Business Line)

The Intellectual Property Appellate Boards decision to set aside Roches patent on its Hepatitis C drug Pegasys comes even as the amended Patent Act gets tested from several quarters. More...



LG Electronics settles LED patent dispute with Siemens' Osram unit
(Reuters , 02-Nov-2012 , The Economic Times)

South Koreas LG Electronics Inc said on Friday it and its component unit LG Innotek Co Ltd had agreed with Siemens light bulb unit Osram to settle all LED patent suits. More...



Microsoft faces patent infringement lawsuit over live tiles in Windows 8
(ANI , 02-Nov-2012 , Zee News)

A small technology company based in Portland has filed a patent infringement lawsuit against software Microsoft over the live tiles feature included in its latest operating system Windows 8. More...



UK judges order Apple to apologise again over patent dispute with Samsung
(AFP , 02-Nov-2012 , The Economic Times)

US tech giant Apple has until Saturday to re-write an inaccurate statement relating to its patent dispute with South Korean rival Samsung British judges have ruled. More...



India EU may go in for partial free trade pact
(PTI , 01-Nov-2012 , The Economic Times)

A day ahead of Prime Minister headed panel taking up the long-pending India-EU free trade agreement, the two sides today indicated they may open their markets in a gradual way instead of signing a full-fledged pact in the wake of differences on several key issues. More...



US is in the pink for local drugmakers
(Priyanka Golikeri , 31-Oct-2012 , DNA)

September was at once the best and worst month of the year for local drugmakers according to analysts. More...



Wait for Indian generic launches gets longer
(Sushmi Dey / New Delhi , 29-Oct-2012 , Business Standard)

USFDA has extended the timeline for granting tentative approval to generic drug applications filed under Para IV of its rules by 10 months. More...



Gaurav Misra: Pricing drugs, culturally
(Gaurav Misra , 29-Oct-2012 , Business Standard)

The price of life saving drugs is an emotive issue. More...



Venus Remedies gets patent from Mexico for antibiotic drug
(Press Trust of India / Chandigarh , 29-Oct-2012 , Business Standard)

The drug has already received seven patent grants More...



Govt scraps patent for jamun-based diabetes drug
(Sidhartha , 27-Oct-2012 , The Times Of India)

After combating bio piracy of neem and haldi in the US and Europe India has now woken up to the problem in its own backyard. More...



Samsung infringes on four Apple patents
(Bloomberg , 26-Oct-2012 , The Times Of India)

Samsung Electronics Co lost the first round of a US trade case brought by Apple Inc its second big defeat this year in America as the companies battle worldwide over smartphone and tablet computer technology. More...



Samsung violates Apple patents: US judge
(Reuters , 25-Oct-2012 , The Times Of India)

South Koreas Samsung Electronics the worlds top maker of smartphones infringed Apple patents to make its smartphones and tablets a US trade panel judge said in a preliminary decision issued on Wednesday. More...



Staff shortage dogs patent office as govt sits on compensation plan
(C.H. Unnikrishnan , 24-Oct-2012 , Livemint)

More than 100 people recruited as patent examiners declined to join several others may quit More...



Samsung doesn’t infringe Apple patent: Dutch court
(Roberta Cowan , 24-Oct-2012 , Livemint)

The court says Samsung does not infringe an Apples patent by using multi-touch techniques More...



Google considering settlement in patent antitrust case: Report
(Reuters , 20-Oct-2012 , The Times Of India)

Google is considering a settlement with the Federal Trade Commission over potential claims it broke antitrust law in its handling of patents for mobile devices, the Wall Street Journal reported on Friday. More...



Apple loses tablet copyright appeal against Samsung
(Reuters , 19-Oct-2012 , The Economic Times)

Apple lost its appeal of a ruling that its rival Samsungs Galaxy tablet computer did not copy Apples registered tablet designs in a British court on Thursday More...



The rise of the patent brigade
(VENKATESH GANESH , 19-Oct-2012 , Business Line)

In 2011 the total number of patent applications for in India was estimated to be 37000 according to controller general of patents designs and trade marks ministry of commerce and industry data. More...



Indian Drugs Manufacturing Association reviewing government directive on drug branding
(DIVYA RAJAGOPALDIVYA RAJAGOPAL , 19-Oct-2012 , The Economic Times)

The government wants to tackle the issue of trademark disputes that comes under their purview when companies with similar sounding brand names come to them for resolution. More...



India fights to protect its traditional home remedies
(AFP , 18-Oct-2012 , Hindustan Times)

Earlier this year India successfully fought off Nestles attempt at the European Patent Office to secure a patent saying that using cows milk as a laxative was mentioned in ancient texts and was therefore not new More...



Indian fashion designers should audit their intellectual property: Safir Anand, Anand and Anand
(Maulik Vyas , 18-Oct-2012 , The Economic Times)

As the Indian fashion industry gains attention from international brands and labels Indian fashion designers are also becoming more savvy of their legal rights to protect their designs. More...



Chidambaram asks NABARD to help innovators get patents
(PTI , 17-Oct-2012 , Zee News)

Finance Minister P Chidambaram Wednesday asked NABARD to help innovators in getting patent of their products and also help them replicate their ideas for benefit of masses. More...



India may win patent claims due to Traditional Knowledge Digital Library: Manmohan Singh
(PTI , 16-Oct-2012 , The Economic Times)

India could win 105 claims on international patents due to its Traditional Knowledge Digital Library Prime Minister Manmohan Singh said here today, opening the high level segment meeting at the Conference of Parties to Convention on Biological Diversity. More...



US market to give Indian pharma a booster shot
(Kiran Kabtta Somvanshi , 16-Oct-2012 , The Economic Times)

Pharma companies are expected to continue their strong performance in the September quarter driven by good performance in the US (aided by certain exclusive launches) and modest growth in the domestic pharma market. More...



Peoples biodiversity festival rejects IPR regime
(Our Bureau , 15-Oct-2012 , Business Line)

The Peoples Biodiversity Festival an event held in the city during the Convention for Biological Diversity says it rejects Intellectual Property Rights regime over peoples natural resources. More...



Opportunities back home for Indian pharma
(NALINAKANTHI V. , 14-Oct-2012 , Business Line)

Higher affordability, increase in penetration and greater awareness can drive growth. More...



Lupin identifies cancer drugs as focus area in Japan
(Press Trust of India / New Delhi , 14-Oct-2012 , Business Standard)

The company is present in Japan through two wholly owned subsidiaries More...



Microsoft to sue Google with Motorola in German patent row
(Reuters , 13-Oct-2012 , The Economic Times)

Microsoft Corp said on Friday it plans to add Google Inc as a defendant in Germany in one of its patent actions against Googles phone maker Motorola Mobility the first time the two tech giants have come into direct legal conflict over Google's Android mobile software. More...



Cadila Pharma files for cancer vaccine patent
(Vishal Dutta , 12-Oct-2012 , The Economic Times)

Ahmedabad-based Cadila Pharmaceuticals has developed a cancer vaccine and has filed for its therapeutic patent with Controller General of Patents Designs and Trademarks Office. More...



Court lifts ban on Samsung Galaxy Nexus in US
(AFP , 12-Oct-2012 , Hindustan Times)

A US appeals court Thursday lifted a sales ban on Google branded Samsung smartphones in a patent fight with Apple saying there was no evidence sales were driven by features copied from the iPhone. More...



Apple-Samsung patent issue: US appeals court lifts ban on Samsung-Google phone
(AFP , 11-Oct-2012 , The Economic Times)

A US appeals court Thursday lifted a sales ban on Google branded Samsung smartphones in a patent fight with Apple saying there was no evidence sales were driven by features copied from the iPhone. More...



Roamware wins patent for its predictive intelligence technology
(Mahesh Kulkarni / Bangalore , 11-Oct-2012 , Business Standard)

Roamware a provider of mobile operator service solutions on Thursday announced that it has won a patent on Predictive Intelligence a technology that will help operators vastly improve their customer experience management capabilities and give local and roaming subscribers a much better service usage experience. More...



SRK to be a trademark!
(Mehul S Thakkar, Mumbai Mirror , 11-Oct-2012 , The Times Of India)

The actor has sent an application to the Trade Mark Registry that his often used initials not be used without his permission More...



Widening scrutiny of Google’s smartphone patent licensing
(New York Times , 11-Oct-2012 , The Indian Express)

For more than a year the Federal Trade Commission has been conducting a broad antitrust investigation into the way Google runs its internet search and search advertising businesses. More...



Patently against public health?
(P.T. JYOTHI DATTA , 10-Oct-2012 , Business Line)

The amended Patent Law is in a sense being pushed poked and prodded by drug companies testing its resilience. More...



Tech fighters in a patent war
(New York Times , 10-Oct-2012 , The Economic Times)

Apple has been involved in 148 smartphone patent lawsuits since 2006. More...



'India needs to work on ensuring intellectual property rights'
(PTI , 09-Oct-2012 , Hindustan Times)

A senior US diplomat has stressed the need for conducting a detailed study on the impact of intellectual property on Indias economy saying the country should examine ways to ensure IP rights in all businesses. More...



No decision immediately on controlling prices of imported patented drugs
(Joseph Alexander, New Delhi , 8-Oct-2012 , Pharmabiz)

Though mentioned in the draft pharmaceutical pricing policy 2011 the government is unlikely to rush to a decision on the price negotiation mechanism of imported patented drugs as it is still examining the report by an expert panel in this regard. More...



Turf war in the pharma industry
(Sushmi Dey / New Delhi , 07-Oct-2012 , Business Standard)

The swadeshi versus videshi battle has broken out afresh in the Rs 67000 cr Indian drug market as mutinationals step up their efforts to enter the branded generic space to compete with domestic drug makers. More...



Motorola wins patent case against Microsoft in Germany
(Reuters , 05-Oct-2012 , NDTV)

Mobile phone maker Motorola achieved a rare victory against software giant Microsoft in a patent case before a German court on Friday the latest in a wave of patent lawsuits by technology firms fighting over market share. More...



Pfizer to appeal India decision to revoke cancer drug patent
(PTI , 05-Oct-2012 , The Economic Times)

Pfizer Ltd the India unit of US drugmaker Pfizer Inc will challenge the countrys patent office for revoking a patent for its cancer drug Sutent. More...



Cipla wins patent opposition against Pfizers cancer drug
(Reghu Balakrishnan / Mumbai , 04-Oct-2012 , Business Standard)

The Delhi patent office judged that Pfizers patent of Sutent does not involve any inventive step. More...



Google denied summary judgment in patent dispute with Vringo
(Reuters , 4-Oct-2012 , The Economic Times)

Mobile phone software maker Vringo Incs shares jumped 39 percent on Wednesday after a judge denied Google Inc a motion for summary judgment in a patent dispute. More...



Tata group's Advinus Pharma ties up with Takeda Pharma for drug R&D
(DIVYA RAJAGOPAL , 4-Oct-2012 , The Economic Times)

Tata group promoted Advinus Pharma has entered into a joint drug discovery deal with Japanese pharma giant Takeda Pharma indicating multinational companies growing interest in Indian drug research and holding out hope for startup firms engaged in research. More...



Google withdraws US patent complaint against Apple
(Reuters , 4-Oct-2012 , Business Standard)

Google subsidiary Motorola Mobility has dropped a complaint of patent infringement against Apple without explanation. More...



DLF files five patents on building safety and security
(Ravi Teja Sharma , 03-Oct-2012 , The Economic Times)

Indias largest real estate developer DLF has filed five patents that are related to inventions for safety and security of its buildings and its residents. More...



European Union wants India to allow extended patent life for drugs
(Amiti Sen , 3-Oct-2012 , The Economic Times)

The European Union is making frantic efforts to convince India to liberalise its patent regime as part of the proposed bilateral free trade agreement. More...



Drug makers eye M&As to tap markets at home and away
(Sushmi Dey / New Delhi , 3-Oct-2012 , Business Standard)

Amid concern multinational companies may buy out Indian drug makers and dominate the pharmaceutical industry here analysts say it is time domestic companies considered acquisitions and alliances both at home and abroad. More...



Google backs off patent complaint against Apple
(AFP , 3-Oct-2012 , Hindustan Times)

Google owned Motorola Mobility withdrew a patent complaint filed with a US commission but remained quiet as to the reason for the legal ceasefire. More...



iPhone 5: Samsung files patent lawsuit against Apple
(Reuters , 2-Oct-2012 , The Times Of India)

Samsung Electronics said on Tuesday that it filed a new lawsuit against Apple in a US court contending the iPhone 5 infringed on Samsungs patents. More...



Drug groups eye Indian legal case
(Ft.com , 1-Oct-2012 , MoneyControl)

Chennai may be a long way from the Leverkusen headquarters of Bayer BAY but the German pharmaceutical group is involved in a legal dispute in the southern Indian city that is being watched by its peers around the world. More...



Infosys way ahead of Indian peers in patent race
(Bibhu Ranjan Mishra / Bangalore , 30-Sep-2012 , Business Standard)

Accenture the only global IT firm that filed more patents in last five years. More...



Lupin aims to double sales in Japan to $500 mn in next 5 yrs
(Press Trust of India / New Delhi , 30-Sep-2012 , Business Standard)

In order to achieve its desired growth in the Japanese market the company may even consider selective acquisitions. More...



Whirpool and LG settle refrigerator patent disputes
(Reuters , 29-Sep-2012 , The Economic Times)

Whirlpool Corp the worlds largest appliance maker and LG Electronics Inc settled three pending patent infringement lawsuits involving refrigerators the companies said on Friday. More...



Pharma industry need to look sustaining growth post 2015 when patent expiries stop
(Nandita Vijay, Bengaluru , 29-Sep-2012 , Pharmabiz)

Baring Private Equity Partners India perceives that India pharma will now need to look at sustaining its growth momentum post 2015 when there will be no major drugs going off patent. More...



Google cant patent injunction against Microsoft in Germany: US court ruling
(Reuters , 29-Sep-2012 , The Economic Times)

A US appeals court on Friday ruled that Google Incs Motorola Mobility unit cannot enforce a patent injunction that it obtained against Microsoft Corp in Germany, diminishing Googles leverage in the ongoing smartphone patent wars. More...



Essential drug prices to come down by 20%
(Amit Mitra , 28-Sep-2012 , Business Line)

There will be an average reduction of 20 per cent in prices of the 348 essential medicines under the new pricing mechanism recommended by the Group of Ministers on Thursday. More...



Bayer AG disappointed after losing India patent fight
(AFP , 28-Sep-2012 , The Economic Times)

Pharmaceutical giant Bayer AG on Wednesday said it was disappointed with an Indian ruling that allows a local firm to produce a cheaper copy of its patented drug Nexavar for liver and kidney cancer. More...



LG: Samsungs Galaxy series phones infringe our patents
(AFP , 27-Sep-2012 , The Times Of India)

South Koreas LG Display, one of the worlds top flat screen TV makers said Thursday it had filed a patent infringement suit against Samsung Electronics over the use of advanced displays. More...



Ministerial panel recommends price control for 348 essential drugs
(Reuters , 27-Sep-2012 , The Times of India)

Patented drugs are not covered by this policy though India is considering a mechanism to regulate prices of medicines which are covered by patent protection. More...



Copyright issue gets louder at live concerts
(Kanu Sarda , 27-Sep-2012 , DNA)

In an attempt to protect the interest of music composers and authors the Delhi high court has ruled that playing music of other composers in live concerts and at disc jockey nights in clubs hotels and restaurants is illegal and an infringement on the Copyright Act. More...



The booming business in biosimilars
(Sushmi Dey / New Delhi , 27-Sep-2012 , Business Standard)

Various drug makers are set to cash in on the opportunity. More...



LG accuses Samsung of infringing OLED patents
(Agence France-Presse , 27-Sep-2012 , NDTV)

South Koreas LG Display one of the worlds top flat screen TV makers said Thursday it had filed a patent infringement suit against Samsung Electronics over the use of advanced displays. More...



European Trade Council, German Tea Association uphold Darjeeling tea's authenticity
(Sutanuka Ghosal , 27-Sep-2012 , The Economic Times)

The European Trade Council and the German Tea Association have agreed to confer the protected geographical indication status on Darjeeling tea the first commodity from India to get such a tag. More...



Googles Eric Schmidt criticises raging mobile patent war
(Agence France Press , 27-Sep-2012 , NDTV)

Google executive chairman Eric Schmidt on Thursday criticised raging patent disputes in the global mobile industry warning that they stifled innovation and reduced consumer choice. More...



India Courts Drug Disaster
(ROGER BATE , 26-Sep-2012 , The Wall Street Journal)

Not to be outdone by the Supreme Court the India Patent Office also is getting in on the drug-pricing game too. More...



Madras court allows GSK to resume distribution of biscuits
(Mihir Dalal , 25-Sep-2012 , Livemint)

The Madras high court allowed GlaxoSmithKline Consumer Healthcare Ltd to resume the sales and distribution of Horlicks Nutribic biscuits after it ordered a halt last month on a complaint of trademark infringement by Britannia Industries Ltd. More...



Apple loses patent case against Samsung Motorola in Germany
(ANI , 25-Sep-2012 , The Hindu)

A German court has dismissed tech giant Apples claims that Google owned Motorola and Korean firm Samsung infringed some of its multi touch patents. More...



Orchid Pharma plans entry into therapeutic new segments
(BS Reporter / Chennai , 25-Sep-2012 , Business Standard)

The company has received patents for this and has a niche biotech lab and pilot facility available which is a kind of 30 people outfit in Sholinganallur near Chennai. More...



Smartphone wars: Patents are the new weapons
(STEVE LOHR, New York Times , 25-Sep-2012 , The Times Of India)

In patent law youre at the cutting edge of everything and thats shifting all the time. More...



Drug patents on the rise: 3,488 in five years
(Sushmi Dey / New Delhi , 24-Sep-2012 , Business Standard)

It was in 2005, India changed its patent law and started granting patents in medicines. More...



A bitter pill
(Kaushik Sunder Rajan , 24-Sep-2012 , The Indian Express)

At issue is a key provision in Indias 2005 Patent Amendment Act section 3(d). More...



Discussions essential to influence drug-price policy: P.H. Kurian
(Staff Reporter , 23-Sep-2012 , The Hindu)

Call to oppose lobbying by MNCs to dilute price control order. More...



Italian firm wins trademark case against UK Modi controlled firm
(PTI , 23-Sep-2012 , The Economic Times)

Rolling mill equipment maker Morgardshammar AB a subsidiary of the Italy based Daineli Group won a trademark case with the Delhi High Court restraining the UK Modi controlled firm from using the trade name Morgardshammar. More...



Just what the doctor ordered
(23-Sep-2012 , Hindustan Times)

The Indian pharma industry won an important battle: the Intellectual Property Appellate Board dismissed German drugmaker Bayer AG's petition seeking a stay on the 'compulsory licence' (CL) issued to Natco Pharma for selling generic copies of the cancer drug Nexavar in India. More...



Apple has ceded the crown to Samsung in emerging markets: Analyst
(James B Stewart, New York Times , 22-Sep-2012 , The Times Of India)

By many measures Samsung Electronics should be on the ropes. More...



Setback for Apple in German patent case against Samsung
(Reuters , 21-Sep-2012 , The Economic Times)

A German court ruled against Apple Inc in two patent cases against Samsung Electronics and Motorola Mobility owned by Google. More...



Niche plays as patent cliff looms
(Ujjval Jauhari & Ram Prasad Sahu / Mumbai , 20-Sep-2012 , Business Standard)

Efforts of Indian pharma majors in US helped improve share of key cos in US generics prescription mkt. More...



Dabur sues Amar Remedies for passing off Siwak as Meswak
(ET Bureau , 19-Sep-2012 , The Times of India)

Dabur has filed a case against Amar Remedies for infringing on the intellectual property rights to its brand Meswak. More...



US probes Apples patent infringement
(IANS , 19-Sep-2012 , DNA)

A US trade panel Tuesday launched a probe after the Motorola company alleged that its patents were infringed by Apple Inc. More...



HC restrains Indian firm from using Morgardshammar trademark
(PTI , 19-Sep-2012 , Hindustan Times)

Modi groups Morgardshammar India a rolling mill equipment manufacturer was today barred by the Delhi High Court from using the Morgardshammar trademark and name of Morgardshammar AB a subsidiary of Danieli group of Italy. More...



Benefits of TRIPS not being utilised by industries
(Express News Service , 19-Sep-2012 , IBN Live)

The benefits and safeguards that have been provided under the Trade Related Intellectual Property Rights are not being utilised properly by our industries according to P H Kurien Principal Secretary Department of Information Technology and former Controller General of Patents Designs and Trademarks India. More...



Benefits of TRIPS not being utilised by industries
(Express News Service , 19-Sep-2012 , IBN Live)

The benefits and safeguards that have been provided under the Trade Related Intellectual Property Rights are not being utilised properly by our industries according to P H Kurien Principal Secretary Department of Information Technology and former Controller General of Patents Designs and Trademarks India. More...



Bayer vows to defend IPR rights on cancer drug
(Press Trust of India / New Delhi , 17-Sep-2012 , Business Standard)

Allellate boardrefuses to stay the compulsory license granted to Natco for its patented cancer drug Nexavar More...



Intellectual Property Appellate Board dismisses Bayers appeal against Natco
(Rupali Mukherjee , 17-Sep-2012 , The Times Of India)

The Intellectual Property Appellate Board has dismissed Bayers request for a stay order against the compulsory license granted by the Patent Controller to Natco on cancer drug Nexavar earlier this year. More...



Start-ups fight back as patent wars intensify
(Reuters , 17-Sep-2012 , NDTV)

The patent wars that have embroiled many of the worlds technology giants in recent years are spreading to a new set of combatants start up companies and their venture capital backers. More...



Bayer plea against Natco on cancer drug dismissed
(R. Sivaraman , 16-Sep-2012 , The Hindu)

Pharma major contested grant of licence to Hyderabad firm for making a drug to treat liver and kidney cancer More...



Bayers appeal for stay on compulsory licence to Natco Pharma rejected
(R. Sivaraman , 15-Sep-2012 , Business Line)

The Intellectual Property Appellate Board has rejected pharma major Bayer Corporations petition seeking a stay on the compulsory licence granted to Hyderabad based Natco Pharma Ltd. More...



Apple did not violate Samsung patents: US judge
(Reuters , 15-Sep-2012 , The Times Of India)

Apple did not violate patents owned by Samsung Electronics in making the iPod touch iPhone and iPad a judge at the International Trade Commission said in a preliminary ruling on Friday. More...



Hearing in Glivec patent case to resume on Sept 18 in Supreme Court
(Our Bureau, Mumbai , 15-Sep-2012 , Pharmabiz)

Hearing in the controversial Glivec patent case remained inconclusive in the Supreme Court with the Novartis lawyer Gopal Subramaniam continuing his arguments in the court. More...



Apple wins German patent case against Motorola
(AFP , 15-Sep-2012 , Hindustan Times)

A German court found Google owned IT company Motorola guilty of infringing Apple patents on the design of smartphones and tablets a court spokesman said on Thursday. More...



DoP to seek public opinion on pricing for patented drugs
(PTI , 14-Sep-2012 , Business Line)

The Department of Pharmaceuticals will seek views from stakeholders on how patented drugs must be priced in the country and will put up draft guidelines in public domain by next week a senior official said today. More...



With patient welfare pitted against corporate social irresponsibility, lives are at stake
(14-Sep-2012 , The Times Of India)

In doing so the multinational has questioned the applicability of section 3d of the Indian Patent Act meant to counter abusive patenting practices such as evergreening or the indefinite extension of patent monopolies through routine modifications of known compounds. More...



Piramal Health set to unveil patented drug in Europe
(Swetha Kannan , 14-Sep-2012 , Business Line)

After 10 years of trials Piramal Healthcare is ready to roll out its first patented product in Europe next month. More...



Google India should not deprive Consim benefit of trademark policy
(PTI , 14-Sep-2012 , The Economic Times)

The Madras High Court bench on Thursday upheld a single judge order that Google India Private Ltd not deprive Chennai based Consim Info Pvt Ltd benefit of their trademark policy and protect their trademarks including Bharat Matrimony, Tamil Matrimony and Telugu Matrimony. More...



Of patients, patents and profits
(Patralekha Chatterjee , 14-Sep-2012 , The Asian Age)

Most Indians depend heavily on local low cost generic drugs. More...



Apple wins German patent case against Motorola
(AFP , 14-Sep-2012 , The Economic Times)

A German court found Google-owned IT company Motorola guilty of infringing Apple patents on the design of smartphones and tablets a court spokesman said on Thursday. More...



We haven't broken any law: Siddharth Roy Kapur
(Press Trust of India / Gurgaon , 13-Sep-2012 , Business Standard)

Barfi producer Siddharth Roy Kapur who has been sent a legal notice from British manufacturers Murphy Radio for alleged trademark infringement says they have not broken any law by using it in the film. More...



Lupin shares drop after US ruling on birth control drug
(Reuters , 13-Sep-2012 , The Economic Times)

The ruling could prevent Lupin from launching a generic version although Barclays Capital said that the drug maker plans to appeal the verdict given the company believes it has a strong basis for invalidating the patent. More...



As hearing continues in SC on Glivec; health groups & experts ask Novartis to drop the case in India
(Ramesh Shankar, Mumbai , 13-Sep-2012 , Pharmabiz)

Even as the Supreme Court has started hearing the arguments on the controversial Glivec patent case some health groups and health experts in the world have written an Open letter to Novartis asking the Swiss drug major to drop the case in India. More...



University of California sues Facebook Wal-mart over patents
(Reuters , 13-Sep-2012 , The Economic Times)

The patents for interactive technology including hypermedia display and interaction were issued to the university and licensed to Eolas a Texas company chaired by Michael Doyle. More...



PRICING PATENTED DRUGS
(P A Francis , 12-Sep-2012 , Pharmabiz)

A fundamental flaw in the current drug pricing policy in India is the absence of regulation on high priced patented drugs. More...



Salman Khan’s ‘Ek The Tiger’ courts copyright controversy
(Zeenews Bureau , 12-Sep-2012 , ZeeNews)

After a series of Bollywood films embroiled in script cheating controversy, like ‘Jannat 2’, ‘Desi Boyz’ and others, Salman Khan’s ‘Ek Tha Tiger’ is the latest film to have landed in copyright row More...



Patent expiries: Dr Reddy's, Lupin to foray into specialty pharma Aurobindo Pharma to focus on services
(Deepika Amirapu , 12-Sep-2012 , The Economic Times)

Indias top pharmaceutical companies are preparing for life after high revenues from expiring patents drops off at the end of this year. More...



Novartis case opens in SC
(BS Reporter / New Delhi , 12-Sep-2012 , Business Standard)

Company ready to promise assistance scheme for patients will continue even after litigation More...



Neck-deep in debt, Deccan Chronicle Holdings Ltd pledges trademarks too
(Swati Bharadwaj Chand , 12-Sep-2012 , The Times Of India)

Its not just shares movable assets and immovable properties that the promoters of beleaguered Deccan Chronicle Holdings Ltd have pledged and mortgaged to raise funds. More...



Rice exporting firm seeks patent for parboiling unit
(Express news service , 12-Sep-2012 , Indian Express)

The wheat eating belt of north India likes it raw when it comes to rice. More...



Off-patent pain drug can kill resistant TB
(ANI , 11-Sep-2012 , The Times Of India)

Their findings point to a potential new therapy for the more than 500000 people worldwide whose TB has become resistant to standard drug treatments. More...



iPhone 5: Samsung to sue Apple over LTE patent
(Zeebiz Bureau , 11-Sep-2012 , ZeeNews)

The persistent battle between tech giants Apple and Samsung takes a new turn almost every day. More...



Novartis argues for Glivec patent at Supreme Court
(Reuters , 11-Sep-2012 , The Economic Times)

Swiss drugmaker Novartis told Indias top court it had demonstrated the improved efficacy of its cancer drug Glivec as the final hearing began on Tuesday of a patent case that could change the rules for the countrys healthcare sector. More...



IPAB adjourns hearing on post-grant opposition to Roche's Pegasys to Sept 21
(Ramesh Shankar , 11-Sep-2012 , Pharmabiz)

Intellectual Property Appellate Board in Chennai has once again adjourned the hearing in the post grant opposition case against the patent granted to Roche for Pegasys to September 21. More...



Novartis India share gains 5.5% ahead of Supreme Court hearing on Glivec in patent case
(Reuters , 10-Sep-2012 , The Economic Times )

The Indian unit of Novartis AG has challenged the countrys patent office decision to refuse to grant a patent for its cancer drug Glivec. More...



Venus bags first patent from Canada for antibiotic drug
(Charanjit Ahuja , 10-Sep-2012 , The Indian Express)

Chandigarh based Venus Remedies Limited a leading research based global pharmaceutical company has secured its first patent from Canada for its novel antibiotic adjuvant entity Vancoplus. More...



Govt looking at riders for foreign investment in pharma
(Our Bureau , 10-Sep-2012 , Business Line)

Some multinational companies operating here are unhappy with tough decisions in recent years by the patent office and Indian courts in rejecting drug patents recognised in many Western nations. More...



Cipla’s patent win against Roche boosts hopes of generic drugmakers
(DIVYA RAJAGOPAL , 10-Sep-2012 , The Economic Times)

The Delhi High Court ruling favouring Indias second largest drugmaker Cipla has come as a shot in the arm for other generic makers who are fighting similar patent infringement cases. More...



Venus gets patent from Canada for antibiotic drug
(Press Trust of India / Chandigarh , 10-Sep-2012 , Business Standard)

The company already has a patent for the drug in US South Africa New Zealand Ukraine and Australia. More...



Could patenting fundamentals be right?
(Raghavendra S. , 09-Sep-2012 , The Hindu)

Ruling upholding Apples design patents may be a setback impacting consumer choice and welfare More...



Cipla wins patent case over Tarceva
(C.H. Unnikrishnan , 8-Sep-2012 , Livemint)

Cipla Ltd won a landmark patent case against Swiss drug maker F Hoffmann-La Roche Ltd in the Delhi high court on Friday over the Indian companys generic copy of lung cancer drug Tarceva after a four-year court battle. More...



Patent drug prices to be set in negotiations with pharma companies
(PTI , 07-Sep-2012 , The Economic Times)

A panel set up to look into the pricing mechanism for patented drugs has said that prices have to be decided after deliberations with manufacturers if the government is to adopt price negotiation model Parliament was informed today. More...



Fixing of patented drug prices only after negotiating with pharma cos’
(PTI , 07-Sep-2012 , Business Line)

A panel set up to look into the pricing mechanism for patented drugs has said that prices have to be decided after deliberations with manufacturers if the government is to adopt price negotiation model Parliament was informed today. More...



iPhone 5: Chinese company may sue Apple
(TOI Tech , 07-Sep-2012 , The Times Of India)

It may still be few days for Apples next generation iPhone unveiling however the much awaited phone is already facing lawsuit threat in China. More...



Move against tiny photocopy shop raises copyright debate
(Aesha Datta , 07-Sep-2012 , Business Line)

The recent crackdown on the Rameshwari Photocopy Service aka the D-School photocopy shop, has fuelled a debate regarding what’s “unlawful” about photocopying for educational purposes. More...



Slow rise in generics share may hold up pharma cos' plan in Japan
(B Dasarath Reddy / Chennai/ Hyderabad , 7-Sep-2012 , Business Standard)

Drug laws in Japan make it tough for generic makers to enter the country More...



India to hunt for patented technology to bridge innovation gap
(PTI , 06-Sep-2012 , The Times Of India)

Seeking to accelerate innovation India will launch a global hunt for patented technology to fill in the gaps in its initiatives and hand them over to small industries to speed product development. More...



Hearing on post-grant opposition to Roche's Pegasys to be held by IPAB on Sept 6
(Ramesh Shankar, Mumbai , 06-Sep-2012 , Pharmabiz)

The post grant opposition on this case was filed by Sankalp Rehab Trust. More...



Samsung faces probe over Apple's antitrust complaint
(Reuters , 06-Sep-2012 , The Times Of India)

South Korean regulators are investigating complaints filed by Apple that Samsung Electronics is abusing its dominant position in wireless technology the Korea Fair Trade Commission said on Thursday. More...



Will India keep Novartis at bay?
(Sushmi Dey / New Delhi , 06-Sep-2012 , Business Standard)

The company wants to patent and sell its anti cancer drug imatinib mesylate known as Glivec in India but so far its efforts have failed. More...



Exide Industries wins 15 year trademark spat
(Ashwin Mohan , 5-Sep-2012 , The Economic Times)

In a huge relief for leading battery-maker Exide Industries the company averted serious competition as it won a 15 year old trademark suit against global battery giant Exide Technologies. More...



India Looks To Expand Drug-Price Controls .
(RUMMAN AHMED , 5-Sep-2012 , The Wall Street Journal)

The new proposals would extend price restrictions beyond generic medicines to apply for the first time to patented drugs. More...



IPAB concludes hearing on Bayer CL appeal
(C H Unnikrishnan , 4-Sep-2012 , Livemint)

The patent office had in February issued a compulsory licence to local drug maker Natco Pharma Ltd to make and sell a low-cost generic version of Bayer’s cancer drug More...



Pharma manufacturers should understand the principles of intellectual property rights: G Selvaraj
(Peethaambaran Kunnathoor, Chennai , 4-Sep-2012 , Pharmabiz)

He said under intellectual property law owners are granted certain exclusive rights including manufacture and distribution of inventions sue in case of unlawful or deceptive copying of their innovations etc. More...



Intellectual property rights for plants animals by western firms a cause of concern?
(Swati Deshpande , 02-Sep-2012 , The Times Of India)

As emerging trends point to intellectual property rights in plants animals genes found in developing countries being patented by western firms retired Supreme Court judge Justice B N Srikrishna recently sounded a warning note for the need to have strong laws to control intellectual property. More...



Patients lose out to patents & profits
(Deepa Kurup , 02-Sep-2012 , The Hindu)

A 2012 WHO study ranks India third behind Myanmar and Bangladesh among countries that fail to provide health cover to people. More...



The Compulsions and Repercussions of Compulsory Licensing
(Shobhika Puri , 02-Sep-2012 , ZeeNews)

The recent erosion of investor confidence in India that is doing the rounds in corporate circles is due to a variety of self-defeating strategies that have been adopted by the government. More...



Apple verdict: Days of design innovation over?
(Reuters , 02-Sep-2012 , The Times Of India)

In a pre-iPhone age, mobile phones came in all shapes and sizes. More...



Pharma Department proposes negotiating patent drug rates with firms
(PTI , 02-Sep-2012 , The Economic Times)

The Department of Pharmaceuticals is understood to have proposed direct negotiations with companies for reducing prices of patent drugs to the rate comparable to the lowest available in the global market. More...



Apple files new Samsung patent action in US
(AFP , 1-Sep-2012 , The Times Of India)

Apple has filed a fresh patent infringement action in the United States against Samsung alleging that the South Korean company is continuing to steal its technology despite a recent court ruling. More...



Samsung wins patent case against Apple in Japan
(AP , 31-Aug-2012 , The Times Of India)

A Tokyo court on Friday dismissed Apple Incs claim that Samsung had infringed on its patent the latest ruling in the global legal battle over smartphones that pits the two technology titans against each other. More...



Google, Apple CEOs in talks on patent issues
(Reuters , 31-Aug-2012 , The Economic Times)

Google Inc Chief Executive Larry Page and Apple CEO Tim Cook have been conducting behind the scenes talks about a range of intellectual property matters including the mobile patent disputes between the companies people familiar with the matter said. More...



Japanese court to rule on Apple-Samsung patent dispute
(PTI , 31-Aug-2012 , Business Line)

A Japanese court today will issue a ruling in a bitter patent dispute between Apple and its South Korean rival Samsung the latest case in a global war between the two technology giants. More...



'Domestic drug company's need to focus on pharmerging mkts'
(Rupali Mukherjee , 30-Aug-2012 , The Times Of India)

This is in the wake of lucrative patent opportunities dying away post 2015, with few blockbuster drugs losing patent protection in the US. More...



Apple vs Samsung: Keeping patent for 20 years patentee pay renewal fees of $880 after 3.5 years
(Krishnamurthy Subramanian , 30-Aug-2012 , The Economic Times)

The litigation resulted because Apple accused Samsung of ripping off the feel of its iPhone and iPad among various other patent violations. More...



Apple Samsung 'war' overshadows tech show
(AFP , 30-Aug-2012 , The Times Of India)

The repercussions of Apples billion dollar patent victory over Samsung were still being felt at Europes biggest consumer electronics show as the South Korean firm launched a host of new gadgets. More...



Mobile patent case: New York Times leads group defense
(AP , 29-Aug-2012 , The Times Of India)

The New York Times is girding for a legal battle that many larger organisations have avoided. More...



Sony not worried by Android legal woes
(Reuters , 30-Aug-2012 , The Times Of India)

Sony Mobile which uses Google Android software for its smartphones has not seen much impact from patent problems of the software platform. More...



Indian drug companies like Glenmark, Dr Reddy's, Sun Pharma break into world’s fastest growing list
(Rupali Mukherjee , 30-Aug-2012 , The Economic Times)

In yet another instance of India Inc occupying a larger seat in the global league tables three out of the top 10 fastest growing generic companies globally are now from India. More...



After patent war, Samsung to take on Apple with 'phablet' & bendable screen smartphones
(Reuters , 29-Aug-2012 , The Economic Times)

Samsung Electronics Co unveils the second generation of its popular Galaxy Note phone cum tablet at Europes biggest electronics show in Berlin later on Wednesday as the South Korean firm comes under pressure to innovate after losing a US patent battle with Apple Inc. More...



Samsung lawyers find blunders in verdict
(Reuters , 29-Aug-2012 , The Times Of India)

The jurys haste takes some of the shine off Apples patent victory. More...



Android’s standard-essential patent hopes hit
(Reuters , 29-Aug-2012 , The Economic Times)

But that wasnt Apples only victory. More...



Apple's victory dents Android's patent hopes
(Reuters , 28-Aug-2012 , The Times Of India)

Standard essential patents arent providing as much leverage in the smart device wars as Google may have hoped when it paid $12.5 billion to acquire Motorola Mobility. More...



Hisars Varsity gets patent for pest control technique
(PTI , 28-Aug-2012 , Business Line)

Hisar based Chaudhary Charan Singh Haryana Agricultural University today said it has been issued a patent on a technique useful for controlling the population of an insect Helicoverpa armigera commonly called sundi. More...



Preserved Apple
(Richard Beales , 28-Aug-2012 , Business Standard)

Apple won big with Fridays $1 billion US patent judgment against Samsung. More...



Desi Boyz makers face trouble over copyright
(Prachi Kadam , 28-Aug-2012 , Mumbai Mirror)

Andheri Magistrate Court issues summons against Rohit Dhawan and an arrest warrant against producer Krishika Lulla after writer Shyam Devkatte scales up his copyright battle. More...



Apples win dents Androids standard-essential patent hopes
(Reuters , 28-Aug-2012 , The Economic Times)

Standard essential patents arent providing as much leverage in the smart device wars as Google may have hoped when it paid $12.5 billion to acquire Motorola Mobility. More...



Apple patent win may slow Google
(AFP , 27-Aug-2012 , The Times Of India\\)

Apples decisive victory in a landmark US patent case against Samsung could reshape the hot sector for mobile devices and slow the momentum of Google and its Android system, analysts say. More...



Apple patent win may slow Google
(AFP , 27-Aug-2012 , The Times Of India)

Apples decisive victory in a landmark US patent case against Samsung could reshape the hot sector for mobile devices and slow the momentum of Google and its Android system, analysts say. More...



Punjab National Bank forwards Ind-Swift case for debt recast
(K Ram Kumar , 27-Aug-2012 , Business Line)

But once orders started drying up they ventured on their own to manufacture and market generic drugs (which are copies of branded drugs whose patent has expired). More...



How Apple overwhelmed Samsung's patent case tactics
(Reuters , 27-Aug-2012 , The Economic Times)

But given the extensive business ties between the two companies Samsung is one of Apples key component suppliers a negotiated solution seemed most likely. More...



Apple patent win may delay Samsung launches
(Bloomberg , 27-Aug-2012 , The Times Of India)

Apple Inc won more than $1 billion after a jury found Samsung Electronics Co infringed six of seven patents for its mobile devices in a verdict that may lead to a ban on US sales of handheld electronics a judge deems to violate Apples rights. More...



We don’t want anything to limit choice: Google
(Our Bureau , 27-Aug-2012 , Business Line)

Google whose Android platform could be impacted because of the victory of Apple against Samsung has come up with a guarded reaction on the development. More...



What Apple's $1bn-patent win means for smartphone market
(27-Aug-2012 , The Times Of India)

It was the $1 billion question Saturday: What does Apple Incs victory in an epic patent dispute over its fiercest rival mean for the US smartphone industry? More...



Apple’s verdict will not impact sales in India, says Samsung
(S. Ronendra Singh , 27-Aug-2012 , Business Line)

Samsung Electronics on Monday said that the verdict in a US court against it on a patent dispute with Apple will not impact its sales of smartphones and tablet computers in India. More...



Apple patent victory muddies the future of innovation
(New York Times , 27-Aug-2012 , The Economic Times)

Apples victory on Friday in a patent lawsuit against Samsung could if upheld give its rivals a kick in the pants to create more original products. More...



API market loses out to formulations
(Sushmi Dey / New Delhi , 27-Aug-2012 , Business Standard)

Change in trend attributed to the high-margin business of finished products More...



Apple vs rest: Some kinds of patent protection go against common good
(ET Bureau , 27-Aug-2012 , The Economic Times)

These questions suggest themselves in the wake of a US court finding in favour of Apple in its lawsuit against Samsung for patent and design violations in smartphones and tablets. More...



Karnataka State Road Transport Corporation files for tagline patent
(Aparajita Ray , 27-Aug-2012 , The Times Of India)

After confirming that it was not a KSRTC bus the transport organization filed a patent for its brand. More...



Apples victory boosts Microsoft as Asian vendors scramble
(Lee Chyen Yee , 27-Aug-2012 , Livemint)

Interest in alternative from Microsoft may intensify as industry officials fear more patent suits from Apple More...



Viewpoint: Apples victory over Samsung is patently absurd
(T K Arun,ET Bureau , 27-Aug-2012 , The Economic Times)

Samsung is unlikely to be significantly hurt by the fine of $1.05 billion. More...



Flip-flop in the pharma sector
(Kumkum Sen , 27-Aug-2012 , Business Standard)

The pharma sector is one such where the products are seldom purchased by choice therefore market forces do not impact prices except for generic drugs. More...



OurView | Users, the ultimate losers
(Shyamal Banerjee , 26-Aug-2012 , Livemint)

While billions of dollars are at stake, it’s thousands of Android users who may have to suffer as prices increase, while competition and innovation decrease More...



Samsung to contest US court verdict in favour of Apple
(AFP , 25-Aug-2012 , The Economic Times)

South Koreas Samsung Electronics said Saturday it will contest a US court ruling that it must pay rival technology giant Apple damages of more than $1 billion for patent violations. More...



Indian companies get US FDA approval for generic versions of four blockbuster drugs: Jena
(Our Bureau, New Delhi , 25-Aug-2012 , Pharmabiz)

During the last two years the US Food and Drugs Administration has given approval to the generic versions of four blockbuster drugs to Indian companies the Parliament was informed. More...



Apple, Samsung infringed each others patents: South Korea court
(Reuters , 24-Aug-2012 , The Economic Times)

Samsung Electronics Cos flagship Galaxy smartphone looks very similar to Apples iPhone but the South Korean firm has not violated the iPhone design a Seoul court ruled on Friday. More...



Kodak to sell retail print, document imaging businesses
(Reuters , 24-Aug-2012 , The Economic Times)

The once dominant photography firm already in the midst of auctioning off its digital patent portfolio hopes to complete the sales by mid-2013 Chief Executive Antonio Perez said in a conference call on Thursday. More...



Pharmaceuticals: June quarter shows the way
(Malini Bhupta / Mumbai , 24-Aug-2012 , Business Standard)

Also with several blockbuster drugs going off patent globally generics companies are reaping rich dividends by launching these drugs in the US. More...



Pfizer settles Impax patent suit over generic Detrol LA
(Nate Raymond in New York , 24-Aug-2012 , Reuters)

Pfizer Inc has settled a lawsuit accusing Impax Laboratories Inc of infringing patents covering the overactive bladder drug Detrol LA. More...



Glenmark gets favourable interim order against Napo Pharma
(P. T. Jyothi Datta/M. Ramesh , 23-Aug-2012 , Business Line)

Dispute over exclusive rights on anti-diarrhoeal drug More...



Madras HC stays GSKs use of Horlicks Nutribic
(Shilpa Phadnis , 23-Aug-2012 , The Times Of India)

The Madras High Court on Thursday passed an interim order restraining directors employees agents distributors and retailers of GSK Consumer Healthcare makers of brand Horlicks from manufacturing selling and advertising Horlicks Nutribic brand of biscuits for trademark and copyright violations of Britannias NutriChoice biscuits. More...



Apple patent infringement case: Jurors to resume deliberations
(AP , 23-Aug-2012 , The Economic Times)

Jurors were set to begin their second day of deliberations Thursday in a multibillion dollar patent infringement case pitting Apple against Samsung over the design of iPhones and iPads. More...



FDA withdraws nod to 27 Ranbaxy ANDAs
(Priyanka Golikeri , 23-Aug-2012 , DNA)

The US Food and Drug Administration has withdrawn approval given to 27 generic products of Ranbaxy Laboratories. More...



Apple Samsung make final pitch to US jury
(Reuters / San Jose (California) , 23-Aug-2012 , Business Standard)

Apple and Samsung are going toe to toe in a patents dispute that mirrors the struggle for industry supremacy between the two companies which control more than half of worldwide smartphone sales. More...



Supreme Court defers Novartis patent appeal to September 11
(Khomba Singh , 22-Aug-2012 , The Economic Times)

Supreme Court on Wednesday deferred Swiss company Novartis case against Indian government over the interpretation of Section 3 (d) of the Indian patent laws to September 11. More...



Nearly 6.50 lakh trademarks applications pending with govt
(Press Trust of India / New Delhi , 22-Aug-2012 , Business Standard)

There has been a nearly 100% rise in the number of requests since 2001-02. More...



Copyright violation: Court verdict to provide relief to news channels
(TNN , 22-Aug-2012 , The Times Of India)

In a verdict that will bring relief to news channels the Delhi High Court has said trivial infractions where a small audio clipping is played in the background cant be termed copyright violation. More...



Apple-Samsung patent case: Alchemy of damages takes the stage
(Reuters , 23-Aug-2012 , The Economic Times)

Between the hotshot designers and brainy engineers Apple Inc questioned for three weeks in the companys bitterly fought patent battle against Samsung Electronics Co Ltd a marketing expert from MIT took Apples lawyers all of three minutes. More...



Indian campaigners say Novartis’ win in landmark drug patent case would be 'death sentence' for poor
(Agencies , 22-Aug-2012 , The Financial Express)

Health campaigners in India have warned that granting Swiss pharmaceutical company Novartis an Indian patent for the cancer drug Glivec would mean handing down a ‘death sentence’ for the poor and ill in the developing world. More...



All eyes on the Novartis case
(Shishir Asthana / Mumbai , 22-Aug-2012 , Business Standard)

SC judgment will impact business of pharma MNCs in India More...



Maharashtra to adopt South Africa variety of grapes
(Tushar Pawar , 22-Aug-2012 , The Times Of India)

In India grapes do not come under patent crop law. More...



Intellectual Property Appellate Board postpones Bayers compulsory licence appeal
(Khomba Singh , 21-Aug-2012 , The Economic Times)

Indias Intellectual Property Appellate Board has postponed German company Bayer AGs appeal against the grant of a compulsory licence of its patented drug Nexavar to Natco Pharma to September 3 a Natco official said. More...



Google sues Apple over Siri voice control software
(Daily Telegraph , 21-Aug-2012 , DNA)

Licensing remains the bone of contention; search giant cites violation of as many as seven patents by Apple More...



Suven Life may tie-up for Alzheimer's drug
(BS Reporter / Chennai/ Hyderabad , 21-Aug-2012 , Business Standard)

Other patented molecules are still at a preclincal stage. More...



Kodak patent auction to be probed
(Reuters , 21-Aug-2012 , The Times Of India)

Kodak which filed for bankruptcy in January began selling 1100 digital patents in early August and extended the auction last week citing ongoing discussions with bidders. More...



Chinas patent targets mask weak innovation, says study
(Reuters , 21-Aug-2012 , The Economic Times)

Chinas ambitious drive to produce millions of new patents in the next few years as part of a switch from a made in China to designed in China economic model will curtail innovation standards a European study warned on Tuesday. More...



When its about tech its not just Samsung
(AP , 21-Aug-2012 , The Times Of India)

After three weeks of listening to technology experts patent professionals and company executives debate the complicated legal claims of Apple and Samsung a jury of nine men and women are set to decide one of the biggest technology disputes in history. More...



Final hearing on Novartis’ case on Sec 3(d) of Patents Act to begin in Supreme Court on Aug 22
(Ramesh Shankar, Mumbai , 21-Aug-2012 , Pharmabiz)

The controversial imatinib mesylate (Glivec) case between the Swiss pharma major Novartis AG and the Union of India & Others will be heard by the Supreme Court on August 22. In this long pending case, Novartis is challenging Section 3(d) of Indias Patents Act which prohibits evergreening the practice of multinational pharma companies to extend their patent terms by making small and trivial changes to existing molecules and thereby preventing manufacture of generic drugs. More...



Apple-Samsung patent trial over iPhone technology wraps up
(AP , 21-Aug-2012 , The Economic Times)

The multibillion dollar patent dispute between the worlds biggest smartphone makers is wrapping up. More...



Apple, Samsung show no progress in patent case
(Bloomberg , 20-Aug-2012 , The Times Of India)

Apple and Samsung Electronics reported they made no progress toward narrowing their dispute over smartphone and computer tablet patents increasing the chances a jury will decide the matter starting August 21. More...



Novartis fights India for cancer drug patent
(Kaustubh Kulkarni and Ben Hirschler , 20-Aug-2012 , Livemint)

Apex court will hear final arguments starting this week in a landmark case over drug patents More...



Showdown for Big Pharma in Supreme Court
(Reuters , 20-Aug-2012 , The Times Of India)

The Supreme Court will hear final arguments starting this week in a landmark case over drug patents that could change the rules for the countrys healthcare sector and potentially curb its global role as a supplier of cut price generic medicines. More...



Apple vs Samsung: Patent verdict to decide future of tab, smartphone industry
(New York Times , 20-Aug-2012 , The Economic Times)

This week nine jurors are expected to hunker down in a federal courthouse here to decide a case that could change how the worlds smartphones and tablet computers look and work. More...



IPAB to hear Bayer’s appeal on granting compulsory license on August 21
(20-Aug-2012 , Contify Banking)

The Intellectual Property Appellate Board is going to hear German drug company Bayers appeal against granting of compulsory license on its anti-cancer drug Nexavar on August 21 2012 reports Pharmabiz. More...



Google's list of paid bloggers not sufficient, judge says
(Reuters , 20-Aug-2012 , The Economic Times)

Google Inc failed to comply with a court order to disclose the bloggers and other commentators on a patent and copyright case who might have been influenced by payments from the Web company a judge said on Monday. More...



Novartis fights India for cancer drug patent
(Kaustubh Kulkarni and Ben Hirschler , 20-Aug-2012 , Livemint)

Indias highest court will hear final arguments starting this week in a landmark case over drug patents that could change the rules for the countrys healthcare sector and potentially curb its global role as a supplier of cut price generic medicines. More...



Apple & Samsung not burying the patent hatchet yet
(Bloomberg / San Francisco , 20-Aug-2012 , Business Standard)

Apple and Samsung Electronics reported they made no progress towards narrowing their dispute over smartphone and computer tablet patents increasing the chances a jury will decide the matter starting August 21. More...



Novartis patent case up for hearing in the Supreme Court this week judgment to have far reaching impact
(Reuters , 20-Aug-2012 , The Economic Times)

The Supreme Court will hear final arguments starting this week in a landmark case over drug patents that could change the rules for the countrys healthcare sector and potentially curb its global role as a supplier of cut price generic medicines. More...



Motorola files new patent case against Apple
(TOI Tech , 18-Aug-2012 , The Times Of India)

Google owned Motorola Mobility has filed a new case against Apple at the US International Trade Commission claiming patent violation. More...



Cipla bats for automatic compulsory licensing
(Our Bureau , 18-Aug-2012 , Business Line)

The Government needs to bring in an automatic system for compulsory licensing if it wants to make medicines both affordable and accessible said drug maker Ciplas Chairman and Managing Director Y.K. Hamied. More...



Apple paid $1.4 billion in patent royalties: Samsung
(Reuters , 17-Aug-2012 , The Times Of India)

A financial expert said Apple has overstated Samsung Electronics Ltds profit margins for mobile products an issue that goes to the heart of damages in the high profile patent trial between the two tech companies. More...



Ranbaxy launches generic diabetes treatment tablets in US
(Press Trust of India / New Delhi , 17-Aug-2012 , Business Standard)

Ranbaxy is among the three companies including Teva and Mylan to have 180 days of marketing exclusivity for the drug in the US market. More...



Samsung settles global patent case with German firm
(AFP , 17-Aug-2012 , The Times Of India)

South Koreas Samsung Electronics said it has reached a deal with German lighting group Osram to settle all their global patent lawsuits as it continues a high stakes US court battle with Apple. More...



Linking patented drug price to per capita income may hit generic drug makers: Experts
(Khomba Singh , 17-Aug-2012 , The Economic Times)

A government panels proposal to link the price of patented drugs to per capita income is likely to shut out the option of compulsory licensing for generic drug makers experts and industry executives warn. More...



Apple Samsung chiefs told to resolve patent spat
(AFP , 16-Aug-2012 , The Times of India)

A US judge today urged the chiefs of Apple and Samsung to negotiate a truce in their high profile patent trial here saying it was time for peace. More...



Prices of patented medicines may come down by a third if panel's recommendation accepted
(Khomba Singh , 16-Aug-2012 , The Economic Times)

An inter ministerial group tasked with regulating prices of patented medicines has recommended using a per capita income linked reference pricing mechanism a proposal that may reduce prices of several patented drugs by up to one third but will hit the profitability of foreign companies. More...



Big Pharma lobbies hard to curb generics
(Rupali Mukherjee , 16-Aug-2012 , The Times Of India)

Indias tag of pharmacy of the developing world is at a serious threat. More...



India needs umbrella body on telecom standards to foster creation of IPR and develop indigenous products
(Abhay Karandikar , 16-Aug-2012 , The Economic Times)

Telecom technology development is heavily driven by intellectual property rights innovations patents and contributions to standards. More...



Watson sues FDA on generic diabetes drug ruling
(Esha Dey in Bangalore and Anna Yukhananov in Washington , 15-Aug-2012 , Reuters)

Generic drugmaker Watson Pharmaceuticals Inc sued the U.S. Food and Drug Administration challenging a ruling against Watsons generic version of a big selling diabetes drug Actos. More...



Apples iPhone iPad violate three Samsung patents: Samsung expert
(Reuters , 15-Aug-2012 , The times Of India)

A Samsung Electronics Co Ltd expert witness testified that Apple Incs iPhone and iPad violate three of Samsungs patents as the South Korean electronics company went on offense in the third week of a high stakes trial. More...



Apples iPhone iPad violate three Samsung patents: Samsung expert
(Reuters , 15-Aug-2012 , The Times Of India)

A Samsung Electronics Co Ltd expert witness testified that Apple Incs iPhone and iPad violate three of Samsungs patents as the South Korean electronics company went on offense in the third week of a high stakes trial. More...



Santarus sues Dr Reddys over heartburn drug
( Prateek Kumar in Bangalore , 15-Aug-2012 , Reuters)

U.S. drugmaker Santarus Inc said it filed a lawsuit against Dr. Reddys Laboratories accusing the Indian drugmaker of infringing its patents on heartburn drug Zegerid. More...



Over 12,000 food, pharma patents pending test; Delhi accounts for half
(Our Bureau, Mumbai , 14-Aug-2012 , FnBnews)

As on December 31 2011 12,690 applications seeking patent for food products medicines and pharmaceutical inventions were pending with the Office of the Controller General of Patents Designs & Trade Marks. More...



Kodak extends patent auction deadline as talks continue
(Caroline Humer , 14-Aug-2012 , Livemint)

Eastman Kodak extended its patent auction on Monday saying it would not announce a winner as planned because it was still in discussions with bidders. More...



Apple alleges Samsung sales result of copying
(Reuters , 14-Aug-2012 , IBN Live)

Apple Inc is claiming that more than a quarter of Samsung Electronics $30.4 billion in US smartphone and tablet sales result from copying of the iPhone and iPad or infringe on other patents a damages expert for the US company said on Monday. More...



Patent office issues list of pending patent applications deemed as TK
(Suja Nair Shirodkar, Mumbai , 13-Aug-2012 , Pharmabiz)

With a view to foster transparency in the system the Controller General of Patents Designs & Trade Marks has made available a list of all the pending patent applications that implicate traditional knowledge. More...



Jobs confronted Samsung over Galaxy: Witness
(Bloomberg / San Francisco , 13-Aug-2012 , Business Standard)

Steve Jobs Apples late co founder confronted Samsung Electronics executives in 2010 after the South Korean company introduced its Galaxy smartphone Apples patent licensing director testified. More...



Samsung takes on Apple over value of phone features
(Reuters , 11-Aug-2012 , The Economic Times)

An Apple Inc expert witness testified on Friday that consumers would be willing to pay $100 for three patented smartphone features that are at issue in its high stakes trial against Samsung Electronics Co Ltd. More...



Kodak receives low bids for patents: WSJ
(Reuters , 11-Aug-2012 , The Times Of India)

As Eastman Kodaks patent auction draws to a close the bankrupt photography company has only received lowball bids for the patents that it believes are worth $2.6 billion the Wall Street Journal reported citing unnamed sources. More...



CNN Time magazine suspend Fareed Zakaria for plagiarism
(PTI , 11-Aug-2012 , The Times Of India)

Noted Indian American journalist and author Fareed Zakaria has been suspended by his employers CNN and Time magazine after he admitted to plagiarism and apologised for the ethical lapse. More...



Nokia sells 500 patents, Qt software to counter losses
(Tarmo Virki , 10-Aug-2012 , Livemint)

The patent deal nets Nokia $22 million while still leaving it with one of the strongest portfolios in the wireless industry More...



RIM off the hook for $147 mn in US patent case
(AFP , 10-Aug-2012 , The Economic Times)

Research In Motion will not have to pay a $147.2 million damages award after an American judge tossed out a jury verdict in a patent case brought by Mformation Technologies. More...



Apple now sued over FaceTime in China
(PTI , 09-Aug-2012 , The Times Of India)

Within weeks of settling a high profile dispute over its iPad trademark Apple now faces a lawsuit by a man in Taiwan over its FaceTime application which he claims is a violation of his patent. More...



RIM vs Mformation: Judge overturns jurys decision
(Reuters , 09-Aug-2012 , The Times Of India)

Research in Motion said a US judge had ruled the company had not infringed on Mformation Technologiess patent and overturned an award of $147.2 million that a jury said the Canadian firm should pay. More...



Alembic enters into license agreement with Accu Break of US
(BS Reporter / Mumbai/ Ahmedabad , 9-Aug-2012 , Business Standard)

ABP patented Accu Break can be split easily by hand into smaller doses to provide maximum flexibility. More...



Apple faces lawsuit in China over FaceTime
(PTI , 9-Aug-2012 , The Times Of India)

Within weeks of settling a high profile dispute over its iPad trademark Apple now faces a lawsuit by a man in Taiwan over its FaceTime application which he claims is a violation of his patent. More...



Dr Reddys prescription to stay ahead of the generic pack
(B Dasarath Reddy / Hyderabad , 9-Aug-2012 , Business Standard)

The company has differentiated itself by focusing on internal processes and staying away from costly acquisitions. More...



Samsung phones confusingly similar to iPhone
(Reuters , 08-Aug-2012 , The Times Of India)

The focus of the courtoom battle between Apple and Samsung Electronics shifted to the iPhones iconic display on Tuesday as the US company called a former employee and award-winning graphic designer to back up claims that Samsung gadgets look confusingly similar. More...



Must watch: The lighter side of Apple vs Samsung patent trial
(NDTV Correspondent , 08-Aug-2012 , NDTV)

The court proceedings began last Monday in the blockbuster Apple Samsung trial a high stakes legal contest over infringement of patents for hot selling smartphones and tablet computers. More...



Plea against Tirupati Laddu GI tag rejected
(Vinson Kurian , 8-Aug-2012 , Business Line)

Rectification applicant fails to prove locus standi and interest with registered good More...



Apple faces lawsuit in China over FaceTime application
(Press Trust of India / Beijing , 08-Aug-2012 , Business Standard)

Within weeks of settling a high profile dispute over its iPad trademark US high tech giant Apple now faces a lawsuit by a man in Taiwan over its FaceTime application which he claims is a violation of his patent. More...



US STAND ON CL UNFAIR
(P A Francis , 8-Aug-2012 , Pharmabiz)

The grant of compulsory licence by Indias Patent Controller in March this year to Natco for the manufacture of generic version of Bayers cancer drug Nexavar has attracted severe criticism from the US Patent and Trademark Office last month. More...



AOL, Vringo reach partial patent settlement
(Associated Press , 08-Aug-2012 , NDTV)

AOL Inc. confirmed Monday that it has reached a partial patent settlement with ringtone company Vringo Inc. related to online search and advertising. More...



French agency fined for pirating Ray classic
(Debashis Konar , 7-Aug-2012 , The Times Of India)

A French agency that was illegally selling DVDs of the award winning Ashani Sanket has been ordered to pay a compensation of euro 10000 around Rs 6.8 lakh to producer Sarbani Bhattacharya for infringing her film rights. More...



Apple, Google bid on Kodak patents: Report
(Reuters , 7-Aug-2012 , The Economic Times)

Eastman Kodak which is planning to auction 1,100 digital patents received two bids from investor groups including Apple Inc and Google Inc of between $150 million and $250 million the Wall Street Journal reported on Monday. More...



Patent war: iPhones created design crisis for Samsung, says Apple
(Reuters , 7-Aug-2012 , The Economic Times)

Apple Inc trotted out a veteran designer to bolster its claims that Samsung Electronics copied the iPhone after the smartphones 2007 launch triggered a crisis in design for the South Korean electronics giant. More...



Apple, Samsung take legal battle to hot tub
(Reuters , 06-Aug-2012 , The Times Of India)

Apple and Samsung Electronics are embroiled in a high stakes patent battle in several countries around the world but only in Australia are they also engaged in hot tubbing. More...



Apple reveals origin and history of iOS in Samsung patent trial
(ANI , 06-Aug-2012 , Hindustan Times)

Tech giant Apples Senior Vice President Scott Forstall has revealed all the secrecy hard work and innovation that went into developing the iOS user interface in its 2.5 billion dollar patent trial with South Korean mobile maker Samsung. More...



Apple versus Samsung patent trial: World starting to learn how Steve Jobs made the company successful
(New York Times , 06-Aug-2012 , The Economic Times)

Back in the early 1930s a magician by the name of Horace Goldin went to court to defend his signature illusion: sawing a woman in half. More...



Apple vs Samsung: Can look and feel be patented?
(Bloomberg / San Francisco , 05-Aug-2012 , Business Standard)

Apple has become the most valuable company by creating products that stand out for design and ease of use stemming from scores of smaller innovations such as rubberbanding rather than epic underlying technology breakthroughs. More...



Apple applies for iPad Smart Cover patent
(IANS , 05-Aug-2012 , IBN Live)

Apple has applied for a patent on iPad Smart Cover with an embedded secondary display designed to enhance the functionality of the tablet computer. More...



Pharma cos set to gain from US nod for asthma drug
(Press Trust of India / New Delhi , 05-Aug-2012 , Business Standard)

Indian drug makers including Aurobindo and Glenmark are set to benefit from a decision by the USFDA to allow sale of generic Singulair tablets used for treating asthma and allergies in the US market. More...



Judge scolds Samsung, lets patent trial proceed
(AFP , 4-Aug-2012 , The Economic Times)

The judge in a massive smartphone patent dispute reprimanded Samsung Friday for releasing excluded evidence but denied a bid by Apple to order a verdict in the case. More...



Kodak posts larger 2nd-quarter loss on eve of patent auction
(Reuters , 4-Aug-2012 , The Economic Times)

Eastman Kodak Co on Friday posted a wider second quarter loss as it prepares for a crucial auction in which it hopes to sell more than 1100 patents to help repay its bankruptcy creditors. More...



Google inks patent licensing pact with Rovi
(Reuters , 03-Aug-2012 , The Times Of India)

Rovi signed an agreement with Google to allow the technology giant to use its interactive program guide patent portfolio for set top boxes sending its shares up 4 per cent in premarket trade. More...



IPAB adjourns hearing on post grant opposition against Roches patent for Pegasys
(Ramesh Shankar, Mumbai , 3-Aug-2012 , Pharmabiz)

The re hearing in the post grant opposition against the patent granted to Roche for Pegasys a key drug used for Hepatitis C treatment has been adjourned by the Intellectual Property Appellate Board in Chennai without fixing any new date for next hearing. More...



Apple asks for verdict after Samsung's 'misconduct'
(AFP , 03-Aug-2012 , The Times Of India)

With a major patent trial barely underway Apple has asked a judge to rule against Samsung saying lawyers for the South Korean firm improperly disclosed information excluded in court in a bid to sway jurors. More...



Generic business may hit drug exports of Indian firms like Cipla and Natco
(Khomba Singh , 3-Aug-2012 , The Economic Times)

The government is apprehensive that the Indian drug companies strategy of launching generic version of patented drugs could trigger retaliation from overseas countries that may hit the countrys ambitious drug export plans. More...



Belgium hopes talks on India-EU FTA will conclude by year end
(PTI , 03-Aug-2012 , The Economic Times)

Belgium today hoped the ongoing negotiations for India EU free trade agreement will conclude by end of this year as it sought access to the countrys public procurement market. More...



Whirlpool Videocon spar over design infringement
(BS Reporter / Mumbai , 3-Aug-2012 , Business Standard)

The Mumbai High Court in an order dated July 25 restrained consumer durables major Videocon Industries Ltd from selling its Pebble brand of washing machines which it said was an imitation of rival Whirlpool of India Ltds Ace brand. More...



Apple applies for iPad Smart Cover patent
(IANS , 3-Aug-2012 , The Times Of India)

Apple has applied for a patent on iPad Smart Cover with an embedded secondary display designed to enhance the functionality of the tablet computer. More...



Sun Pharma considering buying German drug firm
(Bloomberg / Paris/Mumbai , 3-Aug-2012 , Business Standard)

Sun Pharmaceutical Industries Ltd Indias largest drug maker by market value is looking for acquisitions in Europe including a possible takeover of German generic drug maker Stada Arzneimittel AG people familiar with the matter said. More...



Rovi signs patent licensing pact with Google
(Reuters , 3-Aug-2012 , NDTV)

Rovi Corp signed an agreement with Google Inc to allow the technology giant to use its interactive program guide patent portfolio for set-top boxes sending its shares up 4 percent in premarket trade. More...



Govt steps up efforts on intellectual property
(Surabhi Agarwal & Asit Ranjan Mishra , 02-Aug-2012 , Livemint)

India has been under international pressure especially from the US to put in place a robust IPR regime that will not only make multinationals operating in the country more comfortable about their patents but will also boost domestic innovation. More...



Apple 'bet company' with iPhone launch
(ANI , 02-Aug-2012 , The Times Of India)

In the 2.5 billion dollar patent trial between tech giants Apple and Samsung a US court has heard that the former was literally betting the company when it introduced the iPhone. More...



U.S. bankruptcy judge lets Kodak sell key patent
(Reuters , 02-Aug-2012 , NDTV)

Eastman Kodak Co can proceed with the sale of a key digital imaging patent a bankruptcy judge ruled on Wednesday saying that Apple Inc waited too long to raise a claim of infringement. More...



Film ‘Mirattal’ gets copyright cover
(TNN , 2-Aug-2012 , The Times Of India)

Another Tamil film has just prior to its release obtained a John Doe protection order from the Madras high court barring anyone from uploading the film or any portion of it on websites without the authorisation of its producers. More...



Apple claims Samsung copied iPhone technology
(AP , 1-Aug-2012 , The Times Of India)

An attorney for Apple told a jury on Tuesday that bitter rival Samsung faced two options to compete in the booming cellphone market after Steve Jobs introduced the iPhone to critical acclaim in 2007: Innovate or copy. More...



Natco in patent war with BMS
(Rupali Mukherjee , 1-Aug-2012 , The Times Of India)

Natco which successfully managed to reduce prices of Bayers cancer drug Nexavar by 97% through the countrys first compulsory licence recently is headed for another major confrontation. More...



Tirupati temple to keep laddu patent
(Maneesh Chhibber , 31-Jul-2012 , The Indian Express)

The Venkateswara temple in Andhra Pradesh Indias richest temple Monday scored a sweet legal victory: the Geographical Indications Registry upheld its claim of a patent over the famous Tirupati laddu. More...



Apple vs Samsung trial: Jury selection begins
(AFP , 30-Jul-2012 , The Times Of India)

Jury selection was set to open on Monday in a US federal court in the blockbuster patent case pitting Apple against Samsung which accuse each other of copying patents for smartphones and tablets. More...



Apple may launch Google Glasses rival reveals patent filing
(ANI , 31-Jul-2012 , The Times Of India)

Tech giant Apple has raked up speculation that it could be creating an augmented reality head mounted display to compete with Googles Project Glass technology after it reportedly filed for a US patent. More...



‘Patent’ defect left unattended in truck amounts to negligence: Court
(New Delhi-based chartered accountant , 30-Jul-2012 , Business Line)

A public carrier is liable to compensate the shipper for the losses suffered by it on account of damage of goods if the reason for the accident is a patent defect a defect that could have been detected and rectified given reasonable care in the mechanical system of the truck. More...



Taiwan univ sues Apple over Siri patents
(AFP , 30-Jul-2012 , The Times Of India)

Taiwans National Cheng Kung University has filed a suit against US tech giant Apple claiming the companys Siri intelligent assistant has infringed on two of its patents. More...



Apple to face Samsung over patent trial on Monday
(Agency inputs , 29-Jul-2012 , ZeeBiz)

Samsung and Apple will be at logger heads over a crucial patent trial in US federal court on Monday. More...



Google asks court to dismiss authors' copyright case
(AFP , 28-Jul-2012 , The Times Of India)

Google asked a US court Friday to dismiss a lawsuit over the internet giants massive book scanning project saying the effort is not a substitute for books themselves. More...



Price controls ahead for patented drugs
(Kaustubh Kulkarni , 28-Jul-2012 , DNA)

The government is planning to rein in prices of expensive patented drugs to make medicines affordable to the poor. More...



Indian patenting system needs to improve, says WIPO chief
(PTI , 27-Jul-2012 , The Economic Times)

The Geneva based WIPO an arm of the United Nations Organisation helps member countries in legal and technical matters pertaining to intellectual property. More...



Kodak Apple patent fight to remain in bankruptcy court
(Reuters , 27-Jul-2012 , The Economic Times)

Apple Inc lost on Thursday a bid to transfer its patent dispute with Eastman Kodak Co out of bankruptcy court a move that could have complicated the photography companys plan to sell the technology. More...



US doublespeak on patent waiver bared
(Sidhartha , 27-Jul-2012 , The Times of India)

The United States, which is crying foul over a patent waiver for a cancer drug in India has itself resorted to similar steps to reduce disruptions in supply of two medicines and that too through an executive order. More...



Re-hearing on post grant opposition against Roches patent for Pegasys to be held on July 30 at IPAB
(Ramesh Shankar, Mumbai , 27-Jul-2012 , Pharmabiz)

The crucial hearing in the post grant opposition against the patent granted to Roche for Pegasys Peg intergferon alpha 2B a key drug used for Hepatitis-C treatment will be held on July 30-31 by the Intellectual Property Appellate Board in Chennai. More...



Sudarshan Chemicals wins patent case against Clariant
(BS Reporter / Mumbai/ Pune , 26-Jul-2012 , Business Standard)

The court will now assess damages to be paid by Clariant to Sudarshan as a result of its wrongful threats. More...



HCL Infosystems acquires educational content provider Edurix
(PTI , 26-Jul-2012 , The Times Of India)

IT firm HCL Infosystems has acquired educational content provider Edurix a move that will help strengthen its education and learning business. More...



Venus Remedies novel antibiotic product Potentox receives US patent
(Our Bureau, Mumbai , 26-Jul-2012 , Pharmabiz)

The United States Patent and Trademark Office has granted 3rd US patent for Venus Remedies Limited a research based global pharmaceutical company for its novel antibiotic product Potentox. More...



Samsung patent royalty demands unfair: Apple
(Reuters / San Francisco , 26-Jul-2012 , Business Standard)

Apple Inc said Samsung Electronics Co Ltd is demanding from the iPhone maker a far higher patent royalty than Apple pays to other companies at a rate the South Korean company has never sought from any other licensee. More...



Manpower shortage hits patents processing
(Shishir Arya , 25-Jul-2012 , The Times Of India)

Though Union Commerce Minister Anand Sharma while inaugurating the National Institute of Intellectual Property Management in the city last week expressed concern over less number of patents being filed from the country the government too appears slow when it comes to examining the applications. More...



Indian pharma firms prefer alliance pill
(Ujjval Jauhari & Ram Prasad Sahu / Mumbai , 25-Jul-2012 , Business Standard)

Marketing alliances in emerging markets is at the heart of the expansion strategy. More...



EU members oppose treaty on visually challenged
(Aakshi Magazine , 25-Jul-2012 , DNA)

A historic treaty set to end the book famine faced by the visually challenged is being opposed by EU members at the 24th meeting of the standing committee for copyright and related rights at the World Intellectual Property Organisation in Geneva. More...



Patent row: Apple Inc seeks $2.5-bn damages
(Reuters / New York , 25-Jul-2012 , Business Standard)

Apple claims it is entitled to $2.525 billion of damages in its high stake battle against Samsung Electronics over patents for technology used in smartphones and tablets such as the iPhone and iPad. More...



EU stalls treaty talks to allow copyright waiver for print disabilities
(Priscilla Jebaraj , 25-Jul-2012 , The Hindu)

India and other developing countries support such a legally binding treaty. More...



Apple Samsung disagree on patent values: Source
(Reuters , 24-Jul-2012 , The Times Of India)

Apple Chief Executive Tim Cook and top Samsung Electronic executives disagreed last week on the value of each others patents at a settlement conference ahead of a high profile US trial according to a source familiar with the matter. More...



Indian drug firms lobby against EU’s new directive
(Vidya Krishnan , 24-Jul-2012 , Livemint)

Indian drug companies are lobbying against a move by the European Commission to check the import of counterfeit drugs through a directive that comes into effect in about a year from now. More...



Logistics majors focusing on patents to keep technology edge
(Mamuni Das , 23-Jul-2012 , Business Line)

Players in the highly competitive logistics sector are grappling with protecting innovations through the use of patents. More...



Apple and Googles Motorola unit file separate patent appeals
(Bloomberg , 23-Jul-2012 , The Economic Times)

Apple and Googles Motorola Mobility unit filed separate appeals of a federal judges June 22 order dismissing their mutual patent infringement claims. More...



Kodak loses patent case against Apple, RIM
(Reuters , 23-Jul-2012 , Hindustan Times)

Eastman Kodak has lost an appeal of a patent dispute over digital image preview technology with Apple and Research In Motion, which could set back the onetime photography giants efforts to raise money in bankruptcy by selling patents. More...



Apple vs Samsung patent trial begins in Australia
(Reuters , 23-Jul-2012 , The Economic Times)

Apple and Samsung Electronics began the latest round of their long running global patent war on Monday as an Australian judge began hearing evidence for an anticipated three month trial. More...



Health Ministry identifying more essential drugs for compulsory licence as debate still rages on
(Joseph Alexander, New Delhi , 23-Jul-2012 , Pharmabiz)

Even as the debate over India giving compulsory licence heating up with US official too raising apprehensions Union health ministry made it clear that it is strongly in favour of invoking the provision of compulsory licences in the case of more essential medicines. More...



Theres an Indian hand in $147-mn patent blow to BlackBerry maker
(Indira Kannan / Toronto , 22-Jul-2012 , Business Standard)

The patents related to wireless mobile device management and the software found to infringe Mformations patent was RIMs BlackBerry Enterprise Server used by corporate enterprise customers to manage and secure their BlackBerry devices. More...



42,000 patent applications filed last year: Sharma
(PTI , 21-Jul-2012 , ZeeBiz)

The government Saturday said 42000 patent applications were filed in 2011 indicating the rising trend of such filings. More...



Pharmexcil to present patent awards to cos during AGM on Sept 26-28
(Our Bureau, Hyderabad , 21-Jul-2012 , Pharmabiz)

The Pharmaceutical Export Promotion Council Of India will present patent awards to the companies who have shown excellence during the financial year 2011 2012 at its annual general meeting event to be held from September 26-28 this year. More...



Settlement of Somaxon Pharmaceuticals patent suit in US soon: Zydus
(Vishal Dutta , 20-Jul-2012 , The Economic Times)

Ahmedabad based Zydus Cadila says it agreed to settle a patent litigation suit with US based Somaxon Pharmaceuticals for insomnia drug Silenor. More...



Growth rates in US markets will decline: Dr Reddy's
(BS Reporter / Hyderabad , 20-Jul-2012 , Business Standard)

Patent expiries which peaked this year will decrease over the next few years says CEO G V Prasad More...



Natco targets drugs ripe for compulsory licensing
(Viswanath Pilla , 20-Jul-2012 , Livemint)

Natco Pharma Ltd which has started selling a generic version of Bayer AGs patented cancer treatment Nexavar in India at a fraction of the price charged by the German firm plans to use the so called compulsory licensing route to try and win the right to copy more patented drugs said vice chairman and chief executive officer Rajeev Nannapaneni. More...



Apple sued by HTC over patent infringement
(AFP , 19-Jul-2012 , The Times Of India)

Taiwans leading smartphone maker HTC has that it was suing technology giant Apple in the United States claiming it has infringed on its patents. More...



Apple vs Samsung: Plea to use Steve Jobs’ comments rejected
(Reuters , 19-Jul-2012 , The Times Of India)

A US judge on Wednesday approved Apples request to bar disparaging statements by Steve Jobs about Googles Android operating system from an upcoming patent trial against Samsung Electronics. More...



Apple vs Samsung: Key documents to go public
(Reuters , 18-Jul-2012 , The Times Of India)

A US judge rejected several requests by Apple and Samsung Electronics to keep portions of key documents out of public view in their high stakes patent litigation battle set for trial later this month. More...



WTO for cheaper drugs in developing countries
(Virendra Singh Rawat / New Delhi/ Lucknow , 18-Jul-2012 , Business Standard)

TRIPS is a WTO-administered international agreement that sets down minimum standards for many forms of intellectual property regulation on WTO members. More...



18 Motorola phones face ban in US
(Reuters , 18-Jul-2012 , The Times of India)

Google unit Motorola Mobility has said it has taken steps to avert an interruption of US imports and sales of its smartphones after the devices were found to infringe on a Microsoft patent. More...



Google unit Motorola Mobility says will avoid US import ban on smartphones
(Reuters , 18-Jul-2012 , The Economic Times)

Google unit Motorola Mobility said on Tuesday it has taken steps to avert an interruption of US imports and sales of its smartphones after the devices were found to infringe on a Microsoft patent. More...



Judge rejects secrecy bids in Apple vs. Samsung battle
(Reuters , 18-Jul-2012 , NDTV)

A U.S. judge rejected several requests by Apple Inc and Samsung Electronics Co Ltd to keep portions of key documents out of public view in their high stakes patent litigation battle set for trial later this month. More...



Decision on Nexavar not against the law
(Sujay Mehdudia , 17-Jul-2012 , The Hindu)

Asserting that India has not taken any arbitrary decision or gone against the law in issuing compulsory licence for the generic production of patented anti cancer drug Nexavar Commerce and Industry Minister Anand Sharma said the U.S. and European companies had done the same on number of occasions. More...



HTC files counterclaims against Apple with patents from HP
(Steven Musil , 17-Jul-2012 , CNET)

The Taiwanese handset maker is ratcheting up its patent battle with allegations that an array of Apple products infringe on two recently acquired patents. More...



We re sovereign and progressive: Sharma to Barack Obama
(Press Trust Of India / New Delhi , 17-Jul-2012 , Business Standard)

We are fully compliant when it comes to TRIPS Trade Related Aspects of Intellectual Property Rights. More...



US steps up lobbying efforts against compulsory licensing
(C.H. Unnikrishnan , 16-Jul-2012 , Livemint)

The move has irked activists patent experts and drugmakers in India who have written to the government protesting the USs campaign. More...



Is pharma steering India's tryst as a major R&D hub?
( Rohit Joshi & Siddharth Tak , 15-Jul-2012 , DNA)

Rather than innovating new drugs our companies replicate branded drugs when their patent expires. More...



RIM hit with $147.2 million verdict in wireless patent lawsuit
(Reuters , 14-Jul-2012 , The Economic Times)

A northern California jury directed Research in Motion Ltd to pay $147.2 million in patent litigation over a remote management system for wireless devices according to an attorney for the plaintiff Mformation Technologies Inc. More...



Full confidence in Indian legal system, says Germany
(PTI , 14-Jul-2012 , DNA)

His remarks came in the backdrop of a German company Bayers case in Delhi High Court over a patent infringement suit against an Indian company on March 15 2010 in response to a decision of the Drug Controller General of India to grant Cipla marketing authorisation for a generic version of Nexavar a cancer drug. More...



US pushing India to hike cancer drug price
(IANS , 14-Jul-2012 , IBN Live)

Even as President Barack Obama is plugging his signature law to lower health care costs at home his administration is pressurising India and other countries to impose higher prices even for lifesaver cancer drugs. More...



India's patent office calls proposals for a data search system
(Omkar Sapre , 13-Jul-2012 , The Economic Times)

Indias patent authority has called for proposals to provide one point access to databases of patent and non patent literature of all countries and to develop a customised search platform to enable patent examiners search through these databases. More...



US accuses India of WTO rules violation over Nexavar: Report
(Press Trust of India / Washington , 13-Jul-2012 , Business Standard)

The US administration has accused India of violating WTO norms by allowing Hyderabad based Natco Pharma to make generic version of cancer drug Nexavar according to a media report. More...



Worldwide sales of generics to double through 2016
(Ransdell Pierson/Reuters , 13-Jul-2012 , Livemint)

Worldwide sales of generics a mainstay in poorer countries will almost double to between $400 billion and $430 billion by 2016 driving overall spending growth on pharmaceuticals IMS said More...



We are confident of doubling our US sales in 3-5 years: Glenn Saldanha
(Ujjval Jauhari & Ram Prasad Sahu / Mumbai , 13-Jul-2012 , Business Standard)

Our strategy has never focused on the patent cliff. More...



India refuses to hike cancer drug price
(Narayan Lakshman , 12-Jul-2012 , The Hindu)

Stands up to White Houses strong arm tactics against manufacturers of generic equivalent More...



Laws needed to protect knowledge
(Special Correspondent , 12-Jul-2012 , The Hindu)

M. Ajith, Assistant Controller of Patents and Designs Chennai pointed out that patent was a territorial right valid for a period of 20 years. More...



All about the patent wars
(Rajni Bakshi , 11-Jul-2012 , Rediff)

The course of the patent wars is almost certain to remain tortuous writes Rajni Bakshi. More...



Locals go FTF to break Big Pharma hold on generics
( Priyanka Golikeri & KV Ramana , 11-Jul-2012 , DNA)

Despite making a significant dent Indian drug makers have been lagging the multinational players in the lucrative US market but all that is set to change with a lot of off patent opportunities coming up and companies increasingly going for the first to file status. More...



Alcatel-Lucent files 75 patents from India
(BS Reporter / Chennai , 11-Jul-2012 , Business Standard)

France based Alcatel Lucent has filed 75 patents on various technologies which were developed by its research and development centre in Chennai. More...



Alcatel-Lucent files 75 patents from India
(BS Reporter / Chennai , 11-Jul-2012 , Business Standard)

France based Alcatel Lucent has filed 75 patents on various technologies which were developed by its research and development centre in Chennai. More...



Iron grip prised loose
(Deepa Kurup , 10-Jul-2012 , The Hindu)

More compulsory licensing of patent protected medicines coupled with state procurement and distribution could be a panacea for the healthcare system More...



Ranbaxy planning expansion in US
(Press Trust of India / New Jersey , 10-Jul-2012 , Business Standard)

Despite extra oversight from US regulators over quality questions. More...



Pharma cos may have to shift business strategy due to slow growth: Report
(DIVYA RAJAGOPALDIVYA RAJAGOPAL , 10-Jul-2012 , The Economic Times)

In the last three years Indian drug makers have relished the opportunity emerging from patent expiry of blockbuster drugs such as Lipitor. More...



Apple loses British suit over Samsung Galaxy Tab
(AFP , 09-Jul-2012 , The Times Of India)

South Koreas Samsung won a patent battle on Monday against US rival Apple with a British judge ruling that Samsungs Galaxy tablet was not cool enough to be confused with Apples iPad. More...



Cipla Q1 data to reflect generic supply to Teva
(Sushmi Dey / New Delhi , 9-Jul-2012 , Business Standard)

With the expiry of its patent on the blockbuster drug Teva launched its generic version in March and is currently enjoying a 180-day exclusivity on sales. More...



Indian pharma cos secure approval for 88 ANDAs from US FDA in first half of 2012
(Sanjay Pingle, Mumbai , 9-Jul-2012 , Pharmabiz)

The higher number of approvals from highly regulated markets will help to spread market presence in the lucrative markets and it will help to en cash upcoming opportunities with the expiration of patents. More...



Alcatels Chennai centre leads in patent filing
(Staff Reporter , 09-Jul-2012 , The Hindu)

75 patents have been filed over the last six years More...



US retailers sue Pfizer over generic Lipitor delay
(PTI , 08-Jul-2012 , The Business Line)

Five large US drug and grocery chains are suing Pfizer Inc and a second drugmaker alleging they conspired to delay sales of cheap generic versions of the blockbuster cholesterol drug Lipitor. More...



Yahoo and Facebook settle patent suits
(Michael J De La Merced , 08-Jul-2012 , Business Standard)

The agreement does not include any cash payout by Facebook seen as a win for the social networking company. More...



SC to start final hearing on Novartis’ case on Sec 3(d) of Patents Act on August 22
(Our Bureau, Mumbai , 7-Jul-2012 , Pharmabiz)

The final hearing on the controversial case on Sec 3(d) of Indian Patents Act will begin in the Supreme Court on August 22. More...



US retailers sue Pfizer charge generic Lipitor delay
(AP , 7-Jul-2012 , The Economic Times)

Five large US drug and grocery chains are suing Pfizer Inc. and a second drugmaker alleging they conspired to delay sales of cheap generic versions of the blockbuster cholesterol drug Lipitor. More...



Yahoo, Facebook have settled patent fight: Source
(AP , 7-Jul-2012 , The Times Of India)

Facebook and Yahoo have agreed to settle a patent dispute and avert a potentially bitter battle over the technology running two of the Internets most popular destinations according to a person familiar with the matter. More...



Final hearing on Novartis patent petition put off
(Our Bureau , 06-Jul-2012 , Business Line)

The final hearing on drug maker Novartis petition challenging the rejection of its patent application for cancer drug Glivec has been adjourned to late next month. More...



Register your trademark or risk losing it altogether
(Omkar Sapre , 06-Jul-2012 , The Economic Times)

Opting for a well-known brand can have its pitfalls particularly if it sounds similar to a big multinational brand. More...



Patent war: Apple vs Samsung, Motorola & others
(Reuters , 5-Jul-2012 , The Times Of India)

Mobile technology has been a hotbed of patent litigation in recent years. More...



US threatens to take India to WTO over Nexavar Generic
(DIVYA RAJAGOPAL , 5-Jul-2012 , The Economic Times)

The US House of Representatives and the US Patent and Trademark Office have threatened to drag India to the World Trade Organisations dispute panel for issuing the firstever compulsory licence to a domestic company to manufacture generic version of Bayers cancer drug Nexavar saying the move violates international trade laws. More...



European parliament says no global anti-piracy law
(Reuters , 5-Jul-2012 , The Times Of India)

The European Parliament rejected a global agreement against copyright theft on Wednesday handing a victory to protesters who say the legislation would punish people for sharing films and music online. More...



EU parliament rejects anti-generics ACTA
(Priyanka Golikeri , 05-Jul-2012 , DNA)

In a huge boost to makers of generic medicines the European Union parliament on Wednesday rejected a treaty agreement that could have given these companies and the patient groups fighting for low cost medicines a severe migraine. More...



Pureit patent revocation to have minimal impact
(BS Reporter / Mumbai , 5-Jul-2012 , Business Standard)

The recent revocation of a patent granted to Hindustan Unilevers Pureit water filters will have a minimal impact on the brand according to company executives. More...



US ups the ante on Nexavar Generic threatens to take India to WTO
(DIVYA RAJAGOPAL , 5-Jul-2012 , The Economic Times)

The US House of Representatives and the US Patent and Trademark Office have threatened to drag India to the World Trade Organisations dispute panel for issuing the firstever compulsory licence to a domestic company to manufacture generic version of Bayers cancer drug Nexavar saying the move violates international trade laws. More...



Last hurdle for EU patent
(T S Vishwanath , 5-Jul-2012 , Business Standard)

A single EU patent regime may trip at its final stage if the Members of European Parliament are not satisfied More...



Indian pharma: Pricey patented drugs do not seem the norm
(ET Bureau , 5-Jul-2012 , The Economic Times)

There seems considerable policy action in the Indian pharmaceutical scene. More...



Apple planning Google Glass rival?
(ANI , 4-Jul-2012 , The Times Of India)

Software giant Apple has been awarded a patent for a wearable display device by the US Patent and Trademark Office that sounds similar to Googles Project Glass. More...



Kendriya Vidyalaya set to patent new uniforms for its students
(Hema Rawat , 04-Jul-2012 , Hindustan Times)

The Kendriya Vidyalaya Sanghathan has decided to patent the new school uniforms that it will introduce for Class 1 students across the country with effect from the current academic session. More...



European Union rejects anti counterfeiting law
(Rupali Mukherjee , 04-Jul-2012 , The Times Of India)

The European Parliament on Wednesday rejected the anti counterfeiting trade agreement which if passed would have limited the access of legitimate generic medicines exported from developing countries like India. More...



Apples request to ban HTC smartphones rejected
(Reuters , 4-Jul-2012 , The Times Of India)

A US trade panel has turned down Apples request to immediately ban some HTC smartphones from being imported into the United States because of accusations that they infringe on an Apple patent. More...



Apple suffers UK patent defeat to HTC over technology used in mobile tools
(Reuters , 04-Jul-2012 , The Economic Times)

Taiwans HTC on Wednesday won a London court ruling against U.S. tech giant Apple Inc over a series of patent infringement claims linked to technology used in its mobile devices. More...



Kochiite patents six-stroke engine
(Special Correspondent , 4-Jul-2012 , The Hindu)

Anil Cleetus Chanayil a city based motor mechanic-turned-engine designer has won an Indian patent for designing a six-stroke engine which he says will be easy on the environment and light on the bike user s pocket. More...



Samsung Galaxy Nexus sales ban to continue
(Reuters , 4-Jul-2012 , The Times Of India)

A US judge on Tuesday rejected a request by Samsung Electronics to lift a pre-trial injunction against sales of its Galaxy Nexus phone another legal setback for the South Korean firm ahead of an upcoming court battle with Apple. More...



Kodak wins patent fight with Apple
(AFP , 03-Jul-2012 , The Times Of India)

Beleaguered photography pioneer Kodak has said that a US bankruptcy court has approved its bid to auction off more than 1,100 patents despite objections by Apple and FlashPoint over a small number of them. More...



Pharma research to get Rs 2000-cr shot in arm
(Our Bureau , 03-Jul-2012 , Business Line)

The Commerce and Industry Minister Mr Anand Sharma said on Tuesday that his Ministry is actively considering a Rs 2000 crore venture capital fund to be used mostly to boost Research and Development in the pharmaceutical industry. More...



Apple pays $60m to settle iPad patent row
(Saibal Dasgupta , 3-Jul-2012 , The Times Of India)

Apple paid $60 million to settle a legal dispute with Chinese computer maker Shenzhen Proview Technology over the iPad trademark. More...



Govt to discuss FDI export barriers in pharma sector
(Arun S , 2-Jul-2012 , Business Line)

The fear is that takeovers of existing companies would increase the prices of many drugs and reduce generics off patent drug production. More...



Apple wins as Samsung loses bid to lift Galaxy Tab ban in US
(Reuters , 3-Jul-2012 , NDTV)

A U.S. judge on Monday rejected a request by Samsung Electronics Co. to lift a ban on U.S. sales of its Galaxy Tab 10.1 another setback for the South Korean firm in its tablet patent battle with iPad maker Apple Inc. More...



Healthcare industry is a rip-off
(Pradeep S Mehta , 2-Jul-2012 , Business Line)

The absence of regulatory oversight in the health industry needs urgent attention. More...



Indian simvastatin makers line up atorva products
(KV Ramana , 02-Jul-2012 , DNA)

Indian generic companies are realigning strategies in the US statin market with atorvastatin the top selling drug in the category going off patent. More...



USPTO official lambasts issuance of compulsory licensing by Indian patent office
(Ramesh Shankar, Mumbai , 2-Jul-2012 , Pharmabiz)

The first ever compulsory licensing issued by the Indian Patent Controller on March 9 2012 to an Indian generic company to manufacture generic version of Bayers cancer drug Nexavar has come in for severe criticism by the US Patent and Trademark Office. More...



Apple settles China iPad trademark dispute for $60 mln
(Reuters , 2-Jul-2012 , IBN Live)

Apple Inc has paid $60 million to Chinas Proview Technology to settle a dispute over the iPad trademark a Chinese provincial court said on Monday. More...



Author alleges copyright violation by US website
(TNN , 1-Jul-2012 , The Times Of India)

G Reghunath Pillai an inspector with Kerala Road Transport Corporation while penning a book on undesirable truths would not have dreamt that his creation would make him face one in the future. More...



Indian pharma firms prefer alliance pill for expansion
(Ujjval Jauhari & Ram Prasad Sahu / Mumbai , 01-Jul-2012 , Business Standard)

Marketing alliances in emerging markets continue to be at the heart of the expansion strategy of Indian generic players. More...



Drug patents expiry to give generic pharma market shot in arm
(PTI , 01-Jul-2012 , IBN Live)

The patent expiry of several major blockbuster drugs coupled with other factors will fuel growth of global generic pharmaceuticals market by 2017 research firm Frost & Sullivan said. More...



Patent licensing: Google unit under lens in US
(Reuters , 30-Jun-2012 , The Times Of India)

US antitrust regulators are investigating whether Google unit Motorola Mobility is living up to licensing commitments made when its patents were adopted as industry standards two people familiar with the probe said on Friday. More...



Pfizer takes Alembic to US court on drug patent
(BS Reporter / Ahmedabad , 30-Jun-2012 , Business Standard)

Pfizer the pharmaceutical giant has gone to a US court to stop or at least delay Gujarat based Alembic Pharmaceuticals from trying to sell a generic version of the formers anti depressant drug branded Pristiq. More...



Apple scores second courtroom win vs Samsung
(Reuters , 30-Jun-2012 , The Times Of India)

A US judge on Friday granted Apple Incs request for a pre trial injunction against the sale of Samsung Electronics Co Ltds Galaxy Nexus phone handing the iPhone maker its second legal victory against Samsung in a week. More...



Obamacare will be good for Indian pharma and IT
(Shishir Asthana / Mumbai , 29-Jun-2012 , Business Standard)

The US Supreme Court passed the landmark ruling dubbed Obamacare thereby upholding the controversial massive reform of health care coverage which was initiated by President Barack Obama. More...



Pfizer complains against Zydus on US patent violation
(Sohini Das / Ahmedabad , 29-Jun-2012 , Business Standard)

For the second time in a month a complaint of infringement of patent has been filed against Zydus Pharmaceuticals a wholly owned subsidiary of Ahmedabad based pharma major Cadila Health care at a US district court. More...



HC dismisses Sun Pharmas appeal on Acucal trademark
(Vishal Dutta , 28-Jun-2012 , The Economic Times)

Sun Pharmaceuticals appeal in a trademark suit seeking injunction against Ahmedabad based West Coast Pharmaceuticals Ltd has been dismissed by the Gujarat High Court. More...



Qualcomm plans new subsidiary to guard patents
(Reuters , 28-Jun-2012 , The Times Of India)

Cellphone chip supplier Qualcomm plans to spin off its research and development activities and its product and services businesses into a wholly owned unit to better protect its patent portfolio. More...



Delhi HC restrains Indian firm from using trademark Maersk
(Soibam Rocky Singh , 28-Jun-2012 , Law et al News)

The Delhi High Court has restrained an Indian mining and exploration firm from using the word Maersk as part of its corporate name on a plea filed by Danish business conglomerate AP Moller Maersk A/S claiming exclusive right over the service mark. More...



Indian pharma eyes US generic gold rush
(Sushmi Dey / New Delhi , 27-Jun-2012 , Business Standard)

Bulk drug filings from Indian cos in US have increased significantly. More...



Court bans Samsung Galaxy Tab 10.1 sales in US
(Reuters , 27-Jun-2012 , The Times Of India)

A US judge on Tuesday granted Apples bid to stop Samsung Electronics from selling its Galaxy Tab 10.1 tablet in the United States giving the iPhone maker a significant win in the global smartphone and tablet patent wars. More...



Indian scientist gets U.S. patent for cancer treatment
(M. Sai Gopal , 27-Jun-2012 , The Hindu)

Nano particle carries anti cancer drug and releases it only in the cancerous cell. More...



India to talk retail FDI at EU free-trade meet
(Neeraj Thakur , 26-Jun-2012 , DNA)

India is taking an aggressive stance in the free trade agreement negotiations with the European Union. More...



Natco, Mylan to appeal against New York district court verdict
(Deepika Amirapu , 25-Jun-2012 , The Economic Times)

Indias Natco Pharma and USAs Mylan are considering to appeal against the judgement by a district court in New York that dealt the two companies a severe blow denying them permission to make a me too version of generic giant Teva Pharmaceuticals Copaxone. More...



Natco loses patent case against Teva of anti sclerosis drug
(Press Trust of India / Hyderabad , 25-Jun-2012 , Business Standard)

Natco Pharma Ltd has lost a patent litigation against Israels Teva Pharmaceutical Industries Ltd in the US over multiple sclerosis treatment drug Copaxone. More...



Now GTU to train its students on filing patent applications
(Bharat Yagnik , 25-Jun-2012 , The Times Of India)

After successful completion a five different training session on Patenting in Engineering and Patenting in pharmaceuti cals at different places in the state the GTU has decided to train its students on how to file application for patents. More...



India Brazil & China defend generic drugs at WTO
(Amiti Sen , 25-Jun-2012 , The Economics Times)

India Brazil and China have defended the right of poor countries to access cheap generic medicines at the World Trade Organisation resisting attempts by the US Japan and some other developed countries to club counterfeits or copies of patented drugs with fake or spurious ones. More...



Teva shares jump on positive Copaxone patent ruling
(Reuters / By Steven Scheer , 24-Jun-2012 , Business Standard)

Teva Pharmaceutical Industries rose more than 11 percent on Sunday after a U.S. court upheld Tevas patents for multiple sclerosis drug Copaxone well into 2015. More...



India EU to take stock of proposed free trade pact on Tuesday
(PTI , 24-Jun-2012 , Business Standard)

India and EU are scheduled to take stock of the much delayed negotiations on the proposed free trade agreement at a meeting here on Tuesday. More...



Apples patent case against Motorola dismissed
(Reuters , 23-Jun-2012 , The Times Of India)

A US judge on Friday ruled that Apple cannot pursue an injunction against Googles Motorola Mobility unit effectively ending a key case for the iPhone maker in the smartphone patent wars. More...



Teva Patents Are Infringed in Sandoz Mylan Patent Suit
(Joel Rosenblatt , 23-Jun-2012 , Bloomberg)

Patent claims that Teva Pharmaceutical Industries Ltd. brought against Novartis AGs Sandoz unit Mylan Inc. and Momenta Pharmaceuticals Inc. are infringed valid and enforceable a federal judge ruled. More...



Apple filing could delay Kodak patent sale
(Jonathan Stempel REUTERS , 22-Jun-2012 , IBN Live)

Apple Inc on Thursday asked a federal judge to move a lawsuit against it by Eastman Kodak Co to a new court which could derail the photography pioneers plan to quickly sell a large patent portfolio through the bankruptcy process. More...



Jay Z in copyright lawsuit
(IANS , 21-Jun-2012 , The Times Of India)

Singer Jay Z has been sued for copyright infringement. More...



Patent war: Apple told to pay damages to Samsung
(Reuters , 21-Jun-2012 , The Times Of India)

A Dutch court ordered Apple to pay damages to Samsung Electronics Ltd over a patent violation in the Netherlands the latest twist in the global legal battle waged by the two rival phone and computer makers. More...



Microsoft rejects Motorolas patent offer
(Reuters , 21-Jun-2012 , The Times Of India)

Microsoft has brushed off an offer by Motorola the phone maker bought by Google to settle patent disputes with Motorola that are threatening to halt imports of Android devices and Xbox game consoles into the United States. More...



Big pharma firms may learn to live with compulsory licensing
(C.H. Unnikrishnan , 21-Jun-2012 , Livemint)

Taking a cue from India countries have initiated changes in patent laws to lower healthcare costs say experts. More...



Apple grilled in Google smartphone patent case
(Reuters , 21-Jun-2012 , The Times Of India)

A US judge on Wednesday strongly questioned Apples bid for an injunction against Googles Motorola Mobility unit as the iPhone maker tries to salvage its position on a key front in the smartphone patent wars. More...



Microsoft demurs at Motorola patent settlement offer
(Reuters , 21-Jun-2012 , NDTV)

Microsoft Corp has brushed off an offer by Motorola the phone maker bought by Google Inc to settle patent disputes with Motorola that are threatening to halt imports of Android devices and Xbox game consoles into the United States. More...



Court reserves order against Bhandarkar in copyright case
(IANS , 20-Jun-2012 , The Times Of India)

A Delhi court has reserved its order for June 27 on an authors plea for lodging a first information report against Bollywood filmmaker Madhur Bhandarkar for copying the plot of his 2008 film Fashion from her book. More...



Indian drug outlook favourable: ICRA & Moodys
(Ashwin Walunjkar , 20-Jun-2012 , The Economic Times)

Outlook on the Indian pharmaceutical industry remains favourable says ICRA & Moody report released on Wednesday More...



Patent war: Apple-Google lawsuit hearing to begin today
(Reuters , 20-Jun-2012 , The Times Of India)

Apple will try to salvage a high profile lawsuit against Googles Motorola Mobility unit on Wednesday at a crucial hearing in the smartphone patent wars between the two tech companies. More...



Apple Inc to pay damages to Samsung Electronics over patent violation
(AFP , 20-Jun-2012 , The Economic Times)

A Dutch court ordered Apple Inc to pay damages to Samsung Electronics Co Ltd over a patent violation in the Netherlands the latest twist in the global legal battle waged by the two rival phone and computer makers. More...



Kodak sues Apple for interfering in patent sales
(Reuters , 20-Jun-2012 , The Times Of India)

Photography pioneer Eastman Kodak sued Apple to stop it from interfering with plans to sell a large patent portfolio a significant part of its bankruptcy restructuring. More...



Venus Remedies up 38% on winning US patent
(SI Reporter / Mumbai , 19-Jun-2012 , Business Standard)

The company has received patent from the US Patent Office for new antibiotic product CSE 1034 which targets drug resistant infections. More...



Intel to buy InterDigital patents for $375 million
(Reuters , 19-Jun-2012 , The Times Of India)

InterDigital said on Monday it had agreed to sell to Intel about 1700 wireless technology patents for $375 million sending InterDigital shares up 29 percent. More...



Intel to buy InterDigital patents for $375 million
(Reuters , 19-Jun-2012 , IBN Live)

InterDigital Inc said on Monday it had agreed to sell to Intel Corp about 1,700 wireless technology patents for $375 million sending InterDigital shares up 27 per cent. More...



We will look at inorganic growth wherever there's a strategic fit
(Sushmi Dey / New Delhi , 18-Jun-2012 , Business Standard)

At a time when most domestic drug companies are looking West in the wake of the number of patents expiring there Lupin Ltd the Mumbai based transnational drug maker is eyeing a big pie of the Indian market along with its continued growth strategy in America. More...



Ethnic variety on display
(Special Correspondent , 18-Jun-2012 , The Hindu)

The geographical indication received by the handloom products of Kasaragod Balaramapuram Chendamangalam and Palakkad have given a boost to the efforts of the institute. More...



Alembic settles patent dispute with Novartis
(BS Reporter / Mumbai/ Ahmedabad , 16-Jun-2012 , Business Standard)

Vadodara based pharmaceuticals products maker Alembic Pharmaceuticals Ltd along with a US based Breckenridge Pharmaceutical Inc has settled a patent dispute with Novartis AG regarding Rivastigmine Tartrate Capsules a generic version of Exelon. More...



India, Brazil to set up industry-level working group to sort out hurdles faced by pharma exporters
(Joseph Alexander, New Delhi , 16-Jun-2012 , Pharmabiz)

Commerce Minister stressed that the provision in TRIPs of invoking the route of compulsory licensing for making available cheaper drugs though introduced at the behest of developing countries was in fact used more often by developed countries. More...



Apple Motorola patent lawsuit revived by US judge
(Reuters , 15-Jun-2012 , The Times Of India)

A US judge has agreed to hear Apples request for an injunction against the sale of some Motorola phones giving the iPhone maker a chance to head off a damaging ruling in the smartphone patent wars. More...



Alembic settles patent case with Novartis for generic capsules
(Press Trust of India , 15-Jun-2012 , Business Line)

Alembic Pharmaceuticals on Friday said it along with US Breckenridge Pharmaceutical Inc has settled patent case with Novartis for Rivastigmine Tartrate capsules used for treating dementia. More...



India cites WTO accord on drugs patent waiver
(Sidhartha , 15-Jun-2012 , The Times Of India)

India has responded aggressively to protests from developed countries such as the United States over waiving patent rights on a cancer medicine manufactured by Bayer and Hyderabad based Natco Pharma to sell the drug at a lower cost. More...



Apple patent bid hints at changeable iPhone lens
(Agence France-Presse , 15-Jun-2012 , NDTV)

A US patent application made public on Thursday hinted that Apple may be toying with the idea of letting picture loving iPhone users change lenses for the smartphone cameras. More...



Indian drug firms want norms eased in Brazil
(Sidhartha , 14-Jun-2012 , The Times Of India)

The Indian government and pharmaceutical companies have made a strong pitch for easing f norms in Brazil arguing that they are slow and hamper access to the local market. More...



No WTO violation by issuing licence for Nexavar: Sharma
(Press Trust of India / Sao Paulo , 14-Jun-2012 , Business Standard)

Natco Pharma was allowed to sell the cancer treatment drug at a price 30 times lower than charged by patent holder Bayer Corp. More...



Apple bid to block Samsung Galaxy SIII in US stalled
(AFP , 14-Jun-2012 , The Economic Times)

Apples effort to stop South Koreas Samsung from launching its newest iPhone challenger in the US has been derailed by complex maneuvering in the patent war between the companies. More...



China breaks patent barriers on drugs
(Subodh Varma , 14-Jun-2012 , The Times Of India)

In a move full of intriguing possibilities China has changed its patent laws to allow domestic drug makers to manufacture patent protected drugs in case of state emergencies unusual circumstances or in the interests of the public. More...



HTC blocked from using Google patents in Apple dispute
(ANI , 13-Jun-2012 , Zee News)

Taiwanese manufacturer of smartphones and tablets HTC has been blocked from using five patents it secured from Google last year to sue tech giant Apple according to a report. More...



Compulsory pharma licensing, the Indian case of Natco vs Bayer, and the South African context
(Adams & Adams , 13-Jun-2012 , Biz Community)

Indias controller of patents granted the countrys first compulsory licence in the case of Natco Pharma Limited vs Bayer Corporation. More...



Indian companies eye $1billion generic opportunity
(Rupali Mukherjee , 13-Jun-2012 , The Times Of India)

In the wake of patent expiries on three blockbuster drugs over the last six seven months an opportunity worth nearly $1.3 billion is up for grabs for domestic generic players. More...



See what is hurting Apple in smartphone wars
(Reuters , 13-Jun-2012 , The Times Of India)

Apple has spent nearly three years fighting its rivals in a global smartphone patent war. More...



US firm sues Zydus Cadila subsidary for infringement of patents
(BS Reporter / Mumbai/ Ahmedabad , 12-Jun-2012 , Business Standard)

A complaint for infringement of patents with regard to drug for treatment of acne has been filed against Zydus Pharmaceuticals USA Inc a fully owned subsidiary of Ahmedabad based pharma major Cadila Healthcare Ltd in a district court of US. More...



Kodak files for auction of digital imaging patents
(Reuters , 12-Jun-2012 , The Times Of India)

Eastman Kodak filed a motion on Monday seeking approval of bidding procedures for bankruptcy auction of its digital capture and Kodak imaging systems and services patent portfolios which together comprise more than 1100 patents. More...



Venus Remedies gets US patent for antibiotic product
(PTI , 12-Jun-2012 , Business Line)

Drug firm Venus Remedies today said it has received patent from the US Patent Office for new antibiotic product which targets drug resistant infections. More...



TCS ups patent filing; applies for 460 last year
(T.E. Raja Simhan , 11-Jun-2012 , Business Standard)

Tata Consultancy Services has significantly increased its patent filings in 2011-12. More...



Pharma companies need aggressive R&D and patent filing: Experts
(PTI , 11-Jun-2012 , The Economic Times)

Indian pharmaceutical companies need to go for aggressive research and patent filing like China and Japan and unless spending on R&D is scaled up it would be difficult to create new molecules industry experts said. More...



Apples war with Google heats up
(Poornima Gupta , 11-Jun-2012 , Livemint)

When Apple Inc. kicks off its annual conference for software developers on Monday all the power players in the Apple universe will be on hand save the one that is in many ways driving the agenda: Google Inc. More...



US body to bring out drug reference standards for biologics
(G. Naga Sridhar , 10-Jun-2012 , Business Line)

The United States Pharmacopeial Convention is working on developing reference standards for biologics an emerging class of drugs. More...



Copyright amendment: bad, but could have been much worse
(Sunil Abraham , 10-Jun-2012 , Business standard)

When the Copyright Act 2012 was passed unanimously by the Lok Sabha on May 22 it meant that there was little reason for celebration some not so great news and a lot of pretty bad news. More...



Action on Nexavar does not violate any treaty: Anand Sharma
(PTI , 9-Jun-2012 , The Hindu)

India on Friday said it had not violated any multi-lateral trade agreement by issuing compulsory licence for patented anti cancer drug Nexavar to be produced and sold at a much cheaper cost in the country. More...



Animal health product: Cipla looking at appeal options against US court order
(Our Bureau , 9-Jun-2012 , Business Line)

Cipla is examining options of appealing against a US Federal Circuit order in a patent infringement case involving the sale of an animal health product. More...



Cipla losses appeal in US court for animal healthcare product
(Reuters , 8-Jun-2012 , Business Standard)

Drugmaker Cipla said on Thursday a US appeals court had upheld a district courts ruling which last year declared a patent infringement by Cipla over animal healthcare drug PetArmor Plus. More...



Apple may block Samsung Galaxy SIII sales in US
(Reuters , 08-Jun-2012 , The Times Of India)

Samsung attorney William Price also said the technology covered by Apples patents such as auto correcting typed text are not responsible for sales of Galaxy phones. More...



US judge cancels Apple-Google phone patent trial
(Reuters , 08-Jun-2012 , The Economic Times)

A federal judge canceled a scheduled June 11 trial between Apple Inc and Google Incs Motorola Mobility unit over patents related to mobile phones and tablet computers and expects to dismiss the case because neither can prove damages. More...



GSK Pharmas pricing strategy may not extend to alliance products
(BUSINESS LINE , 08-Jun-2012 , Myiris)

Two years ago British drug-maker GlaxoSmithKlins Chief Executive Andrew Witty had told an Indian audience in Nashik the company would pursue customised pricing of its medicines in middle and low income countries. More...



China amends patent law in fight for cheaper drugs
(Tan Ee Lyn in Hong Kong and Beijing, Ben Hirschler in London , 08-Jun-2012 , CNBC)

China has overhauled parts of its intellectual property laws to allow its drugmakers to make cheap copies of medicines still under patent protection in a move likely to unnerve foreign pharmaceutical companies. More...



Dr. Reddys inks drug deal with Merck Serono
(Viswanath Pilla , 7-Jun-2012 , Livemint)

Merck will handle commercialisation in most parts of the world and will pay Dr. Reddy’s royalties More...



Column: Relevance of changes in Indian copyright law
(Pavan Duggal / New Delhi , 06-Jun-2012 , Business Standard)

Copyright (Amendment) Bill 2010 seeks to provide lyricists & artists a level playing field with respect to music companies and producers. More...



Pfizer job cuts highlight Irish exposure to patent expiries
(Conor Humphries , 06-Jun-2012 , Reuters)

Pfizer Inc will cut 177 jobs in Ireland following the expiration of patents on blockbuster cholesterol drug Lipitor highlighting the exposure of Irelands export driven economy to the patent cliff facing many in the pharmaceutical sector. More...



EMC will file 100 patents from India by next year
(Beryl Menezes , 6-Jun-2012 , DNA)

EMC a global IT storage solutions provider is betting big on the Indian data market and has invested $2 billion in the six years of its operations in the country which is the largest investment by an IT multi national company in India. More...



A mission to defend traditional knowledge
(Sidhartha , 5-Jun-2012 , The Time Of India)

In a few weeks negotiators from the group of like minded countries such as India Columbia Peru and New Zealand will converge on Bali to decide on what traditional knowledge is. More...



Domestic pharma industry: Emerging growth avenues
(Rupali Mukherjee , 04-Jun-2012 , The Times Of India)

The domestic pharma industry may maintain a strong growth momentum spurred by patent expiries of blockbuster drugs emerging licensing deals and increasing generic penetration in regulated markets over the next two three years. More...



In search of the right drug pricing formula
(NALINAKANTHI V. , 04-Jun-2012 , Business Line)

The government can make drugs affordable to all without forcing the pharma companies to compromise either on quality or their profitability. More...



WHO will set generics apart from counterfeits
(Vineeta Pandey , 04-Jun-2012 , DNA)

World Health Organisation has adopted a resolution to clearly define counterfeit medical products so as to set them apart from genuine generic drugs. More...



Is Sun Pharma getting back on the acquisition track?
(Mark to Market | Ravi Ananthanarayanan , 04-Jun-2012 , Livemint)

If Sun Pharmas base business gets a boost from successful patent challenges and litigation that would be a plus. More...



Updating our copyright laws
(04-Jun-2012 , The Hindu)

Public discourse on the omnibus copyright law changes approved by Parliament last month has largely focused on the controversy in the film industry over the provision that gives music composers and lyricists the right to claim royalties if their music is used in any other form a ring tone for example apart from the film for which the composition was made and sold. More...



Cisco sues TiVo over DVRs
(Reuters , 04-Jun-2012 , NDTV)

Cisco Systems Inc has filed a lawsuit to void four TiVo Inc patents related to digital video recorders escalating a battle over who has the right to profit from sales of the popular machines. More...



Judge won't bar Steve Jobs quotes from patent trial
(Dan Levine SAN FRANCISCO (Reuters) , 2-Jun-2012 , IBN Live)

Steve Jobs gave a lot of juicy quotes before he died and Apple Inc has failed to keep some of them out of an upcoming patent trial against Googles Motorola Mobility unit according to a court ruling. More...



Steve Jobs quotes set to feature in Apple-Motorola patent trial
(Reuters , 3-Jun-2012 , NDTV)

Steve Jobs gave a lot of juicy quotes before he died and Apple Inc has failed to keep some of them out of an upcoming patent trial against Googles Motorola Mobility unit according to a court ruling. More...



Nokia hits back at Google in latest patent war tussle
(Reuters , 2-Jun-2012 , IBN Live)

Nokia struck back at Google on Friday over its accusation that the cellphone maker was colluding with Microsoft to make money out of their patents. More...



Patents: A prize for inventors will help
(S.MURLIDHARAN , 01-Jun-2012 , Business Line)

A potentially game changing idea is that if an inventor is rewarded with a huge cash award upfront in exchange for his invention becoming available immediately for public use unseemly patent battles waged across continents will be a thing of past. More...



Nokia: Android phones have major patent issues
(Reuters , 01-Jun-2012 , The Times of India)

Nokia struck back at Google over its accusation that the cellphone maker was colluding with Microsoft to make money out of their patents. More...



Google files patent claim against Microsoft Nokia
(AP , 01-Jun-2012 , Hindustan Times)

Google Inc on Thursday accused Microsoft Corp and Nokia of conspiring to use their patents against smartphone industry rivals and said it has filed a formal complaint with the European Commission. More...



Patent wars: French co Technicolor dissects smartphones
(Bloomberg , 31-May-2012 , The Times Of India)

When Apples next iPhone hits store shelves Technicolor SAs engineers will rush to get the handset not to make calls or play games but to rip it apart. More...



Apple-Samsung trials seen solving copycat spat CEOs couldn’t
(Bloomberg , 31-May-2012 , The Times Of India)

Apple and Samsung Electronics the worlds top two smartphone makers are heading to trials that may resolve global patent disputes their chief executive officers couldnt settle on their own. More...



How P H Kurien took on global patents system to make very costly drug affordable for poor
(Arvind Panagariya , 30-May-2012 , The Economic Times)

It is said that only God and a few good men and women run India. More...



HTC phones pass US customs review
(Reuters , 30-May-2012 , The Times Of India)

Earlier in May HTC had said that US sales of two new smartphones the HTC One X and HTC EVO 4G LTE would be delayed due to a requirement for customs inspections after the Taiwanese company lost a patent dispute with Apple. More...



Technicolor dissects iPhones in hunt for patent payoff
(Bloomberg / Paris , 30-May-2012 , Business Standard)

When Apple Incs next iPhone hits store shelves Technicolors engineers will rush to get the handset not to make calls or play games but to rip it apart. More...



Patent law together with IPR imperative for a democratic market based society
(29-May-2012 , IRIS)

A patent law along with an intellectual property law in various categories of copyright trademark right of publicity and others are imperative for shaping an open democratic and market based society corporate affairs minister Dr M Veerappa Moily said while highlighting the importance of a patent system in a democracy at an Assocham event held here in New Delhi today. More...



Teva Pharmaceuticals not to launch Atorvastatin, generic version of Lipitor
(Khomba Singh , 29-May-2012 , The Economic Times)

Israels Teva Pharmaceuticals will not launch atorvastatin the generic version of the worlds best selling drug Lipitor that will help Indian companies Ranbaxy Laboratories and Dr Reddys Laboratories garner larger sales of the medicine in the US.